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Summary 
 Our laboratory has been interested in the development of new 
methodologies and their application to total syntheses of natural products 
for many years. In this context, this work started with an investigation on a 
new polycyclization methodology targeting indole manzamine 1.001 
(Scheme 1). 
 
Scheme 1: Indole manzamine 
 On our endeavour toward the polycyclization precursor, many issues 
were encountered and were successfully solved. Besides this, the first 
precursor 4.092 was obtained after 8 steps from indole 3.025 (Scheme 2). 
 
Scheme 2: Synthesis of Z-ene-dione 4.092 
 The polycyclization attempts of 4.092 were unsuccessful so far in the 
presence of organic bases, strong bases and Lewis acids and regrettably, no 
tetracycle 4.094 were observed (Scheme 3). 
 
Scheme 3: Polycyclization attempts 
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 The reaction and precursors were redesigned and modified towards 
ynone derivatives. Three different substrates were synthetized 5.017, 6.006 
and 6.042 using simple synthetic steps from indole or tryptamine (Scheme 
4). 
 
Scheme 4: Ynone precursors 
 New polycyclization conditions were found and optimized to turn 
5.017 into one single diastereoisomer of compound 5.049. The same 
conditions were ineffective on 6.006 and 6.042 and some mechanistical 
analyses were made to understand the difference between those 
compounds (Scheme 5).  
 
Scheme 5: Polycyclization of ynone 
 To increase the scope of the methodology, some tests were 
performed on other substrates such as E-enone 6.059 and 6.067 or Z-enone 
7.033, 7.036 and 7.022 (Scheme 6). 
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Scheme 6: E-enones and Z-enones 
New scaffolds 3.037, 7.045, 7.047, 7.030 and 7.011 were obtained, 
using the developed polycyclization conditions. Different mechanisms were 
proposed to explain the diastereoselectivities of those transformations 
(Scheme 7). 
 
Scheme 7: Polycyclizations of new precursors 
 Finally, one of the main objectives of this thesis was to create a 
library of compounds that should be submitted to biological testing. To do 
so, diastereocontroled derivatizations were performed on the described 
tetracycles 5.049 and 3.037. Among the new products, ketone 8.012 embeds 
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the desired stereochemistry in its backbone, similar to the one of 1.001. The 
rest of the library offers a wide panel of scaffolds such as 8.014, 8.015, 8.018, 
8.022, 8.024 (Scheme 8). 
 
Scheme 8: Diastereocontrolled derivatisation 
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Résumé 
 Depuis des années, notre laboratoire s’est intéressé au 
développement de méthodologies ainsi qu’à leur application en synthèse 
totale de produit naturel. C’est dans cette optique de travail que démarre ce 
projet sur le développement d’une nouvelle méthode de polycyclisation pour 
atteindre le dérivé manzamine indolique 1.001 (Schéma 1). 
 
Schéma 1: Manzamine indolique 
 En chemin pour le premier précurseur de polycyclisation différents 
problèmes synthétique ont été rencontré et surmonté. Pour amener à une 
synthèse assez rapide du précurseur 4.092 en 8 étapes au départ d’indole 
3.025 (Schéma 2Scheme 2). 
 
Schéma 2: Synthèse de Z-éne-dione 4.092 
 Les tests de polycyclisation ont été infructueux dans l’obtention d’un 
tetracycle de type 4.094 en utilisant des bases fortes ou des acides de Lewis 
(Schéma 3). 
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Schéma 3: Tentatives de polycyclisation 
 Une reconsidération de la réaction et des précurseurs a été effectuée 
pour valoriser et essayer les dérivés de type ynone. Trois de ces composés 
ont été synthétisés 5.017, 6.006 and 6.042 au départ d’indole ou de 
tryptamine (Schéma 4). 
 
Schéma 4: Précurseurs ynone 
 De nouvelles conditions de polycyclisation ont été découverte et 
optimisée pour transformer 5.017 dans le tétracycle 5.049 de façon 
diastéréocontrollée. Les mêmes conditions ont été inefficace sur les deux 
autres substrats 6.006 et 6.042. Différentes hypothèses mécanistiques ont 
été proposées pour expliquer cette modification de réactivité (Schéma 5).  
 
Schéma 5: Polycyclisation d’ynone 
 Pour améliorer la compréhension de notre méthodologie, plusieurs 
tests ont été effectués sur d’autres substrats parmi lesquels, E-enone 6.059 
et 6.067 ou encore Z-enone 7.033, 7.036 et 7.022 (Schéma 6). 
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Schéma 6: E-enones et Z-enones 
De nouvelles structures ont été obtenues grâce aux conditions de 
polycyclisation 3.037, 7.045, 7.047, 7.030 et 7.011. Plusieurs mécanismes ont 
été proposés pour expliquer la différence de diastéréosélectivité de ces 
réactions (Schéma 7). 
 
Schéma 7: Polycyclisation des nouveaux précurseurs 
 L’un des objectifs principaux de ce projet était la création d’une 
bibliothèque de composés pour tester les activités biologiques. Pour mettre 
en place ceci, nous avons eu recours à différente méthodes de 
dérivatisations diastéréocontrollées à partir des tétracycles 5.049 et 3.037. 
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Parmi les nouveaux produits, on peut trouver la cétone 8.012 qui possède les 
quatre centres stéréogéniques requis. Les restes de la bibliothèque offre un 
panel varié de structures tel que 8.014, 8.015, 8.018, 8.022, 8.024 (Schéma 
8). 
 
Schéma 8: Dérivatisation diastéréocontrollée 
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Chapter I 
Manzamines Discovery and Bioactivities 
 
For decades, natural products chemists have been enthusiastic about 
complex molecules originating from marine organisms. Their remarkable 
structural features, properties and their scarcity make them very interesting 
and ambitious synthetic challenges for the scientific community. 
1. Discovery 
In 1986, Sakai and Higa discovered a new type of alkaloid inside the 
genus Haliclona marine sponge from Manzamo, next to Okinawa, Japan (136 
ppm from wet weight). The 3D structure of the hydrochloride salt of 
manzamine A 1.001 was resolved by Jefford and Bernardinelli using X-ray 
diffraction. 
 In the remarkable octa-cyclic structure were embedded fragments 
such as beta-carboline (in red), an octahydroisoquinoline central core (in 
blue) and a thirteen membered ring (in blue and black). On top of that, the 
fearsome natural product encompassed a hexahydroazocine (in pink) and a 
pyrrolidine. Further structural complexity was introduced via a tertiary 
alcohol, five chiral centres and three unsaturations (Scheme 1).1 
                                                          
1 Sakai, R.; Higa, T.; Jefford, C. W.; Bernardinelli, G. J. Am. Chem. Soc. 1986, 108, 6404. 
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Scheme 1: Manzamine A 
Furthermore, this new compound exhibited many interesting 
bioactivities (see page 15). Therefore, interest was initiated in many 
synthetic and natural products groups. Only one year after its initial discovery 
the same group revealed three new scaffolds in the same genus of sponge: 
manzamine B 1.002 (16 ppm from wet weight), manzamine C 1.003 (11 ppm 
from wet weight) and manzamine D 1.004 (Scheme 2).2 
 
Scheme 2: Manzamine B, C, D 
 Like manzamine A 1.001, those new molecules 1.002, 1.003, 1.004 
possess various bioactivities. However, their scaffold was slightly different 
from 1.001: 
                                                          
2 Sakai, R.; Kohmoto, S.; Higa, T.; Jefford, C. W.; Bernardinelli, G. Tetrahedron Lett. 
1987, 28, 5493. 
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 Manzamine B 1.002 own an eleven membered ring at the bottom, an 
epoxide at the central core and six chiral centres instead of five. 
 Manzamine C 1.003 is a carboline with an eleven membered ring but 
does not possess the fused ring complexity of manzamine A 1.001 or B 1.002. 
 Manzamine D 1.004 strongly resembles manzamine A 1.001, except 
for the oxidation state of the β-carboline which is a tryptoline derivative. 
 In 1987, Jun’ichi Kobayashi et al. found similar products in genus 
Pellina marine sponge; keramamine A 1.005 (260 ppm from wet weight) and 
keramamine B 1.006 (480 ppm from wet weight) (Scheme 3).3 
 
Scheme 3: Keramamine A and B 
 In 1988, Higa et al. discovered new compounds in the genus 
Xestospongia. This new publication acted as an erratum for keramamines A 
1.005 and B 1.006, which were proven to be, respectively, manzamine A 
1.001 and manzamine F 1.008 (18 ppm from wet weight). Manzamine E 
1.007 (5 ppm from wet weight) was also reported (Scheme 4).4 
                                                          
3 Nakamura, H.; Deng, S.; Kobayashi, J.; Ohizumi, Y.; Tomotake Y.; Matsuzaki, T.; 
Hirata, Y. Tetrahedron Lett. 1987, 28, 621. 
4 Ichiba, T.; Sakai, R.; Kohmoto, S.; Saucy, G.; Higa, T. Tetrahedron Lett. 1988, 29, 
3083. 
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Scheme 4: Manzamines E and F 
 Manzamine E 1.007 is an oxidized version of manzamine A 1.001 with 
an azocinone moiety instead of an azocine.  
 Manzamine F 1.008 is an oxidized version of manzamine E 1.007 with 
a modified β-carboline. 
In 1992, Kobayashi et al. isolated four new molecules from the genus 
Ircinia: manzamine H 1.009 (7 ppm from wet weight), manzamine J 1.010 (22 
ppm from wet weight), ircinal A 1.011 (57 ppm from wet weight), ircinal B 
1.012 (20 ppm from wet weight). The detection of 1.009 and 1.010 tends to 
prove that there are two classes of manzamines, the first is designed on 
manzamine A 1.001 (including manzamines D, E, F which possess a fused 
pyrrolidine-azocine ring) and the other on manzamine B 1.002 (including 
manzamines H, J which possess a 11-membered ring) (Scheme 5).5 
 
                                                          
5 Kondo, K.; Shigemori, H.; Kikuchi, Y.; Ishibashi, M.; Sasaki, T.; Kobayashi, J. J. Org. 
Chem. 1992, 57, 2480. 
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Scheme 5: Manzamines H and J, ircinals A and B 
 As new features, ircinal A 1.011 and B 1.012 are interesting and 
probably biosynthetic precursors of manzamines. Kobayashi et al. brought to 
light this possibility with a Pictet-Spengler reaction from ircinal A 1.011 to 
manzamine D 1.004 then oxidation with DDQ to obtain manzamine A 1.001. 
The same experiment was conducted from ircinal B 1.012 to manzamine J 
1.010 (Scheme 6). 
 
Scheme 6: Pictet-Spengler and oxidation towards manzamine A 
 In 1994, different groups observed new β-carboline modifications in 
manzamine such as 1.014 (1700 ppm from wet weight), manzamine G 1.015 
(3000 ppm from wet weight) and 1.016. They were found in the genera 
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Pachypellina, Petrosia and Cribochalina (manzamine G 1.015 was referred as 
8-hydroxy-manzamine A) (Scheme 7).6 
 
Scheme 7: Manzamine G, and other derivatives 
 Also, in 1994, Jun’ichi Kobayashi et al. extracted ircinol A 1.017 and 
ircinol B 1.018 from marine sponge Amphimedon. Surprisingly, they are 
enantiomers of the standard scaffold of ircinal A 1.011 (40 ppm from wet 
weight) and B 1.012 (3 ppm from wet weight) from the genus Ircinia (Scheme 
8).7 
 
Scheme 8: Ircinols A and B 
 In 1995, Isao Kitagawa et al. found manzamine X 1.019 (2 ppm in wet 
weight) and manzamine Y 1.020 (2 ppm in wet weight) in marine sponges of 
the genera Xestospongia and Haliclona. Manzamine X 1.019 exhibits a new 
feature since the eight membered ring contains an ether bridge while the 
                                                          
6 (a) Ichiba, T.; Corgiat, J. M.; Scheuer, P. J. J. Nat. Prod. 1994, 57, 168. (b) Crews, P.; 
Cheng, X. C.; Adamczeski, M.; Rodriguez, J.; Jaspars, M.; Schmitz, F. J.; Traeger, S. C.; 
Pordesimo, E. O. Tetrahedron, 1994, 50, 13567. 
7 Tsuda, M.; Kawasaki, N.; Kobayashi, J. Tetrahedron, 1994, 50, 7957. 
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manzamine Y 1.020 is an oxidized version of manzamine A 1.001 (Scheme 
9).8  
 
Scheme 9: Manzamines X and Y 
 The complexity encountered in the manzamine family culminates 
with kauluamine9 1.021 (760 ppm from dry weight inside Prianos sp.) and 
neo-kauluamine 1.022 (48 ppm from wet weight inside Prianos sp.)10 (10 
ppm from wet weight inside Acanthostrongylophora sp.).11 Both are dimers 
of manzamines, kauluamine 1.021 possesses two manzamine B 1.002 
scaffolds with a total of 14 chiral centres, 14 cycles including two 13-
membered rings and two 11-membered rings. One of the 13-membered 
rings was established to be antipodal at C12’ from the classic manzamine 
core. Neo-kauluamine 1.022 is based on manzamine A 1.001 skeleton with a 
total of 14 chiral centres, 17 cycles including two 13-membered rings, one 
11-membered ring and two 8-membered rings (Scheme 10). 
                                                          
8 Kobayashi, M.; Chen, Y. J.; Aoki, S.; In, Y.; Ishida, T.; Kitagawa, I. Tetrahedron, 1995, 
51, 3727. 
9 Ohtani, I. I.; Ichiba, T.; Isobe, M.; Kelly-Borges, M.; Scheuer, P. J. J. Am. Chem. Soc. 
1995, 117, 10743. 
10 El-Sayed, K. A.; Kelly, M.; Kara, U. A. K.; Ang, K. K. H.; Katsuyama, I.; Dunbar, D. C.; 
Khan, A. A.; Hamann, M. T. J. Am. Chem. Soc. 2001, 123, 1804. 
11  El-Desoky, A. H.; Kato, H.; Eguchi, K.; Kawabata, T.; Fujiwara, Y.; Losung, F.; 
Mangindaan, R. E. P.; de Voogd, N. J.; Takeya, M.; Yokosawa, H.; Tsukamoto, S. J. Nat. 
Prod. 2014, 77, 1536. 
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Scheme 10: Kauluamine and neo-kauluamine 
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2. Biosynthesis 
Through the years many groups have tried to elucidate the biological 
origin of manzamines. In 1992, Baldwin and Whitehead proposed a simple 
disconnection for the biosynthesis.12 Only four different units were required, 
tryptophan 1.023, an acrolein equivalent 1.024, ammonia 1.025 and 
dialdehyde 1.026. Applied on manzamine C 1.003 this protocol 
retrosynthetically required only reductive coupling of 1.026 with ammonia, 
followed by Michael addition and finally, a Pictet-Spengler like reaction to 
obtain this target 1.003 (Scheme 11). 
 
Scheme 11: Potential biosynthetic pathway for manzamine C 
The construction of the core of manzamine B 1.002 could be 
performed also from the same units. Deoxygenation of manzamine B 1.002 
followed by removal of tryptophan unit 1.023 leads back to an aldehyde 
1.028 retrosynthetically closed to the iminium salt 1.029. Redox exchange 
between the two piperidine rings of 1.029 give 1.030, which is immediately 
revealed as the Diels-Alder adduct of bis-dihydropyridine 1.031, a tautomer 
of the symmetrical species 1.032. In turn, 1.032 is revealed as the reductive 
coupling product of two equivalents of dialdehyde 1.026 and two equivalents 
of acrolein 1.024 with two molecules of ammonia. The full relative 
stereochemistry and connectivity of manzamine B 1.002 follows from the 
expected endo and regiochemical preference of the Diels-Alder step (Scheme 
12). 
                                                          
12 Baldwin, J. E.; Whitehead, R. C. Tetrahedron Lett. 1992, 33, 2059. 
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Scheme 12: Potential biosynthetic pathway for manzamine B 
Finally, manzamine A 1.001 is simply related to manzamine B 1.002 
by a trans-eliminative opening of the epoxide and allylic oxidation of a double 
bond, followed by ring closure (Scheme 13). 
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Scheme 13: Potential biosynthetic pathway for manzamine A 
 In 1998, to prove the viability of their hypothesis, Baldwin et al.13 
conducted a biomimetic synthesis of their proposal. In few steps, the authors 
created bis-dihydropyridinium 1.035 and cyclised it to 1.036 in 0.2-0.3 % 
yield. The main portion (between 60 and 85 %) of starting material 
disproportionated towards 1.037. Interestingly, in 1994, keramaphidin B 
1.036 was isolated by Kobayashi et al.14 (30 ppm from wet weight inside 
                                                          
13 (a) Baldwin, J. E.; Claridge, T. D. W.; Culshaw, A. J.; Heupel, F. A.; Smrcková, S.; 
Whitehead, R. C. Tetrahedron Lett. 1996, 37, 6919. (b)  Baldwin, J. E.; Claridge, T. D. 
W.; Culshaw, A. J.; Heupel, F. A.; Lee, V.; Spring, D. R.; Whitehead, R. C.; 
Boughtflower, R. J.; Mutton, I. M.; Upton, R. J. Angew. Chem. Int. Ed. 1998, 37, 2661. 
(c) Baldwin, J. E.; Claridge, T. D. W.; Culshaw, A. J.; Heupel, F. A.; Lee, V.; Spring, D. 
R.; Whitehead Chem. Eur. J. 1999, 5, 3156. 
14 Kobayashi, J.; Tsuda, M.; Kawasaki, N.; Matsumoto, K.; Adachi, T. Tetrahedron Lett. 
1994, 35, 4383. 
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Amphimedon sp.) and Andersen et al.15 (85 ppm from wet weight inside 
Xestospongia sp.). This is an evidence that no “Diels-Alderase” would be 
needed to perform the Diels-Alder reaction. A simple conformation provided 
by an enzyme should be enough and would probably also reduce the 
disproportionation towards 1.037 (Scheme 14). 
 
Scheme 14: Proof of hypothesis 
 Keramaphidin B 1.036 was suspected to be a key adduct in many 
biogenetic origins of manzamine derivatives such as halicyclamine A16 1.038 
(29 ppm from wet weight inside Xestospongia sp.) and zamamiphidin A17 
1.039 (1 ppm from wet weight inside Amphimedon sp.). Ircinal A 1.011 is 
probably the biogenic precursor of nakadomarin A18 1.040 (6 ppm from wet 
weight inside Amphimedon sp.) and of course manzamines. Finally, 
manzamines could provide manadomanzamine A19 1.041 (24 ppm from wet 
weight inside Acanthostrongylophora sp.), ma’eganedin A20 1.042 (9 ppm 
from wet weight inside Amphimedon sp.), acantholactam11 1.043 (15 ppm 
                                                          
15 Kong, F.; Andersen, R. J. Tetrahedron 1995, 51, 2895. 
16 Jaspars, M.; Pasupathy, V.; Crews, P. J. Org. Chem. 1994, 59, 3253.  
17 Kubota, T.; Kamijyo, Y.; Takahashi-Nakaguchi, A.; Fromont, J.; Gonoi, T.; Kobayashi, 
J. Org. Lett. 2013, 15, 610. 
18 Kobayashi, J.; Watanabe, D.; Kawasaki, N.; Tsuda, M. J. Org. Chem. 1997, 62, 9236. 
19 Peng, J.; Hu, J-F.; Kazi, A. B.; Li, Z.; Avery, M.; Peraud, O.; Hill, R. T.; Franzblau, S. G.; 
Zhang, F.; Schinazi, R. F.; Wirtz, S. S.; Tharnish, P.; Kelly, M.; Wahyuono, S.; Hamann, 
M. T. J. Am. Chem. Soc. 2003, 125, 13382. 
20 Tsuda, M.; Watanabe, D.; Kobayashi, J. Tetrahedron Lett. 1998, 39, 1207. 
Chapter I 
 
13 
 
from wet weight inside Acanthostrongylophora sp.), zamamidine B21 1.044 
(6 ppm from wet weight inside Amphimedon sp.) and the previous reported 
kauluamine 1.021 and neo-kauluamine 1.022 (Scheme 15). 
 
Scheme 15: manzamine family 
                                                          
21 Takahashi, Y.; Kubota, T.; Fromont, J.; Kobayashi, J. Org. Lett. 2009, 11, 21. 
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3. Bioactivities 
 Nearly thirty years ago, Sakai and Higa tested these new alkaloids 
against P388 mouse leukemia cells.1,2 Manzamine A 1.001, B 1.002, and C 
1.003 exhibited IC50 values of 0.07 µg/ml, 6 µg/ml and 3 µg/ml, respectively, 
revealing the fact that even with a simpler structure, manzamine C 1.003 is 
more active than manzamine B 1.002.  
 Since that day, the manzamine family was proven to exhibit activities 
against Staphylococcus aureus3,17, carcinoma cells5,8,14, was furthermore 
antibacterial18,22 and insecticidal23. Finally, they display antiparasitic activities 
with some of the greatest potential for possible clinical applications existing 
for malaria and Mycobacterium tuberculosis.19,24 
 In 2000, Kara et al. performed in vivo antimalarial experiments. The 
survival over time of mice infected with Plasmodium berghei was compared 
to survival after treatment with a single intraperitoneal injection of 100 
µmol/kg of either manzamine A 1.001, manzamine G 1.015, manzamine F 
1.008, artemisinin 1.045 and chloroquine 1.046. A single intraperitoneal 
administration of manzamine A 1.001 or manzamine G 1.015 prolonged the 
survival of P. berghei-infected mice for more than 10 days, with 40 % of mice 
treated, surviving for more than 60 days and recovering with no detectable 
parasitaemia. The ability of manzamine A 1.001 and G 1.015 to extend the 
                                                          
22 Harrison, B.; Talapatra, S.; Lobkovsky, E.; Clardy, J.; Crews, P. Tetrahedron Lett. 
1996, 37, 9151. 
23 Edrada, R. A.; Proksch, P.; Wray, V.; Witte, L.; Müller, W. E. G.; Van Soest, R. W. M. 
J. Nat. Prod. 1996, 59, 1056. 
24 (a) Ang, K. K. H.; Holmes, M. J.; Higa, T.; Hamann, M. T.; Kara, U. A. K. Antimicrob. 
Agents Chemother. 2000, 44, 1645. (b) El Sayed, K. A.; Kelly, M.; Kara, U. A. K.; Ang, 
K. K. H.; Katsuyama, I.; Dunbar, D. C.; Khan, A. A.; Hamann, M. T. J. Am. Chem. Soc. 
2001, 123, 1804. (c) Rao, K. V.; Santarsiero, B. D.; Mesecar, A. D.; Schinazi, R. F.; 
Tekwani, B. L.; Hamann, M. T. J. Nat. Prod. 2003, 66, 823. (d) Rao, K. V.; Kasanah, N.; 
Wahyuono, S.; Tekwani, B. L.; Schinazi, R. F.; Hamann, M. T. J. Nat. Prod. 2004, 67, 
1314. (e) Arai, M.; Sobou, M.; Vilchéze, C.; Baughn, A.; Hashizume, H.; Pruksakorn, 
P.; Ishida, S.; Matsumoto, M.; Jacobs J. W. R.; Kobayashi, M. Bioorg. Med. Chem. 
2008, 16, 6732. (f) Ashok, P.; Lathiya, H.; Murugesan, S. Eur. J. Med. Chem. 2015, 97, 
928. (g) Ashok, P.; Ganguly, S.; Murugesan, S. Drug. Discov. Today 2014, 19, 1781. 
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lives of infected mice far exceeded that of chloroquine 1.046 and artemisinin 
1.045, two of the most important human therapeutic antimalarial drugs. 
Manzamine A 1.001 was toxic to mice at 500 µmol/kg, but it showed more 
slowly acting toxicity than chloroquine 1.046, which caused almost 
instantaneous death of the treated mice at 500 µmol/kg (Scheme 16) and 
(Table 1). 
Treatment 
No. of mice surviving on the following day after 
treatment 
0 2 4 6 10 15 25 60 
Manzamine A 1.001 5 5 5 5 5 4 2 2 
Manzamine G 1.015 5 5 5 5 5 0   
Manzamine F 1.008 5 5 0      
Artemisinin 1.045 5 5 4 0     
Chloroquine 1.046 5 5 5 5 0    
Control 14 14 0      
Table 1: Survival over time 
 
Scheme 16: Artemisinin and chloroquine 
 Transmission electron microscopy revealed progressive changes in 
the morphology of P. berghei parasites after intraperitoneal administration 
of manzamine A 1.001, with initial changes seen only one hour after 
treatment. One hour of exposure to manzamine A induced the formation of 
membrane-bound vesicles with various electron densities within some 
parasites. Four hours after treatment, other morphological changes, such as 
the development of electron-dense vesicles, were observed in more 
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parasites. By twelve hours after drug exposure, the parasite cytoplasm 
showed marked degeneration and was filled with electron-dense vesicles. 
Almost all parasites had degenerated by one day after exposure to 
manzamine A 1.001. 
 In 2003 and 2004, Hamann et al. performed in vitro experiments 
against Mycobacterium tuberculosis and Plasmodium falciparum (W2 is the 
most highly resistant strains in P. falciparum). Most manzamines were active 
against M. tuberculosis with MICs < 12.5 µg/ml. The minimal difference in the 
Mycobacterium tuberculosis activity of manzamines A 1.001 and J 1.010 may 
indicate that the structure-activity relationship and targets for M. 
tuberculosis and malaria are significantly different (as reminder manzamines 
A 1.001 and J 1.010 only differ by a bond between N-27 and C-34 at the 
bottom). Comparison of manzamine E 1.007 and F 1.008 activities indicate 
that the hydroxyl functionality and its position on the β-carboline moiety may 
play a role in the biological activity. The significant activity of ircinol A 1.017 
against M. tuberculosis suggested that the β-carboline moiety is not essential 
for activity (Table 2). 
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Compound 
M. tuberculosis 
(H37Rv) 
MIC µg/ml 
P. 
falciparum 
(D6 clone) 
IC 50 ng/ml 
P. 
falciparum 
(W2 clone) 
IC 50 ng/ml 
Manzamine A 1.001 1.5 4.5 8.0 
Manzamine E 1.007 3.8 3400 4760 
Manzamine F 1.008 2.6 780 1700 
Manzamine G 1.015 0.9 6.0 8.0 
Manzamine J 1.010 1.7 1300 750 
Manzamine X 1.019 NT 950 2000 
Ircinal A 1.011 30.2 NA NA 
Ircinol A 1.017 1.9 2400 3100 
neo-kauluamine 1.022 2.0 1700 2800 
Rifampin 0.5 NT NT 
Artemisinin 1.045 NT 10 6.3 
Chloroquine 1.046 NT 15.5 170 
NA = not active (centration 5.0 µg/ml); NT = not tested 
Table 2: Activity against tuberculosis and malaria 
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Chapter II 
Previous Syntheses of Manzamines 
 
Since their discovery, manzamines have been a target of synthetic 
interest for many groups around the world. Despite these joined efforts, only 
three manzamines have been synthesized to date; manzamine A 1.001, 
manzamine C 1.003 and manzamine D 1.004 (Scheme 1). Most of the 
pathways for manzamine A synthesis were channelled through the 
production of ircinal A 1.011 and manzamine D 1.004: 
• Manzamine A 1.001: 
o In 1998 by Jeffrey D. Winkler1 
o In 2002 by Stephen F. Martin2 
o In 2010 by Tohru Fukuyama3  
o In 2012 by Darren J. Dixon4 
• Manzamine C 1.003: 
o In 1991 by Tohru Hino5 
o In 1992 by Hans Gerlach6 
o In 2000 by Ellen J. Beck7 
                                                          
1 Winkler, J. D.; Axten, J. M. J. Am. Chem. Soc. 1998, 120, 6425. 
2 (a) Martin, S. F.; Humphrey, J. M.; Ali, A.; Hillier, M. C. J. Am. Chem. Soc. 1999, 121, 
866. (b) Humphrey, J. M.; Liao, Y.; Ali, A.; Rein, T.; Yue-Ling, W.; Chen, H-J.; Courtney, 
A. K.; Martin, S. F. J. Am. Chem. Soc. 2002, 124, 8584. 
3 Toma, T.; Kita, Y.; Fukuyama, T. J. Am. Chem. Soc. 2010, 132, 10233. 
4 Jakubec, P.; Hawkins, A.; Felzmann, W.; Dixon, D. J. J. Am. Chem. Soc. 2012, 134, 
17482. 
5 (a) Torisawa, Y.; Hashimoto, A.; Nakagawa, M.; Hino, T. Tetrahedron Lett. 1989, 30, 
6549. (b) Torisawa, T.; Hashimoto, A.; Nakagawa, M.; Seki, H.; Hara, R.; Hino, T. 
Tetrahedron 1991, 47, 8067.  
6 Nowak, W.; Gerlach, H. Liebigs Ann. Chem. 1993, 153. 
7 MaGee, D. I.; Beck, E. J. Can. J. Chem. 2000, 78, 1060. 
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Unfortunately, manzamine B 1.002 has not been synthetized to date. 
Its scaffold can be considered as more challenging than most of the 
manzaminoids due to two macrocycles and a central cyclohexane carrying six 
stereogenic centres. Its bioactivities are similar to manzamine C 1.003 (Cf. 
Chap I) (Scheme 1). 
 
Scheme 1: Manzamines A, B, C, D and ircinal A 
 
In this chapter we will have an overview of the total syntheses of 
manzamine A 1.001 and their applied methodologies according to 
chronological order.  
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1. Manzamine A in 1998 by Winkler 
The authors planned to use a [2+2] photochemical reaction as key 
step to reach the ABCD scaffold.8 The target molecule 2.006 could come from 
2.007 upon enol addition on iminium. Ketone-iminium 2.007 is a rearranged 
product of cyclobutene 2.008 which derived from 2.009 under specific light 
condition. This closure cascade is called an Intramolecular Vinylogous Amide 
PHotocycloAddition/Retro-Mannich fragmentation/Mannich closure 
Cascade and will be noted “pharM”. In this sequence, only one stereogenic 
centre is required in order to direct all the other chiral centres within the 
central core ABCD (Scheme 2).9 
 
Scheme 2: Winkler's retrosynthesis 
 The synthesis of the photosubstrate started with the alkylation of 
azocinone 2.010 with allylic iodide 2.011 and proceeded to afford ketone 
2.012 in 53 % yield. A separable mixture (4:1) of cis 2.013 and trans 2.014 
alcohols was obtained after sodium borohydride reduction (Scheme 3).  
 
Scheme 3: Synthesis of 2.013 and 2.014 
                                                          
8 (a) Winkler, J. D.; Siegel, M. G.; Stelmach, J. E. Tetrahedron Lett. 1993, 34, 6509. (b) 
Winkler, J. D.; Bowen, C. M.; Liotta, F. Chem. Rev. 1995, 95, 2003. 
9 Winkler, J. D.; Stelmach, J. E.; Siegle, M. G.; Haddad, N.; Axten, J. Dailey, W. P. III Isr. 
J. Chem. 1997, 37, 47. 
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The two amines were debenzylated and condensed with sodium-
formyl-acetone to give 2.015 and 2.016 in 54 % yield over two steps (Scheme 
4). 
 
Scheme 4: Photo-precursors 2.015 and 2.016 
Irradiation of cis-2.015 led to the formation of the aminals 2.017 and 
2.018 in a 2:1 ratio. Exposure of the mixture to triethylamine hydrochloride 
in acetonitrile, followed by the action of DMAP at reflux induced the 
formation of ketoalcohols 2.019 and 2.020 in 50 % overall yield from 2.015 
(Scheme 5). 
 
Scheme 5: PharM sequence on 2.015 
 The stereochemical assignments were made by X-ray analysis of the 
diketone 2.021 obtained through Swern oxidation of 2.019. As the authors 
observed the diketone 2.021 has a relative stereochemistry at C34 epimeric 
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to that of manzamine A 1.001, whereas the diketone 2.022 possesses all the 
correct stereogenic centres. Equilibration studies with sodium methoxide in 
methanol revealed that diketone 2.022 could be converted in diketone 2.021 
while the transformation from 2.021 to 2.022 was not observed. This 
information tends to prove 2.021 as the more stable of both tetracycles 
(Scheme 5). 
 Irradiation of the trans alcohol 2.016 at -78°C followed by retro-
Mannich fragmentation and Mannich closure led to 2.023 as single 
diastereomer in 36 % yield. This material can be converted into the diketone 
2.022 via Swern oxidation (Scheme 6). 
 
Scheme 6: PharM sequence on 2.016 
These preliminary results established that intramolecular vinylogous 
amide photocycloaddition using an eight-membered ring template efficiently 
forge the tetracyclic ring system of manzamine A 1.001. 
A new retrosynthetic analysis was proposed with PharM sequence, 
this time for the construction of ABCDE pentacycle. Once again, only one 
stereogenic centre in the starting material was planned to guide the 
installation of all other stereocentres in the scaffold. The diketone amide 
2.024 should be a suitable precursor for the incorporation of the C10 β-
carboline and the C12 tertiary hydroxyl. The pentacycle 2.024 could be 
derived from Mannich closure of the keto-iminium 2.025, which could result 
from the retro-Mannich fragmentation of 2.026. The cyclobutane 2.026 
could come from the [2+2] photoaddition of macrocyclic vinylogous amide 
2.027. This disconnection represents an efficient concept as the ADE moiety 
is converted in one-pot into the ABCDE pentacycle of manzamine (Scheme 
7). 
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Scheme 7: New retrosynthesis 
 The previous pathways for the synthesis of azocinone 2.010 was 
modified for a larger scale synthesis. A three-step dibromation, bromide-
elimination and hydrolysis sequence starting from commercially available 
caprolactam 2.028 allowed access to keto-lactam 2.029.10 Finally, 2.029 was 
reduced with lithium aluminium hydride, alkylated and oxidized to the 
desired azocinone 2.010 (Scheme 8). 
 
Scheme 8: Azocine synthesis 
 The azocinone 2.010 was C-alkylated with vinyl iodide 2.030 bringing 
forth the bicycle AE 2.031. This intermediate was then debenzylated and 
coupled with 2.032 to produce the vinyl amide 2.033. The introduced side 
chain is capped with an ester at its terminus. The reason for this is that the 
ensuing macrocyclization should occur more easily through macro-
                                                          
10 Brouillette, W. J.; Einspahr, H. M. J. Org. Chem. 1984, 49, 5113. 
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lactamization than macro-alkylation. The additional presence of an acetylene 
further decreases conformational freedom, thereby making the cyclization 
entropically less demanding. The removal of Teoc function, reprotection with 
Boc anhydride and activation of the ester afforded 2.034. The 
macrocyclization materialized in a very good yield furnishing 2.035 in 85 % 
over two steps. The photochemical reaction with similar substrate as 2.035 
led to mixtures of undesired products. To preclude it, the ketone was 
reduced with L-selectride affording the cis-alcohol 2.036 (Scheme 9). 
 
Scheme 9: Synthesis of photo-precursor 2.036 
 Instead of undergoing the planned pharM sequence, alcohol 2.036 
does not lead to product 2.037 but to a complex mixture of products 
containing multiple olefinic moieties. Alternatively, 2.038 was made through 
Lindlar reduction of 2.036. Unfortunately, the pharM sequence did not 
produce the cyclobutane scaffold 2.039 (Scheme 10). 
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Scheme 10: Tests of PharM sequence 
 The failure of the macrocyclic vinylogous amide photosubstrates to 
undergo the desired transannular photocycloaddition led the authors to 
examine an alternative strategy (Scheme 11). In this modified pathway, 
ketone 2.040 was reduced with L-selectride to the cis-alcohol 2.041, followed 
by the pharM sequence to achieve the tetracycles 2.042 and 2.043 in a 2:1 
ratio. 
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Scheme 11: New route 
The epimeric mixture of tetracycles 2.042 and 2.043 was oxidized 
and activated to acquire the ester 2.044. The macrocyclization occurred in 
two steps with trifluoro acetic acid and diisopropylethylamine in a 50 % yield. 
The mixture led to a single product in a stereoconvergent fashion, as 
explained earlier in this chapter (Scheme 12). 
 
Scheme 12: Macrocyclization 
 The pharM sequence was able to forge the pentacycle ABCDE of 
manzamine A 1.001. However, to finish the synthesis, few issues need to be 
fixed such as the presence of the incorrect epimer at C34, some functional 
group transformations and the incorporation of the β-carboline moiety. 
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 At this point of the synthesis, Winkler et al. performed 
conformational calculations to optimize their pathway.11 The ground state 
conformations involved in the cycloadditions of 2.046 and 2.049 were 
analyzed. The computational data showed an energy difference of 1.6 
kcal/mol between the lowest energy conformers leading to 2.047 and 2.048, 
thereby favouring the formation of 2.047. Therefore, in this system, the 
vinylogous amide is located in the same plane as the nitrogen and the tertiary 
carbon of the eight-membered ring. The [2+2] cycloaddition takes place on 
the top face of the vinylogous amide to give the adduct 2.047, hence 
producing the incorrect relative stereochemistry for the synthesis of 
manzamines (Scheme 13). 
 
Scheme 13: Energetic pathways for 2.046 in PharM sequence 
Owing to the unsaturated azocine system in 2.049, the conformation of the 
eight-membered ring will be different. The calculations show an energy 
difference of 3.2 kcal/mol between the lowest energy transition structures 
leading to 2.050 and 2.051, favouring the formation of the product 2.051. 
The unsaturation in the eight-membered ring creates a torsional strain 
affecting a conformational change that places the enone moiety orthogonal 
to the ring plane (Scheme 14). 
                                                          
11 Winkler, J. D.; Axten, J.; Hammach, A. H.; Kwak, Y-S.; Lengweiler, U.; Lucero, M.; 
Houk, K. N. Tetrahedron 1998, 54, 7045. 
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Scheme 14: Energetic pathways for 2.049 in PharM sequence 
 To shed light on the veracity of their calculations, the synthesis of 
2.049 was started with the alcohol 2.052. At first it underwent benzylation, 
then reduction of the pyridinium salt with NaBH4 and purification through a 
protection-deprotection-protection process afforded 2.053. Finally, the 
alcohol was converted to the vinylic bromide 2.054 (Scheme 15). 
 
Scheme 15: Synthesis of 2.054 
 Myers pseudoephedrine alkylation was used to control the absolute 
stereochemistry of 2.056.12 Pseudoephedrine was exchanged for Weinreb 
amide 2.057, followed by reduction and Wittig reaction to afford 2.058. 
Deprotection, activation and macrocyclization in the conditions described by 
Nakagawa et al.13 led to the eight-membered ring 2.059 after deprotection 
of the Alloc function. Conjugate addition to butynone gave the product 2.049 
which went through the calculations (Scheme 16). 
                                                          
12 Myers, A.; Gleason, J.; Yoon, T. J. Am. Chem. Soc. 1995, 117, 8488. 
13 Torisawa, Y.; Motohashi, Y.; Ma, J.; Hino, T.; Nakagawa, M. Tetrahedron Lett. 1995, 
36, 5579. 
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Scheme 16: Enantioselective synthesis of 2.049 
The pharM sequence was successfully tested on substrate 2.049 
which provided the desired tetracycle 2.061 in a 58 % yield (Scheme 17). 
 
Scheme 17: Successful test of PharM sequence 
 In order to disclose the endgame of the synthesis, azocine 2.059 was 
reacted with ynone 2.062 to bring forth the vinylogous amide 2.063 as 
precursor for the pharM sequence. Tetracycle 2.064 was obtained in 20 % 
and underwent the modification of the ketone C11 to the βγ unsaturated 
ester 2.065 and αβ unsaturated ester 2.066, in a 1:2 ratio, respectively. 
Selenation of 2.066 produced 2.067 which eliminated under oxidative 
conditions leading to γ-hydroxy-αβ-unsaturated ester 2.068. Epoxidation of 
2.065, followed by basic conditions provided the desired ester 2.068. The 
macrocyclization sequence consisted in a deprotection-activation-
deprotection-cyclization but met with very poor yield (12 %) in the cyclization 
step towards 2.069. To improve this yield, the use of acetylene derivatives 
was envisioned as mentioned earlier (Scheme 18).  
Chapter II 
 
31 
 
 
Scheme 18: Synthesis of pentacycle 2.069 
 The synthesis continued with 2.070 and a successful 
macrocyclization in 89 % yield, followed by reduction of the triple bond, 
reduction of the ester, and oxidation to the aldehyde to afford for the first 
time ircinal A 1.011 by synthesis. As described in the Kobayashi procedure14, 
ircinal A 1.011 was converted into manzamine D 1.004 via action of 
                                                          
14 Kondo, K.; Shigemori, H.; Kikuchi, Y.; Ishibashi, M.; Sasaki, T.; Kobayashi, J. J. Org. 
Chem. 1992, 57, 2480. 
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tryptamine 1.013. Final oxidation by DDQ led to manzamine A 1.001 (Scheme 
19). 
 
Scheme 19: Final steps of first manzamine synthesis 
 
This concluded the first total synthesis of Ircinal A 1.011, manzamine 
D 1.004 and manzamine A 1.001 after more than 10 years of investigation by 
Winkler group.  
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2. Manzamine A in 2002 by Martin 
The retrosynthetic pathway proposed by Martin et al. suggested the 
use of an intramolecular Diels-Alder reaction to implement the central core 
2.071 starting from diene 2.074 and dienophile 2.073 (Scheme 20).  
 
Scheme 20: Martin's retrosynthesis 
 During early investigations, the viability of several key aspects of this 
strategy were established, in particular, the intramolecular [4+2] 
cycloaddition using the vinylogous imide. Unfortunately, at this stage the 
subunit prepared was not ideally endowed for transformation into 
manzamine A 1.001.15 
 The synthesis commenced with the preparation of the diene 
precursor 2.077. The commercially available amino-alcohol 2.075 was 
protected and reacted with acrolein producing the aldehyde 2.076. Wittig 
olefination and deprotection followed by ammonium salt precipitation 
afforded 2.077 as a stable solid in 77 % yield (Scheme 21). 
                                                          
15 (a) Martin, S. F.; Liao, Y.; Wong, Y.; Rein, T. Tetrahedron Lett. 1994, 35, 691. (b) 
Martin, S. F.; Chen, H. J.; Courtney, A. K.; Liao, Y.; Pätzel, M.; Ramser, M. N.; Wagman, 
A. S. Tetrahedron 1996, 52, 7251. 
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Scheme 21: Synthesis of 2.077 
 The synthesis of the dienophile precursor started with the 
commercially available pyrrolidinone 2.078, which was protected in a two-
step process to 2.079. A “one-pot” procedure involving carbon dioxide, 
reduction and deprotonation provided 2.080 as a stable sodium carboxylate 
salt. These two reagents 2.080 and 2.077 subsequently underwent an amide-
coupling reaction allowing access to the bromo-diene 2.081 in a nice 79 % 
yield. At this stage, the critical domino Stille/Diels-Alder reaction took place. 
In this event, 2.081 reacted with vinyl tributylstanne in the presence of Pd(0) 
to afford the triene 2.082 that spontaneously cyclized via an intramolecular 
Diels-Alder reaction to give solely 2.083 in a 68 % overall yield. In this 
sequence, the single stereocentre of 2.081 defined the absolute and relative 
stereochemistry of all the other chiral centres in 2.083 (Scheme 22). 
 
Scheme 22: Synthesis of tricyclic compound 2.083 
 In the next phase of the synthesis, the 13 and 8 membered rings were 
installed by ring closing metathesis (RCM). Compound 2.083 was submitted 
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to a chromium induced allylic oxidation, a double TBDPS deprotection, 
directly followed by a Swern oxidation and a Wittig reaction, eventually 
leading to 2.084 in a 30 % yield. The ester 2.084 was reduced to the 
corresponding alcohol and oxidized back to aldehyde 2.085 by Dess-Martin 
periodinane. The N-Boc protecting group 2.085 was exchanged for an amide 
2.086. The aldehyde 2.086 was protected as the acetal 2.087 and the ketone 
was selectively alkylated to provide the polyene adduct 2.088 (Scheme 23). 
 
Scheme 23: Synthesis of tetraene 2.088 
 The following extremely ambitious step was to forge both the 13 and 
8 membered rings using the Grubbs’ catalyst 2.089. Unfortunately, no 
detectable amounts of the desired pentacyclic skeleton of protected ircinal 
A were delivered. Rather, an inseparable mixture was isolated that contained 
two compounds identified as the isomeric tetracyclic olefins 2.090 (Scheme 
24). 
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Scheme 24: Grubbs' cyclization of polyene 2.088 
 Instead of bis-macrocyclization, Martin et al. went back to a safer 
process. Protection and alkylation of 2.085 into 2.091 followed by the first 
RCM afforded 2.092 in a 67 % yield. Deprotection of the cyclic carbamate 
2.092 was carried out using potassium hydroxide in methanol and directly 
converting the amine into the amide 2.093. The second RCM was performed 
with the same Grubbs’ catalyst and the final mixture was quenched with 
acidic water furnishing the amide of ircinal A 2.094 in 26 % yield (Scheme 25). 
 
Scheme 25: Synthesis of ircinal A amide 2.094 
 The reduction of 2.094 with DiBAL-H gave Ircinol A 2.095, which was 
oxidized with Dess-Martin periodinane to deliver synthetic Ircinal A in 89 % 
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yield. Then once again, Kobayashi’s method16  was utilized to bring forth 
manzamine A 1.001 (Scheme 26). 
 
Scheme 26: Manzamine A 1.001 synthesis 
 
  
                                                          
16 Kondo, K.; Shigemori, H.; Kikuchi, Y.; Ishibashi, M.; Sasaki, T.; Kobayashi, J. J. Org. 
Chem. 1992, 57, 2480. 
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3. Manzamine A in 2010 by Fukuyama 
The retrosynthetic analysis proposed by Fukuyama et al. envisioned 
that the bicyclic ketone 2.095 would be ideal for controlling the 
stereochemistry of all the stereogenic centres of ircinal A 1.011. This ketone 
could come from a Diels-Alder reaction, as proposed for 2.096 (Scheme 27). 
 
Scheme 27: Fukuyama retrosynthetic pathway 
 Execution of the above strategy required the preparation of 
vinylogous ester 2.100. Starting from alcohol 2.097 which was turned into 
2.098 through nucleophilic substitution and a deprotection. Alcohol 2.098 
underwent activation, an alkylation with methyl acetoacetate and finally, 
reduction with lithium aluminium hydride to afford diol 2.099 in 76 % yield. 
Diol 2.099 was oxidized and protected to vinylogous ester 2.100 which was 
converted into vinyl-enolate and directly used for Diels-Alder reaction with 
2.101 to afford bicyclic 2.102. The use of sodium acetate and molecular 
sieves drastically improved the conversion, as they were proven to block 
hydrolysis of enolate in 2.096. The Diels-Alder adduct 2.102 was modified in 
an opening-Wittig-methylation one-pot process to furnish 2.103. Reduction 
of the methyl ester and protection of the obtained alcohol was followed by 
deprotection of the methyl-enol and its reduction to alcohol 2.104 in the 
presence of an enone. Mitsunobu reaction was carried out to convert the 
alcohol into a nosylamide function, followed by double deprotection, and 
then Mitsunobu reaction once again to create macrocycle 2.095 (Scheme 
28).  
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Scheme 28: Synthesis of macrocycle 2.095 
The next challenge was the creation of the quaternary stereogenic 
centre. Allyl iodide 2.108 was chosen as a key electrophile for accessing the 
substrate for the sigmatropic rearrangement. Enantioselective addition of 
diethylzinc17  to aldehyde afforded the desired alcohol 2.106 in 93 % ee. 
Introduction of a carbamate group and then deprotection and iodination of 
the primary alcohol followed by recrystallisation afforded enantiomerically 
pure iodide 2.108 (Scheme 29). 
 
                                                          
17 Nugent, W. A. Chem. Commun. 1999, 1369. 
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Scheme 29: Synthesis of enantiomerically pure allyl iodide 2.108 
 Following Mander’s protocol18 ketone 2.095 was converted into β-
ketoester, which was subjected to allylation with 2.108. As expected, 
stereoselective alkylation occurred from the sterically less crowded α-face to 
give a single product. Similarly, treatment with TBHP and Triton B afforded 
epoxyketone 2.109 as a single diastereomer. Upon dehydration of 2.109 with 
trifluoroacetic anhydride and triethylamine, the critical [3,3]-sigmatropic 
rearrangement proceeded even at 0°C to give the corresponding isocyanate 
with complete control of stereochemistry. The resulting isocyanate had to be 
converted into imine 2.110 under anhydrous conditions because 2.110 was 
susceptible to hydrolysis even under neutral conditions, triggering 
irreversible lactamization with the methyl ester. After extensive 
experimentation, the authors found that treatment of the isocyanate with 
acetic acid and magnesium perchlorate in the presence of molecular sieves 
enabled the desired transformation into 2.110. Subsequent reduction of 
imine 2.110 and acylation with 5-hexenoyl chloride afford the amide-ester 
which was reduced to alcohol 2.111 using lithium aluminium hydride and 
aluminium trichloride. At this stage, the ring-closing metathesis for 
construction of the azocine ring was attempted. Unfortunately, because of 
the rapid isomerization of the terminal alkene, the ring-closing metathesis 
afforded a significant amount of the undesired seven-membered ring. Thus, 
the decision to create first the piperidine ring was obvious. IBX oxidation of 
2.111 in tert-butyl alcohol, removal of the nosyl group and reduction of the 
resultant hemiaminal afforded diamine 2.112. The last crucial step of the 
synthesis was the ring-closing metathesis of diamine 2.112. Although 
                                                          
18 Mander, L. N.; Sethi, S. P. Tetrahedron Lett. 1983, 24, 5425. 
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isomerization of the terminal alkene was not observed, participation of the 
tertiary amines and the alkyne were the major problems. After extensive 
efforts, reproducible results were obtained when a Hoveyda-Grubbs 
modified catalyst was used to afford pentacycle 2.113 (Scheme 30). 
 
Scheme 30: Synthesis of pentacycle 2.113 
 Deprotection of the TBDPS ether, reduction of the triple bond and 
Dess-Martin oxidation lead to ircinal A 1.011. Ircinal A was converted to 
manzamine A 1.001 through a modified procedure. During the investigation 
of the Pictet-Spengler reaction, they found that condensation of 1.011 with 
tryptamine 1.013 and subsequent cyclization required completely different 
acidic conditions. An efficient conversion of ircinal A 1.011 to manzamine D 
1.004 was achieved when these reactions were conducted separately. 
Subsequent DDQ oxidation was hampered by incomplete conversion, which 
could eventually be solved by the use of DDQ recrystallized from 
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dichloromethane. Manzamine A 1.001 was thus obtained in 75 % overall 
yield (Scheme 31). 
 
Scheme 31: Synthesis of manzamine A 1.001 
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4. Manzamine A in 2012 by Dixon 
In their retrosynthetic pathway, Dixon et al. identified enol triflate 
2.114 as valuable late-stage intermediate, allowing access to manzamine A 
1.001, but also other family members such as ircinol A 2.095 and ircinal A 
1.011.  
A short route initiated by stereoselective Michael addition of 2.118 
to the nitro olefin 2.119. The nitro-ester adduct 2.117 would be primed for 
annulation via nitro-Mannich/lactamization cascade to 2.116. The nitro 
function in 2.116 would play a dual role allowing an intramolecular Mannich 
type reaction and a subsequent oxidation via Nef reaction to cyclohexanone 
2.115. Finally, a stereoselective addition alkylation to the resulting carbonyl 
group followed by enol triflate formation and RCM, would provide the key 
late-stage intermediate 2.114 (Scheme 32). 
 
Scheme 32: Dixon's retrosynthesis 
 The synthesis started with the preparation of the Michael addition 
partners 2.118 and 2.119. Nucleophilic substitution of 2.120 was nontrivial 
but achieved with potassium acetate and Aliquat 336 at 120°C, to provide 
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2.121 as intermediate which underwent smooth methanolysis to alcohol 
2.122 in a very decent yield of 49 %. Swern oxidation occurred without 
incident and the crude aldehyde 2.123 reacted with nitromethane giving the 
Henry adduct 2.124. Condensation of 2.124 with the first partner 2.119 took 
place with methanesulfonyl chloride and triethylamine (Scheme 33). 
 
Scheme 33: Synthesis of first partner 2.119 
 The second partner 2.118 was constructed with the tosylate of 
pyroglutaminol 2.125 which underwent a nucleophilic substitution with 
sodium thiolate 2.126 and thereby afforded sulfide 2.127. N-alkylation with 
2-(4-bromobutyl)-1,3 dioxolane followed by sulfide-to-sulfone oxidation 
yielded 2.129. Deprotection and intramolecular Julia-Kocienski olefination 
lead to 2.131. This was the first example of a highly diastereoselective 
formation a Z alkene in an eight-membered ring via an intramolecular Julia-
Kocienski reaction and the first example of such a process in complex natural 
product synthesis. C-acylation with dimethyl carbonate completed the 
synthetic sequence for the second partner 2.118 (Scheme 34). 
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Scheme 34: Synthesis of second partner 2.118 
 With the two partners 2.118 and 2.119 in hand, unfortunately the 
previously used organocatalysed Michael addition was not viable. 19 
Nonetheless, desirable reactivity was observed when KMDS was used with 
crown-ether. Moderate diastereoselectivity was witnessed towards the 
target isomer (d.r. = 73:27:0:0) but the diastereomers were easily separated 
by flash column chromatography and the desired product 2.117 was 
obtained in 65 % yield (Scheme 35). 
 
Scheme 35: Michael addiction leading to 2.117 
                                                          
19 (a) Jakubec, P.; Cockfield, D. M.; Dixon, D. J. J. Am. Chem. Soc. 2009, 131, 16632. 
(b) Rigby, C. L.; Dixon, D. J. Chem. Commun. 2008, 3798. (c) Jakubec, P.; Kyle, A. F.; 
Calleja, J.; Dixon, D. J. Tetrahedron Lett. 2011, 52, 6094. 
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 Performing the nitro-Mannich/lactamization cascade 20 , the nitro-
ester 2.117 was reacted with formaldehyde and hex-5-en-1-amine to afford 
piperidinone 2.132. Removal of the nitro group under modified Ono’s 
conditions21 gave the tricyclic core 2.133. Conversion of alkene 2.133 to nitro 
2.116 was made possible by anti-Markovnikov addition of HI and reaction 
with silver nitrite in 63 % yield. Reduction of the piperidinone 2.116 to 
piperidine 2.135 was performed with DiBAL-H in very good yield without 
undesired reduction of nitro group (Scheme 36). 
 
Scheme 36: Synthesis of piperidine 2.135 
 Pleasingly, Buchwald’s conditions22  applied to 2.135 provided the 
necessary chemoselectivity and reactivity profile to give 2.136 in an 83:17 
ratio and 81 % yield. A McMurry modification of a reductive Nef reaction23 
employing titanium trichloride in a water-THF mixture gave the key 
tetracyclic ketone 2.115. A highly face selective addition of butenyl cerium 
derivative giving 2.137 followed by TMS protection and enol triflate 
formation provided 2.138 in a decent yield of 65 %. The last step was a Z 
                                                          
20 Jakubec, P.; Helliwell, M.; Dixon, D. J. Org. Lett. 2008, 10 (19), 4267. 
21 Ono, N.; Kaji, A. Synthesis 1986, 693. 
22 Bower, S.; Kreutzer, K. A.; Buchwald, S. L. Angew. Chem. Int. Ed. 1996, 35, 1515. 
23 Ballini, R.; Petrini, M. Tetrahedron 2004, 60, 1017. 
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selective RCM with Grubbs’ first-generation catalyst and an acid work-up to 
afford the key intermediate 2.114 (Scheme 37). 
 
Scheme 37: Synthesis of key intermediate 2.114 
 With access to the key late-stage intermediate 2.114 established, the 
cross-coupling of the β-carboline moiety was investigated. The Stille type 
coupling with tributylstannylated β-carboline 2.139 was successful and 
provided manzamine A 1.001 in 52 % yield. Exploration of 2.114 reactivity 
was performed to obtain ircinal A 1.011 in 58 % yield with carbon monoxide 
and methyl ircinate 2.069 in 78 % yield. This ester was reduced in ircinol A 
2.095, thereby establishing proof that enol triflate 2.114 is an extremely 
suitable intermediate towards many members of the manzamine family 
(Scheme 38). 
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Scheme 38: Synthesis of manzamine A, ircinal A and ircinol A 
 
 
 
 
 
 
 
  
Chapter II 
 
49 
 
5. Summary of achieved syntheses 
To wrap it up, the best synthesis in overall yield has been proposed 
by Fukuyama et al. with almost half a percent yield at the outcome of 31 total 
steps. The shortest synthesis has derived from the work of Dixon et al. with 
a total of 23 steps and a longest sequence of not more than 18 steps (Table 
1). 
Synthesis Longest linear 
sequence 
Total steps Overall yield % 
MZA Winkler 1998 34 37 0.043 
MZA Martin 2002 21 24 0.088 
MZA Fukuyama 2010 27 31 0.493 
MZA Dixon 2012 18 23 0.054 
Table 1: Summary of syntheses 
 From a more personal point of view, the synthesis proposed by 
Fukuyama is really long compared to the others. Martin was unfortunate as 
Winkler published just few months before he could finish his final steps (Even 
if officially, the full paper was published in 2002, the communication about 
almost the total synthesis went out in 1999). However, the polycyclization 
using Grubbs’ catalyst was overambitious and let to many practical 
complications. On my opinion, Dixon developed the best synthesis, through 
several methodologies and with a possibility to extend the scope as final 
step. Unfortunately, the use of metals such as tin as last step makes this 
approach unsuitable for pharmacological applications. 
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Chapter III 
Polycyclization, Previous Work and Objectives 
 
In this chapter I will present a short introduction on polycyclization, 
directly followed by early work and methodologies of anionic polycyclization 
developed in the Markó group. Most of these principles will be useful to 
understand the objectives of this thesis.  
 
1. Polycyclization 
Cascade cyclization or polycyclization reactions are extremely useful 
in organic chemistry. This is mostly due to the fact that this process can fix 
several chiral centres and cycles in one step. Synthetic chemists found 
various ways to apply new polycyclization protocols to reach complex 
targets.1  One of the most famous polycyclizations was demonstrated by 
Corey et al.2 and consists in the polycyclization of epoxy-squalene 3.001 into 
sterol 3.002 using rat liver homogenate (Scheme 1). 
                                                          
1 Anderson, E. A. A. Org. Biomol. Chem. 2011, 9, 3997. 
2 Corey, E. J.; Russey, W. E.; Ortiz, P. R. J. Am. Chem. Soc. 1966, 88, 4750. 
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Scheme 1: Squalene epoxide 3.001 polycyclization 
  
Four different types of cyclization can be found, i.e. cationic such as 
for 3.001, anionic, metal catalysed and finally, radical process. Since in this 
thesis we solely focus on the use of indole to reach our target, the following 
selected examples of polycyclizations will be based on indole chemistry and 
will set an example for the four types of conditions. 
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a. Cationic Polycyclization 
 In 2018, Bu et al. 3  proposed a Lewis acid promoted cationic 
polycyclization to synthetize the complex indole moiety 3.006 using 
substituted indoles of type 3.004 and two equivalents of styryl ketone 3.005. 
The authors created two new cycles and 4 chiral centres. They proposed a 
mechanism based on retro-aldol from 3.005 to 3.007, followed by a 
condensation with indole moiety 3.004. Then, a [4+2] cyclization could take 
place between 3.008 and 3.005. Finally, the cyclized product 3.009 could be 
oxidized by air/oxygen and undergo a Michael addition to produce 3.006 
(Scheme 2). 
 
Scheme 2: Example of cationic polycyclization 
 
  
                                                          
3 (a) Wang, W.; Bai, X.; Jin, S.; Guo, J.; Zhao, Y.; Miao, H.; Zhu, Y.; Wang, Q.; Bu, Z. 
Org. Lett. 2018, 20, 3451. (b) Guo, J.; Bai, X.; Wang, Q.; Bu, Z. J. Org. Chem. 2018, 83, 
3679. 
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b. Anionic Polycyclization 
In 2012, Ma et al.4 built a complex indoline scaffold 3.012 by anionic 
polycyclization with lithium hexamethyldisilazide and iodide. From indole 
3.011, this process required two equivalents of LiHMDS and one equivalent 
of I2, however, it allows the concomitant formation of two chiral centres and 
two cycles in one step. The authors proposed a mechanism based on 
oxidative coupling at first to obtain indoline 3.013 then cyclizing into the 
target molecule 3.012. 
 
Scheme 3: Example of anionic polycyclization 
  
                                                          
4 Fan, F.; Xie, W.; Ma, D. Org. Lett. 2012, 14, 1405. 
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c. Metal catalysed Polycyclization 
An example of polycyclization by Wang et al. 5  is based on an 
asymmetric palladium silver catalyst to obtain tri-indole compound 3.016. 
The authors proposed a mechanism based on a Friedel-Crafts alkylation of 
indole 3.015 on oxindole 3.014 to get the intermediate 3.017. Following ring-
closure under Lewis acidic conditions, iminium 3.019 was obtained. Finally, a 
second Friedel-Crafts alkylation was proposed to create the target molecule 
3.016 (Scheme 4). 
 
Scheme 4: Palladium/Silver catalysed polycyclization 
  
                                                          
5 Li, N-K.; Zhang, J-Q.; Sun, B-B.; Li, H-Y.; Wang, X-W. Org. Lett. 2017, 19, 1954. 
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d. Radical Polycyclization 
The final example of polycyclization was published in 1964 by Scott 
et al.6 and is based the total synthesis of Chimonanthine 3.021 as one-step 
biosynthetic model. A solution of commercially available methyl tryptamine 
3.020 was added on methyl Grignard to form the indole-magnesium 3.022 
reacting with iron trichloride to produce bis-indoline 3.023. Finally, double 
intramolecular cyclization of amine on indoline provided the desired 
compound 3.021 (Scheme 5). 
 
Scheme 5: Radical polycyclization 
 
 
  
                                                          
6 (a) Scott, A. I.; McCapra, F.; Hall, E. S. J. Am. Chem. Soc. 1964, 86, 302. (b) Hall, E. S.; 
McCapra, F.; Scott, A. I. Tetrahedron 1967, 23, 4131. 
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2. Previous work 
The idea of indole-manzamine 3.024 started in the early 1990’s in 
Sheffield in the hands of Mike Southern (Ph.D. thesis in 1994).7 Indole 3.025 
is a cheap and biocompatible scaffold as it can be found in alkaloids, 
pigments and proteins. This building block allows us to directly start the key 
steps for the central core assembly without performing the azocine 3.026 
synthesis (Cf. chapter II) (Scheme 6). 
 
Scheme 6: Indole-manzamine 3.024, indole 3.025 and azocine 3.026 
 
  
                                                          
7 Southern, M. PhD Thesis 1994, University of Sheffield 
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3. First Generation of Anionic Polycyclization 
Mike Southern proposed an intramolecular cyclization of the 
polyunsaturated ester 3.030 in a five-step process to forge the indole-
manzamine central core 3.031. These operations were coined “Anionic 
Polycyclization”. Unfortunately, this procedure suffered from weaknesses in 
that there was no control of the double bond geometry of the 
polyunsaturated system in 3.030 and that low yield of the polycyclization 
itself was poor. However, this method exhibited an interesting potential of 
simplicity and decent yield of 30 % over 5 steps. (Scheme 7).8 
 
Scheme 7: First generation of anionic polycyclization 
 X-ray diffraction was performed on trans-3.032 to confirm the 
hypothesized diastereoselectivity. The structure of cis-3.031 was deduced 
from correlations of its spectroscopic properties with those of 3.032. 
  
                                                          
8 Markó, I. E.; Southern M. J.; Adams H. Tetrahedron Lett. 1992, 33, 4657.  
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4. Second Generation of Anionic Polycyclization 
Laurent Turet used enone 3.035 as cyclization precursor. He found 
that tBuOK or CsOH could promote the reaction. Double cyclization 
proceeded with a nice yield of 65 % and lead to trans-3.036 and cis-3.037 
with an unfortunate preference for 3.037 (Scheme 8).9  
 
Scheme 8: Second generation of anionic polycyclization 
The trans-3.038 could come from epimerization of the α-keto 
hydrogen of cis-3.039 by the action of tBuOK (Scheme 9). 
 
Scheme 9: Epimerisation 3.038-3039 
A simple mechanism was proposed and implied metalation of the 
indole nitrogen of 3.035 by tBuOK, followed by Michael addition of the indole 
3 position on the enone in 3.040. Potassium enolate 3.041 was then 
postulated to equilibrate under the action of tBuOH to bring forth enolate 
                                                          
9 (a) Turet, L.; Markó, I. E.; Tinant, B.; Declercq, J-P.; Touillaux, R. Tetrahedron Lett. 
2002, 43, 6591. (b) Turet, L. PhD Thesis 2004, Université catholique de Louvain. 
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3.042 that cyclized to potassium amide 3.043. Finally, reprotonation with 
tBuOH provided the tetracycle 3.037 (Scheme 10). 
 
Scheme 10: Mechanism of polycyclization 
The methodology was extended to various side chains. Entries 3, 5 
and 7 were designed for macrocyclization but unfortunately could not 
promote the formation of 3.045. The yields in entries 9 & 10 are slightly lower 
with the substrate bearing an N-allyl (Scheme 11 and Table 1). 
 
Scheme 11: Application of polycyclization 
Entry R1 R2 Yield (%) 
1 PMB Et 45 
2 PMB Bu 60 
3 PMB (CH2)2CC(CH2)4Cl 49 
4 PMB H 55 
5 Boc (CH2)2CC(CH2)4Cl 64 
6 (CH2)4CCCH3 (CH2)2CCCH3 49 
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7 (CH2)4CCCH2OTBS H 38 
8 (CH2)4CHCH2 (CH2)2CHCH2 61 
9 Allyl Et 35 
10 Allyl Bu 38 
Table 1: Application of polycyclization 
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5. ACNO derivatives through Acid/Base-Polycyclization 
On his way towards the synthesis of Aspidosperma and Strychnos 
alkaloids, Nicolas Heureux used an Acid/Base-catalyzed polycyclization.10 
Reduction of the imine derived from tryptamine 1.013 and 
benzaldehyde gave the secondary amine 3.046 which underwent amide 
coupling with 3.047 providing the polycyclization precursor 3.048. Direct 
polycyclization with tBuOK afforded the product 3.049 in poor yield (14 %). 
This could be tremendously improved by a two-step process up to 67 %, 
producing the monocyclic intermediate 3.050 in the presence of silica gel. 
This indolenine-ketone 3.050 could perform a ring closure with tBuOK 
leading to 3.049 (Scheme 12). 
 
Scheme 12: Acid-base polycyclization 
  
  
                                                          
10 (a) Heureux, N.; Wouters, J.; Markó, I. E. Org. Lett. 2005, 7, 5245. (b) Heureux, N.; 
Wouters, J.; Norberg, B.; Markó, I. E. Org. Biomol. Chem. 2004, 4, 3898. (c) Heureux 
N. PhD Thesis 2006, Université catholique de Louvain. 
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At the same time, Nicolas detected 3.051 as a major side product of 
the reaction from 3.050 to 3.049 considering the temperature as the primary 
factor for its production because of the basicity of tBuOK. At -78°C, only 3.049 
was recovered (Scheme 13). 
 
Scheme 13: Epimerisation 3.049-3.051 
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6. Objectives of this Ph.D. Thesis 
The main objective is to find the shortest possible way to the 
tetracyclic core of indole-manzamine 3.024 using a new methodology of 
Anionic Polycyclization. 
This new Anionic Polycyclization would be the outcome of everything 
understood in the previous ones: 
a) tBuOK proved to be a good base for this kind of reaction 
b) α-keto-hydrogen can be epimerized in 3.038-3.039 
c) α-amido-hydrogen can be epimerized in 3.049-3.051 
d) polycyclization can be successful on ene-dione system 
Combined, these points led to the following idea: using tBuOK as 
base for an ene-dione indole 3.052 polycyclization and if needed tBuOK 
should be able to epimerise 3.053 into 3.054. This could be tested with a 
simple ene-dione R2 = H or with a Knoevenagel condensate R2 = CO2Me 
(Scheme 14). 
 
Scheme 14: Thesis Project 
 The second objectives are:  
• Using cheap starting materials such as indole 3.025 
• Look for bioactivities of our newly made products 
• Obtain the correct diastereoisomer 3.054 
• Finish the synthesis of indole-manzamine 3.024 
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Chapter IV 
Attempts to reach ene-dione moiety 
 
As has been extensively discussed in the previous chapter, we aimed 
at synthetizing the Knoevenagel adduct 4.001 or ene-dione 4.002 to set the 
stage for the cyclization into the tetracycle 4.003 (Scheme 1). 
 
Scheme 1: Target molecule and precursors 
According to literature, the easiest access to ene-dione 4.002 would 
be the oxidation of furan 4.004 (in blue). Unfortunately, the presence of 
both, the indole (in red) and the amine (in pink) in 4.004 might be 
problematic towards oxidation. Moreover, the use of protections would go 
against our objective of a short synthesis. However, this chemistry could 
serve as a back-up plan in case other pathways failed (Scheme 2). 
 
Scheme 2: Ideal retrosynthesis 
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1. First disconnection with epoxide and β-keto-ester 
The highly activated Michael-acceptor 4.001 was assigned as a first 
target and should be accessible from the oxidation of alcohol 4.005 followed 
by the elimination of HCl to forge the unsaturation of 4.001. Epoxide opening 
of 4.006 with chloro-β-keto-ester 4.007 should provide the requested 
alcohol 4.005. The presumably poor nucleophile 4.007 will be, at first, 
replaced by its non-chlorinated and sterically more appealing homologue 
4.008 to obviate this issue (Scheme 3). 
 
Scheme 3: Disconnection epoxide and β-keto-ester 
 The synthesis of epoxide 4.014 started with high yielding formylation 
of indole 3.025 to 3.027. 1  This operation was followed by reductive 
amination with benzylamine, allowing access to 4.012. Epichlorohydrin 4.013 
was selected as 1,3-bis-electrophile and the addition of amine 4.012 
successfully led to 4.014. Unfortunately, the cyclization to epoxide 4.015 
failed. The reason is the proximity of the pKa range of a secondary alcohol OH 
(in red) and NH of indole (in blue). This deprotonation only afforded an 
undesirable mixture of products. We suspected the formation of cyclized 
product by 5-exo-tet or 6-endo-tet cyclization and even intermolecular 
reaction. Unfortunately, these potential products cannot be useful for us 
(Scheme 4). 
                                                          
1 Smith, G. F. J. Chem. Soc. 1954, 3842. 
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Scheme 4: Synthesis of 4.015 
 The easiest way to confirm this issue would be the removal of the 
acidic proton attached to the indole. Sulfonamide is a classic choice for 
indoles and 3.027 was reacted with benzenesulfonyl chloride to afford the 
sulfonamide 4.016.2  This compound underwent reductive amination with 
benzylamine yielding 4.018. Unfortunately, the presence of this protection 
drastically increased the steric hindrance around the secondary amine, and 
the same reaction as before required stronger conditions to convert 
epichlorohydrin 4.013 into 4.019. The cyclization into epoxide 4.020 was 
performed with a good yield of 80 % from amine 4.018 (Scheme 5). 
 
Scheme 5: Synthesis of epoxide 4.020 
                                                          
2 Tholander, J.; Bergman, J. Tetrahedron 1998, 55, 6243. 
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 As explained before, the epoxide opening tests were performed with 
the dehalogenated β-keto-ester 4.008. Various conditions were tested for 
this reaction. There are two major potential products, namely gamma-
hydroxy-ester 4.021 or the lactone 4.022. Both of them could come from the 
reaction between 4.020 and the anion of 4.008. To our greatest dismay, none 
of them was observed and only starting material was recovered. One 
hypothesis is that the extreme steric hindrance brought forth by the 
phenylsulfonamide moiety and benzyl on the amine shield the epoxide from 
incoming nucleophiles (Scheme 6). 
 
Scheme 6: Epoxide opening with β-keto-ester 
 Due to this issue and the use of protecting group, we reinvestigated 
our disconnection.  
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2. Second disconnection with epoxide and amine 
a. Synthesis of chlorine epoxide 
The target molecule is again 4.001 and was planned to come from 
the oxidation of alcohol 4.005 and elimination of HCl. Contrary to the initial 
strategy, the epoxide 4.023 would be opened by the more nucleophilic amine 
4.024. The opening of epichlorohydrin under these conditions proved to be 
successful in the past (Scheme 7). 
 
Scheme 7: Second disconnection 
 The synthetic sequence that should allow access to 4.023 started 
with C-allylation of keto-ester 4.008 with allyl bromide to lead to mono-allyl 
4.025 in 60 % yield (the 40 % remaining are starting material and undesired 
bis-allylated product). 3  At this point we were facing two possibilities, 
chlorination or a Prilezhaev epoxidation. So, we tried both to see which one 
is more convenient. Epoxidation of 4.025 with mCPBA leads to the desired 
epoxide 4.026. Chlorination with SO2Cl2 was performed to afford the 
unexpected product 4.027. This new product was a single compound by NMR 
and since the same mass as 4.023 was found by mass spectroscopy, 4.027 is 
thought to be a structural isomer and a rearranged product of our target. 
Two hypotheses can be formulated from those results. First, the product is 
unstable and rearranges. Second, the conditions promote the 
rearrangement. The second hypothesis is extremely easy to verify, mono-
allylated product 4.025 was chlorinated with SO2Cl2 into chloro-β-keto-ester 
                                                          
3 Kaoru, N.; Miyai, T.; Ashish, N.; Shinzaburo, O.; Atsuyoshi, O. Bull. Chem. Soc. Jpn. 
1989, 62, 1179. 
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4.028. Epoxidation of 4.028 afforded the same unexpected product 4.027 
together with target molecule 4.029 (Scheme 8). 
 
Scheme 8: Oxidations of allyl-β-keto-ester 4.025 
 The coupling between amine 4.012 and epoxide 4.026 was tested 
and furnished two products: starting material 4.012 and a new product 
4.030. Again, NMR revealed the presence of a single product, not a mixture 
of diastereoisomers and mass spectrometry confirmed that 4.026 and 4.030 
were isomers. (Scheme 9). 
 
Scheme 9: Coupling between amine and epoxide 
The presence of 4.030 can be explained by first deprotonation of 
4.026 by the amine, leading to 4.031. This stabilized enolate could perform a 
5-exo-tet cyclization into dihydrofuran 4.032 which upon reprotonation 
forms 4.030. Being a catalytic process, one equivalent of amine 4.012 was far 
more than enough to quickly convert of the epoxide 4.026 into 4.030 
(Scheme 10). 
 
Scheme 10: Proposed mechanism towards 4.030 
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 The 5-exo-tet cyclization was promoted under basic conditions 
towards 4.030, so similar conditions were tested with acid. Epoxide 4.026 
was submitted to the presence of dry hydrochloric acid and as expected, 
afforded 4.030. There is a suggestion that this transformation occurs via 
conjugated enol 4.033 and intramolecular 5-exo-tet cyclization on activated 
epoxide to afford 4.034. Loss of hydrogen formed 4.030. In case of traces of 
acid in SO2Cl2 during the reaction with 4.026 we can assume that the 
formation of 4.030 is the first step towards 4.027. The chlorination of 4.030 
was tested with SO2Cl2 and as planned we obtained 4.027 but this time, we 
have enough data to understand what has happened. Cyclic enol 4.035 
performs an attack on chlorine (or sulfuryl chloride) providing the α-chloro-
oxonium 4.036 further undergoing an intramolecular 5-exo-trig cyclization. 
By loss of a proton, the resulting product 4.037 delivers the unexpected 
material 4.027 (Scheme 11). 
 
Scheme 11: Cyclization processes during chlorination of epoxide 4.026 
To circumvent this problem, the final procedure consisted in 
chlorination of 4.025 into 4.028 followed by epoxidation with mCPBA in the 
presence of sodium hydrogencarbonate (Scheme 12). 
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Scheme 12: Synthesis of chloro-epoxide 4.029 
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b. Coupling tests 
 The coupling was tested with both, unprotected amine 4.012 or 
protected amine 4.018 in the presence of chloro-epoxide 4.029 to hopefully 
deliver our target 4.038. No matter the conditions tested, amine 4.012 
inevitably leads to decomposition of chloro-epoxide 4.029 or of starting 
material. As expected, amine 4.018 did not react at all (Scheme 13). 
 
Scheme 13: Coupling between amines and epoxides 
Facing all these setbacks, we decided to change the target to the 
simple ene-dione 4.002 without the ester moiety. This ene-dione 4.002 
should be less active for the first cyclization (Knoevenagel adduct in the first 
case against enone in this case) but we expected less problems to obtain it. 
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3. Wittig approach 
A new disconnection was considered, based on a Wittig reaction 
between 4.041 and 4.042 and an SN2 between 4.012 and 4.041 (Scheme 14). 
 
Scheme 14: Disconnection based on Wittig reaction 
Phosphorane 4.041 was synthesised in two steps with excellent yield 
from 1,3 dichloroacetone 4.043.4 Those steps were followed by a Finkelstein 
halogen exchange to afford 4.045 in good yield (Scheme 15). 
 
Scheme 15: Chloro and iodo-phosphorane synthesis 
 Both ketohalides 4.041 and 4.045 were tested under the SN2 reaction 
conditions with amine 4.012. No reaction was observed with 4.041, on the 
other hand, the iodinated material 4.045 lead to 4.046 in a good yield of 75 
% (Scheme 16). 
 
Scheme 16: SN2 between amine 4.012 and Phosphorane 
                                                          
4 Taillier, C.; Hameury, T.; Bellosta, V.; Cossy, J. Tetrahedron 2007, 63, 4472. 
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 Pyruvic acid 4.047 was protected and esterified with methanol to 
produce the ester 4.048.5 Ensuing reduction with DiBAL-H afforded aldehyde 
4.042 in good yield (Scheme 17). 
 
Scheme 17: Synthesis of 4.042 from pyruvic acid 4.047 
 The Wittig reaction was tested with keto-phosphorane 4.046. A 
plethora of high boiling point solvents were used to perform this reaction, 
inclusive of dichloroethane, toluene, p-xylene and chlorobenzene. 
Unfortunately, none of these conditions leads to the desired enone 4.049, 
presumably due to the low nucleophilicity of keto-phosphorane 4.046 and 
the high α steric hindrance of aldehyde 4.042 (Scheme 18). 
 
Scheme 18: Wittig reaction towards 4.049 
 To support his hypothesis, reaction between chlorinated compound 
4.041 and aldehyde 4.042 was tested but to no avail (Scheme 19). 
 
Scheme 19: Proof of low reactivity of 4.041 
  
                                                          
5 Bowman, E. R. J. Chem. Soc. Perkin Trans. I 1982, 1897. 
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4. Horner-Emmons approach 
To improve the nucleophilicity, the β-keto-phosphorane was 
exchanged for a β-keto-phosphonate to set the stage for a Horner-Emmons 
reaction instead of a Wittig. The SN2 between 4.012 and 4.051 was 
untouched (Scheme 20). 
 
Scheme 20: Disconnection based on Horner-Emmons reaction 
 Starting from dichloroacetone 4.043, reaction with methyl 
hydrazinocarboxylate 4.052 lead to 4.053.6 This compound underwent an 
Arbuzov reaction followed by hydrolysis into chloro-keto-phosphonate 4.051 
and by a Finkelstein reaction to afford iodo-keto-phosphonate 4.054 
(Scheme 21). 
 
Scheme 21: Synthesis of chloro and iodophosphonate 
 The coupling was tested between amine 4.012 and chloro-
compound 4.051 or iodo compound 4.054. Once again, the reaction with the 
chloro adduct was unsuccessful. The amino-keto-phosphonate 4.055 was 
obtained in a decent yield of 60 % with an important proportion of another 
product 4.056. The NMR data of this new compound were extremely similar 
to amine 4.012 except that benzylic CH2 integration was half of the required 
number. Therefore, we deduced an indole dimer from our analyses (Scheme 
22). 
                                                          
6 Corbel, B.; Medinger, L.; Haelters, J-P.; Sturtz, G. Synthesis 1985, 11, 1048. 
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Scheme 22: SN2 between amine 4.012 and Phosphonates 4.051 and 4.054 
 Bis-indole 4.056 could come from elimination during the SN2 process. 
The attack of amine 4.012 on iodide 4.057 (X = I) provides ammonium 4.058. 
Two possibilities are available for this ammonium 4.058, first, deprotonation 
towards the target molecule 4.055 or elimination into ene-indoleninium 
4.060 and amine 4.059. As an extremely good electrophile 4.060 can react 
with starting material 4.012 to furnish bis-indole 4.056 (Scheme 23). 
 
Scheme 23: Proposed mechanism for di-indole creation 
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 Product 4.056 was detected in most of our SN2 reactions with amine 
4.012. It could be the major problem in our reactions with those amines. Bis-
indole 4.056 was also detected in the NMR spectra of a former Ph.D. student 
as minor side product. 
 
 To add evidence to the degradation of the ammonium 4.058, we 
performed the reaction using only HCl in aqueous methanol. After few hours 
of reflux, we could isolate 35 % of the bis-indole 4.056. these data support 
our speculation about the degradation (Scheme 24). 
 
Scheme 24: Formation of bis-indole 4.056 in acidic media 
  
Reaction between keto-phosphonate 4.055 and aldehyde 4.042 was tested 
with various bases and solvents. None of them was successful, probably 
because of the NH of indole which is in the same range of pKa as our β-keto-
phosphonate function and only degradation was recovered (Scheme 25). 
 
Scheme 25: Horner-Emmons reaction towards 4.049 
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5. Horner-Emmons approach with amide 
To solve both issues, production of bis-indole and indole-NH acidity, 
the decision of modifying the pathways was taken, again. We already 
protected NH of indole as sulfonamide such as 4.018. Unfortunately, this 
protecting group requires drastic conditions for removal. A carbamate might 
offer an attractive alternative to this. To avoid the bis-indole formation, an 
amide modification was considered to the nitrogen, but there are three 
possibilities 4.061, 4.062, 4.063 (Scheme 26). 
 
Scheme 26: possible amides 
Amides in 4.062 and 4.063 were not chosen due to potential 
problems in the presence of base. We postulate the same elimination in basic 
medium as is observed in acidic conditions. Deprotonation of 4.063 (for 
example) could lead to 4.064 which can fragment into ene-indolenine 4.065 
and 4.066 (Scheme 27). 
 
Scheme 27: Elimination in basic media 
The new disconnection envisioned here is based on amide coupling 
between 4.068 an oxidized form of Vilsmeier adduct 3.027, and the aminol 
4.069 (Scheme 28). 
 
Scheme 28: Amide disconnection 
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The synthesis starts with a Vilsmeier-Haack reaction followed by 
protection of indole as carbamate 4.070 and finally, Pinnick oxidation into 
acid 4.071. At the same time, Arbuzov-Michaelis reaction was conducted on 
triethylphosphite 4.073 with allyl-bromide resulting in allylphosphonate 
4.0747 which was epoxidized with oxone and acetone mixture into 4.075. The 
epoxide 4.075 reacted with allylamine to afford phosphonoaminol 4.076 in 
an excellent overall yield. Acid 4.071 was activated by oxalyl chloride into 
4.072 and reacted with aminol 4.076 to furnish 4.077 in 90 % yield (Scheme 
29). 
 
Scheme 29: Synthesis of alcohol 4.077 
                                                          
7 Platonov, A. Yu.; Sivakov, A. A.; Chistokletov, V. N.; Maiorova, E. D. Russ. Chem. Bull. 
1999, 48, 367. 
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Oxidation of secondary alcohol 4.077 to ketone 4.078 was conducted 
under various conditions such as Swern8, Dess-Martin9, Parikh-Doering10, 
PCC11, bleach, Corey-Kim12, Pfitzner-Moffatt13, copper oxidation14, … Only 
PCC gave a non-reproducible 50 % yield of ketone 4.078 as well as two side 
products 4.079 and 4.080 (Scheme 30). 
 
Scheme 30: Oxidation of alcohol 4.077 
The formation of 4.079 and 4.080 could be explained by the fact that 
alcohol and phosphonate at those position turn the molecule into a good 
chelating agent for chromium in PCC. Two different degradation pathways 
could occur from the same system, the first 4.081 used the lone pair of 
nitrogen to kick out the chelating part, leading to amidium 4.082 which got 
hydrolysed into 4.079. The second is an elimination of allylic hydrogen 4.083 
removing the chelating function from the amide to afford 4.084 which also 
got hydrolysed into 4.080 (Scheme 31). 
                                                          
8 Omura, K.; Swern, D. Tetrahedron 1978, 34, 1651. 
9 Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155. 
10 Parikh, J. R.; Doering, W. V. E. J. Am. Chem. Soc. 1967, 89, 5505. 
11 Corey, E. J.; Suggs, J. W. Tetrahedron Lett. 1975, 16, 2647. 
12 Corey, E. J.; Kim, C. U. J. Am. Chem. Soc. 1972, 94, 7586. 
13 Pfitzner, K. E.; Moffatt, J. G. J. Am. Chem. Soc. 1963, 85, 3027. 
14 Markó, I. E.; Giles, P. R.; Tsukazaki, M.; Brown, S. M.; Urch, C. J. Science, 1996, 274, 
2044. 
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Scheme 31: Eliminations during oxidation 
Because of oxidation issues, this pathway was definitely not suitable 
for the synthesis. 
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6. Synthesis of Ene-dione by mCPBA and Br2 
With the amide and carbamate in place, the Oxidative-Ring-Opening 
(ORO) of furan is available. This pathway starts with a Vilsmeier-Haack 
reaction on 2-methyl-furan 4.085 into 4.086 15 , followed by reductive 
amination of benzylamine to bring forth the secondary amine 4.08716, and 
the major side product 4.08817 resulting from double addition. Activation of 
the acid 4.071 with oxalyl chloride to the acyl chloride 4.072 and coupling 
with our newly formed amine 4.087 afforded 4.089 in 90 % yield. Furan 4.089 
was oxidized to Z-ene-dione 4.090 with mCPBA in an excellent yield of 90 % 
(Scheme 32). 
 
Scheme 32: First synthesis of ene-dione 
 The deprotection-cyclization was tested as a one-pot procedure with 
lithium hydroxide in H2O and THF. Different products were expected from 
                                                          
15 Semple, J. E.; Wang, P. C.; Lysenko, Z.; Jouillé, M. M. J. Am. Chem. Soc. 1980, 102, 
7505. 
16 Heaney, H.; Papageorgiou, G. Tetrahedron, 1996, 52, 3473. 
17 Holdren, R. F.; Hixon, R. M. J. Am. Chem. Soc. 1946, 68, 1198. 
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this reaction: the deprotected adduct 4.092, the first cyclization 4.093 and 
the tetracyclic 4.094. Unfortunately, only degradation was obtained (Scheme 
33). 
 
Scheme 33: Deprotection and cyclization 
 Deprotection of 4.089 prior to oxidation was also tested. The use of 
lithium hydroxide in aqueous tetrahydrofuran was efficient to convert 4.089 
into free indole 4.095. Unfortunately, the ensuing oxidation provided a 
complex mixture of compounds such as 4.096 and 4.097 (Scheme 34). 
 
Scheme 34: Oxidation of furan 4.095 
 A replacement for mCPBA as oxidant could be bromine 18 ; this 
reaction led to a mixture of products. Furan in 4.095 could react with 
bromine leading to 4.098 followed by nucleophilic attack of indole on 
furanoxonium leading to bi-spiro compound 4.099 which could undergo 
                                                          
18 Pikul, S.; Raczko, J.; Ankner, K.; Jurczak, J. J. Am. Chem. Soc., 1987, 109, 3981. 
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many degradations such as hydrolysis of indolenine, hydrolysis of bromo-
furan, and various 1,2 carbon shift, … (Scheme 35). 
 
Scheme 35: Reaction with Bromine 
 The last tests bring to evidence that protection of indole is therefore 
mandatory if we want to successfully oxidize the furan. Since deprotection in 
basic media gave rise to problems, a Boc and acidic deprotection should solve 
this drawback. Protection and oxidation of 4.095 to ene-dione 4.101 was 
carried out without issue in excellent yield (Scheme 36). 
 
Scheme 36: Boc protection and oxidation 
 Many Lewis and Brønsted acid were tested for Boc deprotection, 
bidentate Lewis acid could also activate the ene-dione 4.101 into a 
polycyclization mechanism (Scheme 37) and (Table 1). 
 
Scheme 37: Lewis acid cyclization 
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Entry Acid Solvent Results 
1 Mg(OTf)2 DCM or THF Isomerisation Z-4.101 -> E-4.102 
2 ZnBr2 DCM or THF Isomerisation Z-4.101 -> E-4.102 
3 Zn(OTf)2 DCM or THF Isomerisation Z-4.101 -> E-4.102 
4 BF3.OEt2 THF Degradation 
5 AlMe3 THF Degradation 
6 TMSI CH3CN Diketone 4.105 
7 TMSOTf DCM Isomerisation Z-4.101 -> E-4.102 
8 TFA DCM Isomerisation Z-4.101 -> E-4.102 
9 TFA + HCl DCM Isomerisation Z-4.101 -> E-4.102 
10 TFA + HBr DCM Isomerisation Z-4.101 -> E-4.102 
Table 1: Boc deprotection and potent cyclization 
 
Scheme 38: Isomerisation Z-E 
 Most entries (1, 2, 3, 7, 8, 9, 10) afforded the E-4.102 isomer without 
any deprotection of Boc. Boron trifluoride and trimethylaluminum led to 
degradation and trimethylsilyliodide furnished the diketone 4.105, probably 
by activation of ene-dione 4.101 followed by Michael addition of iodide. The 
second ketone could be activated, and iodide can do iodine elimination 
leading to bis-enol 4.104 which could be hydrolysed into diketone 4.105. This 
mechanism is supported by the presence of iodine in the media at the end of 
the reaction (Scheme 39). 
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Scheme 39: Reduction of ene-dione to diketone 4.105 
 At this stage of the project, it was mandatory to find a way to 
deprotect indole or ene-dione without destroying the sensitive molecule. We 
decided to reinvestigate protecting groups and focused on entities such as 
Teoc 4.106, bromoethanecarbamate 4.107 and p-nitrophenolcarbamate 
4.108 (Scheme 40). 
 
Scheme 40: Several protecting groups 
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7. Synthesis of Ene-dione using bromine 
Another possibility is the use of bromine in methanol to oxidize 4.109 
into dimethoxy-furan 4.110, which could get smoothly hydrolysed into ene-
dione 4.111 (Scheme 41).19 
 
Scheme 41: Oxidation with bromine in methanol 
 This procedure was tested on furan 4.089 and was successful. 
However, the presence of rotamers of amide and carbamate in addition to 
diastereoisomer of dihydrofuran makes it hard to analyse. Dimethoxy-furan 
4.112 was directly deprotected by addition of sodium hydroxide in the 
methanolic reaction into 4.113 which was smoothly hydrolysed to indole-
ene-dione Z-4.092 (Scheme 42).  
 
Scheme 42: Synthesis of indole-ene-dione 
  
                                                          
19 Al-Busafi, S.; Doncaster, J. R.; Drew, M. G. B.; Regan, A. C.; Whitehead R. C. J. Chem. 
Soc., Perkin Trans I, 2002, 476. 
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8. Polycyclization tests 
From this point, the stage was finally set for polycyclization 
conditions to be investigated. Ene-dione 4.092 is presumably more reactive 
than any precursor from the previous generation of anionic polycyclization, 
which were acrylate and enone derivatives. This statement makes the use of 
strong base useless and allowed us to test weak bases first in order to install 
the tetracycle 4.114 (Scheme 43) and (Table 2). 
 
Scheme 43: Cyclization to tetracycle 4.094 
Entry Base Solvent T° Outcome 
1 Pyridine 
DCM RT Isomerisation Z-4.092 -> E-4.114 
THF 0°C Isomerisation Z-4.092 -> E-4.114 
CH3CN 0°C Isomerisation Z-4.092 -> E-4.114 
2 2,6-lutidine 
DCM 0°C Isomerisation Z-4.092 -> E-4.114 
THF 0°C Isomerisation Z-4.092 -> E-4.114 
CH3CN 0°C Isomerisation Z-4.092 -> E-4.114 
3 DMAP 
DCM 0°C Degradation 
THF 0°C Isomerisation Z-4.092 -> E-4.114 
CH3CN 0°C Isomerisation Z-4.092 -> E-4.114 
4 Et3N 
DCM 0°C Degradation 
THF/H2O RT Isomerisation Z-4.092 -> E-4.114 
CH3CN RT Degradation 
5 DABCO 
DCM 0°C Degradation 
THF 0°C Degradation 
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CH3CN 0°C Degradation 
6 DIPEA 
DCM RT Isomerisation Z-4.092 -> E-4.114 
THF RT Isomerisation Z-4.092 -> E-4.114 
CH3CN RT Isomerisation Z-4.092 -> E-4.114 
7 Morpholine 
DCM 0°C Degradation 
THF 0°C Degradation 
CH3CN 0°C Degradation 
8 NMM 
DCM 0°C Degradation 
THF RT Degradation 
CH3CN 0°C Degradation 
9 DBU 
DCM 0°C Degradation 
THF RT Degradation 
CH3CN 0°C Degradation 
10 TMG 
DCM 0°C Degradation 
THF 0°C Degradation 
CH3CN 0°C Degradation 
Table 2: Cyclization with weak bases 
Unfortunately, degradation and isomerisation are the only two types 
of observed outcomes. This is further evidence for our previous statement, 
ene-dione 4.092 is highly reactive. Entry 9 and 10 were misfortune, both are 
on the pKa range of indole and we naively expected interesting results. But 
maybe it could be solved with an inorganic base or a strong organic base 
which would do a total deprotonation instead of equilibrium (Scheme 44). 
 
Scheme 44: Isomerisation Z-E 
Chapter IV 
 
91 
 
Polycyclization tests with stronger bases were performed (Scheme 
45). 
 
Scheme 45: Cyclization with strong bases 
 Degradation was the only outcome obtain with strong bases. The 
molecule is definitely too sensitive to weak or strong bases. 
 Unsuccessful with bases, acid catalytic tests were performed. Both 
Brønsted and Lewis acids were used (Scheme 46). 
 
Scheme 46: Cyclization with acids 
 Isomerisation to E-ene-dione 4.114 was the only outcome except 
with PPTS which provide back the starting material. According to these data 
strong inorganic acid can do the isomerisation. Therefore, the isomerisation 
with metallic Lewis acid is probably due to traces of Brønsted acid. 
 So far, no cyclized product 4.094 could be synthetized.  
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9. Conclusions 
Different pathways were used to reach our polycyclization 
precursors, all along the synthesis was adapted to avoid the detected side 
products, such as 4.027, 4.030, 4.056, 4.079, 4.080 and 4.105 (Scheme 47). 
 
Scheme 47: Example of side products 
 Finally, the desired precursor 4.092 was synthetized, however no 
conditions could cyclize it into the tetracycle 4.094. The high reactivity of 
the ene-dione moiety appears to be problematic (Scheme 48). 
 
Scheme 48: precursor and target molecule 
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10. Perspectives 
Because of the failure to cyclize ene-dione 4.092 into the desired 
tetracycles 4.094, we considered alternatives to obtain similar products 
4.116, 4.118 or 4.120 with 4.115, 4.117 and 4.119 as precursors, respectively 
(Scheme 49). 
 
Scheme 49: Alternatives 
 Precursor 4.119 looks more promising than 4.115 and 4.117. Simple 
ynone 4.119 could be easy solution if we find a way to reduce the 
unsaturation from the α-face. The yne-dione 4.117 would probably afford 
the same difficulties and issues as our ene-dione 4.092. Discrimination 
between the ketones in diketone 4.116 will increase the difficulty of the next 
steps. 
 
 The second part of those perspectives is the presence of the amide 
to avoid ammonium elimination. This carbonyl most probably changes the 
total chemistry of the molecule, just to prevent few percent of side products. 
The synthesis of the next precursors 4.121 will be tested without the amide. 
If a major issue is encountered, it will be set back (Scheme 50).  
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Scheme 50: Future attempts 
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Chapter V 
Third Generation Anionic Polycyclization 
 
1. Ynone synthesis and preliminary tests 
As already mentioned in Chapter IV, 5.001 was assigned as a 
strategic target being derived from intermediate 5.002 upon polycyclization. 
The disconnection we envisioned is based on the mono addition of a double 
anion of 5.004 on Weinreb amide 5.003 (in red). Finally, the amine 5.004 
ought to be an SN2 product between amine 5.005 and homo-propargylic 
moiety 5.006 (in blue) (Scheme 1). 
 
Scheme 1: Disconnection for 5.002 as precursor 
Due to the potential problems that might arise, a model study was 
planned. The use of commercially available and more reactive propargyl 
bromide 5.007 was considered instead of 5.006. The SN2 reaction of amine 
5.005 with propargyl bromide 5.007 (in blue) should lead to 5.008. The [5,6] 
tetracycle 5.009 should be derived as the polycyclization product with 5.008 
as starting material (Scheme 2). 
 
Scheme 2: Use of propargyl bromide 
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a. Synthesis of precursor 
The synthesis starts with Vilsmeier-Haack reaction of indole 3.025 to 
bring forth formyl-indole 3.0271, that is directly submitted to a reductive 
amination with p-methoxy-benzylamine and sodium borohydride to install 
secondary amine 3.033 (Scheme 3). 
 
Scheme 3: Synthesis of amine 3.033 
 Amine 3.033 was conveniently propargylated with 5.007 to form 
5.013. The Weinreb amide 5.015 was produced by condensation of hexanoic 
acid 5.014 and N,O-dimethylhydroxyamine. The double anion 5.016 was 
obtained by reaction of propagylamine 5.013 and two equivalents of n-
butyllithium. Weinreb amide 5.015 was then added to the double anion 
5.016 and the mixture was quenched with a saturated aqueous solution of 
NH4Cl. The ynone 5.017 was obtained as planned with a small quantity of 
side-products. Unfortunately, the ynone 5.017 is unstable on silica gel (even 
neutralised with triethylamine) (Scheme 4). 
 
Scheme 4: Synthesis of ynone 5.017 
                                                          
1 Smith, G. F. J. Chem. Soc. 1954, 3842. 
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b. Polycyclization tests 
With ynone 5.017 in hand, different bases were tested to forge 
tetracycle 5.018 (Scheme 5) and (Table 1). 
 
Scheme 5: Polycyclization of ynone 
Entry Base (eq.) Solvent Outcome 
1 tBuOK (0.25) THF Degradation 
2 tBuOK (0.25) CH3CN Degradation 
3 DBU (0.40) THF New products 
4 DBU (0.40) CH3CN New products 
5 DIPEA (0.40) DCM Starting material 
Table 1: Polycyclization conditions 
 Entries 1 and 2 reveal that potassium tert-butoxide lead to 
degradation in THF or in CH3CN. Entry 5 shows that DIPEA does not promote 
the formation of any new product. As shown in entries 3 and 4, DBU furnishes 
several products which could be a mixture of 5.019, 5.020 or 5.018. The 
vinylic hydrogen (in red) possesses a characteristic shift in NMR, three new 
peaks were observed between 5,5 ppm and 6,5 ppm. Finally, the indolenine 
hydrogen (in blue) possesses the same feature with a chemical shift between 
8 and 8,5 ppm and two new peaks were observed. Purification provides a 
product which could be the tetracycle 5.018 (Scheme 6). 
 
Scheme 6: Potential products of cyclization 
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c. Postulated mechanism 
Since the initial tests showed some priming results, we decided to 
propose a mechanism based on the data we obtained. Indole 5.017 was 
deprotonated with DBU to give 5.021 which can undergo a Michael addition 
in a 5-exo-dig fashion to 5.022 (and its isomer with the side chain down and 
alkoxide up). Reprotonation of 5.022 with DBU-H+ would give cis-5.020 or 
trans-5.019. Enone 5.019 could be deprotonated by DBU into enolate 5.023 
which would perform a 6-exo-trig cyclization on the indolenine moiety to 
yield 5.024. Finally, in our mechanistic proposal 5.024 would be reprotonated 
into our target molecule 5.018 (Scheme 7). 
 
Scheme 7: Proposed mechanism for polycyclization 
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2. Improvement of synthesis 
Propargylation of amine 3.033 leads to two main products, namely 
5.013 and bis-indole 5.025 (Scheme 8) and (Table 2). 
 
Scheme 8: Propargylation of amine 3.033 
Entry Solvent Base (eq.) T (°C) 5.013 (%) 5.025 (%) 
1 THF K2CO3 (1.2) 20 68 10 
2 THF K2CO3 (1.2) 0 72 10 
3 CH3CN K2CO3 (1.2) 20 80 5 
4 CH3CN K2CO3 (1.2) 0 85 5 
5 CH3CN K2CO3 (3) 20 85 5 
6  CH3CN Na2CO3 (3) 20 80 5 
7 CH3CN Cs2CO3 (3) 20 40 20 
8 CH3CN DIPEA (1.2) 20 50 20 
9 DCM DIPEA (1.2) 20 75 10 
10 DCM DBU (1.2) 20 70 10 
Table 2: Conditions for propargylation 
 Most of the entries (1, 2, 3, 6, and 9) provide a proper yield of the 
target product 5.013. The best conditions are summarized in entries 4 and 5 
with an excess of K2CO3 at 0°C or ambient temperate to furnish 85 % of the 
target and around 5 % of bis-indole 5.025. Slightly stronger bases (7 and 10) 
did not improve the outcome of the reaction. 
 In addition to bis-indole 5.025, several other side-products were 
isolated such as bis-propargylamine 5.026, tertiary amine 5.027, 
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anisaldehyde 5.028 (0.05 %) and finally, 5.029 which was observed by mass 
spectrometry (Scheme 9). 
 
Scheme 9: Side-products 
  A proposed mechanism to explain their presence of these side-
products is discussed in this paragraph. Propargylation of amine 3.033 leads 
to ammonium ion 5.030. This ammonium 5.030 could undergo three 
reactions, first deprotonation towards the desired molecule 5.013, the 
second (in blue) fragments into ene-indoleninium 5.031 and amine 5.032 and 
the third (in red) fragments into oxonium 5.035 and amine 5.036. Addition 
of amine 3.033 on ene-indoleninium 5.031 affords the main side product bis-
indole 5.025. Propargylation of amine 5.032 furnishes 5.026 after 
deprotonation. The same amine 5.032 could also react with the oxonium 
5.035 to forge the tertiary amine 5.027 after deprotonation. Addition of 
amine 3.033 on oxonium 5.035 affords tertiary amine 5.029. Finally, the 
speculated secondary amine 5.036 undergoes propargylation and 
deprotonation into 5.038 (Scheme 10). 
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Scheme 10: Mechanism under propargylation 
 The isolation of anisaldehyde 5.028 was a surprise as no anisyl 
alcohol 5.039 or indole 3-carbaldehyde 5.040 were observed. Absence of 
those products promotes a different pathway than addition of water on 
oxonium 5.035 toward alcohol 5.039 then oxidation by air to anisaldehyde 
5.028 (Scheme 11).  
 
Scheme 11: Unobserved side-products 
 The formation of such a small quantity of anisaldehyde 5.028 could 
come from high energy processes, we speculated two hypothetical 
mechanisms. First, hydride elimination from the main product 5.041 and 
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reduction of water (always present in acetonitrile) to form the iminium salt 
5.042 which could react to provide anisaldehyde 5.028 and secondary amine 
5.036. The second option could be a Cope-like 2  rearrangement 5.043 
furnishing imine 5.045 and allene 5.044. Hydrolysis of the imine 5.045 could 
provide primary amine 5.046 and the desired anisaldehyde 5.028 (Scheme 
12). 
 
Scheme 12: Potential anisaldehyde 5.028 formation 
 Luckily, the formation of the ynone 5.017 from the corresponding 
Weinreb amide 5.015 was much easier to optimize. The double 
deprotonation of 5.013 in the presence of nBuLi is instantaneous and can be 
followed visually since the lithium-indole is green, and the bis-metallated 
species 5.016 is pink. As might be expected, the second deprotonation is not 
complete at -78°C and higher temperatures are required to fully convert the 
material into the desired product. The completion with one equivalent of 
Weinreb amide 5.015 is impossible, and a small excess is needed. The 
addition reaction takes place between -20°C and room temperature. No 
addition on indole-lithium anion were observed. The resulting mixture was 
purred on Et2O and a saturated aqueous solution of NH4Cl, any other work-
up resulted in a loss of target product (Scheme 13) and (Table 3). 
                                                          
2 Szabó, A.; Hermecz, I. J. Org. Chem. 2001, 66, 7219. 
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Scheme 13: Double anion chemistry 
Entry T1 (°C) 5.015 (eq.) T2 (°C) Outcome 
1 -78 1 -78°C to 0 Not full conversion 
2 -78 to 0 1 -78°C to 0 Not full conversion 
3 -78 to 0 1.3 -78°C to 0 Not full conversion 
4 -78 to 0 1.3 
-78°C to 
20 
Full conversion, 85 % yield 
Table 3: Optimisation of double anion chemistry 
 Even with a full conversion of the starting material 5.013 and an 
approximate yield of 85 %, the purification of ynone 5.017 was problematic. 
The excess of Weinreb amide 5.015 is a solution for the conversion but an 
issue for the purification. Indeed, the addition of the slight excess of nBuLi 
on Weinreb amide 5.015 furnished decanone 5.047. This speculation was 
tested on the reaction conditions and provide an excellent yield of 5.047 
(Scheme 14). 
 
Scheme 14: Addition of nBuLi on Weinreb amide 
 The two products 5.015 and 5.047 could be a main issue for the 
polycyclization because these substrates are prone to enolization in the 
presence of base. Since ynone 5.017 appears to be extremely reactive on 
many supports as uncontrolled intramolecular and intermolecular reactions 
happened on silica, neutralised silica, alumina, and florisil. A simple way to 
separate the polar and non-polar materials was offered by the partitioning 
between acetonitrile and petroleum ether. Acetonitrile and n-hexane was 
proven to be the best combination for this and removed all undesired 
Chapter V 
104 
 
decanone 5.047 and most of Weinreb amide 5.015 in the hexane phase. The 
product obtained was considered pure enough for polycyclization tests and 
the same procedure could be repeated. 
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3. Third Generation Anionic Polycyclization (TGAP) 
Polycyclization with DBU was reproduced and followed by few 
solvent tests (Scheme 15) and (Table 4). 
 
Scheme 15: Polycyclization with DBU and TMG 
Entry 
Base 
(0.2 eq.) 
Solvent Time 
5.017 
(%) 
5.018 
(%) 
5.019 
(%) 
5.020 
(%) 
1 DBU CH3CN 10 min 30  5  40  25  
2 DBU CH3CN 1h 15  15  40  25  
3 DBU CH3CN 3h / 30  35  25  
4 TMG CH3CN 1h 50  / 30  15  
5 TMG CH3CN 3h 30  / 40  20  
6 DBU DCM 24h / 20  / 30  
7 DBU Benzene 20h / 20  / 40  
8 TMG Benzene 20h 30  / / 50  
9 DBU THF 18h / 40  10  5   
10 DBU THF 42h / 50  / 5  
Table 4: Polycyclization conditions 
In every reaction cis-5.020 could be observed. In most of the case a 
2:1 ratio can be observed between trans-5.019 and cis-5.020 (entries 1, 2, 3, 
4, 5 and 9). As such, the reprotonation step exhibits a facial selectivity of 2:1 
in acetonitrile and tetrahydrofuran. Concerning entry 8, only cis-5.020 was 
detected in benzene with tetramethylguanidine (TMG). In entries 4, 5 and 8 
no product was observed, this is probably because TMG is basic enough to 
deprotonate indole but not basic enough to the second deprotonation in 
those conditions. The use of DBU in acetonitrile and tetrahydrofuran is 
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promising (entries 1, 2, 3, 9 and 10) with so far, a yield of 50 % into our target 
molecule 5.018 in tetrahydrofuran in for 42 hours and a potential conversion 
of 65 % in acetonitrile.  
 
With enough material available, the structures of the main product 
and intermediate could be analytically verified by two-dimensional NMR. All 
the arrows represent observed HMBC correlation inside our target tetracycle 
5.018 and the blue arrows confirm the newly formed vicinity of some carbons 
in the scaffold (Scheme 16). 
 
Scheme 16: HMBC correlations of tetracycle 
 The difference between trans-5.019 and cis-5.020 was made through 
NOESY correlations. Purification appears problematic as 5.019 convert into 
5.020 on triethylamine neutralised silica and both partially decompose in the 
process (similar interactions were removed for the simplicity of 
understanding) (Scheme 17). 
 
Scheme 17: NOESY correlations 
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As simple NOE is not enough to confirm the structure of both 
intermediates. Both underwent the polycyclization conditions and only 5.019 
cyclized (Scheme 18). 
 
Scheme 18: Cyclization of intermediates 
However, the following error occurred. Since at the beginning we 
expected to create 5.018 with diastereoselectivities similar to those in 3.037. 
However, HB is a double triplet (as expected by NMR) with coupling constants 
of 9.6 Hz, 4.8 Hz and 4.8 Hz. The rotation freedom of the side chain should 
make HC and HD identical from the point of view of HB (4.8 Hz looks normal). 
A 9.6 Hz constant in a 6 membered ring implies an anti-relationship between 
HA and HB and of course the other stereochemistry for the side chain. To 
improve the viability of this statement the coupling constant between HE and 
HF in 3.037 is 3.3 Hz for a syn-relationship. From now on we will consider 
5.049 as our major product and 5.018 as a potential minor diastereoisomer. 
The fact that 5.049 is our major product is a tremendously good new, as it 
possesses 3 chiral centres which are identical to those in manzamine A 1.001 
(Scheme 19). 
 
Scheme 19: Confirmation of stereochemistry 
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4. Mechanistical reconsiderations 
To explain this variation in diastereoselectivity, we became focused 
to find a difference between the Second Generation Anionic Polycyclization 
(SGAP) and the Third Generation Anionic Polycyclization (TGAP). We thought 
that the final 6-exo-trig cyclization would be a good starting point. 
In SGAP, four possible enolates from 5.051 could be expected, 
however, only two of them could perform the final cyclization due to correct 
orbital alignments 5.050 and 5.052. The major product 3.037 should emerge 
from enolate 5.050. Steric hinderance could be observed in both enolates 
but R1-HA interaction (red) in 5.052 should make this conformation less 
favoured. In 5.050, HA-HB interaction (blue) is smaller because both are 
hydrogens. It looks like the discrimination is based on steric hinderance with 
HA and provides 3.037 with potential equilibria from the minor product 3.036 
or minor enolate 5.052 (Scheme 20). 
 
Scheme 20: Last steps of SGAP 
 In TGAP, there are two possible enolates from 5.019, respectively 
5.054 and 5.055. The major product 5.049 should come from enolate 5.055. 
Thanks to the unsaturation, there is no hydrogen to create steric hindrance. 
The presence of M (DBU-H+ in this case) induces steric hindrance with R1 and 
make 5.055 the most favoured enolate. Activation due to M could be a 
reason why TMG is not able to cyclize at this stage. The high 
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diastereoselectivity of this step can be explained by potential equilibria from 
minor product 5.018 or minor enolate 5.054 (Scheme 21). 
 
Scheme 21: Last steps of TGAP 
 The third reconsideration is based on the reprotonation of allenolate 
5.056. If M could coordinate the indolenine moiety, the scaffold would be an 
8-membered ring in 5.056. It would rigidify the molecule skeleton and favour 
reprotonation towards 5.019 instead of 5.020. The optimal solution to 
increase the yield would be to find an “M” which can lead only to 5.019 
(Scheme 22). 
 
Scheme 22: Reprotonation of allenolate 5.056 
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5. Organocatalysed polycyclization? 
To optimise our main reaction, we wanted to find the optimal “M”. 
Ricci et al. proposed the addition of indole 5.057 on nitroalkene 5.058 in the 
presence of thiourea derivatives as catalyst to obtain 5.059 (Scheme 23).3  
 
Scheme 23: Thiourea catalyst reaction 
 The reaction is based on the activation of the nitro moiety with 
thiourea and at the same time, activation of indole by the chiral alcohol in 
5.060. Even though our system is less activated than a vinylnitro, the addition 
in 5.061 would be intramolecular and the sterically less demanding ynone 
provides more space around the carbonyl part. With the use of a weak base, 
the cyclized product 5.062 should be extremely stabilized and reprotonation 
could only occur from by the less hindered face (blue arrow) (Scheme 24). 
 
Scheme 24: Plausible activation states 
The idea was tested and diphenylurea 5.064 and diphenylthiourea 
5.066 were synthetized4 (Scheme 25). 
                                                          
3 Herrera, R. P.; Sgarzani, V.; Bernardi, L.; Ricci, A. Angew. Chem. Int. Ed. 2005, 44, 
6576. 
4 Perveen, S.; Hai, S. M. A.; Khan, R. A.; Khan, K. M.; Afza, N.; Sarfaraz, T. B. Synth. 
Commun. 2005, 35, 1663. 
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Scheme 25: Syntheses of urea and thiourea derivatives 
Those catalysts were applied to our polycyclization precursor 
(Scheme 26). 
 
Scheme 26: Organocatalysed tests 
No matter the combination between the base and solvent, no 
reaction happened with urea or thiourea even at higher temperature than 
ambient temperature (higher temperatures led towards degradation of 
starting material). Unfortunately, it is an evidence that this organo-catalyst 
is not convenient for the polycyclization. 
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6. Polycyclization with tBuOK 
Even after the first failures with potassium tert-butoxide, it could be 
a proper base for the TGAP as it is one of the best choices for SGAP. Softer 
conditions were envisioned this time. Entry 1 represents the same conditions 
as previously tested. Time looks like a major factor in this reaction, it appears 
that the product 5.037 degrades under the reaction conditions. The softer 
the reaction the better (entry 5). The reported reaction time for SGAP is 
approximately 1 hour at ambient temperature with 20 mol% of tBuOK at the 
same concentration (Scheme 27) and (Table 5).  
 
Scheme 27: TGAP with tBuOK 
Entry tBuOK (eq.) T  Time 5.049 (%) Outcomes 
1 0.25 RT 30 min / Degradations 
2 0.1 RT 30 min 10 Degradations 
3 0.1  0°C 30 min 20  Degradations  
4 0.1 0°C 15 min 30-35 Degradations  
5 0.1 0°C 5 min 60-65 Cleaner NMR 
Table 5: Conditions with tBuOK 
 After this success, we continued to investigate if potassium can be 
an efficient “M” for the reprotonation. Few conditions and solvents are 
summarized in (Scheme 28) and (Table 6). 
 
Scheme 28: Efficiency of facial reprotonation 
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Entry Solvent 5.049 (%) 5.019 (%) 5.020 (%) 
1 THF 65  / / 
2 CH3CN 60  / / 
3 Toluene / / 65  
4 Benzene / / 65  
5 THF + 1 eq. H2O 5  50  15  
Table 6: tBuOK in various solvents 
 Potassium tert-butoxide exhibited a very high efficiency for the facial 
reprotonation, so potassium can be considered as very good “M” in 
tetrahydrofuran and acetonitrile (entries 1 and 2). The selectivity in aromatic 
solvents is also high but with inverted face-selectivity (entries 3 and 4). Water 
in entry 5 reduced the selectivity and slowed down the rate of the reaction. 
An explanation for entries 3, 4, 5 could be provided from 5.067 as potassium 
might form a chelated intermediate 5.067. 5  If we add water to this 
compound, it will coordinate potassium then there are two options (blue and 
red). If the reprotonation of allenolate 5.068 happens for external face, it will 
furnish the desired intermediate 5.019 (in blue). On the other hand, if the 
water chelated adduct rearranges to allenolate 5.069, reprotonation from 
the internal face is more favoured and will provide 5.020 (red). A similar 
mechanism could explain why toluene and benzene produce only 5.020 (red 
pathway with tert-butanol instead of water) (Scheme 29).  
                                                          
5 Even if potassium is known to be mostly dissociated, there is few examples where 
it can be chelated or coordinated. 
(a) Domingos, A. M.; Sheldrick, G. M. Acta Cryst. 1974, B30, 517. (b) Williard, P. G.; 
Carpenter, G. B. J. Am. Chem. Soc. 1986, 108, 462. (c) Tesh, K. F.; Hanusa, T. P.; 
Huffman, J. C. Inorg. Chem. 1990, 29, 1584. 
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Scheme 29: Variation due to solvent 
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7. Optimisation of TGAP with tBuOK 
Although 65 % yield is already very good, we were curious if a few 
modifications of some parameters could enhance this yield even further. As 
a double intramolecular cyclization, it should be sensitive to the 
concentration of the mixture. Time can play a major role as our product 
slowly degrades. Maybe the proportion of tBuOK is still too high and leads to 
decomposition of our target. 
 
The amount of tBuOK was our first target for optimisation. 
Inconveniently, tBuOK has to be added as a SOLID, any solution will destroy 
the starting material even at -78°C. Slow dissolution of tBuOK in the mixture 
gave the best yield (Scheme 30) and (Table 7). 
 
Scheme 30: Required quantity of tBuOK 
Entry tBuOK (%) 5.049 (%) Comments 
1 10 60-65  Standard  
2 5 55  Messier than Entry 1 
3 2 / Starting material 
4 1 / Starting material 
5 0.5 / Starting material 
Table 7: Required quantity of tBuOK 
 Entries 3, 4 and 5 shed light on the fact that with too small quantity 
of base no reaction occurs. It can be explained by traces of acid such as acetic 
acid from the acetonitrile partitioning or the ammonium chloride quench of 
the reaction. Entry 2 seems to be the minima to deal with acid traces and 
perform the reaction, but it’s slightly messier than entry 1. 
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The reaction time can be modified by the dilution factor, so the next 
parameter to be investigated was the concentration of the mixture (Scheme 
31) and (Table 8). 
 
Scheme 31: Dilution factor 
Entry [C] 5.049 (%) Comments 
1 0.05 M THF 50-55  More degradations 
2 0.1 M THF 65  Standard  
3 0.2 M THF 69  
Totally unexpected behaviour 
4 0.3 M THF 73  
5 0.4 M THF 79  
6 0.5 M THF 85  
7 0.7 M THF 74  Slurry  
8 0.5 M CH3CN 80   
9 0.5 M Toluene 30  30 % of 5.019 and 30 % of 5.020 
10 
0.5 M THF + 
 1 eq. H2O 
/ Full degradations 
Table 8: Analysis of concentration factor 
 The outcome of the dilution table was surprising. The yield increased 
with the concentration of the reaction with a maximum of 85 % at 0.5 M. 
With higher concentration (entry 7) the mixture behaves as a slurry and the 
base was most likely not able to dissolve properly anymore. Entry 8, the 
reaction in acetonitrile at 0.5 M was successful. As a reminder, in toluene at 
0.1 M the reaction provided only 5.020. Interestingly, in entry 9, with toluene 
at 0.5 M we obtain a mixture of all three products 5.049, 5.019 and 5.020. 
This is a total modification of the mechanism as 60 % of the reprotonation 
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occurs from the other face by just increasing the concentration. Entry 10 
furnishes again the fact that Gassman base6 is improper for this reaction. 
 
The last studied factor was time as the concentration was increased, 
it should be reduced (Scheme 32) and (Table 9). 
 
Scheme 32: Reaction time investigation 
Entry Time (s) Outcome 
1 300  
Finished (no starting material or 
intermediates detected) 
2 120  
3 60 
4 30 
5 15 
Table 9: Consideration of reaction time 
 The reaction is finished even after 15 seconds, which correspond to 
the time tBuOK takes to dissolve. Then the product starts to decompose. 
  
                                                          
6 Gassman, P. G.; Hodwon, P. K. G.; Balchunis, R. J. J. Am. Chem. Soc. 1976, 98, 1275. 
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8. Final mechanism 
The final mechanism proposed for this reaction is based on all the 
data collected so far. Some details make us consider the fact that every 
deprotonation-reprotonation process should be between different stages of 
our products, not with tBuOK/tBuOH. A reaction so fast and which need such 
a high concentration is probably not using an intermediate molecule such 
tBuOH. And tBuOK is needed as activator, therefore the following 
mechanism is based on plausible deprotonation-reprotonation between 
intermediates. BUT we suspected that tBuOK/tBuOH approach is still 
credible. 
So, the final mechanism of TGAP in THF 0.5 M with tBuOK as base is 
a combination of both possibilities (Scheme 33). 
The first step is the metallation of starting material 5.017 into 5.057 
by tBuOK. This potassium adduct 5.070 could undergo an intramolecular 5-
exo-dig cyclization on the ynone moiety leading to chelate 5.067 (red). In the 
presence of tert-butanol, it will coordinate the potassium and perform an 
external facial reprotonation (as internal looks forbidden in dry THF) into the 
first observed intermediate 5.019 (blue). In the absence of tert-butanol, the 
allenolate 5.067 (red) is basic enough to deprotonate indole 5.017, allenolate 
5.067 (red) becomes intermediate 5.019 (blue) and indole 5.017 starts the 
cyclization as 5.070. Intermediate 5.019 (blue) can be deprotonated by 
tBuOK or by allenolate 5.067 (red) into enolate 5.059 (pink). As we explained 
earlier, E-enolate is more favoured in this system and furnishes 5.073 by an 
intramolecular 6-exo-trig cyclization. Potassium indoline 5.073 is probably 
the stronger base of this reaction and should be able to metallate any other 
“acidic adduct” such as indole 5.017, intermediate 5.019 (blue) or tert-
butanol turning itself into the final product 5.049 (Scheme 33). 
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Scheme 33: Final mechanism 
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9. Conclusions 
We discovered a new type a polycyclization based on the 
intramolecular cyclization of indole on ynone, to afford the tetracycle 5.049 
(Scheme 34). 
 
Scheme 34: New polycyclization 
Different intermediates and side products were isolated such as 
5.019, 5.020, 5.025, 5.026, 5.027, 5.028, 5.029 and 5.047 (Scheme 35). 
 
Scheme 35: Intermediates and side products 
During optimisation process we proved that tBuOK was probably the 
best base for this reaction. As potassium can coordinate the indolenine 
moiety simultaneously with the allenolate 5.067 (Scheme 36). 
 
Scheme 36: Potential indolenine-allenolate 
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Optimal conditions were unexpected because this intramolecular 
polycyclization needed a high concentration to furnish the best yield 
(Scheme 37). 
 
Scheme 37: Final conditions of TGAP 
Finally, several mechanisms were proposed to explain the empirical 
data that we obtained (Scheme 7), (Scheme 10), (Scheme 14), (Scheme 20), 
(Scheme 21), (Scheme 22), (Scheme 24), (Scheme 29) and (Scheme 33). 
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10. Perspectives 
This polycyclization was tested with only one side chain so far. A 
simple way to extend the methodology would be the use of various side 
chains (noted R) in 5.074 to obtain a library of tetracyclic compounds 5.075 
(Scheme 38). 
 
Scheme 38: Extension of library 
 Application of the double anion chemistry on butyne 5.076 to obtain 
precursor 5.077 and finally application of our conditions toward tetracycle 
5.078. This tetracycle 5.078 is our main target because it could be reduced 
into the correct indole manzamine diastereoisomer 5.079 (Scheme 39).  
 
Scheme 39: Main target 5.079 
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Chapter VI 
Application of the Polycyclization 
 
This chapter will be devoted to the application and extension of our 
methodology towards the synthesis of various target molecules. The 
tetracycles 6.001 and 6.002 could be obtained directly with our ynone 
polycyclization methodology.  The molecule 3.027 is a tetracycle produced 
through the second-generation methodology, a test with our condition could 
be interesting and finally the [7,6] tetracycle 6.004 could be as well a test of 
our conditions on a new compound based on SGAP (Scheme 1). 
 
Scheme 1: Target tetracycles 
 As a reminder the saturated tetracycle 6.005 resulting from the 
reduction of 6.001 is our target, as it possesses the desired stereocentres 
(Scheme 2). 
 
Scheme 2: Desired stereorelationship 
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1. Synthesis of ynone 6.006 
Tetracycle 6.001 should come from the polycyclization of ynone 
6.006, itself a product of the double anion chemistry applied to 5.076 reacted 
with a Weinreb amide as explained in the chapter V (Scheme 3). 
 
Scheme 3: Retrosynthesis 
a. Alkylation 
The butyn-amine 5.076 results from direct N-alkylation of the 
secondary amine 3.033 with mesylate 6.010. The formation of the mesylate 
was performed from commercially available alcohol 6.009 in good yield 
(Scheme 4). 
 
Scheme 4: Synthesis of tertiary amine 5.076 
 The alkylation itself was problematic as the yield did not get higher 
than 35 %. Several products were isolated and identified amongst them the 
bis-indole 6.011, the starting material 3.033, anisaldehyde 5.028, tertiary 
amine 6.013 and secondary amine 6.014 (Scheme 5). 
Chapter VI 
 
125 
 
 
Scheme 5: Isolated side products 
 The presence of these undesired by-products is rationalized in the 
following lines. The main difference between the present alkylation and the 
propargylation in chapter V is an increase of the temperature. The ratio of 
side products has been modified, some of them were not even detected 
compared to the propargylation (Cf. Chapter V). The higher temperature of 
the reaction should increase the elimination rate of the ammonium 6.015 
into ene-indoleninium 6.016 and the secondary amine 6.014. As proposed 
earlier, 6.016 could then react with the starting material to furnish the bis-
indole tertiary amine 6.011. When the secondary amine 6.014 is N-alkylated 
a second time, and the undesired bis-alkylated amine 6.013 is formed 
(Scheme 6). 
 
Scheme 6: Degradation mechanism 
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 In chapter V, the presence of anisaldehyde 5.028 was explained by 
elimination or by a Cope-Like rearrangement. In this case, the Cope 
rearrangement cannot occur, so the formation of 5.028 is probably 
channelled throughout the elimination depicted in Scheme 7. The process 
starts with α-hydride elimination from substrate 6.017 to reduce water, then 
addition of hydroxide on the iminium 6.018 promotes the formation of an 
unstable hemiaminal that collapses into secondary amine 6.019 and 
anisaldehyde 5.028 (Scheme 7). 
 
Scheme 7: Anisaldehyde 5.028 formation 
 The presence of starting material 3.033 (25 %) in the final mixture 
was unexpected and surprising as no remaining mesylate 6.010 was found. 
In the mechanisms described vide supra, in each elementary step one 
equivalent of both is consumed to react or to fragment. The simplest 
conclusion is that mesylate 6.010 reacted to create something unobserved 
by NMR. Because of the acidity of the propargylic hydrogen in 6.010, an acid-
base reaction could potentially afford the stabilized and conjugated 
butenyne 6.020 and the mesylate anion 6.021 (Scheme 8). 
 
Scheme 8: Elimination into 6.020 
 The base used in our conditions is potassium carbonate however, this 
alkoxide does not necessarily promote the elimination reaction. Most 
probably the secondary amine 3.033 or the desired product 5.076 could act 
as an intermediate base. The desired alkylated amine 5.076 is slightly more 
basic than the starting material 3.033. So, the elimination (Scheme 9 in red) 
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of the mesylate 6.010 into butenyne 6.020 could be catalyzed by the product. 
Unfortunately, this catalytic cycle is favoured because butenyne 6.020 
possesses a boiling point of 5°C and the reaction occurs at reflux of 
acetonitrile. Our goal will be to find a way to favour the blue pathway without 
going back to the ammonium 6.015 (Scheme 9). 
 
Scheme 9: Full degradation mechanism 
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b. Double anion chemistry 
One of the possibilities could be the use of anion. Double metallation of 
3.033 into 6.022 could provide a better nucleophile, even at ambient 
temperature without the need for reflux. Therefore, this should avoid the 
ammonium 6.015. Alkylation should be favoured for the amide and furnish 
the mono metallated intermediate 6.023, which can be quenched by acidic 
media into our target molecule 5.076 (Scheme 10). 
 
Scheme 10: Double anions mechanism 
 Unfortunately, with a base strong enough to deprotonate a 
secondary amine a new issue will be encountered, the acetylene 
deprotonation. Despite these bad offs, the test reaction was performed 
anyway. The metallation of the secondary amine 3.033 can be followed 
optically (the starting material is slightly yellow then slightly green with one 
equivalent of nBuLi then 6.022 is blood red at the end of addition). Addition 
of 6.010 creates an instantaneous change of colour towards yellow (Scheme 
11). 
 
Scheme 11: Double anions test 
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Finally, no alkylation product 5.076 was recovered, probably because of the 
suspected deprotonation of acetylene (in blue) and/or the elimination (in 
red) of the mesyl function into butenyne 6.020 (Scheme 12). 
 
Scheme 12: Degradations of mesylate 6.010 
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c. Triple anion chemistry 
A solution to avoid the deprotonation of the terminus triple bond 
would be to voluntary deprotonate it. The use of isopropyl magnesium 
chloride and TMEDA afford the best results for the deuteration of 6.010 
(Scheme 13). 
 
Scheme 13: Triple anions 
 Based on these observations we deprotonated the mesylate 6.010 
prior to cannulation onto the bis metallated amine 6.025. Unfortunately, 20 
% was the best yield so far, because it is possible that lithium amide 6.025 
prefers to act as a base instead of a nucleophile with 6.026 (Scheme 14). 
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Scheme 14: Triple anions procedure 
Of course, we could envision the use of bis anion 6.027 to directly 
react with our Weinreb amide 5.015 to obtain the precursor of 
polycyclization 6.006. Many trans-metallations could be envisioned for this 
kind of chemistry, such as with zinc or copper. Both of them could provide a 
less basic and a more nucleophilic species from 6.025. However, it is unclear 
if the trans-metallation of Grignard 6.026 to one of these metal centres could 
be prevented. However, those tests would be time consuming, so we decided 
to continue the synthesis with those poor yields. 
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d. Synthesis of target ynone 
Double metallation of butyne 5.076 with nBuLi and addition of 
Weinreb amide 5.015 occurred in a very good 85 % yield to give ynone 6.006 
(Scheme 15). 
 
Scheme 15: Ynone 6.006 synthesis 
 Besides the desired product 6.006, some amounts of Weinreb amide 
5.015 were recovered, along with decanone 5.047 derived from butyl 
addition onto the Weinreb amide. Partition between acetonitrile and hexane 
is able to remove most of it to access ynone 6.006 with high purity (Scheme 
16). 
 
Scheme 16: Observed side products 
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e. Polycyclization tests 
The precursor 6.006 was exposed to the previously developed 
polycyclization conditions in hope to obtain the target molecule 6.001. 
Unfortunately, only starting material 6.006 was recovered (Scheme 17). 
 
Scheme 17: Polycyclization test 
 Several speculations were made, first the presence of acid traces 
(NH4Cl from quench, acetic acid from acetonitrile, …) quenched the base. 
Secondly, maybe longer time is needed compared to the previous precursors. 
Third, dilution could be a problem as the precursors are different. Some tests 
should be performed (Scheme 18). 
 
Scheme 18: Polycyclization tests 
 Unfortunately, no conditions using more potassium tert-butoxide or 
a variation of concentration could afford product 6.001. Entry F is an 
additional evidence of the presence of acidic hydrogen in the mixture 
because 0.1 eq. of base provides starting material 6.006 recovery when 0.15 
or 0.2 creates decomposition. If the acid is NH4Cl as suspected, simple 
calculation of the molar mass furnished that 1 % of the total weight would 
be enough to destroy 0.1 eq. of potassium tert-butoxide. The fact that 
decomposition can occur at every concentration is an unfortunate news. 
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 As potassium tert-butoxide is not suitable for this cyclization, various 
alternative bases were tested to cyclize 6.006 into 6.001 (Scheme 19). 
 
Scheme 19: Polycyclization tests 
 DBU and TMG were successful in chapter V but, unfortunately, none 
of the tested conditions furnished more than decomposition (Entries A, B, C, 
D, E, F). Lithium and sodium tert-butoxide could have been suitable 
substitute for potassium, however, no product 6.001 was detected (Entries 
G, H, I, J). The decomposition rate was higher for DBU and TMG in acetonitrile 
and for tBuOLi and tBuONa in tetrahydrofuran (entries B, D, G, I). 
 
 For an unexpected reason, the polycyclization does not occur at all 
here. To understand what the problem is we should take a closer look at the 
expected mechanism. Metallation of indole with the use of potassium tert-
butoxide turns 6.006 into 6.030. A 6-exo-dig cyclization 6.030 should occurs 
between the indole anion and the ynone moiety, this is allowed according to 
the Baldwin rules. This soft-soft addition forges 6.031, as a base it can be 
reprotonated by any acid in the media, probably tert-butanol in our case to 
give enone 6.032. This enone 6.032 can be deprotonated by potassium tert-
butoxide to afford the enolate 6.033 which can cyclize in a 6-exo-trig fashion 
and deprotonate tert-butanol to furnish the desired product 6.001 (Scheme 
20).  
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Scheme 20: Proposed mechanism for 6.001 cyclizations 
 
Everything starting from intermediate 6.031 to the desired molecule 
6.001 is similar to the precursor in the chapter V. But the final outcome is 
totally different as in our actual case, no product 6.001 and no first-
cyclization product 6.032 could be observed. Those indications generate 
several hypotheses: the first would be some coordination problems with the 
metal. The second would be the transition state energy being probably too 
high. And finally, the third would be a substrate dependent issue. 
Hypotheses 1 and 2 come along, coordination between ynone and 
the metal was proposed in the chapter V. It’s a possibility for the activation 
of ynone 6.034 and should increase the stability of the transition state 6.035 
(Scheme 21). 
 
Scheme 21: Mechanism of previous polycyclization 
 There are two classical transition states for this kind of system; chair 
6.037 and boat 6.039. With a chelation to potassium and from a top view 
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6.038 and 6.040. In both cases overlap between the π orbital of indole and 
the π* orbital of the triple bond is needed. But as the sticks model show here, 
the overlap between the reactive positions π2 and π*2 looks really weak. Of 
course, this is a major issue for the reactivity and could explain why no 
product could be observed (Scheme 22). 
 
Scheme 22: Expected transition states 
The same top view projection 6.041 was made from the previous 
precursor 6.035. The overlap between the reactive positions π2 and π*2 
looks efficient enough for a reaction (Scheme 23). 
 
Scheme 23: Third expected transition state 
 The third hypothesis was the fact that this issue is only related to 
ynone 6.006 for unknown reason. If it really is a problem of the transition 
state in the 6-membered ring as we suspect, the easiest solution would be to 
make a same size ring analogue of the precursor 6.006 and see if it is able to 
cyclize.  
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2. Synthesis of tryptamine tetracycle 
In order to find out more about the lacking reactivity, we planned to 
synthesize ynone 6.042. If the polycyclization is successful, it provides the 
tetracycle 6.002 which is a closely related isomer of our target molecule 
6.001. Ynone 6.042 could be synthetized from propargyl 6.043 (Scheme 24). 
 
Scheme 24: Tryptamine derivative retrosynthesis 
 
a. Synthesis of tryptamine ynone 
Tryptamine 1.013 and anisaldehyde 5.028 were condensed into 
imine 6.045 and directly reduced into the secondary amine 6.046. The amine 
was alkylated with propargyl bromide 5.007 to furnish tertiary amine 6.043 
in a very good overall yield of 75 % over three steps (Scheme 25). 
 
Scheme 25: Tryptamine 6.043 synthesis 
 The double anion methodology combined to the addition of Weinreb 
amide 5.015 was successful for the third time. The conversion of 6.043 into 
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ynone 6.042 was achieved with a yield of 85 % and the purification was aided 
by portioning between acetonitrile and n-hexane (Scheme 26). 
 
Scheme 26: Third ynone synthesis 
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b. Polycyclization tests 
With a third ynone in hands, the polycyclization tests were started 
(Scheme 27). 
 
Scheme 27: Polycyclization tests 
 To our greatest disappointment, the attempts with potassium tert-
butoxide met with failure. No reaction was observed at different 
concentrations and reaction times, and in each case only decomposition was 
observed (Entries A, B, C, D and E). 
In order to investigate if a more suitable base can be found, some 
other bases were screened (Scheme 28). 
 
Scheme 28: Polycyclization tests 
 As for the precursor 6.006, none of those bases provided the target 
molecule. Decomposition in acetonitrile appears faster than in THF and 
toluene (Entries B, F). Finally, similar to potassium tert-butoxide, sodium and 
lithium analogues of the base also furnished also decomposition (Entries G, 
H, I, J). 
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c. Speculated transition states 
The same type of transition states can be proposed; chair 6.048 or 
boat 6.050. Again, the overlap between the reactive positions π2 and π*2 
looks weak (Scheme 29).  
 
Scheme 29: Plausible transition states 
 This statement revokes the third hypothesis (Cf. Chapter VI), 
according to which the cyclization problem was substrate dependant.  
  
 A proper way to polycyclize those two precursors 6.006 and 6.042 is 
needed. Potassium tert-butoxide was acting as base and potential Lewis acid. 
The use of base and Lewis acid at the same time could maybe solve this issue. 
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3. Polycyclization tests with Lewis acid and bases 
a. Potential issue 
As explained in the chapter V, there are two possibilities for the 
reprotonation of the intermediate. The use of Lewis acid was obvious, but it 
can totally modify the reprotonation mechanism. Activation of ynone by 
Lewis acid and metallation of indole by potassium tert-butoxide provides 
6.052 which can cyclize into 6.053. The stability of intermediate 6.053 will be 
adapted to the Lewis acid but unfortunately without the speculated cyclic 
form, the reprotonation could happen from both faces, and a higher 
proportion of undesired 6.054 could be observed this time (Scheme 30). 
 
Scheme 30: Postulated mechanism for co-catalysis 
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b. tBuOK + Lewis acid 
Potassium tert-butoxide is probably not the best choice as Lewis acid 
co-catalyst. Lewis acids often contain traces of Brønsted acid and tBuOK likes 
to perform metal exchange reactions. 
 
Both precursors 6.042 and 6.006 were tested with various Lewis 
acids (Scheme 31). 
 
 
Scheme 31: Co-catalysed Polycyclization 
 Some of them are hard to activate the ketone and copper was used 
to activate the triple bond. The only outcome was starting material recovery, 
as suspected 0.2 eq. of potassium tert-butoxide was not the best choice. 
Since there was no modification with time, we suspect that our base was 
destroyed by acid traces or deactivated by coordination. However, an 
interesting information came out, no major decomposition was observed.  
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c. Strong organic bases + Lewis acid 
  DBU and TMG should be a potential solution to this situation and 
both bases were tested in a short screen (Scheme 32). 
 
Scheme 32: Lithium chloride co-catalysed polycyclization 
 Lithium chloride as co-catalyst with DBU in acetonitrile proved 
successful in the literature. 1  However, these conditions appeared to be 
unsuccessful with our tryptamine starting material 6.042. In entries A, B, D, 
E, G, H, I and J where the quantity of base was lower or equal to the quantity 
of Lewis acid, no reaction occurred, not even decomposition. This 
observation tends to correlate with the absence of free base in the mixture. 
A slow decomposition could be observed when the quantity of base is higher 
than the quantity of Lewis acid (Entries C and F). So far, no cyclized product 
could be observed with the use of Lewis acid. 
  
                                                          
1 Kanematsu, M.; Yoshida, M.; Shishido, K. Angew. Chem. 2011, 123, 2666. 
Chapter VI 
144 
 
The same conditions were tested on the substrate 6.006 (Scheme 
33). 
 
Scheme 33: Lithium chloride co-catalysed polycyclization 
 Unfortunately, the exact same outcome was observed with this 
precursor 6.006. A slight excess of bases favoured decomposition (entries C 
and F). No reaction was observed in the case where the amount of lithium 
chloride was equal or superior to the amount of base. The decomposition of 
starting material with DBU is almost complete in 3 hours without lithium 
chloride. The decomposition observed in entries C and F is slower with LiCl. 
The use of Lewis acid does not promote the cyclization of our product 6.006. 
However, lithium chloride can “protect” our product from decomposition, 
most probably by coordination with the nitrogenated-base. 
 
 Many different Lewis acids could be envisioned to favour this 
cyclization, but most of them will be coordinated by the base and probably 
quench the reaction. At this point, no co-catalytic system using base and 
Lewis acid could provide the desired tetracycles 6.001 and 6.002. 
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4. Application of our methodology to enone of SGAP 
A test of our polycyclization conditions must be made on the enone 
precursor of the second generation. 
a. Synthesis of enone 
The procedure developed by Laurent Turet2 was followed to obtain 
the enone 3.035, starting from amine 3.033, acrolein and β-keto 
phosphonate 6.058. Phosphonate 6.056 was stirred with nBuLi at -78°C then 
methyl hexanoate 6.057 was added to obtain β-keto phosphonate 6.058. 
Amine 3.033 was then alkylated using acrolein and a catalytic amount of 
DBU. Then, aldehyde 3.034 underwent a Horner-Emmons reaction with the 
potassium anion of β-keto phosphonate 6.058. The enone 3.035 was 
obtained in a very good yield and with a high E selectivity >95 % (Scheme 34). 
 
Scheme 34: Synthesis of enone 3.035 
 
  
                                                          
2 Turet, L. PhD Thesis 2004, Université catholique de Louvain. 
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b. Tests TGAP with tBuOK on enone  
The polycyclization conditions were tested on enone 3.035 in view of 
the tetracycle 3.027 (Scheme 35) and (Table 1). 
 
Scheme 35: Polycyclization tests 
Entry tBuOK [C] Time 3.035 3.027 
1 0.1 eq. 0.1 1h Full recovery / 
2 0.2 eq. 0.1 45 min / 70 % 
3 0.2 eq. 0.5 1 min 50 % 20 % 
4 0.2 eq. 0.5 5 min / 60 % 
Table 1: Polycyclization tests 
 In entry 1, 0.1 eq. of potassium tert-butoxide does not promote the 
cyclization of 3.035. Entry 2 shows almost identical conditions of SGAP (1 
hour instead of 45 minutes and 0°C instead of ambient temperature) and it’s 
working well. Entries 3 and 4 are TGAP conditions and the cyclizations occur 
as expected. A small variation of the yield can be observed between 0.1 M 
and 0.5 M in favour for 0.1 M. 
 
The NMR observations correlate with Laurent Turet’s work. Mono-
crystals were extremely easy to obtain either from hot methanol, or from 
isopropanol evaporation, from recrystallisation using ethyl acetate and 
methanol and finally, from recrystallisation using ethyl acetate and hexane. 
The solved crystal structure reveals a chair-boat conformation, a trans-fused-
junction and the expected cis-correlation between the side chain and 
indoline. The PMB function is oriented equatorial and the side chain got a 
pseudo-equatorial orientation (Figure 1). 
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Figure 1: X-ray diffraction of 3.027 
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c. Final Mechanism proposal for enone 
Since the cyclization is working in our conditions, we considered that 
the mechanism should be similar to the ynone cyclization involving 
potassium tert-butoxide as initiator to convert enone 3.035 to metallated 
indole 6.060 (red). This indole potassium could have chair-transition state 
with a coordination to the ketone. An eight electron Michael-addition could 
occur to afford enolate 3.041 (blue) which can equilibrate with tert-butanol 
to obtain ketone 5.051. The same enolate 3.041 could do the activation of 
indole 3.035 as the pKa difference is favourable. Ketone 5.051 could be 
deprotonated by potassium tert-butoxide or by enolate 3.041 to afford 
enolate 3.042 (pink). Potassium enolate 3.042 could then cyclize through a 
boat transition state into 3.043. Finally, indoline potassium 3.043 could be 
reprotonated by tert-butanol or by a ketone like 5.051 into the desired 
product 3.027 (Scheme 36).  
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Scheme 36: Full mechanism for 3.027 
 The final part of this mechanism will be the analysis of the top 
projection of our proposed transition state. The main difference will come 
from the angle between the triple bond and carbon a and the double bond 
and carbon b. The 180° angle in 6.038 appears to make the triple bond to far 
from the indole to react properly. When the 120° in 6.065 slightly increases 
the vicinity between the two reactive parts. Both are working on a chair 
transition state and the second main difference is the size of the bond. 
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However, this parameter got a low impact since the bond itself is not located 
inside the chair transition state (Scheme 37). 
 
Scheme 37: Variation between 6.037 and 6.060 
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5. Application of the methodology to tryptamine enone 6.067 
The same protocol could be used with tryptamine derivative 6.046 
as starting material to synthetize a new enone 6.067. 
a. Synthesis of enone 
Amine 6.046 was stirred with acrolein and DBU to obtain aldehyde 
6.066 that subsequently underwent an Horner-Emmons reaction with the 
potassium anion of β-keto-phosphonate 6.058. E-enone 6.067 was obtained 
in very good yield with a high >95% selectivity (Scheme 38).  
 
Scheme 38: Synthesis of enone 6.067 
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b. Tests TGAP with tBuOK on enone 6.067 
Polycyclization attempts were made with this new enone to obtain 
the [7,6] tetracycle 6.004 (Scheme 39). 
 
Scheme 39: Polycyclization of enone 6.067 
 Unfortunately, no cyclized products 6.004 could be observed or 
isolated. In entries A and C a small quantity of tBuOK did not provide anything 
expect starting material. When larger quantities were used, only 
decomposition was observed (entries B and D). DBU and TMG afforded a 
slow decomposition (entries E, F, H, I). However, the time needed to 
decompose all the starting material was tremendously longer than for 
ynones. Finally, the use of lithium chloride only furnished starting material 
(entries G and J). 
  
There was a very high probability for this polycyclization to fail, 
according to our knowledge so far. The addition of one carbon to ynone lead 
to a major issue for the cyclization. The addition of one carbon to enone will 
very likely give the same kind of outcome. 
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6. Conclusions 
In an attempt to reach tetracycles, the four polycyclization 
precursors 6.006, 6.042, 3.035, 6.067 were synthetized (Scheme 40). 
 
Scheme 40: Ynones and enones synthetized 
Among them only 3.035 was suitable for polycyclization into 3.027 
(Scheme 41). 
 
Scheme 41: Successful polycyclization 
 The structure and conformation of 3.027 was established by NMR 
and X-ray diffraction. 
 Various side products were isolated, such as bis-indole 6.011, 
anisaldehyde 5.028, tertiary amine 6.013 and secondary amine 6.014 
(Scheme 42). 
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Scheme 42: Isolated side products 
 Mechanistical speculations were proposed to explain the lacking 
cyclization of 6.006, 6.042 and 6.067 (Scheme 20, Scheme 21, Scheme 22, 
Scheme 23, Scheme 29, Scheme 30, Scheme 36, Scheme 37). And were 
probably due to high energy transition states or transition states’ 
conformational issues. 
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7. Perspectives 
Lithium, sodium and potassium tert-butoxide were unsuccessful 
promoters for the polycyclization of 6.006, 6.042 and 6.067 (Scheme 43).  
 
Scheme 43: Expected polycyclization 
According to actual knowledge, potassium prefers 3 or 4 
coordinations including solvent with tetrahedral geometry. A variation in the 
metal for something with higher coordination abilities would change the 
angle OMN (ketone-metal-indole). This could allow a modification in the 
transition state and increase the vicinity of the reactive sites (Scheme 44). 
 
Scheme 44: Mechanistical variation 
 Almost all metals exist as a tert-butoxide salts, however, caesium, 
barium and cerium (III and IV) should be tested in priority as they possess a 
similar coordination number (up to 9), a similar atomic mass, and their tert-
butoxide salts can still exhibit some basicity. 
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Chapter VII 
Fourth Generation Anionic Polycyclization 
 
1. Hypotheses 
Several mechanistic proposals were suggested throughout the 
chapters V and VI. In chapter V, cyclization of ynone 5.017 into [5,6] 
tetracycle 5.049 furnished some insight into the mechanism. In chapter VI, 
cyclization of enone 3.035 into [6,6] tetracycle 3.037 shed even more light 
on the pathway. This chapter will be devoted to the development of a new 
type of polycyclization based on the successes and failures of the previous 
chapters (Scheme 1).  
 
Scheme 1: Successful polycyclizations 
 
a. Hypothesis 1: Side chain selectivity 
We speculated that the steric hindrance at carbon A possesses a 
prime impact on the side chain selectivity. The second cyclization of the 
enone precursor 5.051 gave 5.050 as potential intermediate. In the case of 
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the second cyclization of ynone 5.019, the intermediate could be 5.055 
(Scheme 2). 
 
Scheme 2: Speculated intermediates 
If this assumption is correct, there is reason to believe that the 
cyclization of a molecule like 7.009 would lead to 7.011. On the other hand, 
transition state 7.012 appears sterically disfavoured due to interactions of 
the side chain R1 and the metal centre (Scheme 3). 
 
Scheme 3: Second cyclization of 7.009 
Since 7.011 encompasses the desired relative configuration and 
according to our current knowledge, the synthesis of 7.009 should lead to 
tetracycle 7.011. 
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b. Hypothesis 2: size of the transition state 
In chapter VI, an issue was encountered with the cyclization of 
ynones 6.037 and 6.048. The weak overlap of the reactive orbitals is depicted 
respectively in structures 6.038 and 6.049 and was used to explain the lack 
in reactivity. Contrarywise, the cyclization of ynone 5.070 and enone 6.060 
was successful and a good overlap was therefore speculated (Scheme 4). 
 
Scheme 4: Overlap of orbital in the first cyclization 
To synthesize the desired intermediate 7.009, the estimation of the 
overlap should be done beforehand (Scheme 5). 
 
Scheme 5: Target intermediate 
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c. Hypothesis 3: Z-enone? 
The Z-enone 7.022 should embody the critical features. It is possible 
that the overlap in the Z-enone 7.022 and the corresponding E-enone 7.020 
are very similar. The stick models of the chair conformer 7.023 and boat 
conformer 7.025 transition states look persuasive so far. The main issue in 
these transition states seems to be the steric hindrance generated by the 
protons of the double bond. This cyclization should furnish the desired 
intermediate 7.009 (Scheme 6). 
 
Scheme 6: Z-enone possibilities 
 According to our hypothesis, Z-enone 7.022 is very promising and a 
polycyclization should furnish the target molecule 7.011 with the desired 
stereo-relationships. 
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d. Confirmation or refutation 
As a fourth type of substrate for polycyclization (Cf. chapter III and 
V), those tests will be called the fourth generation anionic polycyclization 
(FGAP). They will either strengthen or refute our previous statements and 
hypotheses. Four possible outcomes can be envisioned. In the event of no 
reaction or decomposition, hypotheses 2 and 3 will be disproven. The 
formation of 7.028, 7.029, and 7.030 will go in line with hypothesis 2 but 
disprove hypotheses 1 and 3. And finally, the formation of 7.011 will prove 
hypotheses 1, 2 and 3. No matter which tetracycle is obtained, all of them 
could have interesting bioactivities (Scheme 7). 
 
Scheme 7: Possible outcomes 
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2. Lindlar reduction of ynones 
Potentially, the easiest way to synthesize Z-enone 7.022 would be 
through the Lindlar hydrogenation1 of the previously reported ynone 6.006 
(Scheme 8). 
 
Scheme 8: Retrosynthesis of 7.022 
 
a. Lindlar reduction of ynone 5.017 
Test experiments were performed on 5.017. Two major products 
could be expected, the unwanted saturated ketone 7.032 and the desired Z-
enone 7.033 (Scheme 9) and (Table 1). 
 
Scheme 9: Lindlar reduction of ynone 5.017 
  
                                                          
1 Lindlar, H. Helvetica Chimica Acta. 1952, 35, 446. 
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Entry Solvent 
Quinoline 
(eq.) 
Time 
Ratio  
5.017 (%) 7.032 (%) 
7.033 
(%) 
1 EtOH / 2h30 / >95  / 
2 EtOH 0.3 2h30 / >95  / 
3 EtOAc / 2h30 / 30   70  
4 EtOAc 0.3 2h30 / 50  50  
5 Tol / 
15 
min 
75  / 25  
6 Tol / 1h / 30  70  
7 Benz. 0.5 1h / 10  90  
Table 1: Lindlar reduction of ynone 5.017 
 Lindlar reduction using ethanol with quinoline or without quinoline 
was in both cases too active and led only to the saturated product 7.032 
(Entries 1 and 2). Aromatic solvents and ethyl acetate provide the Z-enone 
7.033 (Entries 3, 4, 5, 6, 7). However, the best conditions were in benzene 
(entry 7). 
Isolation of Z-enone 7.033 appeared to be problematic since it slowly 
isomerized on silica into the unwanted E-enone 7.034 along with some 
aldehyde. The aldehyde probably comes from silica-catalyzed retro-aldol of 
the Z-enone 7.033 or the E-enone 7.034 catalysed by silica. The identification 
of both enones was made by 1H-NMR. These data suggest that the Lindlar 
reduction successfully provided the desired Z-enone 7.033 and that the 
product generated during flash silica purification is most probably E-enone 
7.034 (Scheme 10). 
Chapter VII 
164 
 
 
Scheme 10: Enones 
 However, since the purification by silica gel was impossible in the 
classic conditions, a small quantity of quinoline from the Lindlar reduction 
contaminated the product (approximately 10 % of the weight).  
  
Chapter VII 
 
165 
 
b. Lindlar reduction of ynone 6.042 
The same protocol was used on ynone 6.042. Two major products 
could be expected the desired Z-enone 7.036 and the saturated ketone 7.037 
(Scheme 11) and (Table 2). 
 
Scheme 11: Lindlar reduction of ynone 6.042 
Entry Solvent 
Quinoline 
(eq.) 
Time 
Ratio 
6.042 (%) 7.036 (%) 7.037 (%) 
1 Tol / 12h / / >95  
2 Benz. 0.5 1h / 90  10  
Table 2: Lindlar reduction of ynone 6.042 
 Toluene used as solvent without quinoline provided the saturated 
product 7.037 in half a day (Entry 1). And as previously reported, benzene 
and half an equivalent of quinoline appeared to be the best conditions so far 
to obtain 7.036 (Entry 2).  
Similar to the previous results, the NMR data of Z-enone 7.036 was 
compared to E-enone 7.037 which is probably the side product created 
during flash silica purification (Scheme 12). 
 
Scheme 12: E and Z-enones 
  
Chapter VII 
166 
 
c. Lindlar reduction of ynone 6.006 
The Lindlar protocol was further applied to ynone 6.006. Two 
products are expected, the Z-enone 7.022 and the saturated ketone 7.038 
(Scheme 13) and (Table 3). 
 
Scheme 13: Lindlar reduction of ynone 6.006 
Entry Solvent 
Quinoline 
(eq.) 
Time 
Ratio 
6.006 (%) 7.022 (%) 7.038 (%) 
1 Tol / 12h / / >95  
2 Benz. 0.5 1h / 90  10  
Table 3: Lindlar reduction of ynone 6.006 
 Toluene used as solvent without quinoline provided the saturated 
product 7.038 in 12 hours (Entry 1). And as previously reported, benzene and 
a half equivalent of quinoline appears to be the best conditions so far to 
obtain 7.022 (Entry 2). 
 The NMR data of the new product 7.022 was compared to our E-
enone 3.035 (Scheme 14).  
 
Scheme 14: Z and E-enones 
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3. Polycyclization tests on Z-enones 
With the three desired Z-enones 7.033, 7.036 and 7.022 in hands 
polycyclization tests could be started (Scheme 15). 
 
Scheme 15: Z-enones 
 
a. Tests on Z-enone 7.033 
Throughout these tests, we were hoping to prove the proposed 
hypotheses and synthesize intermediate 7.039 or tetracycle 7.040 (Scheme 
16). 
 
Scheme 16: Polycyclization tests 
 The conditions for classic polycyclization were applied and led to 
degradation (Entries A, E and F). Entry B was a test reaction to obtain the 
spiro indolenine 7.039, however, it was unsuccessful. The use of lithium tert-
butoxide provide solely degradation (Entries C and D). Finally, the use of TMG 
did not provide the expected products (Entries G and H). 
So far, the cyclization into [5,6] tetracycle 7.040 was unsuccessful.  
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b. Polycyclization tests on Z-enone 7.036 
Through this cyclization we expected to obtain to products, spiro 
indolenine intermediate 7.041 and tetracycle 7.042 (Scheme 17). 
 
Scheme 17: Polycyclization conditions of enone 7.036 
 After 5 minutes of reaction a new product was observed by TLC and 
was purified by flash column chromatography to afford 25% of the spiro 
indolenine 7.041. This was a very big surprise as spiro-indolenine should be 
highly reactive compounds. The conformation was established by NOESY 
(There is no difference between the blue arrows and the red arrows, it’s just 
to avoid confusion with overlap of arrows) (Scheme 18).  
 
Scheme 18: NOESY of intermediate 7.043 
As there is no up and down in molecule, we need to fix them to 
simplify the following part. The hydrogen HA will be a reference for the 
bottom part of the molecule since it need to be below the new 6-membered 
ring. And the hydrogen HK will be a reference of the top part of the molecule 
since it should point up. HA is able to interact with HB, HH, and HI, this 
observation should place those three hydrogens down. HK can spot HC, HE, 
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HG, and HJ, these data make them point up. Finally, HJ is able to notice HF and 
HG (Scheme 18). 
 Based on these nuclear Overhauser effects, the following relative 
configuration 7.044 was proposed. The freely rotating side chain was 
changed for “R” to make the drawing easier. Proton HA correlates with HB 
and HH. The proton HK can spot HC, HE, HG. And finally, HD cannot observe any 
hydrogen. This conformation fits well enough with the data and is probably 
one of the conformations in CDCl3. As we can observe, HH needs to be down 
to correlate with HA, this evidence is a good point for hypotheses 2 and 3 
(Scheme 19). 
 
Scheme 19: Conformation of intermediate 
 This intermediate should rearrange into the desired product to 
demonstrate hypothesis 1. The molecule 7.045 was resubmitted to the 
polycyclization conditions and the corresponding reaction was also tested 
with the Z-enone for a longer time than 5 minutes (Scheme 20). 
 
Scheme 20: Polycyclizations 
 In both cases, a new product was observed, isolated and 
characterized by NOESY (Scheme 21).  
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Scheme 21: NOESY of tetracycle 
 As explained vide supra, HA will be the down hydrogen and HL will be 
the hydrogen up. In this molecule, we can observe many strong correlations 
by NOESY since the structure possesses only few degrees of freedom. The 
hydrogen HA can interact with HB, HE, HF and HH, which make them down. The 
hydrogen HC can spot HL and HK and HJ. Finally, HL sees HB, HK can observe HJ 
and HI can interact with HG. Unfortunately, if HK can detect upper hydrogens 
HC and HJ it means that the side chain is pointing down and HK is up. By 1H 
NMR the coupling constant HL-HK is around 4 Hz which is a standard coupling 
for cis-vicinal hydrogens in a 6-membered ring. 
 The structural conformation deduced by NOESY in CDCl3 is chair-chair 
and could explain all observed correlations (Scheme 22). 
 
Scheme 22: Conformation 
 Hypothesis 1 appears to be incorrect, since we have the intermediate 
7.045 and the tetracycle 7.047 we could reformulate this hypothesis. 
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c. Second cyclization hypothesis 
Deprotonation of ketone 7.045 could lead to two enolates, 7.048 and 
7.050. These enolates could afford respectively the tetracycles 7.049 and 
7.047 (Scheme 23).  
 
Scheme 23: Enolates and targets 
 In hypothesis 1, we expected a boat conformation for the 6-
membered ring. Unfortunately, the observation made by NOESY suggest the 
intermediate to be in chair conformation. With a chair in 7.048 and 7.050, 
there is a significant difference of steric hindrance. The desired product 7.049 
should come from the E-enolate 7.048 which possesses an H-R steric 
hindrance. The other enolate 7.050 possesses an H-H steric hindrance, and it 
should be smaller. According to the product we obtain and to the difference 
of energy in the transition state, the blue path is favoured.  
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d. Polycyclization test on Z-enone 7.022 
The conditions were tested on the last Z-enone. We expected to 
obtain spiro indolenine 7.028 or tetracycle 7.030 (Scheme 24). 
 
Scheme 24: Cyclization of Z-enone 7.022 
 The outcome of the reaction was slightly different than the expected 
results as two products were obtained. Both possess a similar polarity by TLC 
and by column chromatography. No indolenine was detected so it cannot be 
7.028. 1H NMR revealed two new sets of resonances isolated from the rest 
of the signals. Two doublets, the first around 4.03 (d, J = 8.0 Hz, 1H) and the 
second just next to it at 3.96 (d, J = 3.4 Hz, 1H). No starting material was left 
in the crude NMR spectrum and the rest of the features were very similar to 
the previously reported tetracycles. An 8 Hz coupling constant could come 
from a trans-vicinal HC-HD when a 3.4 Hz coupling constant could come from 
a cis-vicinal HA-HB. Unfortunately, those are just speculations since we could 
not properly separate the two products (Scheme 25). 
 
Scheme 25: Speculations of the stereochemistry 
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4. Conclusions 
The Lindlar reduction appeared to be a nice way to synthesize Z-
enones starting from ynones and allowed access to polycyclization tests on 
7.033, 7.036 and 7.022 (Scheme 26). 
 
Scheme 26: Z-enones 
 These tests were not successful for 7.033. However, intermediate 
7.045 and tetracycle 7.047 were fully characterised from 7.036 as starting 
material (Scheme 27). 
 
Scheme 27: Interesting products 
 Amongst all three hypotheses proposed in the beginning of this 
chapter, two of them were demonstrated successful so far (see pages 159 
and 160). Unfortunately, the first hypothesis was proven to be untrue or at 
least incomplete. The last reaction of this chapter could have changed this, 
however, the two new products 7.030 and 7.011 are just speculations so far 
until they are purified (Scheme 28). 
 
Scheme 28: Speculations 
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5. Perspectives 
The most obvious perspective is the purification of the tetracycle(s) 
7.030 and 7.011 using semi-preparative HPLC, preparative HPLC or paper 
chromatography (Scheme 29). 
 
Scheme 29: Potential tetracycles obtained 
 Isomerisation from Z-enone to E-enone should be improved and 
polycyclization tests should be done on 7.034 and 7.037. To analyse the 
outcome and add more evidence to our hypotheses (Scheme 30). 
 
Scheme 30: E-enones 
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Chapter VIII 
Derivatizations 
 
 Through the previous chapter V, VI and VII various tetracycles were 
produced 5.049, 3.027, and 7.047. Speculations were made about 7.030 and 
7.011 but without full characterization (Scheme 1). 
 
Scheme 1: Formed and speculated tetracycles 
  
This chapter will be devoted to the extension of the library of 
tetracycles through derivatization. The point is to improve the probability to 
find bioactive molecules among them. In addition to those modifications, we 
were expecting to have control of the diastereoselectivity of these reactions 
due to the rigid scaffold of the molecule. 
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1. Modification of tetracycle 5.049 
There are different functionalities on molecule 5.049 including an 
indoline (in pink), vinyl ketone (in blue) and a PMB (in red). The PMB can 
undergo a hydrogenolysis to 8.006. The vinyl ketone could be a precursor of 
alcohol 8.008 or a precursor of saturated ketone 8.010. Finally, alkylation of 
indolenine to 8.009 offers a further option for derivatization (Scheme 2). 
 
Scheme 2: Modification of tetracycle 
The reduction of the vinyl ketone should be easier than alkylation 
and PMB removal. And reduction of the double bond could possibly lead 
toward the desired isomer. So, it will be our first investigation. 
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a. Reduction of the double bond in 5.049 
The reduction of vinyl ketone 5.049 to the trans-fused ketone 8.011 
or the cis-fused ketone 8.012 could be obtained by any Stryker type 
reductant1 or by hydrogen transfer (Scheme 3) and (Table 1). 
 
Scheme 3: Reduction of double bond 
Entry Conditions Outcome  
1 [(PPh3)CuH]6, benzene, RT 5.049 
2 Cu(OAc)2, P(Oi-Pr)3, Me(EtO)2SiH, tol, RT 5.049 
3 Cu(OAc)2, PPh3, Me(EtO)2SiH, tol, RT 5.049 
4 Pd(OH)2, H2 (4 atm.), MeOH, RT New compound 
Table 1: Reduction of double bond 
 The classic reduction of unsaturated ketone with Stryker reagent2 or 
modified Stryker reagent3 did not provide any new compounds and afforded 
a full recovery of starting material (Entries 1, 2 and 3). A new compound was 
observed with hydrogenation by palladium hydroxide4 and hydrogen (Entry 
4). 
The determination of the diastereoselectivity was made by NOESY. 
Many interactions could be observed, and to simplify, the PMB and the side 
chain correlations won’t be showed (Scheme 4).  
                                                          
1 (a) Mahoney, W. S.; Brestensky, D. M.; Stryker, J. M. J. Am. Chem. Soc. 1988, 110, 
291. (b) Bezman, S. A.; Churchill, M. R.; Osborn, J. A.; Wormald, J. J. Am. Chem. Soc. 
1971, 93, 2063. 
2 Riant O. "Copper(I) hydride reagents and catalysts" Patai's Chemistry of Functional 
Groups, 2011, John Wiley & Sons. 
3 Pelss, A.; Kumpulainen E. T. T.; Koskinen A. M. P. J. Org. Chem. 2009, 74, 7598. 
4 Pearlman’s catalyst 
Chapter VIII 
178 
 
 
Scheme 4: NOESY of saturated tetracycle 
 As in chapter VII, the reference needs to be fixed as there is no up 
and down in molecule. The hydrogen HA will be the reference for down and 
HH will be the reference for up. Hydrogen HA can see HB, HD and HF which 
make them down. Hydrogen HH can interact with HC and HG which make them 
up. HI can see HF and HJ, Finally, HJ can detect HK. Hydrogen HJ does very nice 
correlations by NOESY however since it’s a labile hydrogen, it won’t be taken 
in consideration. 
 According to these data, the product is cis-fused, and the side chain 
is up. Hydrogen HF would not be able to interact with HA and HI if it was up. 
 For the first time in this project, the correct isomer could be isolated 
and characterized. The speculated mechanism for this reduction is based on 
coordination of palladium to the indoline moiety as the most electron rich 
system in the molecule. Finally, the speculation about chelation with indoline 
and the double bond should lead to the intermediate 8.013 (Scheme 5). 
 
Scheme 5: Palladium coordination 
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b. Reduction of the ketone 
There are two possible results in the ketone reduction, alcohol 8.014 
and 8.015. Luckily, both are interesting as selective extension of library 
(Scheme 6) and (Table 2). 
 
Scheme 6: Reduction of ketone 
Entry Reducing agent Solvent T (°C) 
Ratio (%) 
8.014 8.015 
1 DIBAL-H (2.5 eq.) Toluene -78 10 90 
2 DIBAL-H (2.5 eq.) DCM -78 10 90 
3 DIBAL-H (2.5 eq.) THF -78 40 60 
4 NaBH4 (2 eq.) MeOH 0 15 85 
5 NaBH4 (2 eq.) EtOH 0 20 80 
6 
NaBH4 (1.3 eq.), 
CeCl3 (2 eq.) 
MeOH 0 80 20 
7 
NaBH4 (1.3 eq.), 
CeCl3 (2 eq.) 
MeOH 0 70 30 
8 
NaBH4 (1.3 eq.), 
CaCl2 (2 eq.) 
MeOH 0 20 80 
Table 2: Reduction of ketone 
 The use of DIBAL-H5 (Entries 1, 2 and 3) provides alcohol 8.014 as the 
major product. Sodium borohydride provides the same results with alcohol 
8.014 as major product (Entries 4 and 5). Classical Luche6 reduction (Entries 
6 on 0.1 g scale and 7 on 0.5 g scale) affords the other alcohol 8.015 as the 
                                                          
5 Ziegler, K.; Martin, H.; Krupp, F. Justus Liebigs Annalen der Chemie 1960, 629, 14. 
6 Luche, J. L. J. Am. Chem. Soc. 1978, 100, 2226. 
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major product. The modified Luche 7  conditions using calcium chloride 
provides the opposite outcome from the use of cerium chloride (Entry 8). 
 Both alcohols were separated flash column chromatography and 
fully characterized. The determination of the diastereo-relationship was not 
easy as NOESY appeared to be inefficient on these compounds. It is mostly 
due to the fact that the newly formed C-H bond is too far away from the rest 
of the molecule to make spatial interactions. 
 
 At the time of characterization, we realized that the hydrogens A-B-
C-D were really different than E-F-G-H. Since these molecules could possess 
various conformations due to the 5 substituents on the cyclohexene ring, the 
decision was made to estimate the stable conformations of those molecule 
8.014 and 8.015 via calculations (Scheme 7). 
 
Scheme 7: epimers of alcohols 
 The first calculation was made on 8.014 and based on one thousand 
iterations the lowest energy value is 384.0497 kJ/mol. Here, different effects 
and angles could be observed. There is a strong anomeric effect between σ 
C-HB and σ* C-O. Hydrogens HA and HB are presumably axial. Finally, the angle 
between HC and HD is 47.9° and according to Karplus-Bothner-By equation8, 
HD should be a doublet with a coupling constant between 4.5 and 6 Hz (Figure 
1). 
                                                          
7 Fujii, H.; Oshima, K.; Utimoto, K. Chem. Lett. 1991, 20, 1847. 
8 (a) Karplus, M. J. Chem Phys. 1959, 30, 11. (b) Karplus, M. J. Am. Chem. Soc. 1963, 
85, 2870. (c) Bothner-By A. A. Adv. Magn. Reson. 1965, 1, 195. 
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Figure 1: Alcohol 8.014 by calculation 
 The calculations were also made for the second alcohol 8.015. An 
issue was encountered as the lowest and the second more stable 
conformations have two very distinct conformations (Figure 2) and (Figure 
3). 
 
Figure 2: Lowest energy for alcohol 8.015 
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Figure 3: Second more stable conformation 
 Both conformations were compared to the 1H NMR. The first 
conformation of 8.015 is 383.0155 kJ/mol and possesses an N-H-O hydrogen 
bond. However, the nitrogen lone pair cannot be devoted completely to this 
hydrogen bond because it’s an indoline and the electrons are shared in the 
aromatic ring. The angle between HG and HH is 23.0° which should make HH 
as a doublet with a coupling constant of 8-10 Hz (Figure 2) and (Scheme 8). 
 The second conformation of 8.015 is 383.5075 kJ/mol. The dihedral 
torsion angle HG-HH is 60.4° which makes HH a doublet with a coupling 
constant of 3-4 Hz. Hydrogens E-F-G are all three axial and should be more 
shielded due to this position (Figure 3) and (Scheme 8). 
 
Scheme 8: Determination of diastereoisomer 
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According to the descriptions vide supra 8.014 embodies the β-
alcohol. It possesses a 5.9 Hz coupling at HD corresponding to HC-HD coupling 
estimated between 4.5 and 6 Hz (Correct). At the same time, HB due to the 
anomeric effect should be less shielded than HF, and at the same time HF 
should be more shielded than HB because HE and HG sigma donation 
(Correct). For 8.015, the most stable conformation needed a coupling 
constant at HD or HH of 8-10 Hz, none of these substrates exhibited such a 
strong coupling (incorrect). However, in the calculated second most stable 
conformer, the same coupling constant could be 3 to 4 Hz. In the suspected 
8.015 with α-alcohol there is a 1.6 Hz coupling constant for HH, it’s a bit lower 
than expected (Almost correct). 
 From now on, we assume that the diastereochemistries are fixed for 
β-ol-8.014 and α-ol-8.015.  
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c. Deprotection of PMB 
Several deprotection protocols of PMB were tested on almost every 
tetracycle in our hands, so to avoid repetition of tables, we will schematize it 
as 8.016 (Scheme 9) and (Table 3). 
 
Scheme 9: Deprotection 
Entry Reagent Solvent T°C Outcome 
1 CAN CH3CN/H2O RT Decomposition 
2 DDQ DCM/H2O RT Decomposition 
3 TFA DCM RT 8.016 
4 TFA DCE Reflux 8.016 
5 
Pd(OH)2 + 
NH4HCO2 
MeOH Reflux Decomposition 
6 
Pd(OH)2 + formic 
acid 
MeOH Reflux Decomposition 
7 Pd(OH)2 + H2 MeOH RT New product 
Table 3: Deprotection 
 Standard deprotection of PMB (Entries 1, 2, 3 and 4) appears to be 
unsuccessful, the oxidation process led to decomposition and the acidic to 
starting material recovery. Hydrogenolysis was also unsuccessful until a new 
product was observed (Entries 5, 6 and 7). 
  
The reaction was carried out on 8.014 which was converted to 8.018 
in 4 days. p-Methoxy-toluene could be observed by 1H NMR. So far, there is 
no certainty about the diastereoselectivity at the junction. Both, the alcohol 
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or the indolenine could direct the palladium catalyst to approach from both 
faces (Scheme 10).  
 
Scheme 10: PMB removal 
  
 The same reaction was tested on 8.015 but appeared to be extremely 
slow with 10 to 15% conversion in a week. Due to the very small amount of 
product and the poor quality of the reaction, poisoning of the catalyst was 
suspected. The palladium could be trapped between α-oxygen and α-
nitrogen, in a 1,3-diaxial conformation to the extent of our knowledge 
(Scheme 11). 
 
Scheme 11: deprotection of 8.015 
 
  
Chapter VIII 
186 
 
2. Modification of [6,6] tetracycle 3.027 
The [6,6] tetracycle 3.027 based on SGAP possesses an indoline (in 
pink) a ketone (in blue) and a PMB (in red). As explained vide supra, there are 
many downstream modifications available for this class of substrates. 
a. Reduction of the ketone 
We will first focus on the reduction of the ketone (Scheme 12) 
 
Scheme 12: Reduction of ketone 3.027 
Both conditions for the reduction of ketone were tested and only one 
diastereoisomer was obtained. The crystal structure of 3.027 (Cf. chapter VI) 
indicates a chair-boat conformation in solid phase. This makes the top face 
extremely easy to access and should provide the α-alcohol 8.022. 
 To support this statement and also to improve the quality of our 
previous calculations, the conformation stability of ketone 3.027 will be 
estimated and compared to the crystal structure (Figure 4). 
 
Figure 4: Calculation for ketone 3.027 
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 The calculated structure and the crystal structure are extremely alike 
(Cf. Chapter VI). This information provides more credibility of the previous 
calculations. 
 Fortunately, crystals of 8.022 could be obtained by slow evaporation 
of n-hexane. The conformation in solid phase appeared to be chair-boat, just 
like the ketone and as expected the reduction happened from the top face 
to furnish the α-alcohol 8.022. Once again, we can confirm the fused-trans-
junction and the cis-junction between indolenine and the side chain (Figure 
5). 
 
Figure 5: X-Ray structure of alcohol 8.022 
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b. Deprotection of the PMB 
The deprotection was tested on the ketone 3.027 to obtain 8.024. 
The conversion was about 60% in 8 days (Scheme 13). 
 
Scheme 13: Deprotection of ketone 
 And finally, the same reaction was tested on alcohol 8.022. The same 
behaviour in 8.015 was observed, an extremely slow conversion into the 
target molecule 8.025. The suspicion of poisoning of palladium catalyst 
increased as both products 8.015 and 8.022 got a similar feature. The 6 
membered ring moiety (right part) possesses a 1,3 diaxial aminol. Due to the 
small quantities of available material, this product has not been fully 
characterized yet (Scheme 14). 
 
Scheme 14: Deprotection of alcohol 8.022 
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3. Conclusions 
In this chapter, 6 new tetracycles were synthetized inclusive of, a 
saturated ketone 8.012, allylic alcohols 8.014 and 8.015, deprotected alcohol 
8.018, alcohol 8.022 and deprotected ketone 8.024 (Scheme 15). 
 
Scheme 15: New tetracycles 
Most of them were obtain as a single diastereoisomer such as 8.012, 
8.018 and 8.022. Alcohols 8.014 and 8.015 could be synthetized from the 
same molecule by the ratio will change depending on the reducing agent 
used. 
  
 Saturated ketone 8.012 appears to be the desired isomer for the 
synthesis of [5,6] indole manzamine. 
 
 X-Ray diffraction confirmed the structure of alcohol 8.022.  
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4. Perspectives 
The use of CDI or oxalyl chloride on 8.015 and 8.022 could lead to the 
synthesis of cyclic carbamates 8.026 and 8.027 or amide-ester 8.028 and 
8.029 (Scheme 16). 
 
Scheme 16: Use of CDI or oxalyl chloride 
 Reduction of ketones 8.012 and 8.031 to the corresponding alcohol 
8.030 and 8.032. Thereby extending even further the landscape of available 
derivatives (Scheme 17). 
 
Scheme 17: Reduction of ketone 
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Chapter IX 
Conclusions & Perspectives 
 
1. Conclusions 
a. Side products 
Throughout this thesis, many side products were characterized, and 
the synthesis pathway was adapted to avoid them or to reduce the obtained 
quantity. Most of them are new for the literature except 6.014, 4.088, 5.047 
and 5.028 (Scheme 1) and (Scheme 2).  
 
Scheme 1: Side products part 1 
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Scheme 2: Side products part 2 
 
b. Precursors synthetized 
A total of 9 polycyclization precursors were synthesized based on 
different functions such as ene-dione 4.092, ynone 5.017, 6.006 and 6.042, 
E-enone 3.035 and 6.067 or Z-enone 7.033, 7.036 and 7.022 (Scheme 3). 
 
Scheme 3: Precursors 
 Among these 9 precursors only 3.035 was described before by our 
group.  
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c. Polycyclizations 
Attempts to cyclize these precursors to the desired tetracycles using 
an anionic polycyclization methodology were investigated. Four of them 
cyclized so far, many mechanistic speculations were proposed to explain the 
obtained results. The final cumulated observation about all those precursors 
is that the size of the first synthetized ring is related to the Michael acceptor 
function in the precursor (Scheme 4). 
 
Scheme 4: Polycyclizations 
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d. Derivatizations & bioactivities 
To extend the library of compounds, some diastereo-controlled 
derivatisations were made (Scheme 5). 
 
Scheme 5: Derivates 
 
e. Completion of objectives  
 
The main objective of this thesis was to develop a short way toward 
tetracycles using a new methodology of anionic polycyclization. Ynone 
precursor and E-enones were cyclized in 5 steps overall and Z-enones in 6 
steps. 
                   → DONE 
 The secondary objectives were: 
 Use of cheap starting materials               → DONE 
 Check for bioactivities of the new compounds             → DONE 
 Obtention the correct diastereoisomer              → DONE 
 Finishing the synthesis of indole-manzamine             → In progress 
Chapter IX 
 
195 
 
2. Perspectives 
Due to the fact that there are few perspectives at the end of the 
chapter IV, V, VI, VII, and VIII. Those final perspectives will not be a 
compilation but additional possibilities. 
 
a. Asymmetric polycyclization 
So far, there are two catalysts able to perform these reactions, 
potassium tert-butoxide and DBU. Unfortunately, the product is racemic, 
however, there are substitutes for these bases in the chiral pool to create 
asymmetric anion polycyclization. 
 
Chiral alcohol 
Potassium anion of (-)-menthol 9.001 could be a potent catalyst for 
this reaction as well as its seven related isomers and they can easily be tested 
for match-mismatch effect (Scheme 6). 
 
Scheme 6: Menthols 
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Cinchonine 9.009 and cinchonidine 9.010 could be alternative to 
menthol (Scheme 7). 
 
Scheme 7: Cinchonine & cinchonidine 
  
Chiral DBN 
 Different processes exist to synthesize chiral derivatives of DBN 
9.012 from pyroglutamic acid 9.011. However, the pKa of DBN is slightly 
lower than DBU, it could worsen the shot (Scheme 8).1 
 
Scheme 8: Chiral DBN 
   
                                                          
1 (a) Kotsuki, H.; Sugino, A.; Sakai, H.; Yasuoka, H. Heterocycles, 2000, 53, 2561. (b) 
Ostendorf, M.; Van der Neut, S.; Rutjes, F. P. J. T.; Hiemstra, H. Eur. J. Org. Chem. 
2000, 105. 
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b. Achievement the synthesis 
One of the possible ways to finish the synthesis using the [5,6] 
tetracycle would be to modify the Weinreb amide to obtain 9.013 with an 
electrophile at the terminus position. Macrocyclisation should be favoured 
with acyl iodide as electrophile but also with iodide due to the elimination of 
PMB. Few reductions should be made, we know the hydrogenation of this 
enone will led to the desired diastereoisomer 9.015.  Then, the following 
steps come from the total syntheses of manzamine A 1.001, use of Mander’s 
reagent with a base to get 9.016 then reduction of the ketone into a double 
bond 9.017. Finally, DiBAL-H reduction into an indole ircinal derivatives 9.018 
should be obtained (Scheme 9). 
 
Scheme 9: Completion of synthesis 
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Chapter X 
Experimental Section 
 
1. Instrumentation 
1H and 13C nuclear magnetic resonance spectra were recorded in 
Belgium on Brucker Avance II-300 spectrometer (1H 300 MHz and 13C 75 MHz) 
and in Finland on Bruker Avance NEO 400 MHz SmartProbe spectrometer (1H 
400 MHz and 13C 100 MHz). 1H chemical shifts are reported in ppm downfield 
from internal tetramethylsilane (δ = 0 ppm) or CHCl3 (δ = 7.26 ppm) or DMSO 
(δ = 2.50 ppm). 13C NMR spectra are reported using CDCl3 as the internal 
standard (δ= 77.16 ppm) or DMSO (δ = 39.52 ppm). If necessary, the 
structures were confirmed by two-dimensional analysis (COSY, HMQC, HSQC 
and HMBC). 1H spectra described as follow: chemical shift (multiplicity, 
coupling constant (Hz), integration, attribution). 13C spectra are described as 
follow: chemical shift (attribution). Multiplicity is designed as: s = singlet; d = 
doublet; t = triplet; q = quartet; qui = quintet; sex = sextet; sep = septet; b = 
broad; and m = multiplet. When the compound presents two diastereotopic 
signals, the attribution is written X and X’ for each signal.  
Infrared spectra were recorded by transmittance on Perkin Elmer 
spectrum one and reported in wavenumber (cm-1). The samples were 
analysed as thin films deposit by solvent evaporation or as compressed 
potassium bromide pils. 
Low and high-resolution mass spectra were recorded by Mr. Raoul 
Rozenberg from the Mass Spectrometry Service, Université catholique de 
Louvain (Belgium) or by Ms. Heidi Meriö-Talvio from the Department of 
Chemical Technology of Aalto University (Finland).  
X-ray diffraction were recorded by Dr. Martin Nieger from the 
Department of Chemistry of University of Helsinki (Finland). 
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Calculation and conformation analyses were performed by Ari M. P. 
Koskinen with Macromodel v11.7. 
 
 
2. Procedure 
Unless otherwise noticed, all manipulations were performed under 
an argon atmosphere using standard glassware. Diethyl ether and 
tetrahydrofuran were distilled on sodium/benzophenone under argon 
atmosphere. Dichloromethane, triethylamine, and toluene were distilled on 
calcium hydride. Solvents used for work-up were of technical grade. 
Commercial reagents were purchased from Acros, Sigma-Aldrich, ABCR, TCI, 
Merck or Fluorochem and used as received unless stated otherwise. 
Thin layer chromatographies were performed on Merck Millipore 
F254 silica gel 60 plates (200 µm thickness, aluminium supported). The plates 
were visualised using ultra-violet light (254 nm) and stained using an alkaline 
potassium permanganate, vanillin, or ninhydrin solution. Column 
chromatographies were performed under pressure with the stated solvents 
using Sigma-Aldrich silica gel 60 (70-230 mesh). 
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N-benzyl-1-(1H-indol-3-yl)methanimine 
Figure 1: imine Bn 
 
To as solution of 1H-indole-3-carbaldehyde (40 g, 0.275 mol, 1 eq.) 
and PTSA (0.24 g, 0.0014 mol, 0.005 eq.) in toluene (350 ml) or benzene (350 
ml) was added benzylamine (31 g, 0.289 mol, 1.05 eq., 31.6 ml). The resulting 
mixture was refluxed with a Dean-Stark apparatus until the correct amount 
of water (5 ml) was retrieved. The solvent was removed at low pressure to 
afford a yellow-orange solid; 64.5 g (quantitative). 
This solid was directly used without more purification. 
 
 
CAS: 57506-52-2 
Formula: C16H14N2 
Molecular weight: 234.30 g/mol 
MP: 117-121°C         Litt1: 121-122°C 
 
1H NMR (300 MHz, CDCl3) δ 8.83 (s, 1H, H1), 8.57 (s, 1H, H10), 8.40 – 8.26 
(m, 1H, H5), 7.43 – 7.15 (m, 9H, H2 + H6 + H7 + H8 + H13 + H14 + H15), 
4.82 (s, 2H, H11). 
 
13C NMR (75 MHz, CDCl3) δ 156.62 (C10), 140.53 (C12), 136.84 (C9), 128.74 
(C2), 128.54 (C13/C14), 127.95 (C13/C14), 126.85 (C15), 125.60 (C4), 
123.41 (C7), 121.89 (C5), 121.51 (C6), 115.74 (C3), 111.39 (C8), 65.58 
(C11). 
 
                                                          
1 Alemany et al. Bull. Soc. Chem. Fr. 1975, 1223. 
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IR (film, cm-1): 3402 (N-H stretching), 3055 (C-H stretching), 3026 (C-H 
stretching), 2971 (C-H stretching), 2836 (C-H stretching), 1626 (C=N 
stretching), 1576 (C=C stretching), 1528 (C=C stretching), 1494 (C=C 
stretching), 1246 (C-N stretching), 733 (C-H bending out of plan of ortho 
di-substituted aromatic ring + C-H bending out of plan of mono-
substituted aromatic ring), 695 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
The compound was already described in the literature:  
Walker, G. N.; Moore, M.A. J. Org. Chem., 1961, 26, 432. 
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N-((1H-indol-3-yl)methyl)-1-phenylmethanamine 
Figure 2: amine Bn 
 
N-benzyl-1-(1H-indol-3-yl)methanimine (64.5 g, 0.275 mol, 1 eq.) 
was dissolved in methanol (300 ml) or ethanol (300 ml) at 0°C. Then NaBH4 
(22.9 g, 0.606 mol, 2.2 eq.) was added portionwise and the temperature was 
kept below 10°C. The mixture was stirred at 0°C for 3 hours then 25-35% 
aqueous ammonia solution was added (300 ml) and the biphasic mixture was 
stirred for 2 hours. The solvent was slowly eliminated under vacuum. The 
resulting aqueous phase was extracted 3 time with dichloromethane, the 
organic layers were combined and dried over Na2SO4. The solvent was 
eliminated under low pressure providing a yellow solid which can be 
precipitated with diethyl ether and pentane to a white solid; 61.8 g (95%). 
 
 
CAS: 57506-64-6 
Formula: C16H16N2 
Molecular weight: 236.32 g/mol 
MP: 82-84°C         Litt2: 89-90°C 
 
1H NMR (300 MHz, CDCl3) δ 8.13 (s, 1H, H1), 7.65 (d, J = 7.8 Hz, 1H, H5), 
7.41 – 7.25 (m, 6H, H8 + H14 + H15 + H16), 7.23 – 7.16 (m, 1H, H7), 7.16 – 
7.06 (m, 2H, H2 + H6), 4.01 (s, 2H, H10), 3.88 (s, 2H, H12), 1.71 (s, 1H, H11). 
 
13C NMR (75 MHz, CDCl3) δ 140.60 (C13), 136.54 (C9), 128.53 (C14/C15), 
128.38 (C14/C15), 127.24 (C4), 127.04 (C16), 122.66 (C2), 122.26 (C7), 
                                                          
2 Bandini, M.; Melloni, A.; Piccinelli, F.; Sinisi, R.; Tommasi, S.; Umani-Ronchi, A. J. 
Am. Chem. Soc. 2006, 128, 1424. 
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119.65 (C6), 119.09 (C5), 115.16 (C3), 111.30 (C8), 53.55 (C12), 44.31 
(C10). 
 
IR (film, cm-1): 3412 (N-H stretching), 3057 (C-H stretching), 3028 (C-H 
stretching), 2918 (C-H stretching), 2832 (C-H stretching), 1619 (C=C 
aromatic stretching), 1494 (C=C aromatic stretching), 1453 (CH2 
scissoring), 1232 (C-N stretching), 1090 (C-N stretching), 737 (C-H bending 
out of plan of ortho di-substituted aromatic ring + C-H bending out of plan 
of mono-substituted aromatic ring), 697 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
HRMS m/z calculated for C16H17N2 [M+H]+: 237.13863. Found: 237.13812. 
 
The compound was already described in the literature:  
Walker, G. N.; Moore, M.A. J. Org. Chem., 1961, 26, 432. 
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1-(((1H-indol-3-yl)methyl)(benzyl)amino)-3-chloropropan-2-ol 
Figure 3: epi amine Bn 
 
N-((1H-indol-3-yl)methyl)-1-phenylmethanamine (4 g, 16.9 mmol, 1 
eq.) was dissolved in isopropanol (80 ml), epichlorohydrin (1.7 g, 18.6 mmol, 
1.1 eq., 1.46 ml) was added at room temperature. The mixture was stirred at 
room temperature for 18 hours then the volatiles were removed in vacuo to 
afford a sticky orange oil. This oil was purified by column chromatography 
using flash silica gel, petroleum ether and ethyl acetate to afford a colourless 
sticky oil; 5.3 g (95%). 
 
 
CAS: / 
Formula: C19H21ClN2O 
Molecular weight: 328.84 g/mol 
1H NMR (300 MHz, CDCl3) δ 8.09 (s, 1H, H1), 7.58 (dd, J = 7.9, 0.6 Hz, 1H, 
H5), 7.39 – 7.26 (m, 6H, H8 + H13 + H14 + H15), 7.23 – 7.16 (m, 1H, H7), 
7.16 – 7.07 (m, 2H, H2 + H6), 3.97 (d, J = 13.6 Hz, 1H, H10), 3.90 (dq, J = 
8.0, 5.3 Hz, 1H, H17), 3.85 (d, J = 13.6 Hz, 1H, H11), 3.72 (d, J = 13.6 Hz, 1H, 
H10’), 3.54 (d, J = 13.3 Hz, 1H, H11’), 3.42 (d, J = 5.4 Hz, 2H, H19), 3.37 (bs, 
1H, H18), 2.67 (dd, J = 12.9, 5.2 Hz, 1H, H16), 2.62 (dd, J = 12.9, 8.2 Hz, 1H, 
H16’). 
 
13C NMR (75 MHz, CDCl3) δ 138.77 (C12), 136.57 (C9), 129.32 (C13), 128.60 
(C14), 127.58 (C4), 127.48 (C15), 123.98 (C2), 122.42 (C7), 119.97 (C6), 
119.24 (C5), 112.70 (C3), 111.39 (C8), 67.83 (C17), 59.16 (C12), 56.76 
(C16), 49.93 (C10), 47.38 (C19). 
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IR (film, cm-1): 3413 (O-H stretching), 3302 (N-H stretching), 3057 (C-H 
stretching), 2829 (C-H stretching), 1619 (C=C aromatic stretching), 1493 
(C=C aromatic stretching), 1454 (CH2 scissoring), 1264 (O-H bending in 
plan), 1237 (C-N stretching), 1091 (C-O stretching), 731 (C-H bending out 
of plan of ortho di-substituted aromatic ring + C-H bending out of plan of 
mono-substituted aromatic ring), 696 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
MS (FTMS +p ESI Full ms) m/z (%): 332.141 (2.6), 331.147 (0.9), 331.138 
(12.8), 330.144 (8.8), 329.14 [M+H]+ (40.0), 293.165 (30.0), 259.123 (5.0), 
202.080 (32.0), 200.084 (100.0), 164.107 (60.0), 130.065 (10.0), 91.054 
(10.0). 
 
HRMS m/z calculated for C19H22O1N235Cl1 [M+H]+: 329.14152. Found: 
329.14206. 
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N-benzyl-1-(1-(phenylsulfonyl)-1H-indol-3-yl)methanimine 
Figure 4: SO2Ph imine Bn 
 
To as solution of 1-(phenylsulfonyl)-1H-indole-3-carbaldehyde (20 g, 
70 mmol, 1 eq.) and PTSA (0.12 g, 0.7 mmol, 0.01 eq.) in toluene (200 ml) or 
benzene (200 ml) was added benzylamine (7.88 g, 73.6 mmol, 1.05 eq., 8.04 
ml). The resulting mixture was refluxed with a Dean-Stark apparatus until the 
correct amount of water (1.25 ml) was retrieved. The solvent was removed 
at low pressure to afford a yellow solid; 26.2 g (quantitative). 
This solid was directly used without more purification. 
 
 
CAS: / 
Formula: C22H18N2O2S 
Molecular weight: 374.45 
g/mol 
MP: 102-105°C      Litt: / 
 
1H NMR (300 MHz, CDCl3) δ 8.54 (t, J = 1.3 Hz, 1H, H7), 8.39 (dd, J = 7.0, 
0.9 Hz, 1H, H9), 8.01 – 7.95 (m, 1H, H12), 7.95 – 7.83 (m, 3H, H3 + H5), 7.56 
(m, 1H, H1), 7.50 – 7.41 (m, 2H, H2), 7.41 – 7.29 (m, 5H, H11 + H16 + H17), 
7.29 – 7.23 (m, 1H, H10 + H18), 4.83 (d, J = 0.8 Hz, 2H, H14). 
 
13C NMR (75 MHz, CDCl3) δ 155.05 (C7), 139.74 (C15), 138.02 (C4), 135.68 
(C13), 134.30 (C1), 129.84 (C5), 129.57 (C2), 128.61 (C17), 128.19 (C8), 
127.95 (C16), 127.04 (C3 + C18), 125.86 (C11), 124.43 (C10), 123.39 (C9), 
120.92 (C6), 113.34 (C12), 65.81 (C14). 
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IR (film, cm-1): 3061 (C-H stretching), 3028 (C-H stretching), 2840 (C-H 
stretching), 1642 (C=N stretching), 1582 (C=C stretching), 1550 (C=C 
stretching), 1495 (C=C stretching), 1478 (C=C stretching), 1444 (CH2 
scissoring), 1366 (S=O stretching), 1173 (S=O stretching), 1122, 1098 (C-H 
bending in plan of mono-substituted aromatic ring), 1084 (C-H bending in 
plan of mono-substituted aromatic ring), 974, 747 (C-H bending out of plan 
of mono-substituted aromatic ring), 724 (C-H bending out of plan of ortho-
disubstituted aromatic ring), 697 (C-H bending out of plan of mono-
substituted aromatic ring), 681 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
MS (FTMS +p APCI corona Full lock ms) m/z (%): 378.115 (1.1), 377.122 
(3.2), 377.112 (4.6), 376.119 (24.4), 375.116 [M+H]+ (100.0), 286.053 
(15.0), 234.116 (100.0), 91.055 (100.0). 
 
HRMS m/z calculated for C22H19O2N232S1 [M+H]+: 375.11618. Found: 
375.11611. 
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N-benzyl-1-(1-(phenylsulfonyl)-1H-indol-3-yl)methanamine 
Figure 5: PhSO2 amine 
 
N-benzyl-1-(1-(phenylsulfonyl)-1H-indol-3-yl)methanimine (25 g, 
66.7 mmol, 1 eq.) was dissolved in methanol (300 ml) or ethanol (300 ml) at 
0°C. Then NaBH4 (5.56 g, 146.9 mol, 2.2 eq.) was added portionwise and the 
temperature was kept below 10°C. The mixture was stirred at 0°C for 4 hours 
then 25-35% aqueous ammonia solution was added (300 ml) and the biphasic 
mixture was stirred for 6 hours. The solvent was slowly eliminated under 
vacuum. The resulting aqueous phase was extracted 3 time with 
dichloromethane, the organic layers were combined and dried over Na2SO4. 
The solvent was eliminated under low pressure providing a yellow solid 
which can be precipitated with diethyl ether and pentane to a white solid; 
23.9 g (95%). 
 
 
CAS: / 
Formula: C22H20N2O2S 
Molecular weight: 376.47 g/mol 
MP: 112-115°C        Litt: / 
 
1H NMR (300 MHz, CDCl3) δ 8.00 (d, J = 8.2 Hz, 1H, H9), 7.94 – 7.83 (m, 2H, 
H3), 7.56 (d, J = 8.1 Hz, 1H, H12), 7.54 – 7.48 (m, 2H, H1 + H5), 7.42 (m, 2H, 
H2), 7.37 – 7.28 (m, 8H, H2 + H11 + H17 + H18 + H19), 7.28 – 7.20 (m, 1H, 
H10), 3.90 (s, 2H, H7), 3.83 (s, 2H, H15), 1.55 (s, 1H, H14). 
 
13C NMR (75 MHz, CDCl3) δ 140.17 (C16), 138.38 (C4), 135.63 (C13), 133.87 
(C1), 130.45 (C8), 129.36 (C2), 128.60 (C18), 128.32 (C17), 127.22 (C19), 
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126.88 (C3), 125.01 (C11), 123.79 (C5), 123.37 (C10), 121.95 (C6), 119.99 
(C12), 113.87 (C9), 53.53 (C15), 43.97 (C7). 
 
IR (film, cm-1): 3061 (C-H stretching), 3027 (C-H stretching), 2826 (C-H 
stretching), 1604 (C=C stretching), 1494 (C=C aromatic stretching), 1445 
(CH2 scissoring), 1364 (S=O stretching), 1172 (S=O stretching), 1118, 1091 
(C-H bending in plan of mono-substituted aromatic ring), 973, 743 (C-H 
bending out of plan of mono-substituted aromatic ring), 722 (C-H bending 
out of plan of ortho-disubstituted aromatic ring), 698 (C-H bending out of 
plan of mono-substituted aromatic ring), 684 (C-H bending out of plan of 
mono-substituted aromatic ring). 
 
MS (FTMS +p APCI corona Full lock ms) m/z (%): 380.131 (0.3), 379.138 
(1.0), 379,127 (1.4), 378.135 (7.3), 377.131 (30.0), 270.058 (100). 
 
HRMS m/z calculated for C22H21O2N232S1 [M+H]+: 377.13183. Found: 
377.13176. 
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1-(benzyl((1-(phenylsulfonyl)-1H-indol-3-yl)methyl)amino)-3-
chloropropan-2-ol 
Figure 6: PhSO2 amine epi 
 
N-benzyl-1-(1-(phenylsulfonyl)-1H-indol-3-yl)methanamine (3 g, 7.9 
mmol, 1 eq.) was dissolved in isopropanol (40 ml) and dichloromethane (20 
ml), then epichlorohydrin (2.2 g, 23.9 mmol, 3 eq., 1.87 ml) was added at 
room temperature. The mixture was stirred at reflux for 48 hours then the 
volatiles were removed in vacuo to afford the desired product as a sticky 
orange oil; 3.55 g (95%). 
 
 
CAS: / 
Formula: C25H25ClN2O3S 
Molecular weight: 468.99 g/mol 
1H NMR (300 MHz, CDCl3) δ 7.98 (d, J = 8.3 Hz, 1H, H9), 7.88 – 7.79 (m, 2H, 
H3), 7.55 – 7.46 (m, 2H, H1 + H5), 7.46 – 7.36 (m, 3H, H12 + H2), 7.36 – 
7.17 (m, 7H, H11 + H10 + H20 + H21 + H22), 3.93 – 3.72 (m, 3H, H7 + H15 
+ H18), 3.61 (d, J = 13.7 Hz, 1H, H7’), 3.50 (d, J = 13.2 Hz, 1H, H18’), 3.41 – 
3.29 (m, 2H, H16), 2.99 (bs, 1H, H17), 2.68 – 2.50 (m, 2H, H14). 
 
13C NMR (75 MHz, CDCl3) δ 138.12 (C19), 137.93 (C4), 135.53 (C13), 133.84 
(C1), 130.47 (C8), 129.25 (C20), 129.19 (C2), 128.53 (C21), 127.52 (C22), 
126.62 (C3), 125.23 (C5), 125.08 (C11), 123.52 (C10), 119.98 (C12), 119.92 
(C6), 113.81 (C9), 67.84 (C15), 59.20 (C18), 56.79 (H14), 49.48 (C7), 47.38 
(C16). 
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IR (film, cm-1): 3425 (O-H stretching), 3062 (C-H stretching), 3028 (C-H 
stretching), 2830 (C-H stretching), 1605 (C=C aromatic stretching), 1494 
(C=C aromatic stretching), 1446 (CH2 scissoring), 1366 (C-N stretching of 
tertiary amine + S=O stretching), 1279 (O-H bending in plan), 1173 (S=O 
stretching), 1119 (C-O stretching), 977, 908, 745 (C-H bending out of plan 
of mono-substituted aromatic ring), 724 (C-H bending out of plan of ortho 
di-substituted aromatic ring + C-H bending out of plan of mono-
substituted aromatic ring), 699 (C-H bending out of plan of mono-
substituted aromatic ring), 684 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
MS (FTMS +p APCI corona Full lock ms) m/z (%): 473.136 (1.7), 473.128 
(1.7), 472.134 (10.3), 471.131 (36.9), 470.137 (28.1), 469.134 [M+H]+ 
(100.0), 433.157 (20.0), 375.115 (12.2), 286.052 (10.0), 270.057 (70.0). 
 
HRMS m/z calculated for C25H26O3N235Cl132S1 [M+H]+: 469.13472. Found: 
469.13434. 
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N-benzyl-1-(oxiran-2-yl)-N-((1-(phenylsulfonyl)-1H-indol-3-
yl)methyl)methanamine 
Figure 7: epoxide SO2Ph Bn 
 
1-(benzyl((1-(phenylsulfonyl)-1H-indol-3-yl)methyl)amino)-3-
chloropropan-2-ol (3.55 g, 7.5 mmol, 1 eq.) was dissolved in methanol (80 
ml) at room temperature then potassium carbonate (5.23 g, 37.8 mmol, 5 
eq.) was added at once. The resulting mixture was stirred at room 
temperature for 1 hour. Water and dichloromethane were added, and the 
solution extracted with dichloromethane, the organic phases were combined 
and dried over magnesium sulfate. The volatiles were removed in vacuo to 
afford the desired product as a colourless oil; 2.78 g (85%).  
 
 
CAS: / 
Formula: C25H24N2O3S 
Molecular weight: 432.53 g/mol 
1H NMR (300 MHz, CDCl3) δ 7.98 (d, J = 8.2 Hz, 1H, H9), 7.87 – 7.80 (m, 2H, 
H3), 7.65 (d, J = 7.8 Hz, 1H, H12), 7.52 (s, 1H, H5), 7.52 – 7.44 (m, 1H, H1), 
7.41 – 7.33 (m, 3H, H2 + H10), 7.33 – 7.19 (m, 6H, H11 + H19 + H20 + H21), 
3.89 (d, J = 13.9 Hz, 1H, H7), 3.79 (d, J = 13.5 Hz, 1H, H17), 3.67 (d, J = 14.2 
Hz, 1H, H7), 3.51 (d, J = 13.5 Hz, 1H, H17’), 3.07 (td, J = 6.7, 3.2 Hz, 1H, 
H15), 2.81 (dd, J = 13.8, 3.3 Hz, 1H, H14), 2.69 – 2.62 (m, 1H, H16), 2.38 
(dd, J = 5.6, 3.4 Hz, 1H, H16’), 2.36 (dd, J = 14.5, 5.9 Hz, 1H, H14’). 
 
13C NMR (75 MHz, CDCl3) δ 139.06 (C18), 138.10 (C4), 135.68 (C13), 133.80 
(C1), 130.86 (C8), 129.24 (C2), 129.00 (C19), 128.35 (C20), 127.17 (C21), 
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126.70 (C3), 124.95 (C5 + C10), 123.33 (C11), 120.95 (C6), 120.74 (C12), 
113.75 (C9), 59.17 (C17), 55.96 (C14), 51.10 (C15), 49.84 (C7), 44.84 (C16). 
 
IR (film, cm-1): 3083 (C-H stretching), 3061 (C-H stretching), 3028 (C-H 
stretching), 2922 (C-H stretching), 2803 (C-H stretching), 1604 (C=C 
aromatic stretching), 1494 (C=C aromatic stretching), 1446 (CH2 
scissoring), 1368 (S=O stretching + C-N stretching of tertiary amine), 1174 
(S=O stretching), 1095 (C-O stretching), 978, 746 (C-H bending out of plan 
of mono-substituted aromatic ring), 724 (C-H bending out of plan of ortho 
di-substituted aromatic ring + C-H bending out of plan of mono-
substituted aromatic ring), 699 (C-H bending out of plan of mono-
substituted aromatic ring), 685 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
MS (FTMS +p ESI Full ms) m/z (%): 455.142 [M+Na]+ (15.0), 436.157 (1.3), 
435.163 (4.4), 435.154 (4.8), 434.161 (28.0), 433.158 [M+H]+ (100.0), 
369.234 (5.0), 314.213 (30.0), 270.059 (42.5), 244. 131 (10), 242.131 (30), 
206.155 (16.0). 
 
HRMS m/z calculated for C25H25O3N232S1 [M+H]+: 433.15804. Found: 
433.16059. 
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methyl 2-(oxiran-2-ylmethyl)-3-oxobutanoate 
Figure 8: epoxy beta ceto 
 
To a solution of methyl 2-acetylpent-4-enoate (6.06 g, 38.8 mmol, 1 
eq., 6 ml) in dichloromethane (120 ml) was added dry meta-
chloroperoxybenzoic acid (7.7 g, 44.4 mmol, 1.15 eq.) at room temperature. 
The mixture was stirred at this temperature until completion by TLC 
approximately 3 days and quenched by addition of isoprene. The resulting 
mixture was washed with a saturated solution of sodium bicarbonate in 
water, and the water phase was extracted with dichloromethane. The 
organic layers were combined and dried over sodium sulfate to afford a 
colourless oil; 6 g (90 %) 
 
 
CAS: / 
Formula: C8H12O4 
Molecular weight: 172.18 g/mol 
1H NMR (300 MHz, CDCl3) δ 3.77 (d, J = 4.9 Hz, 3H, H1 + H1’), 3.74 – 3.65 
(m, 1H, H3), 3.04 – 2.91 (m, 1H, H7), 2.78 (dd, J = 8.8, 4.7 Hz, 1H, H8), 2.51 
(dt, J = 5.0, 2.6 Hz, 1H, H8’), 2.40 – 2.22 (m, 4H, H5 + H6), 1.95 – 1.76 (m, 
1H, H6’). 
 
13C NMR (75 MHz, CDCl3) δ 202.21 (C4), 202.17 (C4’), 169.79 (C2), 169.70 
(C2’), 56.36 (C3), 55.90 (C3’), 52.81 (C1), 52.76 (C1’), 50.05 (C7), 49.94 
(C7’), 47.57 (C8), 47.35 (C8’), 31.00 (C6), 30.73 (C6’), 29.67 (C5), 29.22 
(C5’). 
 
IR (film, cm-1): 3001 (C-H stretching), 2956 (C-H stretching), 2930 (C-H 
stretching), 1738 (C=O stretching from saturated acyclic ester), 1714 (C=O 
stretching from saturated acyclic ketone), 1435 (CH3 asymmetric 
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deformation), 1359 (CH in plan bending), 1231 (C-O stretching), 1195 (C-O 
stretching), 1148 (C-O stretching), 874.  
 
 
(MS (FTMS +p APCI corona Full ms) m/z (%): 175.085 (0.8), 174.084 (8.8), 
173.080 (100.0), 155.070 (32.01), 141.054 (17.4), 113.0599 (12.6), 99.044 
(30.5). 
 
HRMS m/z calculated for C8H13O4 [M+H]+: 173.08084. Found: 173.08084. 
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methyl 2-acetyl-2-chloropent-4-enoate 
Figure 9: chloro beta ceto 
 
To a solution of methyl 2-acetylpent-4-enoate (1.01 g, 6.5 mmol, 1 
eq., 1 ml) in dichloromethane (12 ml) at room temperature was added 
dropwise sulfuryl chloride (0.96 g, 7.1 mmol, 1.1 eq., 0.58 ml) and the mixture 
was stirred for 4 hours at room temperature. The mixture was purred in 
water (16 ml) and extracted with dichloromethane. The organic phases were 
combined, dried over sodium sulfate and the volatiles were removed without 
an excessive vacuum to afford the desired product as a colourless oil; 1.18 g 
(95%). 
 
 
CAS: / 
Formula: C8H11ClO3 
Molecular weight: 190.62 g/mol 
1H NMR (300 MHz, CDCl3) δ 5.79 (dddd, J = 16.7, 14.2, 10.0, 5.2 Hz, 1H, 
H7), 5.24 – 5.13 (m, 2H, H8), 3.82 (s, 3H, H1), 2.91 (qdt, J = 14.6, 7.0, 1.1 
Hz, 2H, H6), 2.35 (s, 3H, H5). 
 
13C NMR (75 MHz, CDCl3) δ 198.22 (C4), 167.65 (C2), 130.76 (C7), 120.64 
(C8), 74.55 (C3), 53.82 (C1), 41.25 (C6), 26.16 (C5). 
 
IR (film, cm-1): 3082 (C-H stretching), 3012 (C-H stretching), 2985 (C-H 
stretching), 2957 (C-H stretching), 1727 (C=O stretching), 1643 (C=C 
stretching from mono-alkylated alkene), 1262, 1236 (C-O stretching), 
1216, 1178 (C-O stretching), 1130 (C-C stretching), 993 (C-H bending out 
of plan of mono-substituted alkene), 927 (C-H bending out of plan of 
mono-substituted alkene).  
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MS (FTMS +p ESI Full ms) m/z (%): 219.099 (100.0), 213.029 (60.1), 
197.117 (22.9), 173.078 (4.2), 151.005 (22.1), 77.022 (5.0). 
 
HRMS m/z calculated for C8H11O335Cl123Na1 [M+Na]+: 213.02889. Found: 
213.02939 
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methyl 2-chloro-2-(oxiran-2-ylmethyl)-3-oxobutanoate 
Figure 10: chloro epoxi 
 
To a solution of methyl 2-acetyl-2-chloropent-4-enoate (3.0 g, 15.7 
mmol, 1 eq.) and sodium bicarbonate 3  (2.0 g, 23.6 mmol, 1.5 eq.) in 
dichloromethane (60 ml) was added dry meta-chloroperoxybenzoic acid 
(4.65 g, 18.9 mmol, 1.2 eq.) at room temperature. The mixture was stirred at 
this temperature until completion by TLC and quenched by addition of 
isoprene. The resulting mixture was washed with a saturated solution of 
sodium bicarbonate in water, and the water phase was extracted with 
dichloromethane. The organic layers were combined and dried over sodium 
sulfate to afford a colourless oil; 2.76 g (85 %).4 
 
CAS: / 
Formula: C8H11ClO4 
Molecular weight: 206.62 g/mol 
1H NMR (400 MHz, CDCl3) δ 3.87 (s, 3H, H1), 3.85 (s, 3H, H1’), 3.16 (qdd, J 
= 5.8, 4.1, 2.6 Hz, 2H, H7 + H7’), 2.80 (ddd, J = 6.7, 4.9, 4.1 Hz, 2H, H8), 2.57 
– 2.44 (m, 4H, H6 + H8’), 2.42 (s, 3H, H5), 2.36 (s, 3H, H5’), 2.33 – 2.23 (m, 
2H, H6’). 
 
13C NMR (100 MHz, CDCl3) δ 198.57 (C4), 197.18 (C4’), 167.76 (C2), 167.61 
(C2’), 72.99 (C3), 72.63 (C3’), 54.17 (C1), 54.06 (C1’), 48.09 (C7), 47.96 
                                                          
3 Tip: the use of sodium bicarbonate in the reaction is not mandatory if methyl 2-
acetyl-2-chloropent-4-enoate was washed with a saturated aqueous solution of 
sodium bicarbonate. The presence of HCl in the reaction increase the quantity of 
bicyclic side product and decrease the yield.  
4 By NMR two diastereoisomers could be observed with a 1:1 ratio. 
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(C7’), 47.09 (C8), 46.94 (C8’), 40.39 (C6), 40.14 (C6’), 26.18 (C5), 25.28 
(C5’). 
 
IR (film, cm-1): 3066 (C-H stretching), 3006 (C-H stretching), 2957 (C-H 
stretching), 2929 (C-H stretching), 1726 (C=O stretching), 1434 (CH3 
asymmetric deformation), 1237 (C-O stretching), 738 (C-Cl stretching). 
 
HRMS m/z calculated for C8H1135Cl1O423Na1 [M+Na]+: 229.0243. Found: 
229.0235. 
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methyl 5-(hydroxymethyl)-2-methyl-4,5-dihydrofuran-3-carboxylate 
Figure 11 ester cyclic 
Methode A: 
 
 To a solution of N-((1H-indol-3-yl)methyl)-1-phenylmethanamine 
(0.92 g, 3.9 mmol, 0.6 eq.) in isopropanol (20 ml) at room temperature was 
added methyl 2-(oxiran-2-ylmethyl)-3-oxobutanoate (1.11 g, 6.5 mmol, 1 
eq.). The mixture was stirred at room temperature for 12 hours then the 
solvent was evaporated under vacuum to provide a yellow oil. This oil was 
purified by column chromatography using flash silica gel, petroleum ether 
and ethyl acetate to afford a colourless oil; 1.11 g (quantitative). 
 
Methode B: 
 
To a solution of methyl 2-(oxiran-2-ylmethyl)-3-oxobutanoate (1.11 
g, 6.5 mmol, 1 eq.) in dichloromethane (20 ml) at room temperature was 
added a solution of dry HCl (0.01 eq.) in dichloromethane (1 ml) then the 
mixture was stirred at room temperature for 12 hours. The volatiles were 
removed in vacuo to obtain a colourless oil; 1.11 g (quantitative). 
CAS: / 
Formula: C8H12O4 
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Molecular weight: 172.18 g/mol 
1H NMR (300 MHz, CDCl3) δ 4.75 (dddd, J = 10.4, 7.8, 6.5, 3.7 Hz, 1H, H7), 
3.76 – 3.62 (m, 5H, H1 + H8), 2.93 (ddq, J = 13.7, 10.6, 1.5 Hz, 1H, H6), 2.62 
(ddq, J = 14.4, 7.8, 1.6 Hz, 1H, H6’), 2.20 (t, J = 1.6 Hz, 3H, H5), 1.99 (bs, 1H, 
H9). 
 
13C NMR (75 MHz, CDCl3) δ 167.90 (C4), 166.56 (C2), 102.09 (C3), 82.57 
(C7), 65.10 (C8), 51.04 (C1), 31.37 (C6), 14.18 (C5). 
 
IR (film, cm-1): 3410 (O-H stretching), 2951 (C-H stretching), 2871 (C-H 
stretching), 1682 (C=C stretching of tetra-substituted alkene), 1637 (C=O 
stretching of enol-ester), 1438 (CH3 asymmetric deformation), 1385 (CH3 
symmetric deformation), 1225 (C-O stretching), 1088 (C-O stretching). 
  
HRMS m/z calculated for C8H13O4 [M+H]+: 173.08084. Found: 173.08080. 
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methyl 6-chloro-1-methyl-2,7-dioxabicyclo[2.2.1]heptane-6-carboxylate5 
Figure 12 bicyle 
Methode A: 
 
 To a solution of methyl 2-chloro-2-(oxiran-2-ylmethyl)-3-
oxobutanoate (0.5 g, 2.9 mmol, 1 eq.) in dichloromethane (10 ml) was added 
drop wisely sulfuryl chloride (0.4 g, 3 mmol, 1.05 eq. 0.25 ml) at room 
temperature, the mixture was stirred at room temperature for 4 hours then 
purred on a saturated aqueous solution of sodium bicarbonate and 
dichloromethane. The resulting biphasic mixture was vigorously shake and 
extracted with dichloromethane, dried over sodium sulfate, then the 
volatiles were removed in vacuo to afford a colourless oil; 0.51 g (85%). 
 
Methode B: 
 
 
To a solution of methyl 5-(hydroxymethyl)-2-methyl-4,5-
dihydrofuran-3-carboxylate (0.5 g, 2.9 mmol, 1 eq.) in dichloromethane (10 
ml) was added drop wisely sulfuryl chloride (0.4 g, 3 mmol, 1.05 eq. 0.25 ml) 
at room temperature, the mixture was stirred at room temperature for 1 
                                                          
5  Tip: This product can appear as crystalline drops, the small proportion of 
diastereoisomer probably prevent a proper crystallisation. This diastereoisomer can 
be observed by 13C NMR as small picks next the major product. 
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hour then purred on a saturated aqueous solution of sodium bicarbonate and 
dichloromethane. The resulting biphasic mixture was vigorously shake and 
extracted with dichloromethane, dried over sodium sulfate, then the 
volatiles were removed in vacuo to afford a colourless oil; 0.54 g (90%). 
 
CAS: / 
Formula: C8H11ClO4 
Molecular weight: 206.62 g/mol 
 
1H NMR (400 MHz, CDCl3) δ 4.83 (dd, J = 5.4, 3.1 Hz, 1H, H7), 3.82 (s, 3H, 
H1), 3.66 (ddd, J = 6.5, 3.1, 2.3 Hz, 1H, H8), 3.63 (t, J = 6.6 Hz, 1H, H8’), 3.13 
(d, J = 13.5 Hz, 1H, H6), 2.35 (ddd, J = 13.7, 5.5, 2.2 Hz, 1H, H6’), 1.85 (s, 
3H, H5). 
 
13C NMR (100 MHz, CDCl3) δ 168.71 (C2), 109.61 (C4), 76.57 (C7), 71.69 
(C3), 70.13 (C8), 53.45 (C1), 44.83 (C6), 14.90 (C5). 
 
IR (film, cm-1): 3007 (C-H stretching), 2955 (C-H stretching), 2899 (C-H 
stretching), 1739 (C=O stretching of acyclic saturated ester), 1436 (CH3 
asymmetric deformation), 1393, 1299 (C-O stretching), 1265 (C-O 
stretching), 1060 (C-O stretching), 964 (C-O stretching).  
 
MS (FTMS +p ESI Full ms) m/z (%): 326.115 (100.0), 319.144 (40.1), 
207.041 (10.1), 198.127 (40.0). 
 
HRMS m/z calculated for C8H12O435Cl1 [M+H]+: 207.04186. Found: 
207.04195 
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1-iodo-3-(triphenyl-l5-phosphaneylidene)propan-2-one 
Figure 13: iodo phosphorane 
 
To a solution of 1-chloro-3-(triphenyl-l5-phosphaneylidene)propan-
2-one (3 g, 8.5 mmol, 1 eq.) in anhydrous acetonitrile (40 ml) was added 
sodium iodide (3.2 g, 21.3 mmol, 2.5 eq.). The mixture was stirred for 24 
hours at room temperature then solvent was removed in vacuo and the 
resulting solid was dissolved in dichloromethane and water. The aqueous 
phase was extracted with dichloromethane, the organic phases were 
combined and dried over sodium sulfate. All the volatiles were removed to 
afford the desired iodophosphorane as a brown solid; 3.4 g (90%)  
 
 
CAS: / 
Formula: C21H18IOP 
Molecular weight: 444.25 g/mol 
MP: decomp > 110°C 
 
1H NMR (300 MHz, CDCl3) δ 7.72 – 7.61 (m, 6H, H5), 7.61 – 7.53 (m, 3H, 
H7), 7.53 – 7.43 (m, 6H, H6), 4.12 (d, J = 24.2 Hz, 1H, H3), 3.85 (d, J = 2.3 
Hz, 2H, H1). 
 
13C NMR (75 MHz, CDCl3) δ 185.51 (d, J = 5.6 Hz, C2), 133.12 (d, J = 10.2 
Hz, C5), 132.46 (C7), 129.07 (d, J = 12.4 Hz, C6), 126.19 (d, J = 90.5 Hz, C4), 
51.91 (d, J = 104.9 Hz, C3), 9.76 (d, J = 18.2 Hz, C1). 
 
IR (film, cm-1): 3053 (C-H stretching), 1625 (C=O stretching/ C=C 
stretching), 1574 (C=C aromatic stretching), 1534 (C=C aromatic 
stretching), 1435, 1380, 1102, 714 (C-H bending out of plan of mono-
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substituted aromatic ring), 686 (C-H bending out of plan of mono-
substituted aromatic ring), 495 (C-I stretching). 
 
MS (FTMS +p ESI Full ms2) m/z (%): 445.020 [M+H]+ (100.0), 318.116 
(30.0), 303.092 (3.0), 275.097 (3.0), 275.097 (9.0), 227.061 (12.0), 203.061 
(42.5), 185.051 (1.0). 
 
HRMS m/z calculated for C21H19O1127I1P1 [M+H]+: 445.02127. Found: 
445.02146. 
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1-(((1H-indol-3-yl)methyl)(benzyl)amino)-3-(triphenyl-l5-
phosphaneylidene)propan-2-one 
Figure 14 amine Bn phosphorane 
 
To a solution of N-((1H-indol-3-yl)methyl)-1-phenylmethanamine 
(1.59 g, 6.7 mmol, 1 eq.) and potassium carbonate (1.12 g, 8.1 mmol, 1.2 eq.) 
in dichloromethane (30 ml) at room temperature was added 1-iodo-3-
(triphenyl-l5-phosphaneylidene)propan-2-one (15 ml) in dichloromethane 
and the mixture was stirred at room temperature for 32 hours then extracted 
with dichloromethane and water. The organic phases were combined and 
dried over sodium sulfate, the volatiles were removed in vacuo to afford a 
brown solid. This solid was dropped in diethyl ether and stirred overnight to 
obtain the desired product as a yellow solid; 2.8 g (75%) 
 
 
CAS: / 
Formula: C37H33N2OP 
Molecular weight: 552.65 g/mol 
MP: decomp >130°C 
 
1H NMR (300 MHz, CDCl3) δ 7.74 – 7.30 (m, 16H, H5 + H20 + H21 + H22), 
7.29 – 7.13 (m, 6H, H8 + H13 + H14 + H15), 7.10 – 7.01 (m, 1H, H7), 6.93 
(d, J = 2.1 Hz, 1H, H2), 6.88 – 6.79 (m, 1H, H6), 3.90 (s, 2H, H10), 3.78 (s, 
2H, H11), 3.77 (d, J = 23.1 Hz, 1H, H18), 3.23 (s, 2H, H16). 
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13C NMR (75 MHz, CDCl3) δ 191.33 (d, J = 2.3 Hz, C17), 139.66 (C12), 136.68 
(C9), 136.63 (C9), 133.10 (d, J = 10.2 Hz, C20), 132.13 (d, J = 9.7 Hz, C22), 
129.23 (C13), 128.91 (d, J = 12.3 Hz, C21), 128.19 (C14), 126.85 (C15), 
126.82 (d, J = 90.6 Hz, C19), 124.77 (C2), 124.23 (C2’), 121.40 (C7), 121.27 
(C7’), 119.71 (C5), 119.61 (C5’), 118.82 (C6), 118.73 (C6’), 112.05 (C3), 
111.53 (C8), 111.39 (C8’), 62.69 (d, J = 13.2 Hz, C16), 59.03 (C11), 51.96 (d, 
J = 111.6 Hz, C18), 50.27 (C10). 
 
IR (film, cm-1): 3174 (N-H stretching), 3055 (C-H stretching), 2915 (C-H 
stretching), 2782 (C-H stretching), 1518 (C=C stretching), 1491 (C=C 
stretching), 1482 (CH2 scissoring), 1436, 1107, 738 (C-H bending out of 
plan of ortho di-substituted aromatic ring + C-H bending out of plan of 
mono-substituted aromatic ring), 718 (C-H bending out of plan of mono-
substituted aromatic ring), 692 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
MS (FTMS +p APCI corona Full lock ms) m/z (%): 556.250 (0.2), 555.246 
(1.7), 554.243 (8.1), 553.240 [M+H]+ (20.0), 424.181 (17.5), 319.124 (10.0), 
279.092 (90.2), 263.097 (71.0), 162.091 (20.9), 130.064 (100.0). 
 
HRMS m/z calculated for C37H34O1N2P1 [M+H]+: 553.24033. Found: 
553.23937. 
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diethyl (3-iodo-2-oxopropyl)phosphonate 
Figure 15 iodo phosphonate 
 
To as solution of diethyl (3-chloro-2-oxopropyl)phosphonate (1.2 g, 
5.3 mmol, 1 eq., 1 ml) in anhydrous acetonitrile (20 ml) was added sodium 
iodide (2.4 g, 16.0 mmol, 3 eq.) and the mixture was stirred for 6 hours at 
room temperature. Water was added as quench and the mixture was 
extracted with dichloromethane. The organic phases were combined and 
dried over magnesium sulfate, then volatiles were removed in vacuo to 
afford the desired iodo-keto-phosphonate as a slightly yellow oil; 1.7 g (85%).  
 
 
CAS: / 
Formula: C7H14IO4P 
Molecular weight: 320.06 g/mol 
 
1H NMR (300 MHz, CDCl3) δ 4.26 – 4.07 (m, 4H, H4), 4.03 (s, J = 3.9 Hz, 2H, 
H1), 3.34 (d, J = 22.5 Hz, 2H, H3), 1.32 (t, J = 7.1 Hz, 6H, H5). 
 
13C NMR (75 MHz, CDCl3) δ 194.73 (d, J = 5.6 Hz, C2), 63.06 (d, J = 6.5 Hz, 
C4), 38.95 (d, J = 128.1 Hz, C3), 16.42 (d, J = 6.2 Hz, C5), 7.03 (C1). 
 
IR (film, cm-1): 2983 (C-H stretching), 2931 (C-H stretching), 2912 (C-H 
stretching), 1712 (C=O stretching from saturated acyclic ketone), 1477 
(CH2 scissoring), 1444 (CH3 asymmetric deformation), 1392 (CH3 
symmetric deformation), 1241 (P=O stretching), 1015 (C-O stretching), 
965 (P-O stretching). 
  
HRMS m/z calculated for C7H15127I1O4P1 [M+H]+: 320.9752. Found: 
320.9747. 
HRMS m/z calculated for C7H14127I1O4P123Na1 [M+Na]+: 342.9572. Found: 
342.9567. 
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diethyl-(3-(((1H-indol-3-yl)methyl)(benzyl)amino)-2-
oxopropyl)phosphonate 
Figure 16 amine phosphonate 
 
To as solution of N-((1H-indol-3-yl)methyl)-1-phenylmethanamine 
(0.94 g, 4 mmol, 1eq.) and potassium carbonate (0.66 g, 4.8 mmol, 1.2 eq.) 
in tetrahydrofuran (12 ml) and water (3 ml) was added diethyl (3-iodo-2-
oxopropyl)phosphonate (1.28 g, 4 mmol, 1 eq.) at room temperature and the 
mixture was stirred for 1 hour. Addition of water as quench, the mixture was 
extracted with dichloromethane and the organic layers were dried over 
sodium sulfate. All volatiles were removed in vacuo and the crude oil was 
purified by column chromatography using flash silica gel, diethyl ether and 
ethyl acetate. To afford the desired product as a colourless oil; 1.7 g (60%).  
 
 
CAS: / 
Formula: C23H29N2O4P 
Molecular weight: 428.46 
g/mol 
1H NMR (400 MHz, CDCl3) δ 8.38 (bs, 1H, H1), 7.71 – 7.66 (m, 1H, H5), 7.42 
– 7.37 (m, 2H, H13), 7.36 – 7.30 (m, 3H, H8 + H14), 7.26 (tt, J = 7.1, 1.4 Hz, 
1H, H15), 7.19 – 7.14 (m, 1H, H7), 7.14 – 7.09 (m, 1H, H6), 7.07 (d, J = 2.4 
Hz, 1H, H2), 3.99 – 3.88 (m, 4H, H19), 3.86 (s, 2H, H10), 3.75 (s, 2H, H11), 
3.36 (s, 2H, H16), 2.95 (d, J = 22.2 Hz, 2H, H18), 1.21 – 1.16 (m, 6H, H20). 
 
13C NMR (100 MHz, CDCl3) δ 202.54 (d, J = 6.5 Hz, C17), 138.76 (C12), 
136.60 (C9), 129.30 (C13), 128.39 (C14), 127.65 (C4), 127.31 (C15), 124.73 
(C2), 121.95 (C7), 119.50 (C5), 119.46 (C6), 112.02 (C3), 111.36 (C8), 64.22 
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(d, J = 1.6 Hz, C16), 62.39 (d, J = 6.4 Hz, C19), 59.59 (C11), 50.21 (C10), 
38.36 (d, J = 128.5 Hz, C18), 16.23 (d, J = 6.1 Hz, C20). 
 
IR (film, cm-1): 3405 (O-H stretching of enol form), 3263 (N-H stretching), 
3060 (C-H stretching), 3029 (C-H stretching), 2983 (C-H stretching), 2928 
(C-H stretching), 2908 (C-H stretching), 2808 (C-H stretching), 1716 (C=O 
stretching of saturated acyclic ketone), 1619 (C=C aromatic stretching), 
1554 (C=C aromatic stretching), 1494 (C=C aromatic stretching), 1454 (CH2 
scissoring), 1237 (P=O stretching + C-N stretching), 1019 (C-O stretching), 
967 (P-O stretching), 907, 725 (C-H bending out of plan of ortho di-
substituted aromatic ring + C-H bending out of plan of mono-substituted 
aromatic ring), 697 (C-H bending out of plan of mono-substituted aromatic 
ring). 
 
MS (FTMS +p ESI Full ms) m/z (%): 431.199 (0.7), 430.197 (4.6), 429.193 
[M+H]+ (18.3), 366.195 (40.0), 300.135 (100.0), 237.138 (12.7), 130.065 
(69.8). 
 
HRMS m/z calculated for C23H30O4N2P1 [M+H]+: 429.19377. Found: 
429.19302. 
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N,N-bis((1H-indol-3-yl)methyl)-1-phenylmethanamine 
Figure 17 bis indole Bn 
 
To a solution of N-((1H-indol-3-yl)methyl)-1-phenylmethanamine (1.0 g, 4.2 
mmol, 1 eq.) in methanol (15 ml) was added aqueous HCl 32% (0.2 ml). The 
solution was refluxed for 8 hours then the volatiles were removed in vacuo 
to afford a yellow oil. This oil was purified by column chromatography using 
flash silica gel, methanol and dichloromethane to afford the product as a 
white solid; 0.54 g (35%). 
 
 
CAS: / 
Formula: C25H23N3 
Molecular weight: 365.48 
g/mol 
MP: 50-52°C       Litt: / 
 
1H NMR (300 MHz, CDCl3) δ 7.96 (bs, 2H, H1), 7.68 (d, J = 7.8 Hz, 2H, H5), 
7.41 (d, J = 7.6 Hz, 2H, H13), 7.37 – 7.12 (m, 9H, H2 + H7 + H8 + H14 + H15), 
7.12 – 7.04 (m, 2H, H6), 3.81 (s, 4H, H10), 3.64 (s, 2H, H11). 
 
13C NMR (75 MHz, CDCl3) δ 140.56 (C12), 136.57 (C9), 129.16 (C13), 128.21 
(C14), 128.00 (C4), 126.73 (C15), 123.49 (C2), 122.05 (C7), 120.19 (C5), 
119.40 (C6), 114.32 (C3), 111.01 (C8), 58.26 (C11), 49.41 (C10). 
 
IR (film, cm-1): 3413 (N-H stretching), 3057 (C-H stretching), 3028 (C-H 
stretching), 2921 (C-H stretching), 2790 (C-H stretching), 1618 (C=C 
aromatic stretching), 1556 (C=C aromatic stretching), 1492 (C=C aromatic 
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stretching), 1455 (CH2 scissoring), 1235 (C-N stretching), 739 (C-H bending 
out of plan of ortho di-substituted aromatic ring + C-H bending out of plan 
of mono-substituted aromatic ring), 699 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
HRMS m/z calculated for C25H24N3 [M+H]+: 366.19647. Found: 366.19585. 
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ethyl 3-formyl-1H-indole-1-carboxylate 
Figure 18 indole vil COOEt 
 
Ethyl chloroformate (22.4 g, 0.206 mol, 1.2 eq., 19.7 ml) was added 
dropwise with stirring to 1H-indole-3-carbaldehyde (25 g, 0.17 mol, 1 eq.) 
and triethylamine (22.6 g, 0.22 mol, 1.3 eq., 30.2 ml) in tetrahydrofuran (400 
ml) at 0°C over 1 hour. The mixture was stirred at this temperature for 2 
additional hours then water (10 g, 0.55 mol, 2.7 eq., 10 ml) is added and the 
stirring continues over night at room temperature. A 1M HCl aqueous 
solution was added and the resulting solution was vigorously shaken for few 
seconds then extracted three time with ethyl acetate. The combined organic 
layers were washed by a saturated solution of sodium bicarbonate in water 
then dried over sodium sulfate. All volatiles were removed in vacuo to afford 
a yellowish solid; 31.4 g (85%). 
 
 
CAS: 500995-08-4 
Formula: C12H11NO3 
Molecular weight: 217.22 g/mol 
MP: 69-71°C         Litt6: 74°C 
 
1H NMR (300 MHz, CDCl3) δ 10.11 (s, 1H, H6), 8.30 (d, J = 7.0 Hz, 1H, H8), 
8.28 (s, 1H, H4), 8.19 (d, J = 7.7 Hz, 1H, H11), 7.54 – 7.33 (m, 2H, H9 + H10), 
4.57 (q, J = 7.1 Hz, 2H, H2), 1.52 (t, J = 7.1 Hz, 3H, H1). 
 
                                                          
6 Chakrabarty, M.; Basak, R.; Harigaya, Y.; Takayanagi, H. Tetrahedron 2005, 61, 1793. 
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13C NMR (75 MHz, CDCl3) δ 185.85 (C6), 150.38 (C3), 136.21 (C4), 136.09 
(C12), 126.43 (C10), 126.17 (C7), 124.97 (C9), 122.33 (C8), 122.24 (C5), 
115.27 (C11), 64.51 (C2), 14.45 (C1). 
 
IR (film, cm-1): 2984 (C-H stretching), 2818 (C-H stretching), 1744 (C=O 
stretching of carbamate), 1671 (C=O stretching), 1549 (C=C stretching), 
1479 (C=C stretching), 1449 (CH2 scissoring), 1222 (C-N stretching), 1088 
(C-O stretching), 1000 (C-O stretching), 745 (C-H bending out of plan of 
para disubstituted aromatic ring). 
 
MS (FTMS +p ESI Full ms2) m/z (%): 218.080 [M+H]+ (80.0), 190.049 (33.0), 
174.090 (4.0), 146.059 (52.0), 118.065 (100.0), 91.054 (2.0). 
 
HRMS m/z calculated for C12H12O3N1 [M+H]+: 218.08117. Found: 
218.08128. 
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1-(ethoxycarbonyl)-1H-indole-3-carboxylic acid 
Figure 19 indole acid 
 
To a solution of Ethyl 3-formyl-1H-indole-1-carboxylate (20 g, 92 
mmol, 1 eq.) in tert-butyl alcohol (200 ml) was added 2-methyl-2-butene 
(12.9 g, 184 mmol, 2 eq., 19.5 ml) at room temperature. Potassium 
dihydrogenphosphate (28.2 g, 207 mmol, 2.25 eq.) and sodium chlorite (25 
g, 276 mmol, 3 eq.) were dissolved in water (200 ml). When the aqueous 
solution is free of solid salt, it’s added on the organic phase and stirred over 
night at room temperature. A 1M HCl solution is added to quench the 
reaction, the resulting mixture was extracted four time with ethyl acetate. 
The organic phases were combined and dried over sodium sulfate. All the 
volatiles were removed in vacuo to afford a yellow solid. Dry diethyl ether 
(50 ml) was added to this yellow solid and the mixture was stirred at room 
temperature. After at least 8 hours, the suspension was filtered and rinsed 
with diethyl ether, then dried in vacuo to afford the off-white product; 17.2 
g (80%). 
 
 
CAS: / 
Formula: C12H11NO4 
Molecular weight: 233.22 g/mol 
MP: 209-211°C       Litt: / 
 
1H NMR (300 MHz, DMSO) δ 12.82 (s, 1H, H7), 8.21 (s, 1H, H4), 8.14 (dd, J 
= 7.4, 0.9 Hz, 1H, H12), 8.10 (dd, J = 7.5, 1.0 Hz, 1H, H9), 7.46 – 7.39 (m, 
1H, H11), 7.40 – 7.33 (m, 1H, H10), 4.48 (q, J = 7.1 Hz, 2H, H2), 1.41 (t, J = 
7.1 Hz, 3H, H1). 
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13C NMR (75 MHz, DMSO) δ 164.68 (C6), 149.86 (C3), 135.03 (C13), 131.44 
(C4), 127.31 (C8), 125.22 (C11), 123.98 (C10), 121.33 (C9), 114.85 (C12), 
112.85 (C5), 64.07 (C2), 13.98 (C1). 
 
IR (film, cm-1): 2986 (C-H stretching), 2545 (O-H stretching), 1757 (C=O 
stretching of carbamate), 1670 (C=O stretching), 1555 (C=C stretching), 
1487 (C=C stretching), 1284 (C-O acid stretching), 1210 (C-N stretching), 
1075 (C-O stretching), 761 (C-H bending out of plan of para disubstituted 
aromatic ring), 749 (C-H bending out of plan of para disubstituted aromatic 
ring). 
 
MS (FTMS +p ESI Full ms2) m/z (%): 234.075 [M+H]+ (20.0), 216.065 (2.0), 
206.044 (14.0), 190.085 (16.0), 172.075 (2.0), 162.054 (35.0), 146.096 
(25.0), 126.58 (5.0), 118.065 (100.0), 91.054 (2.0). 
 
HRMS m/z calculated for C12H12O4N1 [M+H]+: 234.07608. Found: 
234.07613. 
 
The compound was already described in the literature: 
Tsai, A-I.; Lin, C-H.; Chuang, C-P., Heterocycles, 2005, 65, 2381. 
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diethyl (oxiran-2-ylmethyl)phosphonate 
Figure 20 epoxy phosphonate 
 
To a solution of diethyl allylphosphonate (21.1 g, 118 mmol, 1 eq., 
20.0 ml) in acetone (200 ml) and water (200 ml) was added first sodium 
bicarbonate (16.9 g, 200 mmol, 1.7 eq.) and then Oxone (36.4 g, 118 mmol, 
1 eq.). The addition of sodium bicarbonate then Oxone were repeated until 
completion of the reaction (4 additions were need here). Then the mixture 
was extracted four time with ethyl acetate, the organic phases were 
combined and dried over magnesium sulfate. The volatiles were removed 
under low vacuum to afford a colourless oil; 22.9 g (85%). 
This product was used without any further purification. 
 
 
 
CAS: 7316-37-2 
Formula: C7H15O4P 
Molecular weight: 194.16 g/mol 
1H NMR (300 MHz, CDCl3) δ 4.25 – 4.06 (m, 4H, H4), 3.25 – 3.14 (m, 1H, 
H2), 2.89 – 2.80 (m, 1H, H1), 2.60 (dd, J = 4.8, 2.5 Hz, 1H, H1’), 2.22 (ddd, J 
= 18.3, 15.2, 5.7 Hz, 1H, H3), 1.87 (ddd, J = 19.9, 15.2, 6.5 Hz, 1H, H3’), 1.35 
(t, J = 7.0 Hz, 6H, H5). 
 
13C NMR (75 MHz, CDCl3) δ 62.07 (d, J = 6.4 Hz, C4), 47.41 (d, J = 7.2 Hz, 
C1), 46.94 (d, J = 1.9 Hz, C2), 30.30 (d, J = 139.0 Hz, C3), 16.55 (d, J = 6.0 
Hz, C5). 
 
IR (film, cm-1): 2958 (C-H stretching), 2931 (C-H stretching), 2913 (C-H 
stretching), 1481 (CH2 scissoring), 1445 (CH3 asymmetric deformation), 
1395 (CH3 symmetric deformation), 1273 (C-O stretching), 1220 (P=O 
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stretching of phosphonate), 1015 (C-O stretching), 959 (P-O stretching), 
840.  
 
The compound was already described in the literature: 
Arbusow; Lugowkin, Zhurnal Obshchei Khimii, 1952, 22, 1193. 
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diethyl (3-(allylamino)-2-hydroxypropyl)phosphonate 
Figure 21 allyl amine ol phosphonate 
 
To a solution of diethyl (oxiran-2-ylmethyl)phosphonate  (20.0 g, 0.10 
mol, 1 eq.) in methanol (400 ml) was added allylamine (30.9 g, 0.54 mol, 5.25 
eq., 40.5 ml) and the mixture was refluxed overnight. All volatiles were 
removed under vacuum to afford the desired product as a colourless oil; 25.9 
g (quantitative).  
 
 
CAS: / 
Formula: C10H22NO4P 
Molecular weight: 251.26 g/mol 
1H NMR (300 MHz, CDCl3) δ 5.89 (ddt, J = 16.3, 10.2, 6.0 Hz, 1H, H2), 5.19 
(ddd, J = 17.2, 3.2, 1.6 Hz, 1H, H1), 5.11 (ddd, J = 10.2, 1.5 Hz, 1H, H1’), 4.21 
– 4.03 (m, 5H, H6 + H9), 3.36 – 3.21 (m, 2H, H3), 3.21 – 2.92 (bs, 2H, H4 + 
H7), 2.78 (dd, J = 12.1, 3.6 Hz, 1H, H5), 2.64 (dd, J = 12.1, 8.0 Hz, 1H, H5’), 
1.98 (dqd, J = 19.6, 15.3, 6.3 Hz, 2H, H8), 1.34 (t, J = 7.1 Hz, 6H, H10). 
 
13C NMR (75 MHz, CDCl3) δ 136.42 (C2), 116.44 (C1), 65.22 (d, J = 4.0 Hz, 
C6), 61.97 (t, J = 6.3 Hz, C9), 55.14 (d, J = 16.2 Hz, C5), 52.13 (s, J = 9.5 Hz, 
C3), 31.65 (d, J = 139.5 Hz, C8), 16.53 (d, J = 6.0 Hz, C10). 
 
IR (film, cm-1): 3356 (O-H stretching + N-H stretching), 2982 (C-H 
stretching), 2909 (C-H stretching), 2834 (C-H stretching), 1644 (C=C 
stretching of mono-substituted alkene), 1444 (CH3 asymmetric 
deformation), 1392 (CH3 symmetric deformation), 1217 (P=O stretching of 
phosphonate), 1018 (C-O stretching), 958 (P-O stretching) 
  
HRMS m/z calculated for C10H23O4N1P1 [M+H]+: 252.13592. Found: 
252.13601 
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ethyl 3-(allyl(3-(diethoxyphosphoryl)-2-hydroxypropyl)carbamoyl)-1H-
indole-1-carboxylate 
Figure 22: indole allyl alco phospho 
 
Oxalyl chloride (11.2 g, 88 mmol, 1.25 eq., 7.6 ml) was added dropwise on 
one hour to a solution of 1-(ethoxycarbonyl)-1H-indole-3-carboxylic acid 
(16.5 g, 70 mmol, 1 eq.) in dichloromethane (400 ml) at 0°C, followed by 
addition of dimethylformamide (0.5 ml). The mixture was stirred for two 
additional hours at room temperature. The solution was cooled to 0°C and 
triethylamine (21.5 g, 212 mmol, 3 eq., 28.6 ml) was added on half an hour, 
followed by addition of diethyl (3-(allylamino)-2-
hydroxypropyl)phosphonate (26.2 g, 104 mmol, 1.47 eq.) in 
dichloromethane (10 ml) on less than one minute. The resulting mixture was 
stirred for four additional hours at room temperature. The solvents were 
removed under vacuum and the oil was dissolved in ethyl acetate and 1M 
HCl aqueous solution. The biphasic system was vigorously shaken, then 
separated. The aqueous phase was extracted three more time with ethyl 
acetate, all four organic phases were combined and dried over sodium 
sulfate. All volatiles were removed in vacuo to afford the desired product as 
a brown solid; 29.7 g (90%). 
 
CAS: / 
Formula: C22H31N2O7P 
Molecular weight: 466.47 g/mol 
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MP: 53-56°C        Litt: / 
 
1H NMR (300 MHz, CDCl3) δ 8.17 (d, J = 8.1 Hz, 1H, H10), 7.91 (s, 1H, H4), 
7.77 (d, J = 7.4 Hz, 1H, H7), 7.43 – 7.35 (m, 1H, H9), 7.35 – 7.28 (m, 1H, H8), 
5.91 – 5.75 (m, 1H, H14), 5.35 – 5.17 (m, 2H, H15), 4.51 (q, J = 7.1 Hz, 2H, 
H2), 4.45 – 4.20 (m, 3H, H13 + H17), 4.21 – 4.04 (m, 4H, H20), 3.70 (s, 2H, 
H16), 2.04 (bs, 2H, H19), 1.47 (t, J = 7.1 Hz, 3H, H1), 1.33 (tt, J = 9.0, 4.5 Hz, 
6H, H21). 
 
13C NMR (75 MHz, CDCl3) δ 167.68 (C12), 150.75 (C3), 134.96 (C11), 133.58 
(C14), 128.62 (C6), 125.48 (C4+C9), 123.89 (C8), 121.08 (C7), 117.67 (C15), 
115.93 (C5), 115.24 (C10), 66.60 (C17), 63.85 (C2), 62.10 (t, J = 6.6 Hz, C20), 
53.24 (C13), 52.46 (C16), 31.90 (d, J = 138.4 Hz, C19), 16.49 (d, J = 5.6 Hz, 
C21), 14.40 (C1). 
 
IR (cm-1): 3366 (O-H stretching), 2983 (C-H stretching), 2933 (C-H 
stretching), 1743 (C=O stretching of carbamate), 1622 (C=O stretching), 
1559 (C=C aromatic stretching), 1453 (CH2 scissoring), 1239 (P=O 
stretching), 1211 (O-CH2 stretching), 1024 (P-O stretching), 765 (C-H 
bending out of plan of para disubstituted aromatic ring), 750 (C-H bending 
out of plan of para disubstituted aromatic ring). 
 
HRMS m/z calculated for C22H32O7N2P1 [M+H]+: 467.19416. Found: 
467.19409 
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ethyl 3-(allylcarbamoyl)-1H-indole-1-carboxylate 
Figure 23 allyl indole COOEt 
 
 
CAS: / 
Formula: C15H16N2O3 
Molecular weight: 272.30 g/mol 
 
Off-white solid 
 
MP: 114-116°C Litt: / 
 
1H NMR (400 MHz, CDCl3) δ 8.21 (d, J = 8.1 Hz, 1H, H10), 8.11 (s, 1H, H4), 
8.04 (dd, J = 7.1, 1.2 Hz, 1H, H7), 7.43 – 7.38 (m, 1H, H9), 7.38 – 7.33 (m, 
1H, H8), 6.04 (s, 1H, H13), 5.98 (ddt, J = 17.1, 10.2, 5.7 Hz, 1H, H15), 5.30 
(ddd, J = 17.2, 3.0, 1.6 Hz, 1H, H16), 5.22 (dq, J = 10.2, 1.4 Hz, 1H, H16’), 
4.53 (q, J = 7.1 Hz, 2H, H2), 4.13 (tt, J = 5.8, 1.5 Hz, 2H, H14), 1.49 (t, J = 7.1 
Hz, 3H, H1). 
 
13C NMR (100 MHz, CDCl3) δ 164.03 (C12), 150.45 (C3), 135.32 (C11), 
134.26 (C15), 127.48 (C6), 127.25 (C4), 125.16 (C9), 123.80 (C8), 121.13 
(C7), 116.49 (C5), 116.34 (C16), 115.07 (C10), 63.79 (C2), 41.95 (C14), 
14.21 (C1). 
 
IR (cm-1): 3274 (N-H stretching), 3080 (C-H stretching), 3056 (C-H 
stretching), 2988 (C-H stretching), 2922 (C-H stretching), 1741 (C=O 
stretching of carbamate), 1632 (C=C stretching of mono-substituted 
alkene), 1560 (C=C aromatic stretching), 1530 (C=C aromatic stretching), 
1487 (CH2 scissoring), 1451 (CH2 scissoring), 1430 (CH3 asymmetric 
deformation), 1385 (CH3 symmetric deformation), 1276 (C-H bending of 
mono-substituted alkene), 1242 (C-N stretching), 763 (C-H bending out of 
plan), 749 (C-H bending out of plan of ortho di-substituted aromatic ring). 
 
HRMS m/z calculated for C15H17O3N2 [M+H]+: 273.123369. Found: 
273.123284. 
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ethyl 3-carbamoyl-1H-indole-1-carboxylate 
Figure 24 COOEt indole NH2 
 
 
CAS: / 
Formula: C12H12N2O3 
Molecular weight: 232.24 g/mol 
 
Off-white solid 
 
MP: 222-224°C      Litt: / 
 
1H NMR (400 MHz, DMSO) δ 8.50 (s, 1H, H4), 8.25 (d, J = 7.7 Hz, 1H, H7), 
8.11 (d, J = 8.2 Hz, 1H, H10), 7.87 (bs, 1H, H13), 7.41 – 7.35 (m, 1H, H9), 
7.31 (t, J = 7.1 Hz, 1H, H8), 7.17 (bs, 1H, H13’), 4.49 (q, J = 7.1 Hz, 2H, H2), 
1.42 (t, J = 7.1 Hz, 3H, H1). 
 
13C NMR (100 MHz, DMSO) δ 164.97 (C12), 150.22 (C3), 134.82 (C11), 
128.29 (C6), 128.07 (C4), 124.87 (C9), 123.53 (C8), 122.02 (C7), 115.42 
(C5), 114.60 (C10), 63.82 (C2), 14.11 (C1). 
 
IR (cm-1): 3422 (N-H stretching), 3158 (C-H stretching), 3089 (C-H 
stretching), 3053 (C-H stretching), 2982 (C-H stretching), 1733 (C=O 
stretching of carbamate), 1660 (C=O stretching of primary amide), 1624 
(NH2 scissoring), 1451 (CH2 scissoring), 1402, 1382 (CH3 symmetric 
deformation), 1309 (C-C stretching), 1250 (C-N stretching), 760 (C-H 
bending out of plan), 743 (C-H bending out of plan of ortho di-substituted 
aromatic ring). 
 
HRMS m/z calculated for C12H13O3N2 [M+H]+: 233.092069. Found: 
233.091923. 
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ethyl 3-(benzyl ((5-methylfuran-2-yl)methyl)carbamoyl) -1H-indole -1- 
carboxylate 
Figure 25: indole COOEt furan 
 
To a solution of 1-(ethoxycarbonyl)-1H-indole-3-carboxylic acid (10 
g, 43 mmol, 1 eq.) in dichloromethane (200 ml) and dimethylformamide (0.5 
ml) at room temperature was added oxalyl chloride (6 g, 47.3 mmol, 1.1 eq, 
4.05 ml). The mixture was stirred for 1 hour then cool to 0°C. A dropwise 
addition of triethylamine (10.8 g, 107 mmol, 2.5 eq., 14.5 ml) on 10 minutes 
followed by stirring for additional 10 minutes at 0°C.  A dropwise addition of 
N-benzyl-1-(5-methylfuran-2-yl)methanamine (9.9 g, 49 mmol, 1.15 eq., 9.4 
ml) at 0°C then the mixture was allowed to evolve towards room 
temperature for 5 hours. The solvent was removed under vacuum then the 
viscous oil was dissolved in ethyl acetate and 1M aqueous HCl and extracted 
with ethyl acetate. The organics phases were combined and dried over 
sodium sulfate. The volatiles were removed in vacuo to afford the desired 
product as a sticky yellow oil; 16.1 g (90%). 
 
 
CAS: / 
Formula: C25H24N2O4 
Molecular weight: 416.47 g/mol 
1H NMR (400 MHz, CDCl3) δ 8.18 (d, J = 7.9 Hz, 1H, H10), 7.82 (d, J = 7.2 Hz, 
1H, H7), 7.44 – 7.27 (m, 8H, H4 + H8 + H9 + H15 + H16 + H17), 6.11 (s, 1H, 
H20), 5.92 (dd, J = 3.0, 0.9 Hz, 1H, H21), 4.73 (s, 2H, H13), 4.65 – 4.31 (m, 
4H, H2 + H18), 2.30 (d, J = 0.6 Hz, 3H, H23), 1.45 (t, J = 6.3 Hz, 3H, H1). 
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13C NMR (100 MHz, CDCl3) δ 166.06 (C12), 152.34 (bs, C22), 150.59 (C3), 
147.97 (bs, C19), 136.93 (C14), 134.96 (C11), 128.69 (C6 + C15 + C16), 
127.48 (C17), 125.67 (bs, C4), 125.30 (C9), 123.70 (C8), 120.98 (C7), 116.07 
(C5), 115.13 (C10), 109.97 (C20), 106.21 (C21), 63.62 (C2), 47.35 (bs, C13), 
44.81 (bs, C18), 14.25 (C1), 13.55 (C23). 
 
IR (film, cm-1): 3031 (C-H stretching), 2984 (C-H stretching), 2922(C-H 
stretching), 1742 (C=O stretching of carbamate), 1627 (C=O stretching of 
tertiary amide), 1560 (C=C aromatic stretching), 1451 (CH2 scissoring), 
1423 (CH3 asymmetric deformation), 1398 (CH3 symmetric deformation), 
1238 (C-N stretching), 1210 (C-N stretching), 907, 764 (C-H bending out of 
plan of mono-substituted aromatic ring), 723 (C-H bending out of plan of 
ortho di-substituted aromatic ring), 696 (C-H bending out of plan of mono-
substituted aromatic ring), 645 (C-H bending). 
 
MS (FTMS +p ESI Full ms) m/z (%): 833.353 [2M+H]+ (100.0), 439.162 
[M+Na]+ (15.0), 417.180 [M+H]+ (50.2),  323.139 (10.9), 296.164 (71.2), 
95.049 (17.3). 
 
HRMS m/z calculated for C25H25O4N2 [M+H]+: 417.180884. Found: 
417.180773. 
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ethyl (Z)-3-(benzyl(2,5-dioxohex-3-en-1-yl)carbamoyl)-1H-indole-1-
carboxylate 
Figure 26 indole COOEt Z ene dione 
 
To a solution of ethyl 3-(benzyl((5-methylfuran-2-
yl)methyl)carbamoyl)-1H-indole-1-carboxylate (4.6 g, 11 mmol, 1 eq.) in 
dichloromethane (60 ml) at 0°C was added solid meta-chloroperoxybenzoic 
acid (2.72 g, 12.1 mmol, 1.1 eq.). The reaction was allowed to warm at room 
temperature and stirred for 8 hours. Quench was made by addition of a 
saturated solution of sodium hydrogencarbonate in water, then extracted by 
dichloromethane. The organic phases were combined and dried over sodium 
sulfate and the volatiles were removed in vacuo to afford the desired product 
as a sticky yellow oil; 4.3 g (90%). 
 
 
CAS: / 
Formula: C25H24N2O5 
Molecular weight: 432.47 g/mol 
1H NMR (400 MHz, CDCl3) δ 8.18 (d, J = 8.2 Hz, 1H, H10), 7.94 (d, J = 4.8 
Hz, 1H, H, H7), 7.81 (s, 1H, H4), 7.49 – 7.18 (m, 7H, H8 + H9 + H15 + H16 + 
H17), 6.53 – 6.33 (m, 2H, H20 + H21), 4.83 (s, 2H, H13), 4.57 – 4.36 (m, 4H, 
H2 + H18), 2.30 (s, 3H, H23), 1.42 (t, J = 7.0 Hz, 3H, H1). 
 
13C NMR (100 MHz, CDCl3) δ 199.74 (C22), 198.06 (C19), 166.85 (C12), 
150.56 (C3), 136.70 (C11), 135.88 (C20/C21), 135.49 (C20/21), 134.94 
(C11), 128.95 (C16), 128.47 (C15), 127.82 (C17), 127.07 (C4), 125.52 (C9), 
123.97 (C8), 121.29 (C7), 115.72 (C5), 115.22 (C10), 63.76 (C2), 53.89 
(C18), 53.66 (C13), 29.96 (C23), 14.30 (C1). 
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IR (film, cm-1): 3057 (C-H stretching), 3030 (C-H stretching), 2983 (C-H 
stretching), 2932 (C-H stretching), 1742 (C=O stretching of carbamate), 
1712 (C=O stretching), 1697 (C=O stretching), 1632 (C=O stretching of 
tertiary amide + C=C stretching of cis di-substituted alkene), 1557 (C=C 
aromatic stretching), 1452 (CH2 scissoring), 1429 (CH3 asymmetric 
deformation), 1397 (CH3 symmetric deformation), 1238 (C-N stretching), 
1208 (C-N stretching), 1090 (C-O stretching), 764 (C-H bending out of plan 
of mono-substituted aromatic ring), 749 (C-H bending out of plan of ortho 
di-substituted aromatic ring), 732 (C-H bending out of plan of cis di-
substituted alkene), 697 (C-H bending out of plan of mono-substituted 
aromatic ring). 
 
MS (FTMS +p ESI Full ms) m/z (%): 455.157 [M+Na]+ (12.8), 436.184 (0.6), 
435.181 (4.5), 434.179 (27.6), 433.175 [M+H]+ (100.0), 415.165 (5.0), 
312.159 (7.5), 216.065 (5.0), 144.044 (5.2). 
 
HRMS m/z calculated for C25H25O5N2 [M+H]+: 433.175798. Found: 
433.175784. 
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N-benzyl-N-((5-methylfuran-2-yl)methyl)-1H-indole-3-carboxamide 
Figure 27 indole furan 
 
To a solution of (7.1 g, 17 mmol, 1 eq.) in tetrahydrofuran (100 ml) at 
room temperature was added a solution of lithium hydroxide (0.81 g, 
34mmol, 2 eq.) in water (100 ml). The mixture was stirred for 14 hours at 
room temperature then quenched by addition of a saturated solution of 
ammonium chloride in water. After extraction with ethyl acetate, the organic 
phases were combined and dried over sodium sulfate. All volatiles were 
removed in vacuo and the product was purified by precipitation in acetone 
and water to afford the desired compound as an off-white solid; 4.68 g (80%). 
 
 
CAS: / 
Formula: C22H20N2O2 
Molecular weight: 344.41 g/mol 
MP: 121-124°C 
 
1H NMR (300 MHz, CDCl3) δ 10.39 (s, 1H, H1), 7.89 (d, J = 7.9 Hz, 1H, H5), 
7.37 – 7.16 (m, 5H, H13 + H14 + H15), 7.16 – 6.98 (m, 4H, H2 + H6 + H7 + 
H8), 6.03 (s, 1H, H18), 5.96 – 5.76 (m, 1H, H19), 4.74 (s, 2H, H11), 4.56 (s, 
2H, H16), 2.21 (s, 3H, H21). 
 
13C NMR (75 MHz, CDCl3) δ 168.74 (C10), 152.19 (C20), 148.55 (C17), 
137.23 (C12), 136.06 (C9), 128.71 (C14), 127.70 (bs, C13), 127.40 (C15), 
126.85 (C2), 126.44 (C4), 122.45 (C7), 120.80 (C6), 120.28 (C5), 112.10 
(C8), 109.74 (C18), 109.62 (C3), 106.26 (C19), 48.89 (bs, C11), 44.15 (bs, 
C16), 13.62 (C21). 
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IR (film, cm-1): 3213 (N-H stretching), 3061 (C-H stretching), 2921 (C-H 
stretching), 1594 (C=C aromatic stretching), 1573 (C=C aromatic 
stretching), 1525 (C=C aromatic stretching), 1494 (C=C aromatic 
stretching), 1450 (CH2 scissoring), 1183 (C-N stretching), 1020 (C-O 
stretching), 976, 780 (C-H bending out of plan), 733 (C-H bending out of 
plan of ortho di-substituted aromatic ring+ C-H bending out of plan of 
mono-substituted aromatic ring), 696 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
MS (FTMS +p ESI Full ms2) m/z (%): 367.141 [M+Na]+ (20.0), 345.159  
[M+H]+ (2.0), 263.011 (5.0), 251.117 (45.0), 144.044 (100.0), 95.049 (46.0). 
 
HRMS m/z calculated for C22H21O2N2 [M+H]+: 345.15975. Found: 
345.15975. 
  
Chapter X 
262 
 
tert-butyl 3-(benzyl((5-methylfuran-2-yl)methyl)carbamoyl)-1H-indole-1-
carboxylate 
Figure 28 Boc indole furan 
 
To a solution of N-benzyl-N-((5-methylfuran-2-yl)methyl)-1H-indole-
3-carboxamide (2 g, 5.8 mmol, 1 eq.) in dichloromethane (40 ml) and 
triethylamine (0.75 g, 7.4 mmol, 1.25 eq., 1 ml) at room temperature was 
added 4-dimethylaminopyridine (0.14 g, 0.6 mmol, 0.2 eq.) followed by di-
tert-butyl dicarbonate (1.4 g, 6.4 mmol, 1.1 eq.). The mixture was stirred for 
1 hour at room temperature then water (5 ml) was added as quench. After 
stirring for 2 additional hours the mixture was decanted and extracted with 
dichloromethane. The organic phases were combined and dried over sodium 
sulfate and the volatiles were removed in vacuo to afford the desired product 
as a sticky slightly yellow oil; 2.45 g (95%).  
 
 
CAS: / 
Formula: C27H28N2O4 
Molecular weight: 444.53 g/mol 
1H NMR (400 MHz, CDCl3) δ 8.16 (d, J = 7.9 Hz, 1H, H10), 7.85 – 7.77 (m, 
1H, H7), 7.48 – 7.27 (m, 8H, H4 + H8 + H9 + H15 + H16 + H17), 6.12 (s, 1H, 
H20), 5.92 (dd, J = 3.0, 0.9 Hz, 1H, H21), 4.74 (s, 2H, H13), 4.50 (s, 2H, 18), 
2.29 (d, J = 0.6 Hz, 3H, H23), 1.63 (s, 9H, H1). 
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13C NMR (100 MHz, CDCl3) δ 166.33 (C12), 152.39 (C22), 149.29 (C3), 
148.22 (C19), 137.07 (C14), 135.04 (C11), 128.77 (C6 + C16 + C17), 127.53 
(C15), 126.06 (bs, C4), 125.15 (C9), 123.52 (C8), 121.00 (C7), 115.53 (C5), 
115.23 (C10), 109.91 (C20), 106.26 (C21), 84.45 (C2), 47.41 (bs, C13), 45.01 
(bs, C18), 28.12 (C1), 13.67 (C23). 
 
IR (film, cm-1): 3030 (C-H stretching), 2980 (C-H stretching), 2924 (C-H 
stretching), 1738 (C=O stretching of carbamate), 1627 (C=O stretching of 
tertiary amide), 1558 (C=C aromatic stretching), 1450 (CH2 scissoring), 
1422 (CH3 asymmetric deformation), 1368 (CH3 symmetric deformation of 
tert-butyl), 1246 (C-N stretching), 1148, 907, 767 (C-H bending out of plan 
of mono-substituted aromatic ring), 724 (C-H bending out of plan of ortho 
di-substituted aromatic ring), 696 (C-H bending out of plan of mono-
substituted aromatic ring). 
 
MS (FTMS +p ESI Full ms) m/z (%): 467.194 [M+Na]+ (12.1), 448.221 (0.6), 
447.218 (5.0), 446.215 (29.8), 445.212 [M+H]+ (100.0), 355.201 (2.0), 
295.107 (7.1), 144.044 (10.2), 95.049 (4.1). 
 
HRMS m/z calculated for C27H29O4N2 [M+H]+: 445.212184. Found: 
445.212134. 
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tert-butyl (Z)-3-(benzyl(2,5-dioxohex-3-en-1-yl)carbamoyl)-1H-indole-1-
carboxylate 
Figure 29 Boc indole Z ene dione 
 
To a solution of tert-butyl 3-(benzyl((5-methylfuran-2-
yl)methyl)carbamoyl)-1H-indole-1-carboxylate (2.58 g , 5.8 mmol, 1 eq.) in 
dichloromethane (20 ml) at 0°C was added solid meta-chloroperoxybenzoic 
acid (1.49 g, 6.6 mmol, 1.15 eq.). The reaction was allowed to warm at room 
temperature and stirred for 12 hours. Quench was made by addition of a 
saturated solution of sodium hydrogencarbonate in water, then extracted by 
dichloromethane. The organic phases were combined and dried over sodium 
sulfate and the volatiles were removed in vacuo to afford the desired product 
as a slightly yellow sticky solid; 2.4 g (90%). 
 
 
CAS: / 
Formula: C27H28N2O5 
Molecular weight: 460.53 g/mol 
MP: 33-34°C        Litt: / 
 
1H NMR (400 MHz, CDCl3) δ 8.15 (d, J = 8.3 Hz, 1H, H10), 7.94 (s, 1H, H7), 
7.77 (s, 1H, H4), 7.53 – 7.19 (m, 7H, H8 + H9 + H15 + H16 + H17), 6.54 – 
6.31 (m, 2H, H20 + H21), 4.85 (s, 2H, H13), 4.41 (s, 2H, H18), 2.30 (s, 3H, 
H23), 1.60 (s, 9H, H1). 
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13C NMR (100 MHz, CDCl3) δ 199.77 (C22), 198.18 (C19), 167.09 (C12), 
149.17 (C3), 136.79 (C14), 135.92 (C20/21), 135.50 (C20/21), 135.00 (C11), 
128.99 (C16), 128.53 (C6), 127.83 (C15), 127.01 (C4), 126.11 (C17), 125.32 
(C9), 123.75 (C8), 121.29 (C7), 115.24 (C10), 114.87 (C5), 84.63 (C2), 53.94 
(C18), 53.54 (C13), 30.00 (C23), 28.11 (C1). 
 
IR (cm-1): 3030 (C-H stretching), 2980 (C-H stretching), 2932 (C-H 
stretching), 1737 (C=O stretching), 1715 (C=O stretching), 1698 (C=O 
stretching), 1629 (C=O stretching of tertiary amide + C=C stretching of cis 
di-substituted alkene), 1584 (C=C aromatic stretching), 1556 (C=C 
aromatic stretching), 1496 (C=C aromatic stretching), 1451 (CH2 
scissoring), 1429 (CH3 asymmetric deformation), 1362 (CH3 deformation of 
tert-butyl), 1244 (C-N stretching), 1208 (C-N stretching), 1149 (C-O 
stretching), 1088 (C-O stretching), 767 (C-H bending out of plan of mono-
substituted aromatic ring), 724 (C-H bending out of plan of ortho di-
substituted aromatic ring + C-H bending out of plan of cis di-substituted 
alkene), 696 (C-H bending out of plan of mono-substituted aromatic ring). 
 
MS (FTMS +p ESI Full ms) m/z (%): 461.207 [M+H]+ (2.5), 405.143 (18.3), 
387.132 (14.2), 244.096 (11.7), 218.117 (46.1), 200.106 (63.4), 188.033 
(100.0), 154.049 (7.3), 144.044 (39.7), 120.080 (46.2), 91.054 (23.1). 
 
HRMS m/z calculated for C27H29O5N2 [M+H]+: 461.207098. Found: 
461.207081. 
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tert-butyl (E)-3-(benzyl(2,5-dioxohex-3-en-1-yl)carbamoyl)-1H-indole-1-
carboxylate 
Figure 30 Boc indole E ene dione 
 
To a solution of tert-butyl (Z)-3-(benzyl(2,5-dioxohex-3-en-1-
yl)carbamoyl)-1H-indole-1-carboxylate (0.46 g, 1 mmol, 1 eq.) in 
dichloromethane (15 ml) at room temperature was added magnesium 
triflate (0.39 g, 1.2 mmol, 1.2 eq.) and the solution was stirred for 30 minutes. 
Addition of a saturated solution of sodium hydrogencarbonate in water as 
quench followed by extraction with dichloromethane. The organic phases 
were combined and dried over sodium sulfate, the solvent was removed in 
vacuo to afford the desired product as a sticky yellow solid; 0.46 g 
(quantitative). 
 
 
 
CAS: / 
Formula: C27H28N2O5 
Molecular weight: 460.53 g/mol 
MP: 33-35°C        Litt: / 
 
1H NMR (400 MHz, CDCl3) δ 8.15 (d, J = 7.9 Hz, 1H, H10), 7.93 (s, 1H, H7), 
7.80 (s, 1H, H4), 7.42 – 7.28 (m, 5H, H8 + H9 + H16 + H17), 7.23 (s, 2H, 
H15), 6.91 (s, 2H, H20 + H21), 4.80 (s, 2H, H13), 4.51 (s, 2H, H18), 2.35 (s, 
3H, H23), 1.60 (s, 9H, H1). 
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13C NMR (100 MHz, CDCl3) δ 197.81 (C22), 194.65 (C19), 166.91 (C12), 
149.00 (C3), 137.62 (C20), 136.20 (C14), 134.88 (C11), 134.41 (C21), 
129.02 (C16), 128.37 (C6), 127.93 (C17), 126.86 (C15), 126.07 (C4), 125.27 
(C9), 123.68 (C8), 121.06 (C7), 115.18 (C10), 114.59 (C5), 84.60 (C2), 53.86 
(C13), 53.48 (C18), 27.97 (C21). 
 
IR (cm-1): 3058 (C-H stretching), 3030 (C-H stretching), 2980 (C-H 
stretching), 2932 (C-H stretching), 1737 (C=O stretching of carbamate), 
1691 (C=O stretching), 1683 (C=O stretching), 1629 (C=O stretching of 
tertiary amide + C=C stretching of trans di-substituted alkene), 1556 (C=C 
aromatic stretching), 1479 (CH2 scissoring), 1451 (CH2 scissoring), 1429 
(CH3 asymmetric deformation), 1360 (CH3 deformation of tert-butyl), 1244 
(C-N stretching), 1208 (C-N stretching), 1147 (C-O stretching), 1088 (C-O 
stretching), 970 (C-H bending out of plan of trans di-substituted alkene), 
767 (C-H bending out of plan of mono-substituted aromatic ring), 724 (C-
H bending out of plan of ortho di-substituted aromatic ring), 698 (C-H 
bending out of plan of mono-substituted aromatic ring). 
 
HRMS m/z calculated for C27H29O5N2 [M+H]+: 461.207098. Found: 
461.2070.  
HRMS m/z calculated for C27H28O5N223Na1 [M+Na]+: 483.1895. Found: 
483.1889. 
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tert-butyl 3-(benzyl(2,5-dioxohexyl)carbamoyl)-1H-indole-1-carboxylate 
Figure 31: Boc indole di ketone 
 
To a solution of tert-butyl (Z)-3-(benzyl(2,5-dioxohex-3-en-1-
yl)carbamoyl)-1H-indole-1-carboxylate  (0.46 g, 1 mmol, 1 eq.) in anhydrous 
acetonitrile at 0°C was added sodium iodide (0.30 g, 2 mmol, 2 eq.) followed 
by dropwise addition of trimethylchlorosilane (0.22 g, 2 mmol, 2 eq., 0.25 
ml). The mixture was stirred at 0°C for 10 minutes then purred on 
dichloromethane and a saturated solution of sodium thiosulfate and 
extracted with dichloromethane. The organic phases were combined, dried 
over magnesium sulfate and the volatiles were removed in vacuo to afford 
the desired diketone as colourless oil; 0.42 g (90%). 
 
 
CAS: / 
Formula: C27H30N2O5 
Molecular weight: 462.54 g/mol 
1H NMR (400 MHz, CDCl3) δ 8.15 (d, J = 8.1 Hz, 1H, H10), 7.93 (bs, 1H, H7), 
7.77 (s, 1H, H4), 7.42 – 7.16 (m, 7H, H8 + H9 + H15 + H16 + H17), 4.75 (s, 
2H, H13), 4.34 (s, 2H, H18), 2.83 (bs, 2H, H21), 2.71 (bs, 2H, H20), 2.20 (s, 
3H, H23), 1.61 (s, 9H, H1). 
 
13C NMR (100 MHz, CDCl3) δ 206.81 (C22), 203.89 (C19), 166.70 (C12), 
148.97 (C3), 136.49 (C14), 134.79 (C11), 128.84 (C16), 128.39 (C6), 127.67 
(C17), 126.82 (C15), 125.76 (C4), 125.09 (C9), 123.51 (C8), 121.08 (C7), 
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115.04 (C10), 114.85 (C5), 84.39 (C2), 54.11 (C18), 53.73 (C13), 37.00 
(C21), 33.44 (C20), 29.57 (C23), 27.90 (C1). 
 
IR (film, cm-1): 3059 (C-H stretching), 3030 (C-H stretching), 2979 (C-H 
stretching), 2931 (C-H stretching), 1737 (C=O stretching of carbamate), 
1715 (C=O stretching), 1633 (C=O stretching of tertiary amide), 1557 (C=C 
aromatic stretching), 1479 (CH2 scissoring), 1451 (CH2 scissoring), 1429 
(CH3 asymmetric deformation), 1363 (CH3 deformation of tert-butyl), 1245 
(C-N stretching), 1209 (C-N stretching), 1150 (C-O stretching), 1089 (C-O 
stretching), 767 (C-H bending out of plan of mono-substituted aromatic 
ring), 730 (C-H bending out of plan of ortho di-substituted aromatic ring), 
698 (C-H bending out of plan of mono-substituted aromatic ring). 
 
MS (FTMS +p ESI Full ms) m/z (%): 485.205 [M+Na]+ (55.5), 466.231 (0.7), 
465.228 (5.2), 464.226 (29.9), 463.222 [M+H]+ (100.0), 407.160 (6.0), 
234.091 (17.2), 220.133 (95.6), 91.055 (8.5).  
 
HRMS m/z calculated for C27H31O5N2 [M+H]+: 463.222749. Found: 
463.223422. 
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N-benzyl-N-((2,5-dimethoxy-5-methyl-2,5-dihydrofuran-2-yl)methyl)-1H-
indole-3-carboxamide 
Figure 32 : indole di MeO furan 
 
To a solution of N-benzyl-N-((5-methylfuran-2-yl)methyl)-1H-indole-
3-carboxamide (1.78 g, 4.28 mmol, 1 eq.) in methanol (14 ml) and diethyl 
ether (10 ml) at 0°C was added sodium hydrogencarbonate (1.3 g, 15 mmol, 
3.5 eq.) then bromine (0.75 g, 4.7 mmol, 1.1 eq., 0.24 ml) in methanol (1 ml) 
was added drop wisely. The solution was stirred for 20 minutes at 0°C then 
was allowed to evolve towards room temperature for 40 minutes. Solid 
sodium hydroxide (0.68 g, 17 mmol, 4 eq.) was added, and the solution was 
stirred over night at room temperature. Quench was performed by addition 
of water and diethyl ether, the resulting biphasic mixture was extracted with 
another portion of diethyl ether. The organic phases were combined and 
dried over sodium sulfate. All volatiles were removed in vacuo to afford a 
slightly brown solid; 1.56 g (90%). 
 
 
CAS: / 
Formula: C24H26N2O4 
Molecular weight: 406.48 g/mol 
MP: 60-63°C  
 
1H NMR (300 MHz, CDCl3) δ 10.37 (s, 1H, H1), 7.83 (s, 1H, H5), 7.53 – 6.83 
(m, 9H, H2 + H6 + H7 + H8 + H13 + H14 + H15), 5.93 (s, 2H, H19 + H20), 
4.95 (s, 2H, H11), 4.18 – 3.54 (m, 2H, H16), 3.49 – 2.95 (m, 6H, H18 + H23), 
1.76 – 1.22 (m, 3H, H22). 
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13C NMR (75 MHz, CDCl3) δ 169.52 (C10), 169.32 (C10’), 137.62 (C12), 
135.88 (C9), 134.57 (C20), 131.17 (C19), 128.71 (C13/14), 128.64 (C13/14), 
127.49 (C2), 127.34 (C15), 127.30 (C2’), 126.93 (C2’’), 126.25 (C4), 126.02 
(C4’), 122.35 (C7), 120.77 (C6), 120.10 (C5), 114.19 (C17), 113.15 (C17’), 
112.04 (C8), 110.75 (C3), 110.30 (C3’), 110.00 (C21), 54.12 (C11), 50.47 
(C18/23), 50.20 (C18’/23’), 50.15 (C18’’/23’’), 49.64 (C16), 23.61 (C22), 
23.16 (C22’). 
 
IR (cm-1): 3221 (N-H stretching), 2985 (C-H stretching), 2939 (C-H 
stretching), 1597 (C=C stretching), 1529 (C=C aromatic stretching), 1495 
(C=C aromatic stretching), 1244 (C-N stretching), 1025 (C-O stretching), 
777 (C-H bending out of plan), 733 (C-H bending out of plan of ortho di-
substituted aromatic ring + C-H bending out of plan of mono-substituted 
aromatic ring), 697 (C-H bending out of plan of mono-substituted aromatic 
ring). 
 
MS (FTMS +p ESI Full ms) m/z (%): 429.177 [M+Na]+ (10.1), 376.173 (22.1), 
375.169 (100.0), 200.106 (13.4), 144.044 (10.9). 
 
HRMS m/z calculated for C24H26O4N223Na1 [M+Na]+: 429.17848. Found: 
429.17793. 
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(Z)-N-benzyl-N-(2,5-dioxohex-3-en-1-yl)-1H-indole-3-carboxamide 
Figure 33  indole Z ene dione 
 
To a solution of N-benzyl-N-((2,5-dimethoxy-5-methyl-2,5-
dihydrofuran-2-yl)methyl)-1H-indole-3-carboxamide (0.5 g, 1.23 mmol, 1 
eq.) in tetrahydrofuran (15 ml) at room temperature was added a solution of 
concentrated sulfuric acid (0.01 g, 0.12 mmol, 0.1 eq., 0.005 ml) in water (5 
ml). The mixture was stirred for 2 hours at room temperature then water and 
diethyl ether were added for extraction. The organic phases were dried over 
sodium sulfate and sodium hydrogencarbonate. The volatiles were removed 
in vacuo to afford the desired product as a yellow solid; 0.42 g (95%). 
 
 
CAS: / 
Formula: C22H20N2O3 
Molecular weight: 360.41 g/mol 
MP: 41-43°C 
 
1H NMR (400 MHz, CDCl3) δ 8.73 (s, 1H, H1), 7.97 (s, 1H, H5), 7.46 – 7.18 
(m, 9H, H2 + H6 + H7 + H8 + H13 + H14 + H15), 6.40-6.30 (m, 2H, H18 + 
H19), 4.91 (s, 2H, H11), 4.37 (s, 2H, H16), 2.28 (s, 3H, H21). 
 
13C NMR (100 MHz, CDCl3) δ 200.19 (C20), 198.94 (C17), 168.95 (C10), 
136.88 (C12), 135.89 (C9), 135.74 (C18/19), 135.38 (C18/19), 128.87 (C14), 
127.65 (C13), 127.25 (C2), 126.66 (C15), 126.32 (C4), 122.77 (C7), 121.11 
(C6), 120.57 (C5), 111.97 (C8), 109.24 (C3), 54.71 (C16), 53.81 (C11), 29.83 
(C21). 
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IR (film, cm-1): 3233 (N-H stretching), 3060 (C-H stretching), 2922 (C-H 
stretching), 1694 (C=O stretching), 1603 (C=C aromatic stretching +  
stretching of cis di-substituted alkene), 1576 (C=C aromatic stretching), 
1527 (C=C aromatic stretching), 1495 (C=C aromatic stretching), 1454 (CH2 
scissoring), 1433 (CH3 asymmetric deformation), 1388 (CH3 symmetric 
deformation), 1244 (C-N stretching), 1191, 973, 748 (C-H bending out of 
plan of mono-substituted aromatic ring), 734 (C-H bending out of plan of 
ortho di-substituted aromatic ring + C-H bending out of plan of cis di-
substituted alkene), 698 (C-H bending out of plan of mono-substituted 
aromatic ring). 
 
HRMS m/z calculated for C22H21N2O3 [M+H]+: 361.1552. Found: 361.1539. 
HRMS m/z calculated for C22H20N2O323Na1 [M+Na]+: 383.1371. Found: 
383.1359. 
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(E)-N-benzyl-N-(2,5-dioxohex-3-en-1-yl)-1H-indole-3-carboxamide 
Figure 34 indole E ene dione 
Methode A 
 
To a solution of N-benzyl-N-((2,5-dimethoxy-5-methyl-2,5-
dihydrofuran-2-yl)methyl)-1H-indole-3-carboxamide (0.5 g, 1.23 mmol, 1 
eq.) in tetrahydrofuran (15 ml) at room temperature was added a solution of 
concentrated sulfuric acid (0.01 g, 0.12 mmol, 0.1 eq., 0.005 ml) in water (5 
ml). The mixture was stirred for 8 hours at room temperature then water and 
diethyl ether were added for extraction. The organic phases were dried over 
sodium sulfate and sodium hydrogencarbonate. The volatiles were removed 
in vacuo to afford the desired product as a yellow solid; 0.42 g (95%). 
 
Methode B 
 
To a solution of (Z)-N-benzyl-N-(2,5-dioxohex-3-en-1-yl)-1H-indole-
3-carboxamide (0.44 g, 1.23 mmol, 1 eq.) in dichloromethane (24 ml) at room 
temperature was added para-toluene sulfonic acid (1 mg, 6 µmol, 0.005 eq.) 
and the mixture was stirred for 18 hours. The mixture was quenched by a 
saturated solution of sodium hydrogencarbonate in water and extracted with 
dichloromethane. All the organic phases were combined and dried over 
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sodium sulfate. The volatiles were removed in vacuo to afford the desired 
product as a slightly yellow solid; 0.44 g (quantitative). 
 
 
CAS: / 
Formula: C22H20N2O3 
Molecular weight: 360.41 g/mol 
MP: 39-41°C 
 
1H NMR (400 MHz, CDCl3) δ 8.74 (s, 1H, H1), 7.96 (d, J = 8.9 Hz, 1H, H5), 
7.46 – 7.19 (m, 9H, H2 + H6 + H7 + H8 + H13 + H14 + H15), 6.87 (s, 2H, H18 
+ H19), 4.88 (s, 2H, H11), 4.47 (s, 2H, H16), 2.33 (s, 3H, H21). 
 
13C NMR (100 MHz, CDCl3) δ 198.15 (C20), 195.23 (C17), 168.96 (C10), 
137.46 (C19), 136.49 (C12), 135.91 (C9), 134.26 (C18), 129.04 (C14), 
127.90 (C13), 127.28 (C4), 126.73 (C15), 126.27 (C2), 122.87 (C7), 121.25 
(C6), 120.56 (C5), 112.00 (C8), 109.23 (C3), 54.60 (C16), 53.47 (C11), 28.21 
(C21). 
 
IR (film, cm-1): 3247 (N-H stretching), 3060 (C-H stretching), 2923 (C-H 
stretching), 1685 (C=O stretching), 1600 (C=C aromatic stretching +  
stretching of cis di-substituted alkene), 1576 (C=C aromatic stretching), 
1527 (C=C aromatic stretching), 1495 (C=C aromatic stretching), 1454 (CH2 
scissoring), 1433 (CH3 asymmetric deformation), 1245 (C-N stretching), 
1193, 974, 748 (C-H bending out of plan of mono-substituted aromatic 
ring), 735 (C-H bending out of plan of ortho di-substituted aromatic ring + 
C-H bending out of plan of cis di-substituted alkene), 698 (C-H bending out 
of plan of mono-substituted aromatic ring). 
 
HRMS m/z calculated for C22H21N2O3 [M+H]+: 361.1552. Found: 361.1542. 
HRMS m/z calculated for C22H20N2O323Na1 [M+Na]+: 383.1371. Found: 
383.1364. 
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1-(1H-indol-3-yl)-N-(4-methoxybenzyl)methanimine 
Figure 35 imine PMB 
 
To a solution of 1H-indole-3-carbaldehyde (40 g, 0.275 mol, 1 eq.) 
and PTSA (0.24 g, 0.0014 mol, 0.005 eq.) in toluene (350 ml) or benzene (350 
ml) was added p-methoxy-benzylamine (39.69 g, 0.289 mol, 1.05 eq., 37.8 
ml). The resulting mixture was refluxed with a Dean-Stark apparatus until the 
correct amount of water (5 ml) was retrieved. The solvent was removed at 
low pressure to afford a yellow-orange solid; 72.8 g (quantitative). 
This solid was directly used without more purification. 
 
 
CAS: 86427-28-3 
Formula: C17H16N2O1 
Molecular weight: 264.34 
g/mol 
MP: 85-89°C      Litt7: 162°C 
 
1H NMR (300 MHz, CDCl3) δ 8.57 (s, 1H, H10), 8.40 – 8.30 (m, 1H, H5), 7.48 
(s, 1H, H5), 7.37 – 7.26 (m, 3H, H8 + H13), 7.26 – 7.17 (m, 2H, H6 + H7), 
6.92 – 6.85 (m, 2H, H14), 4.77 (s, 2H, H11), 3.80 (s, 3H, H16). 
 
13C NMR (75 MHz, CDCl3) δ 158.60 (C15), 156.17 (C10), 136.84 (C9), 132.65 
(C12), 129.11 (C13), 128.62 (C2), 125.62 (C4), 123.40 (C7), 121.94 (C5), 
121.48 (C6), 115.84 (C3), 113.96 (C14), 111.35 (C8), 65.01 (C11), 55.44 
(C16). 
 
                                                          
7 Kumar, P.; Nath, C.; Bhargava, K. P.; Shanker, K. Indian J. Chem. B, 1982, 21, 1128.  
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IR (film, cm-1): 3398 (N-H stretching), 3057 (C-H stretching), 3004 (C-H 
stretching), 2955 (C-H stretching), 2929 (C-H stretching), 2833 (C-H 
stretching), 1629 (C=N stretching), 1608 (C=C aromatic stretching), 1577 
(C=C aromatic stretching), 1509 (C=C aromatic stretching), 1439 (CH2 
scissoring), 1239 (C-N stretching), 1172 (C-O stretching), 1027 (C-O 
stretching), 818 (C-H bending out of plan of para disubstituted aromatic 
ring), 733 (C-H bending out of plan of para disubstituted aromatic ring). 
 
MS (FTMS +p ESI Full ms2) m/z (%): 265.132 [M+H]+ (25.0), 121.064 
(100.0). 
 
HRMS m/z calculated for C17H17O1N2 [M+H]+: 265.13354. Found: 
265.13342. 
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N-((1H-indol-3-yl)methyl)-1-(4-methoxyphenyl)methanamine 
Figure 36 amine PMB 
 
1-(1H-indol-3-yl)-N-(4-methoxybenzyl)methanimine (72.8 g, 0.275 
mol, 1 eq.) was dissolved in methanol (300 ml) or ethanol (300 ml) at 0°C. 
Then NaBH4 (22.9 g, 0.60 mol, 2.2 eq.) was added portionwise and the 
temperature was kept below 10°C. The mixture was stirred at 0°C for 3 hours 
then 25-35% aqueous ammonia solution was added (300 ml) and the biphasic 
mixture was stirred for 2 hours. The solvent was slowly eliminated under 
vacuum. The resulting aqueous phase was extracted 3 time with 
dichloromethane, the organic layers were combined and dried over Na2SO4. 
The solvent was eliminated under low pressure providing a yellow solid 
which can be precipitated with diethyl ether and pentane to a white solid; 
69.7 g (95%). 
 
 
CAS: / 
Formula: C17H18N2O1 
Molecular weight: 266.34 
g/mol 
MP: 77-79°C      Litt8: 89°C 
 
1H NMR (400 MHz, CDCl3) δ 8.15 (s, 1H, H1), 7.65 (d, J = 7.8 Hz, 1H, H5), 
7.38 – 7.31 (m, 1H, H8), 7.31 – 7.25 (m, 2H, H14), 7.23 – 7.16 (m, 1H, H7), 
7.16 – 7.08 (m, 2H, H2 + H6), 6.93 – 6.83 (m, 2H, H15), 3.99 (s, 2H, H10), 
3.82 (s, 2H, H12), 3.80 (s, 3H, H17), 1.57 (s, 1H, H11). 
                                                          
8 Turet, L.; Markó, I. E.; Tinant, B.; Declercq, J-P.; Touillaux, R. Tetrahedron lett., 2002, 
43, 6591. 
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13C NMR (100 MHz, CDCl3) δ 158.55 (C16), 136.30 (C9), 131.69 (C13), 
129.43 (C14), 126.89 (C4), 123.22 (C2), 121.67 (C7), 119.14 (C6), 118.44 
(C5), 113.75 (C15), 113.35 (C3), 111.41 (C8), 55.04 (C17), 52.45 (C12), 
43.66 (C10). 
 
IR (cm-1): 3410 (N-H stretching) 3159 (N-H stretching), 2911 (C-H 
stretching), 2833 (C-H stretching), 1610 (C=C aromatic stretching), 1510 
(C=C aromatic stretching), 1454 (CH2 scissoring), 1243 (C-N stretching), 
1176 (C-O stretching), 1031 (C-O stretching), 813 (C-H bending out of plan 
of para disubstituted aromatic ring), 741 (C-H bending out of plan of ortho 
disubstituted aromatic ring). 
 
MS (FTMS +p ESI Full ms2) m/z (%): 267.148 [M+H]+ (5.0), 130.064 (100.0), 
121.064 (17.0). 
 
HRMS m/z calculated for C17H19O1N2 [M+H]+: 267.14919. Found: 
267.14894. 
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N-methoxy-N-methylhexanamide 
Figure 37 weinreb amide 
 
Hexanoic acid (27.1 g, 0.233 mmol, 1 eq., 29.1 ml) is dissolved in 
dichloromethane (500 ml) at 0°C then 1,1’-carbonyldiimidazole (41.6 g, 0.256 
mmol, 1.1 eq.) is added portionwise at 0°C. When no more gas is produced, 
triethylamine (25.9 g, 0.256 mmol, 1.1 eq., 34.6 ml) is added followed by N, 
O-dimethyl-hydroxylamine (25 g, 0.256 mmol, 1.1 eq.) at 0°C. The final 
mixture is stirred at room temperature for 2 hours then a three-molar 
solution of aqueous hydrochloric acid is added as quench and the mixture is 
extracted with diethyl ether. The organic phases are combined and dried 
over sodium sulfate, the volatiles are removed in vacuo to afford a slightly 
yellow oil. This oil was distilled under vacuum to afford the desired product 
as a colourless oil; 31.5 g (85%).  
 
 
CAS: 64214-56-8 
Formula: C8H17NO2 
Molecular weight: 159.22 g/mol 
 
BP: 100-102°C at 12 torrs             Litt: / 
 
1H NMR (300 MHz, CDCl3) δ 3.68 (s, 3H, H1), 3.18 (s, 3H, H2), 2.41 (t, J = 
7.6 Hz, 2H, H4), 1.71 – 1.57 (m, 2H, H5), 1.41 – 1.26 (m, 4H, H6 + H7), 0.90 
(t, J = 6.9 Hz, 3H, H8). 
 
13C NMR (100 MHz, CDCl3) δ 174.76 (C3), 61.12 (C1), 32.08 (C2), 31.80 (C4), 
31.56 (C6), 24.28 (C5), 22.42 (C7), 13.88 (C8). 
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IR (film, cm-1): 2956 (C-H stretching), 2933 (C-H stretching), 2872 (C-H 
stretching), 1661 (C=O stretching from tertiary amide), 1467 (CH2 
scissoring), 1413 (CH3 asymmetric deformation), 1382 (CH3 asymmetric 
deformation), 1176 (C-O stretching + C-N stretching), 1002 (N-O 
stretching). 
 
The compound was already described in the literature: 
Lee, N. R.; Lee, J. I. Synth. Comm., 1999, 29, 1249. 
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N-((1H-indol-3-yl)methyl)-N-(4-methoxybenzyl)prop-2-yn-1-amine 
Figure 38 prop PMB 
 
N-((1H-indol-3-yl)methyl)-1-(4-methoxyphenyl)methanamine (20 g, 
75 mmol, 1 eq.) and potassium carbonate (31 g, 225 mmol, 3 eq.) were 
suspended in stirring acetonitrile (400) at room temperature. Then propargyl 
bromide (80% in toluene) (82.6 mmol, 1.1 eq., 9.2 ml) was drop wisely added 
and the resulting mixture was stirred for 3 hours at room temperature. Water 
was added, and the solution was extracted three time with dichloromethane, 
the organic phases were combined, and the volatiles were removed in vacuo 
to afford a yellow oil. This oil was suspended in diethyl ether, a precipitate 
was formed and filtered. The solvent was removed under vacuum to afford 
a yellow solid. This solid was suspended in pentane then diethyl ether was 
added, and the mixture was stirred during 8 hours at room temperature. A 
white solid was filtered off and dried under vacuum to afford the desired 
compound as an off-white solid; 19.4 g (85%). 
 
 
CAS: / 
Formula: C20H20N2O 
Molecular weight: 304.39 
g/mol 
MP: 96-97°C      Litt: / 
 
1H NMR (400 MHz, CDCl3) δ 8.04 (s, 1H, H1), 7.76 (d, J = 7.7 Hz, 1H, H5), 
7.30 (d, J = 8.6 Hz, 2H, H13), 7.25 (d, J = 7.8 Hz, 1H, H8), 7.16 (td, J = 7.4, 
1.0 Hz, 1H, H7), 7.13 – 7.08 (m, 1H, H6), 7.05 (d, J = 2.2 Hz, 1H, H2), 6.84 
(d, J = 8.6 Hz, 2H, H14), 3.85 (s, 2H, H10), 3.75 (s, 3H, H16), 3.66 (s, 2H, 
H11), 3.25 (d, J = 2.3 Hz, 2H, H17), 2.27 (t, J = 2.3 Hz, 1H, H19). 
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13C NMR (100 MHz, CDCl3) δ 158.77 (C15), 136.49 (C9), 131.13 (C12), 
130.38 (C13), 127.78 (C4), 123.91 (C2), 122.10 (C7), 119.83 (C5), 119.52 
(C6), 113.76 (C14), 113.07 (C3), 111.16 (C8), 79.03 (C18), 73.49 (C19), 
56.95 (C11), 55.31 (C16), 48.58 (C10), 40.82 (C7). 
 
IR (film, cm-1): 3413 (N-H stretching), 3287 (C-H stretching from triple 
bond), 2920 (C-H stretching), 2832 (C-H stretching), 1610 (C=C aromatic 
stretching), 1509 (C=C aromatic stretching), 1454 (CH2 scissoring), 1243 (C-
N stretching), 1032 (C-O stretching), 809 (C-H bending out of plan of para 
disubstituted aromatic ring), 740 (C-H bending out of plan of ortho 
disubstituted aromatic ring), 636 (C-H bending out of plan of terminus 
alkynes). 
 
HRMS m/z calculated for C20H21N2O1 [M+H]+: 305.1653. Found: 305.1651. 
HRMS m/z calculated for C20H20N2O123Na1 [M+Na]+: 327.1473. Found: 
327.1477. 
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N,N-bis((1H-indol-3-yl)methyl)-1-(4-methoxyphenyl)methanamine 
Figure 39 bis indole PMB 
 
 
CAS: / 
Formula: C26H25N3O 
Molecular weight: 395.50 
g/mol 
Off-white solid 
 
MP: 45-52°C       Litt: / 
 
1H NMR (400 MHz, CDCl3) δ 7.97 (s, 2H, H1), 7.67 (d, J = 7.8 Hz, 2H, H5), 
7.34 (dt, J = 8.2, 0.8 Hz, 2H, H8), 7.32 – 7.28 (m, 2H, H13), 7.20 – 7.13 (m, 
4H, H2 + H7), 7.08 (ddd, J = 8.0, 7.1, 1.0 Hz, 2H, H6), 6.88 – 6.81 (m, 2H, 
H14), 3.79 (s, J = 6.9 Hz, 7H, H10 + H16), 3.57 (s, 2H, H11). 
 
13C NMR (100 MHz, CDCl3) δ 158.47 (C15), 136.49 (C9), 132.42 (C12), 
130.27 (C13), 127.95 (C4), 123.57 (C2), 121.95 (C7), 120.10 (C5), 119.31 
(C6), 114.08 (C3), 113.61 (C14), 111.05 (C8), 57.50 (C11), 55.35 (C16), 
49.15 (C10). 
 
IR (film, cm-1): 3411 (N-H stretching), 3054 (C-H stretching), 2930 (C-H 
stretching), 2791 (C-H stretching), 1610 (C=C aromatic stretching), 1509 
(C=C aromatic stretching), 1454 (CH2 scissoring), 1238 (C-N stretching),  
1031 (C-O stretching), 817 (C-H bending out of plan of para disubstituted 
aromatic ring, 739 (C-H bending out of plan of ortho disubstituted 
aromatic ring). 
 
HRMS m/z calculated for C26H26N3O [M+H]+: 396.2075. Found: 396.2067. 
HRMS m/z calculated for C26H25N3O23Na1 [M+Na]+: 418.1895. Found: 
418.1903. 
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N-(4-methoxybenzyl)-N-(prop-2-yn-1-yl)prop-2-yn-1-amine 
Figure 40 bis prop PMB 
 
 
CAS: / 
Formula: C14H15NO 
Molecular weight: 213.28 
g/mol 
Colourless oil 
 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.26 (m, 2H, H6), 6.89 – 6.82 (m, 2H, 
H7), 3.80 (s, 3H, H9), 3.62 (s, 2H, H4), 3.40 (d, J = 2.4 Hz, 4H, H3), 2.26 (t, J 
= 2.4 Hz, 2H, H1). 
 
13C NMR (100 MHz, CDCl3) δ 159.03 (C8), 130.46 (C6), 129.75 (C5), 113.81 
(C7), 78.96 (C2), 73.27 (C1), 56.50 (C4), 55.26 (C9), 41.68 (C3). 
 
IR (film, cm-1): 3289 (C-H stretching from terminus alkyne), 2932 (C-H 
stretching), 2833 (C-H stretching), 1611 (C=C aromatic stretching), 1510 
(C=C aromatic stretching), 1243 (C-N stretching), 1172 (C-O stretching), 
1033 (C-O stretching), 809 (C-H bending out of plan of para disubstituted 
aromatic ring), 635 (C-H bending out of plan of terminus alkyne). 
 
HRMS m/z calculated for C14H16N1O1 [M+H]+: 214.1231. Found: 214.1230. 
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N,N-bis(4-methoxybenzyl)prop-2-yn-1-amine 
Figure 41 prop Bis PMB 
 
 
CAS: / 
Formula: C19H21NO2 
Molecular weight: 295.38 
g/mol 
Colourless oil 
 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.26 (m, 4H, H8), 6.89 – 6.82 (m, 4H, 
H7), 3.79 (s, 6H, H9), 3.60 (s, 4H, H4), 3.22 (d, J = 2.4 Hz, 2H, H3), 2.26 (t, J 
= 2.4 Hz, 1H, H1). 
 
13C NMR (100 MHz, CDCl3) δ 158.79 (C8), 130.90 (C5), 130.21 (C6), 113.72 
(C7), 78.72 (C2), 73.39 (C1), 56.69 (C4), 55.26 (C9), 40.81 (C3). 
 
IR (film, cm-1): 3290 (C-H stretching from terminus alkyne), 2932 (C-H 
stretching), 2834 (C-H stretching), 1612 (C=C aromatic stretching), 1510 
(C=C aromatic stretching), 1244 (C-N stretching), 1173 (C-O stretching), 
1034 (C-O stretching), 809 (C-H bending out of plan of para disubstituted 
aromatic ring), 635 (C-H bending out of plan of terminus alkyne). 
 
HRMS m/z calculated for C19H22N1O2 [M+H]+: 296.1650. Found: 296.1648. 
HRMS m/z calculated for C19H21N1O223Na1 [M+Na]+: 318.1469. Found: 
318.1451. 
 
 
 
  
Chapter X 
 
287 
 
4-methoxybenzaldehyde 
Figure 42 anisal 
 
 
CAS: 123-11-5 
Formula: C8H8O2 
Molecular weight: 136.15 g/mol 
Colourless oil 
 
1H NMR (400 MHz, CDCl3) δ 9.88 (s, 1H, H1), 7.87 – 7.79 (m, 2H, H3), 7.03 
– 6.96 (m, 2H, H4), 3.89 (s, 3H, H6). 
 
13C NMR (100 MHz, CDCl3) δ 190.75 (C1), 164.58 (C5), 131.91 (C3), 129.90 
(C2), 114.28 (C4), 55.52 (C6). 
 
IR (film, cm-1): 2840 (C-H stretching), 2739 (C-H stretching), 1678 (C=O 
stretching), 1594 (C=C aromatic stretching), 1575 (C=C aromatic 
stretching), 1509 (C=C aromatic stretching), 1155 (C-O stretching), 1020 
(C-O stretching), 827 (C-H bending out of plan of para disubstituted 
aromatic ring. 
 
The compound was already described in the literature: 
Cahours, v. A. Justus Liebigs Annalen der Chemie, 1842, 41, 65. 
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1-(((1H-indol-3-yl)methyl)(4-methoxybenzyl)amino)non-2-yn-4-one 
Figure 43 ynone 5, 6 
 
To a solution of N-((1H-indol-3-yl)methyl)-N-(4-methoxybenzyl)prop-
2-yn-1-amine (12 g, 39.4 mmol, 1 eq.) in anhydrous tetrahydrofuran (240 ml) 
at -78°C was added n-butyllithium 2.5M in hexane (91 mmol, 2.3 eq., 36.3 
ml) in 2 minutes. The acetone/dry ice bath was removed to a water/ice bath 
for 30 minutes. The mixture was cooled to -78°C again and N-methoxy-N-
methylhexanamide (8.2 g, 51.2 mmol, 1.3 eq., 8.8 ml) was added neat. The 
acetone/dry ice bath was removed, and the reaction was stirred for 30 
minutes. The solution was purred on diethyl ether and 5M aqueous solution 
of ammonium chloride, the aqueous phase was extracted once with diethyl 
ether. The ether phases were combined and dried over sodium sulfate then 
the volatiles were removed in vacuum to provide a yellow-orange oil. This oil 
was dissolvent in acetonitrile (10 ml for 1 g of N-((1H-indol-3-yl)methyl)-N-
(4-methoxybenzyl)prop-2-yn-1-amine starting material) and the acetonitrile 
phase was washed 6 times with hexane (5 ml for 1 g of N-((1H-indol-3-
yl)methyl)-N-(4-methoxybenzyl)prop-2-yn-1-amine). The acetonitrile was 
dried again on sodium sulfate and the volatiles were removed in vacuo to 
afford the desired product as a yellow oil; 13.5 g (85%).  
 
CAS: / 
Formula: C26H30N2O2 
Molecular weight:  
402.53 g/mol 
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1H NMR (400 MHz, CDCl3) δ 8.08 (s, 1H, H1), 7.76 (d, J = 7.4 Hz, 1H, H5), 
7.39 – 7.33 (m, 1H, H8), 7.33 – 7.27 (m, 2H, H13), 7.24 – 7.18 (m, 1H, H7), 
7.17 – 7.09 (m, 2H, H2 + H6), 6.89 – 6.84 (m, 2H, H14), 3.89 (s, 2H, H10), 
3.80 (s, 3H, H16), 3.69 (s, 2H, H11), 3.42 (s, 2H, H17), 2.60 (t, J = 7.5 Hz, 2H, 
H21), 1.82 – 1.70 (m, 2H, H22), 1.44 – 1.28 (m, 4H, H23 + H24), 0.92 (t, J = 
7.0 Hz, 3H, H25). 
 
13C NMR (100 MHz, CDCl3) δ 188.38 (C20), 158.72 (C15), 136.51 (C9), 
130.42 (C12), 130.11 (C13), 127.44 (C4), 124.01 (C2), 121.84 (C7), 119.46 
(C5), 119.22 (C6), 113.65 (C14), 112.05 (C3), 111.23 (C8), 89.15 (C19), 
85.30 (C18), 57.10 (C11), 55.04 (C16), 48.93 (C10), 45.60 (C21), 40.75 
(C17), 31.04 (C23), 23.88 (C22), 22.33 (C24), 13.85 (C25). 
 
IR (film, cm-1): 3408 (N-H stretching), 2954 (C-H stretching), 2929 (C-H 
stretching), 2204 (C≡C stretching), 1665 (C=O stretching), 1611 (C=C 
aromatic stretching), 1510 (C=C aromatic stretching), 1455 (CH2 
scissoring),  1244 (C-N stretching), 811 (C-H bending out of plan of para 
disubstituted aromatic ring), 740 (C-H bending out of plan of ortho 
disubstituted aromatic ring). 
 
HRMS m/z calculated for C26H31N2O2 [M+H]+: 403.2385. Found: 403.2373. 
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decan-5-one 
Figure 44 decanone 
 
 To a solution of N-methoxy-N-methylhexanamide (0.46 g, 2.9 mmol, 
1 eq., 0.5 ml) in tetrahydrofuran (20 ml) at -78°C was added drop wisely n-
Butyl Lithium 2.5 Molar in hexane (3.8 mmol, 1.3 eq., 1.5 ml). At the end of 
the addition the mixture was allowed to evolve to 0°C over 30 minutes, then 
it was quenched by dropwise addition of a saturated aqueous solution of 
ammonium chloride. The biphasic mixture was extracted with diethyl ether, 
the organic phases were combined and dried over sodium sulfate. The 
volatiles were removed without vacuum to afford the desired product as a 
colourless oil; 0.4 g (90%). 
 
 
CAS: 820-29-1 
Formula: C10H20O1 
Molecular weight: 156.27 g/mol 
 
1H NMR (400 MHz, CDCl3) δ 2.38 (t, J = 7.5 Hz, 2H, H4/6), 2.37 (t, J = 7.5 
Hz, 2H, H4/6), 1.61 – 1.49 (m, 4H, H3 + H7), 1.37 – 1.19 (m, 6H, H2 + H8 + 
H9), 0.89 (t, J = 7.3 Hz, 3H, H1/10), 0.90 – 0.85 (m, 3H, H1/H10). 
 
13C NMR (100 MHz, CDCl3) δ 211.79 (C5), 42.86 (C6), 42.61 (C4), 31.54 (C8), 
26.08 (C3), 23.66 (C7), 22.56 (C9), 22.47 (C2), 14.00 (C10), 13.94 (C1). 
 
IR (cm-1): 3956 (C-H stretching), 2931 (C-H stretching), 2872 (C-H 
stretching), 1712 (C=O stretching of acyclic saturated ketone), 1464 (CH2 
scissoring), 1410 (CH3 asymmetric deformation), 1377 (CH3 symmetric 
deformation), 1132 (C-C stretching), 1048 (C-C stretching), 748 (CH2 
rocking), 731 (CH2 rocking). 
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The compound was already described in the literature: 
Church, J. M.; Whitmore, F. C.; McGrew R. V.  J. Am. Chem. Soc., 1934, 
56, 176. 
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(6S,6aS,11bS)-6-butyl-2-(4-methoxybenzyl)-2,3,6a,7-tetrahydro-1H-
pyrrolo[3,4-d]carbazol-5(6H)-one 
Figure 45 tetra 5,6 
 
To a solution of ynone (8.5 g, 21.1 mmol, 1eq.) in anhydrous 
tetrahydrofuran (42 ml) at 0°C was added solid potassium tert-butoxide (0.24 
g, 2.1 mmol, 0.1 eq.). After 15 seconds of reaction, the mixture is purred on 
diethyl ether and 5M ammonium chloride aqueous solution and shook 
vigorously. The aqueous phase was extracted with diethyl ether. All the ether 
phases were combined and dried over sodium sulfate. The volatiles were 
removed in vacuo leading to a brownish oil which can be purified by column 
chromatography using flash silica gel, petroleum ether and diethyl ether to 
afford the product as a yellow solid; 7.22 g (85%). 
 
 
CAS: / 
Formula: C26H30N2O2 
Molecular weight: 
402.53 g/mol 
MP: 36-39°C        Litt: / 
 
1H NMR (400 MHz, CDCl3) δ 7.29 – 7.25 (m, 1H, H22), 7.23 (d, J = 8.6 Hz, 
2H, H4), 7.13 (td, J = 7.6, 1.3 Hz, 1H, H20), 6.87 – 6.81 (m, 3H, H3 + H21), 
6.72 (d, J = 7.6 Hz, 1H, H19), 5.92 (t, J = 1.6 Hz, 1H, H9), 4.13 – 4.04 (bs, 1H, 
H17), 4.09 (dd, J = 17.4, 1.8 Hz, 1H, H7), 3.80 (d, J = 12.9 Hz, 1H, H6), 3.80 
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(s, 3H, H1), 3.79 (d, J = 9.5 Hz, 1H, H16), 3.56 (d, J = 13.0 Hz, 1H, H6’), 3.20 
(d, J = 17.6 Hz, 1H, H7’), 3.09 (d, J = 8.0 Hz, 1H, H25), 2.58 (d, J = 8.1 Hz, 1H, 
H25’), 2.33 (dt, J = 9.6, 4.8 Hz, 1H, H11), 1.75 – 1.61 (m, 2H, H12), 1.46 – 
1.15 (m, 4H, H13 + H14), 0.91 (t, J = 7.1 Hz, 3H, H15). 
 
13C NMR (100 MHz, CDCl3) δ 198.62 (C10), 164.12 (C8), 158.87 (C2), 148.34 
(C18), 132.36 (C23), 130.64 (C5), 129.67 (C4), 128.62 (C20), 124.82 (C22), 
122.39 (C9), 119.60 (C21), 113.89 (C3), 110.59 (C19), 67.17 (C16), 65.69 
(C25), 58.81 (C6), 56.86 (C7), 55.72 (C24), 55.38 (C1), 48.40 (C11), 29.14 
(C13), 26.72 (C12), 23.27 (C14), 14.13 (C15). 
 
IR (film, cm-1): 3363 (N-H stretching), 2954 (C-H stretching), 2930 (C-H 
stretching), 1665 (C=O stretching from α,β unsaturated ketone in a 6 
membered ring), 1606 (C=C aromatic stretching), 1510 (C=C aromatic 
stretching), 1463 (CH2 scissoring), 1247 (C-N stretching),  1033 (C-O 
stretching), 819 (C-H bending out of plan of para disubstituted aromatic 
ring + C-H bending out of plan of trisubstituted alkene), 745 (C-H bending 
out of plan of ortho disubstituted aromatic ring). 
 
HRMS m/z calculated for C26H31N2O2 [M+H]+: 403.2385. Found: 403.2369. 
HRMS m/z calculated for C26H30N2O223Na1 [M+Na]+: 425.2204. Found: 
425.2192. 
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Final report; processing .tmp file: 
  169 unique conformations found so far 
  169 minimized with good convergence 
Found     7 confs within  1.00 kcal/mol ( 4.18 kJ/mol) of glob. min. 
Found    26 confs within  2.00 kcal/mol ( 8.37 kJ/mol) of glob. min. 
Found    57 confs within  3.00 kcal/mol (12.55 kJ/mol) of glob. min. 
Found   168 confs within  5.00 kcal/mol (20.92 kJ/mol) of glob. min. 
Found   169 confs within 10.00 kcal/mol (41.84 kJ/mol) of glob. min. 
Global minimum E =    386.23 found     5 times. 
 1000 steps performed so far, out of  1000 
 E of low-energy structures above global min [kJ/mol],  and no. times 
found: 
    E:  0.00  0.95  1.22  2.16  2.97  3.30  4.04  4.49  4.51  4.53  4.78  4.95 
  No.:     5     3    12    12     4     4     5     3     7     7     3     8 
  
Input structure with title on the next line is given SerNo:        1 
O=C1[C@@H](CCCC)[C@@H]([C@@]23C(CN(CC4=CC=C(OC)C=C4)C3)=C
1)NC5=C2C=CC=C5 
Auto summary for input structure      1: 
 Total number of structures processed =        1000 
 Conformations with poor convergence marked with a * 
 Conformation       1  ( 386.2272     kJ/mol) was found     5 times 
 Conformation       2  ( 387.1737     kJ/mol) was found     3 times 
 Conformation       3  ( 387.4503     kJ/mol) was found    12 times 
 Conformation       4  ( 388.3887     kJ/mol) was found    12 times 
 Conformation       5  ( 389.1987     kJ/mol) was found     4 times 
 Conformation       6  ( 389.5239     kJ/mol) was found     4 times 
 Conformation       7  ( 390.2685     kJ/mol) was found     5 times 
 Conformation       8  ( 390.7177     kJ/mol) was found     3 times 
 Conformation       9  ( 390.7361     kJ/mol) was found     7 times 
 Conformation      10 ( 390.7552     kJ/mol) was found     7 times 
 Conformation      11 ( 391.0072     kJ/mol) was found     3 times 
 Conformation      12 ( 391.1813     kJ/mol) was found     8 times 
 Conformation      13 ( 391.2146     kJ/mol) was found     6 times 
 Conformation      14 ( 391.6545     kJ/mol) was found     5 times 
 Conformation      15 ( 391.6986     kJ/mol) was found     6 times 
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N-((1H-indol-3-yl)methyl)-N-(4-methoxybenzyl)but-3-yn-1-amine 
Figure 46 indole butyn PMB 
 
To a solution of N-((1H-indol-3-yl)methyl)-1-(4-
methoxyphenyl)methanamine (3.6 g, 13.5 mmol, 1 eq.) and potassium 
carbonate (5.9 g, 42.7 mmol, 3 eq.) in anhydrous acetonitrile (70 ml) was 
added but-3-yn-1-yl methanesulfonate (2.1 g, 14.2 mmol, 1.05 eq.) and the 
reaction was stirred at reflux for 18 hours. The mixture was cooled to room 
temperature and extracted with water and diethyl ether, the organic phases 
were combined and dried over sodium sulfate, finally the volatiles were 
removed in vacuo to furnish a yellow/orange oil. This oil was solubilised in 
diethyl ether and the precipitate was filtered. The ether phase was 
recovered, and the solvent was removed in vacuo to afford a yellow oil. This 
oil was purified by column chromatography using flash silica gel, 
dichloromethane and methanol to afford the desired product as a pale-
yellow oil; 1.5 g (35%). 
 
 
CAS: / 
Formula: C21H22N2O 
Molecular weight: 318.42 
g/mol 
1H NMR (400 MHz, CDCl3) δ 7.99 (bs, 1H, H1), 7.75 (d, J = 7.9 Hz, 1H, H5), 
7.40 – 7.31 (m, 1H, H8), 7.27 (d, J = 8.4 Hz, 2H, H13), 7.19 (t, J = 7.4 Hz, 1H, 
H6), 7.16 – 7.09 (m, 2H, H2 + H7), 6.84 (d, J = 8.4 Hz, 2H, H14), 3.81 (s, 2H, 
H10), 3.79 (s, 3H, H16), 3.59 (s, 2H, H11), 2.72 (t, J = 7.5 Hz, 2H, H17), 2.38 
(td, J = 7.5, 2.6 Hz, 2H, H18), 1.92 (dt, J = 2.7, 1.3 Hz, 1H, H20). 
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13C NMR (100 MHz, CDCl3) δ 158.61 (C15), 136.55 (C9), 131.82 (C12), 
130.06 (C13), 127.76 (C4), 123.45 (C7), 122.08 (C2), 120.00 (C5), 119.42 
(C6), 113.67 (C14), 113.63 (C3), 111.09 (C8), 83.53 (C19), 69.06 (C20), 
57.59 (C11), 55.32 (C16), 51.99 (C17), 49.41 (C10), 17.12 (C18). 
 
IR (film, cm-1): 3415 (N-H stretching), 3290 (C-H stretching from triple 
bond), 2930 (C-H stretching), 2833 (C-H stretching), 1610 (C=C aromatic 
stretching), 1509 (C=C aromatic stretching), 1454 (CH2 scissoring), 1237 (C-
N stretching), 1072 (C-O stretching), 1030 (C-O stretching), 814 (C-H 
bending out of plan of para disubstituted aromatic ring), 739 (C-H bending 
out of plan of ortho disubstituted aromatic ring), 635  (C-H bending out of 
plan of terminus alkynes). 
 
HRMS m/z calculated for C21H23N2O1 [M+H]+: 319.1810. Found: 319.1809 
HRMS m/z calculated for C21H22N2O123Na1 [M+Na]+: 341.1629. Found: 
341.1636. 
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N-(but-3-yn-1-yl)-N-(4-methoxybenzyl)but-3-yn-1-amine 
Figure 47 bis but PMB 
 
 
CAS: / 
Formula: C16H19NO 
Molecular weight: 241.33 
g/mol 
1H NMR (400 MHz, CDCl3) δ 7.24 (d, J = 8.8 Hz, 2H, H7), 6.88 – 6.81 (m, 2H, 
H8), 3.80 (s, J = 2.2 Hz, 3H, H10), 3.60 (s, 2H, H5), 2.73 (t, J = 7.4 Hz, 4H, 
H4), 2.33 (td, J = 7.4, 2.7 Hz, 4H, H3), 1.95 (t, J = 2.7 Hz, 2H, H1). 
 
13C NMR (100 MHz, CDCl3) δ 158.72 (C9), 131.12 (C6), 129.80 (C7), 113.68 
(C8), 82.94 (C2), 69.04 (C1), 57.60 (C5), 55.26 (C10), 52.24 (C4), 17.28 (C3). 
 
IR (film, cm-1): 3291 (C-H stretching terminus triple bond), 2953 (C-H 
stretching), 2914 (C-H stretching), 2834 (C-H stretching), 1610 (C=C 
aromatic stretching), 1509 (C=C aromatic stretching), 1460 (CH2 
scissoring), 1241 (C-N stretching), 1171 (C-O stretching), 1033 (C-O 
stretching), 816 (C-H bending out of plan of para disubstituted aromatic 
ring), 633 (C-H bending out of plan of terminus alkyne). 
 
HRMS m/z calculated for C16H20N1O1 [M+H]+: 242.1544. Found: 242.1531. 
HRMS m/z calculated for C16H19N1O123Na1 [M+Na]+: 264.1364. Found: 
264.1340. 
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N-(4-methoxybenzyl)but-3-yn-1-amine 
Figure 48 but PMB 
 
 
CAS: 146980-79-2 
Formula: C12H15N1O1 
Molecular weight: 189.25 
g/mol 
1H NMR (400 MHz, CDCl3) δ 7.27 – 7.22 (m, 2H, H8), 6.89 – 6.84 (m, 2H, 
H9), 3.80 (s, 3H, H11), 3.76 (s, 2H, H6), 2.79 (t, J = 6.6 Hz, 2H, H4), 2.41 (td, 
J = 6.6, 2.7 Hz, 2H, H3), 1.99 (t, J = 2.7 Hz, 1H, H1), 1.58 (s, 1H, H5). 
 
13C NMR (100 MHz, CDCl3) δ 158.78 (C10), 132.30 (C7), 129.40 (C8), 113.93 
(C9), 82.61 (C2), 69.65 (C1), 55.37 (C11), 52.85 (C6), 47.30 (C4), 19.61 (C3). 
 
IR (film, cm-1): 3289 (C-H stretching terminus triple bond), 2941 (C-H 
stretching), 2834 (C-H stretching), 1611 (C=C aromatic stretching), 1510 
(C=C aromatic stretching), 1455 (CH2 scissoring), 1241 (C-N stretching), 
1175 (C-O stretching), 1032 (C-O stretching), 811 (C-H bending out of plan 
of para disubstituted aromatic ring), 634 (C-H bending out of plan of 
terminus alkyne). 
 
HRMS m/z calculated for C12H16N1O1 [M+H]+: 190.1231. Found: 190.1228. 
HRMS m/z calculated for C12H15N1O123Na1 [M+Na]+: 212.1051. Found: 
212.1048. 
 
The compound was already described in the literature: 
Read, M. W.; Miller, M. L.; Ray, P. S. Tetrahedron, 1999, 55, 373. 
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1-(((1H-indol-3-yl)methyl)(4-methoxybenzyl)amino)dec-3-yn-5-one 
Figure 49 ynone 6, 6 
 
To a solution of N-((1H-indol-3-yl)methyl)-N-(4-methoxybenzyl)but-
3-yn-1-amine (2.1 g, 6.6 mmol, 1 eq.) in anhydrous tetrahydrofuran (40 ml) 
at -78°C was added n-butyllithium 2.5 M in hexane (15 mmol, 2.3 eq., 6.1 ml) 
in 2 minutes. The acetone/dry ice bath was removed to a water/ice bath for 
30 minutes. The mixture was cooled to -78°C again and N-methoxy-N-
methylhexanamide (1.36 g, 8.5 mmol, 1.3 eq., 1.47 ml) was added neat. The 
acetone/dry ice bath was removed, and the reaction was stirred for 30 
minutes. The solution was purred on diethyl ether and 5M aqueous solution 
of ammonium chloride, the aqueous phase was extracted once with diethyl 
ether. The ether phases were combined and dried over sodium sulfate then 
the volatiles were removed in vacuum to provide a yellow-orange oil. This oil 
was dissolvent in acetonitrile (10 ml for 1 g of N-((1H-indol-3-yl)methyl)-N-
(4-methoxybenzyl)but-3-yn-1-amine starting material) and the acetonitrile 
phase was washed 6 times with hexane (5 ml for 1 g of N-((1H-indol-3-
yl)methyl)-N-(4-methoxybenzyl)but-3-yn-1-amine). The acetonitrile was 
dried again on sodium sulfate and the volatiles were removed in vacuo to 
afford the desired product as a yellow oil; 2.33 g (85%).  
CAS: / 
Formula: C27H32N2O2 
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Molecular weight: 416.56 
g/mol 
1H NMR (400 MHz, CDCl3) δ 8.08 (bs, 1H, H1), 7.77 – 7.72 (m, 1H, H5), 7.35 
(dt, J = 8.1, 0.9 Hz, 1H, H8), 7.30 – 7.26 (m, 2H, H13), 7.22 – 7.16 (m, 1H, 
H7), 7.15 (d, J = 2.3 Hz, 1H, H2), 7.11 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H, H6), 6.88 
– 6.78 (m, 2H, H14), 3.81 (s, 1H, H10), 3.79 (s, 3H, H16), 3.60 (s, 2H, H11), 
2.75 (t, J = 7.2 Hz, 2H, H17), 2.51 (t, J = 7.3 Hz, 2H, H18), 2.48 – 2.44 (m, 
2H, H22), 1.69 – 1.56 (m, 2H, H23), 1.36 – 1.22 (m, 4H, H24 + H25), 0.87 (t, 
J = 7.0 Hz, 3H, H26). 
 
13C NMR (100 MHz, CDCl3) δ 188.63 (C21), 158.71 (C15), 136.63 (C9), 
131.56 (C12), 130.03 (C13), 127.68 (C4), 123.58 (C7), 122.10 (C2), 119.89 
(C5), 119.43 (C6), 113.71 (C14), 113.41 (C3), 111.17 (C8), 93.18 (C20), 
81.53 (C19), 57.73 (C11), 55.33 (C16), 51.14 (C17), 49.60 (C10), 45.51 
(C22), 31.20 (C24), 23.80 (C23), 22.46 (C25), 17.73 (C18), 13.98 (C26). 
 
IR (film, cm-1): 3311 (N-H stretching), 2954 (C-H stretching), 2929 (C-H 
stretching), 2869 (C-H stretching), 2834 (C-H stretching), 2209 (C≡C 
stretching), 1662 (C=O stretching), 1611 (C=C aromatic stretching), 1584 
(C=C aromatic stretching), 1509 (C=C aromatic stretching), 1456 (CH2 
scissoring), 1240 (C-N stretching), 819 (C-H bending out of plan of para 
disubstituted aromatic ring), 740 (C-H bending out of plan of ortho 
disubstituted aromatic ring). 
 
HRMS m/z calculated for C27H33N2O2 [M+H]+: 417.2542. Found: 417.2524. 
HRMS m/z calculated for C27H32N2O223Na1 [M+Na]+: 439.2361. Found: 
439.2350. 
 
 
  
Chapter X 
 
301 
 
N-(2-(1H-indol-3-yl)ethyl)-1-(4-methoxyphenyl)methanimine 
Figure 50 trip imine PMB 
 
To a solution of tryptamine (15 g, 0.093 mol, 1 eq.) and PTSA (0.08 g, 
0.4 mmol, 0.005 eq.) in toluene (180 ml) or benzene (180 ml) was added p-
anisaldehyde (13.3 g, 0.098 mol, 1.05 eq., 11.9 ml). The resulting mixture was 
refluxed with a Dean-Stark apparatus until the correct amount of water (1.7 
ml) was retrieved. The solvent was removed at low pressure to afford a 
yellow-orange solid; 26 g (quantitative). 
This solid was directly used without more purification. 
 
 
CAS: 93879-05-1 
Formula: C18H18N2O1 
Molecular weight: 278.35 g/mol 
MP: 116-118°C        Litt9: 119°C 
 
1H NMR (400 MHz, CDCl3) δ 8.11 (s, 1H, H12), 7.94 (bs, 1H, H1), 7.71 – 7.63 
(m, 3H, H5 + H14), 7.36 (dt, J = 8.0, 0.9 Hz, 1H, H8), 7.19 (ddd, J = 8.1, 7.1, 
1.2 Hz, 1H, H7), 7.12 (ddd, J = 8.0, 7.1, 1.1 Hz, 1H, H6), 7.02 (d, J = 2.3 Hz, 
1H, H2), 6.95 – 6.89 (m, 2H, H15), 3.90 (td, J = 7.4, 1.2 Hz, 2H, H11), 3.84 
(s, 3H, H17), 3.15 (td, J = 7.3, 0.7 Hz , 2H, H10). 
 
                                                          
9 Protiva et al. Collect. Czech. Chem. Commun., 1963, 28, 629. 
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13C NMR (100 MHz, CDCl3) δ 161.55 (C16), 161.01 (C12), 136.31 (C9), 
129.68 (C14), 129.10 (C13), 127.55 (C4), 122.33 (C2), 121.74 (C7), 119.07 
(C6), 118.92 (C5), 114.01 (C15), 113.72 (C3), 111.23 (C8), 61.91 (C11), 
55.28 (C17), 27.05 (C10). 
 
IR (film, cm-1): 3411 (N-H stretching), 3047 (C-H stretching), 3004 (C-H 
stretching), 2959 (C-H stretching), 2909 (C-H stretching), 2836 (C-H 
stretching), 1645 (C=N stretching), 1603 (C=C aromatic stretching), 1575 
(C=C aromatic stretching), 1510 (C=C aromatic stretching), 1456 (CH2 
scissoring), 1243 (C-N stretching), 1166 (C-O stretching), 1028 (C-O 
stretching), 834 (C-H bending out of plan of para disubstituted aromatic 
ring), 737 (C-H bending out of plan of para disubstituted aromatic ring). 
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2-(1H-indol-3-yl)-N-(4-methoxybenzyl)ethan-1-amine 
Figure 51 trip PMB 
 
N-(2-(1H-indol-3-yl)ethyl)-1-(4-methoxyphenyl)methanimine (26 g, 
0.093 mol, 1 eq.) was dissolved in methanol (200 ml) at 0°C. Then NaBH4 (7.8 
g, 0.206 mol, 2.2 eq.) was added portionwise and the temperature was kept 
below 10°C. The mixture was stirred at 0°C for 3 hours then 25-35% aqueous 
ammonia solution was added (150 ml) and the biphasic mixture was stirred 
for 2 hours. The solvent was slowly eliminated under vacuum. The resulting 
aqueous phase was extracted 3 time with dichloromethane, the organic 
layers were combined and dried over Na2SO4. The solvent was eliminated 
under low pressure providing a yellow solid which can be precipitated with 
diethyl ether and pentane to a white solid; 23.6 g (90%). 
 
 
CAS: 7390-67-2 
Formula: C18H20N2O1 
Molecular weight: 280.37 g/mol 
MP: 74-75°C       Litt: / 
 
1H NMR (300 MHz, CDCl3) δ 8.26 (s, 1H, H1), 7.60 (d, J = 7.8 Hz, 1H, H5), 
7.34 – 7.28 (m, 1H, H8), 7.21 – 7.14 (m, 3H, H7 + H15), 7.13 – 7.05 (m, 1H, 
H6), 6.96 (d, J = 2.1 Hz, 1H, H2), 6.85 – 6.78 (m, 2H, H16), 3.77 (s, 3H, H18), 
3.74 (s, 2H, H13), 3.05 – 2.90 (m, 4H, H10 + H11), 1.71 (s, 1H, H12). 
 
13C NMR (100 MHz, CDCl3) δ 158.38 (C17), 136.32 (C9), 131.81 (C14), 
129.21 (C15), 127.22 (C4), 122.22 (C2), 121.51 (C7), 118.79 (C6), 118.55 
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(C5), 113.60 (C16), 112.85 (C3), 111.20 (C8), 54.89 (C18), 52.83 (C13), 
48.98 (C11), 25.37 (C10). 
 
IR (film, cm-1): 3412 (N-H stretching), 3054 (C-H stretching), 2915 (C-H 
stretching), 2834 (C-H stretching), 1610 (C=C aromatic stretching), 1510 
(C=C aromatic stretching), 1454 (CH2 scissoring), 1440 (CH3 asymmetric 
deformation), 1243 (C-N stretching), 1175 (C-O stretching), 1031 (C-O 
stretching), 811 (C-H bending out of plan of para disubstituted aromatic 
ring), 737 (C-H bending out of plan of ortho disubstituted aromatic ring). 
 
The compound was already described in the literature: 
Protiva et al. Collect. Czech. Chem. Commun., 1963, 28, 629. 
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N-(2-(1H-indol-3-yl)ethyl)-N-(4-methoxybenzyl)prop-2-yn-1-amine 
Figure 52 trip prop PMB 
 
2-(1H-indol-3-yl)-N-(4-methoxybenzyl)ethan-1-amine (6.00 g, 21.4 
mmol, 1 eq.) and potassium carbonate (8.87 g, 64.2 mmol, 3 eq.) were 
suspended in stirring acetonitrile (120 ml) at room temperature. Then 
propargyl bromide (80% in toluene) (22.4 mmol, 1.05 eq., 2.42 ml) was drop 
wisely added and the resulting mixture was stirred for 3 hours at room 
temperature. Water was added, and the solution was extracted three time 
with dichloromethane, the organic phases were combined, and the volatiles 
were removed in vacuo to afford a yellow oil. This oil was suspended in 
diethyl ether, a precipitate was formed and filtered. The solvent was 
removed under vacuum to afford the desired product as a yellow solid; 5.45 
g (80%). 
 
 
CAS: / 
Formula: C21H22N2O1 
Molecular weight: 318.42 g/mol 
1H NMR (400 MHz, CDCl3) δ 8.07 (s, 1H, H1), 7.58 (d, J = 7.8 Hz, 1H, H5), 
7.32 – 7.24 (m, 2H, H14), 7.19 – 7.12 (m, 2H, H7 + H8), 7.12 – 7.06 (m, 1H, 
H6), 6.89 – 6.74 (m, 3H, H2 + H15), 3.70 (s, 3H, H17), 3.66 (s, 2H, H12), 3.41 
(d, J = 2.3 Hz, 2H, H18), 3.03 – 2.86 (m, 4H, H10 + H11), 2.26 (t, J = 2.3 Hz, 
1H, H20). 
 
13C NMR (100 MHz, CDCl3) δ 158.70 (C16), 136.15 (C9), 130.51 (C13), 
130.39 (C14), 127.47 (C4), 121.76 (C2), 121.73 (C7), 119.03 (C6), 118.80 
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(C5), 113.86 (C3), 113.70 (C15), 111.16 (C8), 78.68 (C19), 73.51 (C20), 
57.20 (C12), 55.12 (C17), 53.82 (C11), 41.17 (C18), 23.51 (C10). 
 
IR (film, cm-1): 3416 (N-H stretching), 3285 (C-H stretching from triple 
bond), 2930 (C-H stretching), 2833 (C-H stretching), 1610 (C=C aromatic 
stretching), 1509 (C=C aromatic stretching), 1455 (CH2 scissoring), 1244 (C-
N stretching), 1031 (C-O stretching), 815 (C-H bending out of plan of para 
disubstituted aromatic ring), 740 (C-H bending out of plan of ortho 
disubstituted aromatic ring), 637  (C-H bending out of plan of terminus 
alkynes). 
 
HRMS m/z calculated for C21H23N2O1 [M+H]+: 319.1810. Found: 319.1803 
HRMS m/z calculated for C21H22N2O123Na1 [M+Na]+: 341.1629. Found: 
341.1615. 
 
The compound was already described in the literature: 
Magné, V.; Marinetti, A.; Gandon, V.; Voituriez, A.; Guinchard, X. Adv. 
Synth. Catal, 2017, 359, 4036. 
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1-((2-(1H-indol-3-yl)ethyl)(4-methoxybenzyl)amino)non-2-yn-4-one 
Figure 53 ynone 6' 6 
 
To a solution of N-(2-(1H-indol-3-yl)ethyl)-N-(4-methoxybenzyl)prop-
2-yn-1-amine (5.8 g, 18.2 mmol, 1 eq.) in anhydrous tetrahydrofuran (115 ml) 
at -78°C was added n-butyllithium 2.5M in hexane (41.8 mmol, 2.3 eq.) in 2 
minutes. The acetone/dry ice bath was removed to a water/ice bath for 30 
minutes. The mixture was cooled to -78°C again and N-methoxy-N-
methylhexanamide (3.77 g, 23.7 mmol, 1.3 eq., 4.07 ml) was added neat. The 
acetone/dry ice bath was removed, and the reaction was stirred for 30 
minutes. The solution was purred on diethyl ether and 5M aqueous solution 
of ammonium chloride, the aqueous phase was extracted once with diethyl 
ether. The ether phases were combined and dried over sodium sulfate then 
the volatiles were removed in vacuum to provide a yellow-orange oil. This oil 
was dissolvent in acetonitrile (10 ml for 1 g of N-(2-(1H-indol-3-yl)ethyl)-N-
(4-methoxybenzyl)prop-2-yn-1-amine starting material) and the acetonitrile 
phase was washed 6 times with hexane (5 ml for 1 g of N-(2-(1H-indol-3-
yl)ethyl)-N-(4-methoxybenzyl)prop-2-yn-1-amine). The acetonitrile was 
dried again on sodium sulfate and the volatiles were removed in vacuo to 
afford the desired product as a yellow oil; 6.5 g (85%).  
 
CAS: / 
Formula: C27H32N2O2 
Molecular weight: 416.56 
g/mol 
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1H NMR (400 MHz, CDCl3) δ 8.00 (s, 1H, H1), 7.57 (dd, J = 7.5, 0.5 Hz, 1H, 
H5), 7.35 (dt, J = 8.1, 0.8 Hz, 1H, H8), 7.30 – 7.22 (m, 2H, H14), 7.18 (ddd, J 
= 8.2, 7.1, 1.1 Hz, 1H, H7), 7.10 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H, H6), 7.04 (d, J 
= 2.3 Hz, 1H, H2), 6.89 – 6.82 (m, 2H, H15), 3.80 (s, 3H, H17), 3.67 (s, 2H, 
H12), 3.57 (s, 2H, H18), 3.02 – 2.96 (m, 2H, H10), 2.96 – 2.89 (m, 2H, H11), 
2.56 (t, J = 7.5 Hz, 2H, H22), 1.76 – 1.64 (m, 2H, H23), 1.38 – 1.26 (m, 4H, 
H24 + H25), 0.89 (t, J = 7.0 Hz, 3H, H26). 
 
13C NMR (101 MHz, CDCl3) δ 188.20 (C21), 158.91 (C16), 136.30 (C9), 
130.28 (C14), 130.18 (C13), 127.47 (C4), 121.82 (C2), 121.80 (C7), 119.08 
(C6), 118.70 (C5), 113.79 (C15), 113.70 (C3), 111.24 (C8), 88.46 (C20), 
85.20 (C19), 57.52 (C12), 55.23 (C17), 54.13 (C18), 45.67 (C22), 41.57 
(C18), 31.12 (C24), 23.88 (C23), 23.69 (C10), 22.40 (C25), 13.91 (C26). 
 
IR (film, cm-1): 3414 (N-H stretching), 2954 (C-H stretching), 2929 (C-H 
stretching), 2205 (C≡C stretching), 1667 (C=O stretching), 1611 (C=C 
aromatic stretching), 1510 (C=C aromatic stretching), 1456 (CH2 
scissoring), 1245 (C-N stretching), 1032 (C-O stretching), 817 (C-H bending 
out of plan of para disubstituted aromatic ring), 737 (C-H bending out of 
plan of ortho disubstituted aromatic ring). 
 
HRMS m/z calculated for C27H33N2O2 [M+H]+: 417.2542. Found: 417.2534. 
HRMS m/z calculated for C27H32N2O223Na1 [M+Na]+: 439.2361. Found: 
439.2356. 
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(E)-1-(((1H-indol-3-yl)methyl)(4-methoxybenzyl)amino)dec-3-en-5-one 
Figure 54 LT enone 
 
Solution A: to a solution of N-((1H-indol-3-yl)methyl)-1-(4-
methoxyphenyl)methanamine (4 g, 15 mmol, 1 eq.) and 1,8-Diazabicyclo 
(5.4.0) undec-7-ene (0.1 g, 0.75 mmol, 0.05 eq., 0.11 ml) in tetrahydrofuran 
(40 ml) at 0°C was added acrolein (0.84 g, 15 mmol, 1 eq., 1.05 ml) dropwise 
on 1 minute, then the mixture was stirred at 0°C for 30 minutes.  
Solution B: to a solution of dimethyl (2-oxoheptyl)phosphonate (3.3 g, 15 
mmol, 1 eq., 3.17 ml) in tetrahydrofuran (160 ml) was added solid potassium 
tert-butoxide (1.7 g, 15 mmol, 1 eq.) at room temperature, then the mixture 
was stirred for 20 minutes10 at room temperature.  
Solution A was added to Solution B at room temperature then the resulting 
mixture was stirred for 1 hour at room temperature. A saturated aqueous 
solution of sodium chloride was added, and the mixture was extracted two 
times with diethyl ether. The ether phases were combined and dried over 
sodium sulfate, then the volatiles were removed in vacuo to afford the 
desired product as a pale-yellow oil; 5.65 g (90%). 
CAS: / 
Formula: C27H34N2O2 
                                                          
10  Tip: more time than 20-30 minutes will turn the mixture in a dense solid 
suspension. And will decrease the yield. 
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Molecular weight: 418.58 
g/mol 
1H NMR (400 MHz, CDCl3) δ 8.20 (s, 1H, H1), 7.69 (d, J = 7.9 Hz, 1H, H5), 
7.35 – 7.31 (m, 1H, H8), 7.26 – 7.21 (m, 2H, H13), 7.20 – 7.15 (m, 1H, H7), 
7.12 – 7.06 (m, 2H, H2 + H6), 6.87 – 6.79 (m, 2H, H14), 6.70 (dt, J = 16.0, 
6.9 Hz, 1H, H19), 6.01 (dt, J = 16.0, 1.4 Hz, 1H, H20), 3.78 (s, 3H, H16), 3.75 
(s, 2H, H10), 3.54 (s, 2H, H11), 2.60 (t, J = 6.9 Hz, 2H, H17), 2.45 – 2.36 (m, 
4H, H18 + H22), 1.57 (dt, J = 14.8, 7.5 Hz, 2H, H23), 1.36 – 1.23 (m, 4H, H24 
+ H25), 0.89 (t, J = 7.0 Hz, 3H, H26). 
 
13C NMR (100 MHz, CDCl3) δ 201.15 (C21), 158.44 (C15), 146.40 (C19), 
136.55 (C9), 131.68 (C12), 130.96 (C20), 129.96 (C13), 127.58 (C4), 123.64 
(C2), 121.67 (C7), 119.64 (C5), 119.01 (C6), 113.46 (C14), 112.99 (C3), 
111.14 (C8), 57.61 (C11), 55.03 (C16), 51.46 (C17), 49.48 (C10), 39.39 
(C22), 31.39 (C24), 30.24 (C18), 23.88 (C23), 22.42 (C25), 13.90 (C26). 
 
IR (film, cm-1): 3356 (N-H stretching), 2953 (C-H stretching), 2929 (C-H 
stretching), 1662 (C=O stretching from an acyclic α, β unsaturated ketone+ 
C=C stretching of unsaturation), 1611 (C=C aromatic stretching), 1509 (C=C 
aromatic stretching), 1455 (CH2 scissoring), 1244 (C-N stretching), 1032 (C-
O stretching), 816 (C-H bending out of plan of para disubstituted aromatic 
ring), 738 (C-H bending out of plan of ortho disubstituted aromatic ring). 
 
HRMS m/z calculated for C27H35N2O2 [M+H]+: 419.2698. Found: 419.2692 
HRMS m/z calculated for C27H34N2O223Na1 [M+Na]+: 441.2517. Found: 
441.2513. 
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(4aR,7R,7aS,12bS)-7-butyl-2-(4-methoxybenzyl)-1,2,3,4,4a,5,7a,8-
octahydropyrido[4,3-d]carbazol-6(7H)-one 
Figure 55 tetra 6,6 
 
To a solution of (E)-1-(((1H-indol-3-yl)methyl)(4-methoxy-benzyl) 
amino)dec-3-en-5-one (6.3 g, 15 mmol, 1 eq.) in tetrahydrofuran (34 ml) was 
added solid potassium tert-butoxide (0.34 g, 3 mmol, 0.2 eq.) and the 
solution was stirred at 0°C for 5 minutes. The mixture was purred on a 5M 
aqueous solution of ammonium chloride and diethyl ether and vigorously 
shaken then extracted two times with diethyl ether. The ether phases were 
combined and dried over sodium sulfate. The volatiles were removed in 
vacuo to afford a yellow-brown solid. This solid was purified11 by column 
chromatography using flash silica gel, petroleum ether and ethyl acetate to 
afford a white powder; 3.75 g (60%). 
 
 
CAS: / 
Formula: 
C27H34N2O2 
Molecular 
weight: 418.58 
g/mol 
MP: 137-138°C          Litt12: 89°C 
 
                                                          
11  The product can be recrystallised from hot methanol, or from isopropanol 
evaporation, from recrystallisation using ethyl acetate and methanol and finally, 
from recrystallisation using ethyl acetate and hexane.  
12 Turet, L. PhD Thesis 2004, Université catholique de Louvain. 
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1H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 7.0 Hz, 1H, H23), 7.19 (d, J = 8.6 Hz, 
2H, H4), 7.03 (td, J = 7.7, 1.2 Hz, 1H, H21), 6.85 – 6.78 (m, 2H, H3), 6.70 (td, 
J = 7.5, 1.0 Hz, 1H, H22), 6.47 (d, J = 7.8 Hz, 1H, H20), 3.81 (bs, 1H, H18), 
3.80 (d, J = 3.2 Hz, 1H, H17), 3.78 (s, 3H, H1), 3.50 (d, J = 13.1 Hz, 1H, H6), 
3.41 (d, J = 13.1 Hz, 1H, H6’), 3.10 (dt, J = 11.0, 1.6 Hz, 1H, H7), 3.05 (d, J = 
10.4 Hz, 1H, H26), 2.70 – 2.63 (m, 1H, H12), 2.29 – 2.07 (m, 4H, H7’ + H9 + 
H10 + H26’), 2.07 – 1.95 (m, 1H, H8’), 1.95 – 1.81 (m, 2H, H10’ + H13), 1.54 
– 1.46 (m, 1H, H8), 1.44 – 1.23 (m, 5H, H13’ + H14 + H15), 0.93 (t, J = 7.0 
Hz, 3H, H16). 
 
13C NMR (100 MHz, CDCl3) δ 212.00 (C11), 158.55 (C2), 150.44 (C19), 
130.73 (C5), 130.36 (C24), 129.90 (C4), 129.25 (C23), 128.25 (C21), 117.55 
(C22), 113.55 (C3), 108.49 (C20), 65.38 (C26), 64.68 (C17), 62.32 (C6), 
55.17 (C1), 53.28 (C7), 49.94 (C12), 49.29 (C25), 42.45 (C10), 38.73 (C9), 
29.53 (C14), 26.57 (C8), 25.08 (C13), 22.95 (C15), 14.08 (C16). 
 
IR (cm-1): 3381 (N-H stretching), 2931 (C-H stretching), 2868 (C-H 
stretching), 1712 (C=O stretching from a 6 membered ring saturated 
ketone), 1606 (C=C aromatic stretching), 1510 (C=C aromatic stretching), 
1483 (C=C aromatic stretching), 1463 (CH2 scissoring), 1244 (C-N 
stretching), 1172 (C-O stretching), 1030 (C-O stretching), 829 (C-H bending 
out of plan of para disubstituted aromatic ring), 734 (C-H bending out of 
plan of ortho disubstituted aromatic ring). 
 
HRMS m/z calculated for C27H35N2O2 [M+H]+: 419.2698. Found: 419.2691 
HRMS m/z calculated for C27H34N2O223Na1 [M+Na]+: 441.2517. Found: 
441.2498. 
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Final report; processing .tmp file: 
   94 unique conformations found so far 
   94 minimized with good convergence 
Found    17 confs within  1.00 kcal/mol ( 4.18 kJ/mol) of glob. min. 
Found    44 confs within  2.00 kcal/mol ( 8.37 kJ/mol) of glob. min. 
Found    60 confs within  3.00 kcal/mol (12.55 kJ/mol) of glob. min. 
Found    94 confs within  5.00 kcal/mol (20.92 kJ/mol) of glob. min. 
Global minimum E =    358.65 found     9 times. 
 1000 steps performed so far, out of  1000 
 E of low-energy structures above global min [kJ/mol],  and no. times 
found: 
    E:  0.00  0.43  0.59  1.11  1.21  1.80  2.61  2.86  2.90  3.25  3.30  3.45 
  No.:     9    11    13    21    18     7    12    10    10    13    11    11 
  
Input structure with title on the next line is given SerNo:        1 
O=C1[C@@H](CCCC)[C@@H]([C@@]23C(CN(CC4=CC=C(OC)C=C4)C3)=C
1)NC5=C2C=CC=C5 
Auto summary for input structure      1: 
 Total number of structures processed =        1000 
 Conformations with poor convergence marked with a * 
 Conformation       1 ( 358.6519     kJ/mol) was found     9 times 
 Conformation       2 ( 359.0804     kJ/mol) was found    11 times 
 Conformation       3 ( 359.2433     kJ/mol) was found    13 times 
 Conformation       4 ( 359.7627     kJ/mol) was found    21 times 
 Conformation       5 ( 359.8592     kJ/mol) was found    18 times 
 Conformation       6 ( 360.4518     kJ/mol) was found     7 times 
 Conformation       7 ( 361.2623     kJ/mol) was found    12 times 
 Conformation       8 ( 361.5161     kJ/mol) was found    10 times 
 Conformation       9 ( 361.5558     kJ/mol) was found    10 times 
 Conformation      10 ( 361.8976     kJ/mol) was found    13 times 
 Conformation      11 ( 361.9515     kJ/mol) was found    11 times 
 Conformation      12 ( 362.0987     kJ/mol) was found    11 times 
 Conformation      13 ( 362.1584     kJ/mol) was found    16 times 
 Conformation      14 ( 362.3195     kJ/mol) was found     9 times 
 Conformation      15 ( 362.4659     kJ/mol) was found     9 times 
 
 
Chapter X 
 
315 
 
(E)-1-((2-(1H-indol-3-yl)ethyl)(4-methoxybenzyl)amino)dec-3-en-5-one 
Figure 56 enone 7,6 
 
Solution A: to a solution of 2-(1H-indol-3-yl)-N-(4-
methoxybenzyl)ethan-1-amine (4 g, 14.3 mmol, 1 eq.) and 1,8-Diazabicyclo 
(5.4.0) undec-7-ene (0.1 g, 0.75 mmol, 0.05 eq., 0.11 ml) in tetrahydrofuran 
(40 ml) at 0°C was added acrolein (0.8 g, 14.3 mmol, 1 eq., 1 ml) dropwise on 
1 minute, then the mixture was stirred at 0°C for 30 minutes.  
Solution B: to a solution of dimethyl (2-oxoheptyl)phosphonate (3.17 g, 14.2 
mmol, 1 eq., 3 ml) in tetrahydrofuran (160 ml) was added solid potassium 
tert-butoxide (1.6 g, 14.2 mmol, 1 eq.) at room temperature, then the 
mixture was stirred for 20 minutes13 at room temperature.  
Solution A was added to Solution B at room temperature then the resulting 
mixture was stirred for 1 hour at room temperature. A saturated aqueous 
solution of sodium chloride was added, and the mixture was extracted two 
times with diethyl ether. The ether phases were combined and dried over 
sodium sulfate, then the volatiles were removed in vacuo to afford the 
desired product as a pale-yellow oil; 5.55 g (90%). 
CAS: / 
Formula: C28H36N2O2 
                                                          
13  Tip: more time than 20-30 minutes will turn the mixture in a dense solid 
suspension. And will decrease the yield. 
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Molecular weight: 432.60 
g/mol 
1H NMR (400 MHz, CDCl3) δ 8.12 (s, 1H, H1), 7.49 (d, J = 8.0 Hz, 1H, H5), 
7.32 (dt, J = 8.1, 0.8 Hz, 1H, H8), 7.25 – 7.20 (m, 2H, H14), 7.18 – 7.13 (m, 
1H, H7), 7.07 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H, H6), 6.96 (d, J = 2.3 Hz, 1H, H2), 
6.86 – 6.80 (m, 2H, H15), 6.75 (dt, J = 16.0, 7.0 Hz, 1H, H20), 6.03 (dt, J = 
15.9, 1.4 Hz, 1H, H21), 3.79 (s, 3H, H17), 3.63 (s, 2H, H12), 2.97 – 2.88 (m, 
2H, H10), 2.84 – 2.77 (m, 2H, H11), 2.66 (t, J = 7.1 Hz, 2H, H18), 2.50 – 2.43 
(m, 2H, H23), 2.36 (qd, J = 7.1, 1.1 Hz, 2H, H19), 1.65 – 1.54 (m, 2H, H24), 
1.39 – 1.24 (m, 4H, H25 + H26), 0.89 (t, J = 7.0 Hz, 3H, H27). 
 
13C NMR (100 MHz, CDCl3) δ 201.05 (C22), 158.54 (C16), 145.91 (C20), 
136.27 (C9), 131.45 (C13), 131.00 (C21), 129.90 (C14), 127.44 (C4), 121.76 
(C2), 121.59 (C7), 118.86 (C6), 118.58 (C5), 113.94 (C3), 113.54 (C15), 
111.21 (C8), 57.75 (C12), 55.11 (C17), 54.13 (C11), 52.03 (C18), 39.73 
(C23), 31.43 (C25), 30.31 (C19), 23.95 (C24), 23.03 (C10), 22.44 (C26), 
13.93 (C27). 
 
IR (film, cm-1): 3408 (N-H stretching), 2952 (C-H stretching), 2929 (C-H 
stretching), 1663 (C=O stretching from an acyclic α, β unsaturated ketone+ 
C=C stretching of unsaturation), 1611 (C=C aromatic stretching), 1509 (C=C 
aromatic stretching), 1456 (CH2 scissoring), 1242 (C-N stretching), 1032 (C-
O stretching), 817 (C-H bending out of plan of para disubstituted aromatic 
ring), 737 (C-H bending out of plan of ortho disubstituted aromatic ring). 
 
HRMS m/z calculated for C28H37N2O2 [M+H]+: 433.2855. Found: 433.2849. 
HRMS m/z calculated for C28H36N2O223Na1 [M+Na]+: 455.2674. Found: 
455.2677. 
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1-(((1H-indol-3-yl)methyl)(4-methoxybenzyl)amino)nonan-4-one 
Figure 57: 5,6 sat 
 
Lindlar catalyst (Palladium 5% on calcium carbonate poisoned with 
Lead) (50 mg) was suspended in toluene (5 ml) at room temperature, 
quinoline (48 mg, 0.37 mmol, 0.3 eq., 0.044 ml) was added and the mixture 
was stirred for 30 minutes at room temperature. Then 1-(((1H-indol-3-
yl)methyl)(4-methoxybenzyl)amino)non-2-yn-4-one (0.5 g, 1.2 mmol, 1 eq.) 
in toluene (5 ml) was added and the mixture was flushed with hydrogen 
during 30 minutes at room temperature and stirred for 18 hours under 
hydrogen pressure. The volatiles were removed, and the brown oil was 
purified by column chromatography using flash silica gel, petroleum ether 
and diethyl ether to afford the desired product as a pale-yellow oil; 0.45 g 
(90%). 
 
CAS: / 
Formula: C26H34N2O2 
Molecular weight: 406.57 
g/mol 
1H NMR (400 MHz, CDCl3) δ 8.00 (s, 1H, H1), 7.67 (dd, J = 7.9, 0.5 Hz, 1H, 
H5), 7.36 – 7.32 (m, 1H, H8), 7.24 (d, J = 9.0 Hz, 2H, H13), 7.18 (ddd, J = 8.2, 
7.2, 1.2 Hz, 1H, H7), 7.13 – 7.07 (m, 2H, H2 + H6), 6.87 – 6.81 (m, 2H, H14), 
3.79 (s, 3H, H16), 3.71 (s, 2H, H10), 3.51 (s, 2H, H11), 2.41 (t, J = 6.8 Hz, 2H, 
H17), 2.33 (t, J = 7.2 Hz, 2H, H19), 2.20 – 2.12 (m, 2H, H21), 1.76 (p, J = 7.0 
Hz, 2H, H18), 1.44 (dt, J = 15.0, 7.4 Hz, 2H, H22), 1.35 – 1.13 (m, 4H, H23 + 
H24), 0.88 (t, J = 7.2 Hz, 3H, H25). 
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13C NMR (100 MHz, CDCl3) δ 211.82 (C20), 158.59 (C15), 136.58 (C9), 
132.21 (C12), 130.23 (C13), 127.90 (C4), 123.58 (C2), 122.04 (C7), 119.98 
(C5), 119.39 (C6), 114.01 (C3), 113.61 (C14), 111.11 (C8), 57.98 (C11), 
55.35 (C16), 52.34 (C17), 49.52 (C10), 42.83 (C21), 40.35 (C19), 31.52 
(C23), 23.60 (C22), 22.59 (C24), 21.30 (C18), 14.07 (C25). 
 
IR (film, cm-1): 3411 (N-H stretching), 3056 (C-H stretching), 2997 (C-H 
stretching), 2952 (C-H stretching), 2929 (C-H stretching), 2869 (C-H 
stretching), 2833 (C-H stretching), 2802 (C-H stretching), 1702 (C=O 
stretching of saturated acyclic ketone), 1611 (C=C aromatic stretching), 
1584 (C=C aromatic stretching), 1509 (C=C aromatic stretching), 1455 (CH2 
scissoring), 1241 (C-N stretching), 1033 (C-O stretching), 811 (C-H bending 
out of plan of para disubstituted aromatic ring), 738 (C-H bending out of 
plan of ortho disubstituted aromatic ring). 
 
HRMS m/z calculated for C26H35N2O2 [M+H]+: 407.2698. Found: 407.2693. 
HRMS m/z calculated for C26H34N2O223Na1 [M+Na]+: 429.2517. Found: 
429.2501. 
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(Z)-1-(((1H-indol-3-yl)methyl)(4-methoxybenzyl)amino)non-2-en-4-one 
Figure 58: 5,6 Z enone 
 
Lindlar catalyst (Palladium 5% on calcium carbonate poisoned with 
Lead) (0.08 g, 0.015 eq.) was suspended in benzene (15 ml) at room 
temperature, quinoline (160 mg, 1.24 mmol, 0.5 eq., 0.15 ml) was added and 
the mixture was stirred for 40 minutes at room temperature. Then 1-(((1H-
indol-3-yl)methyl)(4-methoxybenzyl)amino)non-2-yn-4-one (1 g, 2.48 mmol, 
1 eq.) in benzene (10 ml) was added and the mixture was flushed with 
hydrogen during 30 minutes at room temperature and stirred for another 30 
minutes under hydrogen pressure. The mixture was filtered through a pad of 
celite and eluate with diethyl ether, then the volatiles were removed to 
afford a pale-yellow oil. The yellow oil was used as such.14 
 
CAS: / 
Formula: C26H32N2O2 
Molecular weight: 404.55 
g/mol 
1H NMR (400 MHz, CDCl3) δ 8.10 (s, 1H, H1), 7.73 (d, J = 6.9 Hz, 1H, H5), 
7.33 (d, J = 8.1 Hz, 1H, H8), 7.28 – 7.24 (m, 2H, H13), 7.21 – 7.14 (m, 1H, 
H7), 7.13 – 7.07 (m, 2H, H2 + H6), 6.86 – 6.80 (m, 2H, H14), 6.28 (dt, J = 
11.4, 5.6 Hz, 1H, H18), 6.11 (dt, J = 11.6, 2.2 Hz, 1H, H19), 3.78 (s, 3H, H16), 
3.73 (s, 2H, H10), 3.63 (dd, J = 5.6, 2.2 Hz, 2H, H17), 3.53 (s, 2H, H11), 2.42 
                                                          
14  Approximately 10% of the final weight is constituted of quinoline. And since 
purification by flash silica gel messed the product the following steps were made 
with a part of quinoline. 
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– 2.35 (m, 2H, H21), 1.55 (dt, J = 14.8, 7.4 Hz, 2H, H22), 1.39 – 1.20 (m, 4H, 
H23 + H24), 0.88 (t, J = 7.0 Hz, 3H, H25). 
 
13C NMR (100 MHz, CDCl3) δ 201.97 (C20), 158.66 (C15), 148.98 (C18), 
136.62 (C9), 131.78 (C12), 130.26 (C13), 127.83 (C4), 126.68 (C19), 123.75 
(C2), 122.00 (C7), 119.97 (C5), 119.36 (C6), 113.86 (C3), 113.65 (C14), 
111.13 (C8), 58.52 (C11), 55.33 (C16), 53.30 (C17), 50.29 (C10), 44.08 
(C21), 31.48 (C23), 23.78 (C22), 22.58 (C24), 14.03 (C25). 
 
IR (film, cm-1): 3342 (N-H stretching), 3057 (C-H stretching), 2954 (C-H 
stretching), 2929 (C-H stretching), 2870 (C-H stretching), 2834 (C-H 
stretching), 1671 (C=O stretching of acyclic unsaturated ketone), 1611 
(C=C aromatic stretching), 1584 (C=C aromatic stretching), 1557 (C=C 
aromatic stretching), 1509 (C=C aromatic stretching), 1455 (CH2 
scissoring), 1244 (C-N stretching), 1100 (C-O stretching), 1034 (C-O 
stretching), 806 (C-H bending out of plan of para di-substituted aromatic 
ring), 739 (C-H bending out of plan of ortho di-substituted aromatic ring). 
 
HRMS m/z calculated for C26H33N2O2 [M+H]+: 405.2542. Found: 405.2536. 
HRMS m/z calculated for C26H32N2O223Na1 [M+Na]+: 427.2361. Found: 
427.2355. 
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1-((2-(1H-indol-3-yl)ethyl)(4-methoxybenzyl)amino)nonan-4-one 
Figure 59 6'6 sat 
 
Lindlar catalyst (Palladium 5% on calcium carbonate poisoned with 
Lead) (50 mg) was suspended in toluene (5 ml) at room temperature, then 1-
((2-(1H-indol-3-yl)ethyl)(4-methoxybenzyl)amino)non-2-yn-4-one (0.5 g, 1.2 
mmol, 1 eq.) in toluene (5 ml) was added and the mixture was flushed with 
hydrogen during 30 minutes at room temperature and stirred for 12 hours 
under hydrogen pressure. The volatiles were removed, and the brown oil was 
purified by column chromatography using flash silica gel, petroleum ether 
and diethyl ether to afford the desired product as a pale-yellow oil; 0.4 g 
(80%). 
 
CAS: / 
Formula: C27H36N2O2 
Molecular weight: 420.59 
g/mol 
1H NMR (400 MHz, CDCl3) δ 7.91 (s, 1H, H1), 7.49 (d, J = 7.5 Hz, 1H, H5), 
7.33 (d, J = 8.1 Hz, 1H, H8), 7.25 – 7.20 (m, 2H, H14), 7.20 – 7.12 (m, 1H, 
H7), 7.07 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H, H6), 6.96 (d, J = 2.3 Hz, 1H, H2), 6.87 
– 6.81 (m, 2H, H15), 3.80 (s, 3H, H17), 3.60 (s, 2H, H12), 2.93 – 2.87 (m, 2H, 
H10), 2.79 – 2.73 (m, 2H, H11), 2.49 (t, J = 6.9 Hz, 2H, H18), 2.36 (t, J = 7.3 
Hz, 2H, H20), 2.33 – 2.26 (m, 2H, H22), 1.74 (p, J = 7.1 Hz, 2H, H19), 1.52 
(dt, J = 14.9, 7.5 Hz, 2H, H23), 1.36 – 1.17 (m, 4H, H24 + H25), 0.88 (t, J = 
7.1 Hz, 3H, H26). 
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13C NMR (100 MHz, CDCl3) δ 211.73 (C21), 158.61 (C16), 136.32 (C9), 
131.92 (C13), 130.12 (C14), 127.67 (C4), 121.89 (C7), 121.62 (C2), 119.17 
(C6), 118.93 (C5), 114.68 (C3), 113.63 (C15), 111.16 (C8), 57.96 (C12), 
55.33 (C17), 54.17 (C11), 52.86 (C18), 42.91 (C22), 40.41 (C20), 31.53 
(C24), 23.65 (C23), 23.08 (C10), 22.57 (C25), 21.40 (C19), 14.05 (C26). 
 
IR (film, cm-1): 3410 (N-H stretching), 3056 (C-H stretching), 2996 (C-H 
stretching), 2952 (C-H stretching), 2929 (C-H stretching), 2857 (C-H 
stretching), 2807 (C-H stretching), 1703 (C=O stretching of saturated 
acyclic ketone), 1611 (C=C aromatic stretching), 1509 (C=C aromatic 
stretching), 1456 (CH2 scissoring), 1243 (C-N stretching), 1033 (C-O 
stretching), 816 (C-H bending out of plan of para disubstituted aromatic 
ring), 738 (C-H bending out of plan of ortho disubstituted aromatic ring). 
 
HRMS m/z calculated for C27H37N2O2 [M+H]+: 421.2855. Found: 421.2852. 
HRMS m/z calculated for C27H36N2O223Na1 [M+Na]+: 443.2674. Found: 
443.2659. 
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(Z)-1-((2-(1H-indol-3-yl)ethyl)(4-methoxybenzyl)amino)non-2-en-4-one 
Figure 60 6'6 Z enone 
 
Lindlar catalyst (Palladium 5% on calcium carbonate poisoned with 
Lead) (91 mg, 0.015 eq.) was suspended in benzene (20 ml) at room 
temperature, quinoline (186 mg, 1.44 mmol, 0.5 eq., 0.17 ml) was added and 
the mixture was stirred for 50 minutes at room temperature. Then 1-((2-(1H-
indol-3-yl)ethyl)(4-methoxybenzyl)amino)non-2-yn-4-one (1.2 g, 2.88 mmol, 
1 eq.) in benzene (12 ml) was added and the mixture was flushed with 
hydrogen during 30 minutes at room temperature and stirred for an 
additional 30 minutes under hydrogen pressure. The mixture was filtered 
through a pad of celite and elute with diethyl ether, then the volatiles were 
removed to afford a pale-yellow oil. The yellow oil was used as such. 15 
 
CAS: / 
Formula: C27H34N2O2 
Molecular weight: 418.58 
g/mol 
1H NMR (400 MHz, CDCl3) δ 7.98 (s, 1H, H1), 7.48 (d, J = 7.3 Hz, 1H, H5), 
7.32 (d, J = 8.1 Hz, 1H, H8), 7.24 (d, J = 8.2 Hz, 2H, H14), 7.21 – 7.11 (m, 1H, 
H7), 7.11 – 7.02 (m, 1H, H6), 6.96 (d, J = 2.2 Hz, 1H, H2), 6.86 – 6.80 (m, 
2H, H15), 6.27 (dt, J = 11.6, 5.5 Hz, 1H, H19), 6.18 (dt, J = 11.6, 2.0 Hz, 1H, 
H20), 3.79 (s, 3H, H17), 3.74 (dd, J = 5.3, 2.0 Hz, 2H, H18), 3.63 (s, 2H, H12), 
                                                          
15  Approximately 10% of the final weight is constituted of quinoline. And since 
purification by flash silica gel messed the product the following steps were made 
with a part of quinoline. 
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3.01 – 2.87 (m, 2H, H10), 2.83 – 2.74 (m, 2H, H11), 2.43 (t, J = 7.4 Hz, 2H, 
H22), 1.64 – 1.48 (m, 2H, H23), 1.37 – 1.18 (m, 4H, H24 + H25), 0.88 (t, J = 
7.0 Hz, 3H, H26). 
 
13C NMR (100 MHz, CDCl3) δ 201.94 (C21), 158.69 (C16), 148.32 (C19), 
136.33 (C9), 131.36 (C13), 130.18 (C14), 127.62 (C4), 127.01 (C20), 121.80 
(C7), 121.68 (C2), 119.07 (C6), 118.89 (C5), 114.38 (C3), 113.67 (C15), 
111.17 (C8), 58.45 (C12), 55.29 (C17), 54.89 (C11), 53.32 (C18), 44.10 
(C22), 31.45 (C24), 23.75 (C23), 23.16 (C10), 22.55 (C25), 14.00 (C26). 
 
IR (film, cm-1): 3306 (N-H stretching), 3056 (C-H stretching), 2953 (C-H 
stretching), 2929 (C-H stretching), 2857 (C-H stretching), 1670 (C=O 
stretching of acyclic unsaturated ketone), 1611 (C=C aromatic stretching), 
1585 (C=C aromatic stretching), 1510 (C=C aromatic stretching), 1456 (CH2 
scissoring), 1245 (C-N stretching), 1101 (C-O stretching), 1033 (C-O 
stretching), 806 (C-H bending out of plan of para di-substituted aromatic 
ring), 736 (C-H bending out of plan of ortho di-substituted aromatic ring). 
 
HRMS m/z calculated for C27H35N2O2 [M+H]+: 419.2698. Found: 419.2694. 
HRMS m/z calculated for C27H34N2O223Na1 [M+Na]+: 441.2517. Found: 
441.2516. 
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1-((3S,3'S)-1'-(4-methoxybenzyl)spiro[indole-3,4'-piperidin]-3'-yl)heptan-
2-one 
Figure 61 spiro indolenine 
 
Crude (Z)-1-((2-(1H-indol-3-yl)ethyl)(4-methoxybenzyl)amino)non-2-
en-4-one (containing quinoline) (0.5 g, 1.2 mmol, 1 eq.) was solubilised in 
tetrahydrofuran (10 ml) at 0°C then solid potassium tert-butoxide (27 mg, 
0.23 mmol, 0.2 eq.) was added and the mixture was stirred at 0°C for 5 
minutes. The mixture was purred on diethyl ether and a saturated aqueous 
solution of ammonium chloride then extracted twice with diethyl ether, the 
organic phases were combined and dried over sodium sulfate. The volatiles 
were removed in vacuo to afford an orange oil. This residue was purified by 
column chromatography using flash silica gel, hexane and ethyl acetate to 
afford the desired product as pale-yellow oil; 0.12 g (25%). 
 
CAS: / 
Formula: C27H34N2O2 
Molecular weight: 418.58 
g/mol 
1H NMR (400 MHz, CDCl3) δ 8.45 (s, 1H, H17), 7.63 (d, J = 7.6 Hz, 1H, H19), 
7.37 – 7.31 (m, 1H, H20), 7.30 – 7.23 (m, 4H, H3 + H21 + H22), 6.87 (t, J = 
8.6 Hz, 2H, H2), 3.80 (s, 3H, H1), 3.68 (d, J = 12.9 Hz, 1H, H6), 3.51 (d, J = 
13.0 Hz, 1H, H6’), 3.09 (dd, J = 11.5, 3.4 Hz, 1H, H7), 2.99 (d, J = 11.4 Hz, 
1H, H25), 2.93 (ddd, J = 12.6, 8.4, 4.4 Hz, 1H, H8), 2.39 – 2.30 (m, 1H, H25’), 
2.28 (dd, J = 12.9, 3.2 Hz, 1H, H24), 2.21 (t, J = 11.5 Hz, 1H, H7’), 2.01 – 1.93 
(m, 1H, H11), 1.90 (dd, J = 8.3, 6.6 Hz, 1H, H11), 1.83 (dd, J = 16.9, 8.9 Hz, 
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1H, H9), 1.46 (dd, J = 17.1, 3.6 Hz, 1H, H9’), 1.38 (d, J = 13.1 Hz, 1H, H24’), 
1.34 – 1.21 (m, 2H, H12), 1.21 – 1.11 (m, 2H, H14), 1.09 – 0.98 (m, 2H, 
H13), 0.80 (t, J = 7.3 Hz, 3H, H15). 
 
13C NMR (100 MHz, CDCl3) δ 209.11 (C10), 175.10 (C17), 158.83 (C2), 
154.93 (C18), 141.82 (C23), 130.27 (C4), 129.86 (C5), 128.33 (C20), 126.71 
(C21), 122.16 (C22), 121.15 (C19), 113.72 (C3), 62.47 (C6), 60.17 (C16), 
57.73 (C7), 55.25 (C1), 51.69 (C25), 43.02 (C11), 40.86 (C9), 37.06 (C8), 
33.13 (C24), 31.14 (C13), 23.22 (C12), 22.32 (C14), 13.86 (C15). 
 
IR (film, cm-1): 2952 (C-H stretching), 2931 (C-H stretching), 2870 (C-H 
stretching), 2834 (C-H stretching), 2802 (C-H stretching), 2763 (C-H 
stretching), 1712 (C=O stretching of acyclic saturated ketone), 1611 (C=C 
aromatic stretching), 1585 (C=C aromatic stretching), 1547 (C=C aromatic 
stretching), 1511 (C=C aromatic stretching), 1456 (CH2 scissoring), 1344 (C-
H bending in plan), 1246 (C-N stretching), 1104 (C-O stretching), 1035 (C-
O stretching), 823 (C-H bending out of plan of para di-substituted aromatic 
ring), 754 (C-H bending out of plan of ortho di-substituted aromatic ring). 
 
HRMS m/z calculated for C27H35N2O2 [M+H]+: 419.2698. Found: 419.2694. 
HRMS m/z calculated for C27H34N2O223Na1 [M+Na]+: 441.2517. Found: 
441.2506. 
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(4aS,7S,7aS,12bS)-7-butyl-3-(4-methoxybenzyl)-1,2,3,4,4a,5,7a,8-
octahydropyrido[3,4-d]carbazol-6(7H)-one 
Figure 62: tetra tryp 
Methode A: 
 
To a solution of 1-((3S,3'S)-1'-(4-methoxybenzyl)spiro[indole-3,4'-
piperidin]-3'-yl)heptan-2-one (0.1 g, 0.24 mmol, 1 eq.) in tetrahydrofuran (10 
ml) at 0°C was added solid potassium tert-butoxide (5.3 mg, 0.047 mmol, 0.2 
eq.) and the mixture was stirred at 0°C for 1 hour. The mixture was purred 
on diethyl ether and a saturated aqueous solution of ammonium chloride 
then extracted twice with diethyl ether, the organic phases were combined 
and dried over sodium sulfate. The volatiles were removed in vacuo to afford 
an orange oil. This residue was purified by column chromatography using 
flash silica gel, hexane and ethyl acetate to afford the desired product as 
pale-yellow oil; 0.08 g (80%). 
 
Methode B: 
 
Crude (Z)-1-((2-(1H-indol-3-yl)ethyl)(4-methoxybenzyl)amino)non-2-
en-4-one (containing quinoline) (0.5 g, 1.2 mmol, 1 eq.) was solubilised in 
tetrahydrofuran (10 ml) at 0°C then solid potassium tert-butoxide (27 mg, 
0.23 mmol, 0.2 eq.) was added and the mixture was stirred at 0°C for 5 
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minutes. The mixture was purred on diethyl ether and a saturated aqueous 
solution of ammonium chloride then extracted twice with diethyl ether, the 
organic phases were combined and dried over sodium sulfate. The volatiles 
were removed in vacuo to afford an orange oil. This residue was purified by 
column chromatography using flash silica gel, hexane and ethyl acetate to 
afford the desired product as pale-yellow oil; 0.27 g (55%). 
 
CAS: / 
Formula: C27H34N2O2 
Molecular weight: 418.58 
g/mol 
1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 7.0 Hz, 1H, H23), 7.27 (d, J = 8.7 
Hz, 2H, H4), 7.07 (td, J = 7.6, 1.2 Hz, 1H, H21), 6.91 – 6.86 (m, 2H, H4), 6.77 
(td, J = 7.5, 0.9 Hz, 1H, H22), 6.65 (d, J = 7.6 Hz, 1H, H20), 3.90 – 3.86 (m, 
2H, H17 + H18), 3.83 (s, 3H, H1), 3.60 (d, J = 13.0 Hz, 1H, H6), 3.51 (d, J = 
13.0 Hz, 1H, H6’), 3.06 – 2.94 (m, 1H, H9’), 2.91 – 2.76 (m, 2H, H26 + H26’), 
2.70 (td, J = 6.4, 4.0 Hz, 1H, H11), 2.55 (dd, J = 12.0, 3.4 Hz, 1H, H7), 2.35 
(dd, J = 12.0, 4.4 Hz, 1H, H7’), 2.33 – 2.24 (m, 1H, H25’), 2.17 (dd, J = 14.1, 
4.9 Hz, 1H, H9), 2.11 (dd, J = 10.4, 4.5 Hz, 1H, H8), 2.05 – 1.97 (m, 2H, H12 
+ H25), 1.46 – 1.25 (m, 5H, H12 + H13 + H14), 0.95 (t, J = 7.1 Hz, 3H, H15). 
 
13C NMR (100 MHz, CDCl3) δ 212.07 (C10), 158.66 (C2), 148.89 (C19), 
137.24 (C24), 130.58 (C5), 129.87 (C4), 127.70 (C21), 124.33 (C23), 118.62 
(C22), 113.60 (C3), 110.04 (C20), 72.62 (C17), 62.30 (C6), 55.18 (C1), 54.67 
(C7), 50.97 (C26), 48.30 (11), 44.64 (C16), 42.95 (C9), 40.20 (C8), 31.56 
(C25), 29.60 (C13), 25.68 (C12), 22.86 (C14), 14.01 (C15). 
 
IR (film, cm-1): 3358 (N-H stretching), 3035 (C-H stretching), 3002 (C-H 
stretching), 2953 (C-H stretching), 2931 (C-H stretching), 2870 (C-H 
stretching), 2814 (C-H stretching), 2769 (C-H stretching), 1711 (C=O 
stretching of cyclic 6-membered ring saturated ketone), 1609 (C=C 
aromatic stretching), 1510 (C=C aromatic stretching), 1502 (C=C aromatic 
Chapter X 
 
329 
 
stretching), 1464 (CH2 scissoring), 1243 (C-N stretching), 1178 (C-O 
stretching), 1035 (C-O stretching), 906, 805 (C-H bending out of plan of 
para di-substituted aromatic ring), 724 (C-H bending out of plan of ortho 
di-substituted aromatic ring). 
 
HRMS m/z calculated for C27H35N2O2 [M+H]+: 419.2698. Found: 419.2693. 
HRMS m/z calculated for C27H34N2O223Na1 [M+Na]+: 441.2517. Found: 
441.2513. 
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1-(((1H-indol-3-yl)methyl)(4-methoxybenzyl)amino)decan-5-one 
Figure 63 6,6 sat 
Methode A: 
 
Lindlar catalyst (Palladium 5% on calcium carbonate poisoned with 
Lead) (50 mg) was suspended in toluene (5 ml) at room temperature, then 1-
(((1H-indol-3-yl)methyl)(4-methoxybenzyl)amino)dec-3-yn-5-one (0.5 g, 1.2 
mmol, 1 eq.) in toluene (5 ml) was added and the mixture was flushed with 
hydrogen during 30 minutes at room temperature and stirred for 12 hours 
under hydrogen pressure. The mixture was filtered through a pad of celite 
and elute with diethyl ether, then the volatiles were removed to afford a 
pale-yellow oil. This oil was purified by column chromatography using flash 
silica gel, petroleum ether and ethyl acetate to afford the desired product as 
a pale-yellow oil; 0.4 g (80%). 
 
Methode B:  
 
Lindlar catalyst (Palladium 5% on calcium carbonate poisoned with 
Lead) (50 mg) was suspended in toluene (20 ml) at room temperature, then 
(E)-1-(((1H-indol-3-yl)methyl)(4-methoxybenzyl)amino)dec-3-en-5-one (2 g, 
4.7 mmol, 1 eq.) in toluene (20 ml) was added and the mixture was flushed 
with hydrogen during 30 minutes at room temperature and stirred for 18 
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hours under hydrogen pressure. The mixture was filtered through a pad of 
celite and elute with diethyl ether, then the volatiles were removed to afford 
a pale-yellow oil and this oil was purified by column chromatography using 
flash silica gel, petroleum ether and ethyl acetate to afford the desired 
product as a pale-yellow oil; 1.9 g (95%). 
 
CAS: / 
Formula: C27H36N2O2 
Molecular weight: 
420.59 g/mol 
1H NMR (400 MHz, CDCl3) δ 8.01 (s, 1H, H1), 7.70 (d, J = 7.9 Hz, 1H, H5), 
7.36 – 7.32 (m, 1H, H8), 7.26 – 7.22 (m, 2H, H13), 7.19 – 7.14 (m, 1H, H7), 
7.12 – 7.06 (m, 2H, H2 + H6), 6.86 – 6.81 (m, 2H, H14), 3.79 (s, 3H, H16), 
3.72 (s, 2H, H10), 3.50 (s, 2H, H11), 2.42 (t, J = 6.5 Hz, 2H, H17), 2.28 – 2.22 
(m, 2H, H22), 2.22 (t, J = 7.1 Hz, 2H, H20), 1.57 – 1.46 (m, 6H, H18 + H19 + 
H23), 1.34 – 1.17 (m, 4H, H24 + H25), 0.88 (t, J = 7.1 Hz, 3H, H26). 
 
13C NMR (100 MHz, CDCl3) δ 211.99 (C21), 158.52 (C15), 136.54 (C9), 
132.26 (C12), 130.17 (C13), 127.92 (C4), 123.51 (C2), 121.98 (C7), 119.91 
(C5), 119.36 (C6), 113.97 (C3), 113.58 (C14), 111.08 (C8), 57.85 (C11), 
55.33 (C16), 52.61 (C17), 49.47 (C10), 42.74 (C22), 42.38 (C20), 31.52 
(C24), 26.59 (C18), 23.60 (H23), 22.56 (C25), 21.56 (C19), 14.05 (C26). 
 
IR (film, cm-1): 3412 (N-H stretching), 3057 (C-H stretching), 2997 (C-H 
stretching), 2951 (C-H stretching), 2930 (C-H stretching), 2860 (C-H 
stretching), 2833 (C-H stretching), 2797 (C-H stretching), 1703 (C=O 
stretching of acyclic saturated ketone), 1611 (C=C aromatic stretching), 
1509 (C=C aromatic stretching), 1455 (CH2 scissoring), 1243 (C-N 
stretching), 1177 (C-O stretching), 1034 (C-O stretching), 817 (C-H bending 
out of plan of para di-substituted aromatic ring), 741 (C-H bending out of 
plan of ortho di-substituted aromatic ring). 
 
HRMS m/z calculated for C27H37N2O2 [M+H]+: 421.2855. Found: 421.2850. 
HRMS m/z calculated for C27H36N2O223Na1 [M+Na]+: 443.2674. Found: 
443.2665. 
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(Z)-1-(((1H-indol-3-yl)methyl)(4-methoxybenzyl)amino)dec-3-en-5-one 
Figure 64: 6,6 Z enone 
 
Lindlar catalyst (Palladium 5% on calcium carbonate poisoned with 
Lead) (76 mg, 0.015 eq.) was suspended in toluene (15 ml) at room 
temperature, quinoline (155 mg, 1.2 mmol, 0.5 eq., 0.14 ml) was added and 
the mixture was stirred for 50 minutes at room temperature. Then 1-(((1H-
indol-3-yl)methyl)(4-methoxybenzyl)amino)dec-3-yn-5-one (1 g, 2.4 mmol, 1 
eq.) in toluene (10 ml) was added and the mixture was flushed with hydrogen 
during 30 minutes at room temperature and stirred for an additional 30 
minutes under hydrogen pressure. The mixture was filtered through a pad of 
celite and eluate with diethyl ether, then the volatiles were removed to 
afford a pale-yellow oil. The yellow oil was used as such. 16 
 
CAS: / 
Formula: C27H34N2O2 
Molecular weight: 
418.58 g/mol 
1H NMR (400 MHz, CDCl3) δ 8.06 (s, 1H, H1), 7.70 (d, J = 7.1 Hz, 1H, H5), 
7.35 – 7.32 (m, 1H, H8), 7.25 – 7.22 (m, 2H, H13), 7.20 – 7.14 (m, 1H, H7), 
7.13 – 7.07 (m, 2H, H2 + H6), 6.87 – 6.79 (m, 2H, H14), 6.12 (dt, J = 11.4, 
1.5 Hz, 1H, H20), 6.04 (dt, J = 11.5, 6.7 Hz, 1H, H19), 3.78 (s, 3H, H16), 3.76 
(s, 2H, H10), 3.54 (s, 2H, H11), 2.89 (qd, J = 6.9, 1.5 Hz, 2H, H18), 2.56 (t, J 
                                                          
16  Approximately 10% of the final weight is constituted of quinoline. And since 
purification by flash silica gel messed the product the following steps were made 
with a part of quinoline. 
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= 6.9 Hz, 2H, H17), 2.43 – 2.37 (m, 2H, H22), 1.68 – 1.48 (m, 2H, H23), 1.35 
– 1.20 (m, 4H, H24 + H25), 0.87 (t, J = 7.0 Hz, 3H, H26). 
 
13C NMR (100 MHz, CDCl3) δ 202.18 (C21), 158.50 (C15), 147.51 (C19), 
136.60 (C9), 132.10 (C12), 130.17 (C13), 127.87 (C4), 126.87 (C20), 123.66 
(C2), 121.89 (C7), 120.03 (C5), 119.24 (C6), 113.67 (C3), 113.54 (C14), 
111.07 (C8), 57.40 (C11), 55.28 (C16), 52.05 (C17), 49.13 (C10), 44.31 
(C22), 31.49 (C24), 27.14 (C18), 23.80 (C23), 22.56 (C25), 14.02 (C26). 
 
IR (film, cm-1): 3351 (N-H stretching), 3057 (C-H stretching), 2953 (C-H 
stretching), 2929 (C-H stretching), 2859 (C-H stretching), 20833 (C-H 
stretching), 2807 (C-H stretching), 1685 (C=O stretching of unsaturated 
acyclic ketone), 1611 (C=C aromatic stretching), 1509 (C=C aromatic 
stretching), 1455 (CH2 scissoring), 1240 (C-N stretching), 1171 (C-O 
stretching), 1033 (C-O stretching), 806 (C-H bending out of plan of para 
disubstituted aromatic ring), 738 (C-H bending out of plan of ortho 
disubstituted aromatic ring). 
 
HRMS m/z calculated for C27H35N2O2 [M+H]+: 419.2698. Found: 419.2695. 
HRMS m/z calculated for C27H34N2O223Na1 [M+Na]+: 441.2517. Found: 
441.2508. 
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(3aS,6S,6aS,11bS)-6-butyl-2-(4-methoxybenzyl)-2,3,3a,4,6a,7-hexahydro-
1H-pyrrolo[3,4-d]carbazol-5(6H)-one 
Figure 65 satura keton 5,6 
 
To as solution of (6S,6aS,11bS)-6-butyl-2-(4-methoxybenzyl)-
2,3,6a,7-tetrahydro-1H-pyrrolo[3,4-d]carbazol-5(6H)-one (1 g, 2.48 mmol, 1 
eq.) in methanol (50 ml) was added Pd(OH)2 supported on carbon (0.1 g, 10% 
w.). The solvent and atmosphere were saturated with H2. After 12 hours, the 
mixture was filtered through a pad of celite and eluted with methanol then 
the volatiles were removed in vacuo. The resulting residue was purified by 
column chromatography using flash silica gel, pentane and diethyl ether to 
afford the desired product as pale-yellow oil; 0.7 g (70%).  
 
 
CAS: / 
Formula: C26H32N2O2 
Molecular weight: 
404.55 g/mol 
1H NMR (400 MHz, CDCl3) δ 7.23 – 7.19 (m, 2H, H4), 7.17 (dd, J = 7.4, 0.6 
Hz, 1H, H22), 7.07 (td, J = 7.6, 1.2 Hz, 1H, H20), 6.86 – 6.81 (m, 2H, H3), 
6.79 (td, J = 7.5, 1.0 Hz, 1H, H21), 6.65 (d, J = 7.7 Hz, 1H, H19), 3.96 (s, 1H, 
H17), 3.78 (s, 3H, H1), 3.75 (d, J = 8.8 Hz, 1H, H16), 3.62 (d, J = 12.8 Hz, 1H, 
H6), 3.54 (d, J = 12.8 Hz, 1H, H6’), 3.06 (d, J = 9.4 Hz, 1H, H25’), 2.92 (dd, J 
= 9.1, 7.6 Hz, 1H, H7), 2.85 – 2.76 (m, 1H, H8), 2.55 (dd, J = 15.0, 5.7 Hz, 
1H, H9’), 2.55 (d, J = 9.4 Hz, 2H, H7’+ H25), 2.45 (dd, J = 15.3, 8.9 Hz, 1H, 
H9), 2.28 (ddd, J = 8.8, 6.9, 4.1 Hz, 1H, H11), 1.72 (dddd, J = 14.0, 11.6, 6.8, 
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4.8 Hz, 1H, H12), 1.62 (ddd, J = 14.1, 9.9, 4.8 Hz, 1H, H12’), 1.37 – 1.26 (m, 
3H, H13 + H14), 1.25 – 1.13 (m, 1H, H13’), 0.90 (t, J = 7.1 Hz, 3H, H15). 
 
13C NMR (100 MHz, CDCl3) δ 211.84 (C10), 158.69 (C2), 148.63 (C18), 
135.32 (C23), 131.06 (C5), 129.72 (C4), 128.22 (C20), 123.21 (C22), 119.40 
(C21), 113.71 (C3), 109.98 (C19), 68.42 (C16), 66.27 (C25), 59.62 (C7), 
59.02 (C6), 55.30 (C1), 53.99 (C24), 51.12 (C11), 43.16 (C9), 41.90 (C8), 
29.23 (C13), 26.92 (C12), 23.12 (C14), 14.06 (C15). 
 
IR (film, cm-1): 3367 (N-H stretching), 2954 (C-H stretching), 2929 (C-H 
stretching), 1705 (C=O stretching from a 6 membered ring saturated 
ketone), 1608 (C=C aromatic stretching), 1510 (C=C aromatic stretching), 
1463 (CH2 scissoring), 1243 (C-N stretching), 1172 (C-O stretching), 1034 
(C-O stretching), 819 (C-H bending out of plan of para disubstituted 
aromatic ring), 725 (C-H bending out of plan of ortho disubstituted 
aromatic ring). 
 
HRMS m/z calculated for C26H33N2O2 [M+H]+: 405.2542. Found: 405.2535 
HRMS m/z calculated for C26H32N2O223Na1 [M+Na]+: 427.2361. Found: 
427.2350. 
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(5R,6S,6aS,11bS)-6-butyl-2-(4-methoxybenzyl)-2,3,5,6,6a,7-hexahydro-
1H-pyrrolo[3,4-d]carbazol-5-ol 
Figure 66 alcohol beta 5,6 
 
To a solution of (6S,6aS,11bS)-6-butyl-2-(4-methoxybenzyl)-2,3,6a,7-
tetrahydro-1H-pyrrolo[3,4-d]carbazol-5(6H)-one (2.3 g, 5.7 mmol, 1 eq.) in 
dichloromethane (60 ml) at -78°C was added dropwise a 1 Molar solution of 
DiBAL-H in toluene (14.2 mol, 2.5 eq., 14 ml) on 2 minutes. After 15 minutes 
at -78°C, the reaction was quenched with a saturated aqueous solution of 
potassium sodium tartrate and allowed to reach room temperature and 
stirred for 2 additional hours. The mixture was extracted two time with 
dichloromethane, the organic phases were combined and dried over sodium 
sulfate. The volatiles were removed in vacuo to afford a yellow oil. The 
resulting residue was purified by column chromatography17 using flash silica 
gel, pentane and diethyl ether to afford the desired product as an off-white 
solid; 1.7 g (75%). 
 
 
CAS: / 
Formula: 
C26H32N2O2 
Molecular 
weight: 404.55 
g/mol 
MP: 47-48°C 
 
                                                          
17 Tip: the Δ RF is sufficient to separate both alcohols from each other. 
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1H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 7.5 Hz, 1H, H23), 7.29 (d, J = 8.5 Hz, 
2H, H4), 7.06 (td, J = 7.6, 1.0 Hz, 1H, H21), 6.86 (d, J = 8.6 Hz, 2H, H3), 6.84 
– 6.76 (m, 1H, H22), 6.62 (d, J = 7.7 Hz, 1H, H20), 5.78 (d, J = 5.9 Hz, 1H, 
H9), 4.21 – 4.08 (m, 1H, H10), 3.92 (dd, J = 14.0, 1.4 Hz, 1H, H7), 3.86 – 3.76 
(m, 2H, H6 + H17), 3.80 (s, 3H, H1), 3.66 (d, J = 13.0 Hz, 1H, H6’), 3.11 (d, J 
= 7.6 Hz, 1H, H26), 3.10 (d, J = 15.2 Hz, 1H, H7’), 2.49 (d, J = 8.0 Hz, 1H, 
H26’), 2.08 – 2.00 (m, 1H, H12), 1.39 – 1.29 (m, 5H, H13 + H14 + H15), 1.29 
– 1.18 (m, 1H, H13’), 0.91 (t, J = 6.9 Hz, 3H, H16). 
 
13C NMR (100MHz, CDCl3) δ 158.58 (C2), 147.46 (C19), 143.08 (C8), 135.12 
(C24), 131.31 (C5), 129.52 (C4), 127.99 (C21), 125.22 (C23), 120.43 (C9), 
119.91 (C22), 113.70 (C3), 110.05 (C20), 68.60 (C10), 65.48 (C26), 63.70 
(C17), 59.49 (C6), 55.44 (C7), 55.22 (C1), 53.55 (C25), 44.26 (C12), 30.25 
(C13), 29.40 (C14), 22.96 (C15), 14.07 (C16). 
 
IR (film, cm-1): 3336 (O-H stretching + N-H stretching), 2953 (C-H 
stretching), 2927 (C-H stretching), 1607 (C=C aromatic stretching), 1510 
(C=C aromatic stretching), 1462 (CH2 scissoring), 1242 (C-N stretching), 
1022 (C-O stretching), 908, 817 (C-H bending out of plan of para 
disubstituted aromatic ring, 730 (C-H bending out of plan of ortho 
disubstituted aromatic ring). 
 
HRMS m/z calculated for C26H33N2O2 [M+H]+: 405.2542. Found: 405.2533. 
HRMS m/z calculated for C26H32N2O223Na1 [M+Na]+: 427.2361. Found: 
427.2357. 
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Final report; processing .tmp file: 
  241 unique conformations found so far 
  241 minimized with good convergence 
Found    11 confs within  1.00 kcal/mol ( 4.18 kJ/mol) of glob. min. 
Found    40 confs within  2.00 kcal/mol ( 8.37 kJ/mol) of glob. min. 
Found    77 confs within  3.00 kcal/mol (12.55 kJ/mol) of glob. min. 
Found   240 confs within  5.00 kcal/mol (20.92 kJ/mol) of glob. min. 
Found   241 confs within 10.00 kcal/mol (41.84 kJ/mol) of glob. min. 
Global minimum E =    384.05 found     8 times. 
 1000 steps performed so far, out of  1000 
 E of low-energy structures above global min [kJ/mol],  and no. times 
found: 
    E:  0.00  1.70  1.88  2.90  3.13  3.31  3.61  3.63  3.87  4.08  4.14  4.48 
  No.:     8     4     7     7     5     6     4     5     1     2     4     6 
  
Input structure with title on the next line is given SerNo:        1 
O=C1[C@@H](CCCC)[C@@H]([C@@]23C(CN(CC4=CC=C(OC)C=C4)C3)=C
1)NC5=C2C=CC=C5 
Auto summary for input structure      1: 
 Total number of structures processed =        1000 
 Conformations with poor convergence marked with a * 
 Conformation       1 ( 384.0497     kJ/mol) was found     8 times 
 Conformation       2 ( 385.7525     kJ/mol) was found     4 times 
 Conformation       3 ( 385.9331     kJ/mol) was found     7 times 
 Conformation       4 ( 386.9464     kJ/mol) was found     7 times 
 Conformation       5 ( 387.1773     kJ/mol) was found     5 times 
 Conformation       6 ( 387.3549     kJ/mol) was found     6 times 
 Conformation       7 ( 387.6554     kJ/mol) was found     4 times 
 Conformation       8 ( 387.6832     kJ/mol) was found     5 times 
 Conformation       9 ( 387.9191     kJ/mol) was found     1 times 
 Conformation      10 ( 388.1345     kJ/mol) was found     2 times 
 Conformation      11 ( 388.1875     kJ/mol) was found     4 times 
 Conformation      12 ( 388.5331     kJ/mol) was found     6 times 
 Conformation      13 ( 388.5791     kJ/mol) was found     4 times 
 Conformation      14 ( 388.6996     kJ/mol) was found     3 times 
 Conformation      15 ( 388.7537     kJ/mol) was found     4 times 
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(5S,6S,6aS,11bS)-6-butyl-2-(4-methoxybenzyl)-2,3,5,6,6a,7-hexahydro-
1H-pyrrolo[3,4-d]carbazol-5-ol 
Figure 67 alcohol alpha 5,6 
 
To as solution of (6S,6aS,11bS)-6-butyl-2-(4-methoxybenzyl)-
2,3,6a,7-tetrahydro-1H-pyrrolo[3,4-d]carbazol-5(6H)-one (1.2 g, 2.98 mmol, 
1 eq.) in methanol (60 ml) at 0°C was added cerium trichloride heptahydrate 
(2.2 g, 5.96 mmol, 2 eq.) and the mixture was stirred for 30 minutes. Then 
sodium borohydride (135 mg, 3.57 mmol, 1.2 eq.) was added portion wise on 
15 minutes. The mixture was stirred for an additional 5 minutes then 
quenched a 25% aqueous solution of ammonia and left under stirring for 3 
hours at room temperature. The mixture was extracted with 
dichloromethane, the organic phases were combined and dried over sodium 
sulfate. The volatiles were removed in vacuo to afford a yellow-brown oil. 
The resulting residue was purified by column chromatography18 using flash 
silica gel, pentane and diethyl ether to afford the desired product as an off-
white solid; 0.6 g (50%19).  
 
CAS: / 
Formula: C26H32N2O2 
Molecular weight: 
404.55 g/mol 
                                                          
18 Tip: the Δ RF is sufficient to separate both alcohols from each other. 
19 Tip: 1-gram scale appears to be the worse in term of facial selectivity and decrease 
the yield in the target product. (1 g = 6/4 when 0.1 g = 8/2). 
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MP: 49-52°C 
 
1H NMR (400 MHz, CDCl3) δ 7.34 (dd, J = 7.4, 0.8 Hz, 1H, H23), 7.25 (d, J = 
8.6 Hz, 2H, H4), 7.04 (td, J = 7.6, 1.2 Hz, 1H, H21), 6.89 – 6.80 (m, 2H, H3), 
6.72 (td, J = 7.4, 0.9 Hz, 1H, H22), 6.59 (d, J = 7.7 Hz, 1H, H20), 5.61 (dt, J = 
1.8, 1.6 Hz, 1H, H9), 4.26 – 4.23 (m, 1H, H10), 3.89 (dt, J = 14.2, 2.1 Hz, 1H, 
H7), 3.79 (s, 3H, H1), 3.76 (d, J = 13.5 Hz, 1H, H6), 3.58 (d, J = 13.0 Hz, 1H, 
H6’), 3.56 (d, J = 6.9 Hz, 1H, H17), 3.09 (d, J = 12.6 Hz, 1H, H7’), 3.06 (d, J = 
7.8 Hz, 1H, H26), 2.48 (d, J = 8.0 Hz, 1H, H26’), 1.72 – 1.64 (m, 1H, H12), 
1.64 – 1.52 (m, 1H, H13), 1.47 – 1.20 (m, 5H, H13’+ H14 + H15), 0.90 (t, J = 
7.0 Hz, 3H, H16). 
 
13C NMR (100 MHz, CDCl3) δ 158.67 (C2), 149.12 (C19), 142.03 (C8), 135.08 
(C24), 131.41 (C5), 129.64 (C4), 127.88 (C21), 124.88 (C23), 121.86 (C9), 
118.68 (C22), 113.77 (C3), 109.35 (C20), 66.69 (C26), 66.13 (C10), 62.25 
(C17), 59.35 (C6), 56.30 (C7), 55.36 (C1), 55.19 (C25), 44.37 (C12), 29.65 
(C14), 26.60 (C13), 23.23 (C15), 14.19 (C16). 
 
IR (film, cm-1): 3387 (O-H stretching + N-H stretching), 2953 (C-H 
stretching), 2928 (C-H stretching), 1603 (C=C aromatic stretching), 1510 
(C=C aromatic stretching), 1481 (C=C aromatic stretching), 1462 (CH2 
scissoring), 1242 (C-N stretching), 1029 (C-O stretching), 908, 820 (C-H 
bending out of plan of para disubstituted aromatic ring, 730 (C-H bending 
out of plan of ortho disubstituted aromatic ring). 
 
HRMS m/z calculated for C26H33N2O2 [M+H]+: 405.2542. Found: 405.2533. 
HRMS m/z calculated for C26H32N2O223Na1 [M+Na]+: 427.2361. Found: 
427.2354. 
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Final report; processing .tmp file: 
  226 unique conformations found so far 
  226 minimized with good convergence 
Found    22 confs within  1.00 kcal/mol ( 4.18 kJ/mol) of glob. min. 
Found    58 confs within  2.00 kcal/mol ( 8.37 kJ/mol) of glob. min. 
Found   103 confs within  3.00 kcal/mol (12.55 kJ/mol) of glob. min. 
Found   226 confs within  5.00 kcal/mol (20.92 kJ/mol) of glob. min. 
Global minimum E =    383.02 found     5 times. 
 1000 steps performed so far, out of  1000 
 E of low-energy structures above global min [kJ/mol],  and no. times 
found: 
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    E:  0.00  0.49  0.54  0.72  1.42  1.55  1.56  1.58  1.60  1.61  2.55  2.63 
  No.:     5     6     5     3     4     5     6     5    10     2    10     7 
  
Input structure with title on the next line is given SerNo:        1 
O=C1[C@@H](CCCC)[C@@H]([C@@]23C(CN(CC4=CC=C(OC)C=C4)C3)=C
1)NC5=C2C=CC=C5 
Auto summary for input structure      1: 
 Total number of structures processed =        1000 
 Conformations with poor convergence marked with a * 
 Conformation       1 ( 383.0155     kJ/mol) was found     5 times 
 Conformation       2 ( 383.5075     kJ/mol) was found     6 times 
 Conformation       3 ( 383.5546     kJ/mol) was found     5 times 
 Conformation       4 ( 383.7386     kJ/mol) was found     3 times 
 Conformation       5 ( 384.4391     kJ/mol) was found     4 times 
 Conformation       6 ( 384.5617     kJ/mol) was found     5 times 
 Conformation       7 ( 384.5798     kJ/mol) was found     6 times 
 Conformation       8 ( 384.5994     kJ/mol) was found     5 times 
 Conformation       9 ( 384.6167     kJ/mol) was found    10 times 
 Conformation      10 ( 384.6298     kJ/mol) was found     2 times 
 Conformation      11 ( 385.5630     kJ/mol) was found    10 times 
 Conformation      12 ( 385.6447     kJ/mol) was found     7 times 
 Conformation      13 ( 385.7111     kJ/mol) was found     7 times 
 Conformation      14 ( 385.9957     kJ/mol) was found     5 times 
 Conformation      15 ( 386.1260     kJ/mol) was found     2 times 
 
  
Chapter X 
 
343 
 
(3aS,5R,6S,6aS,11bS)-6-butyl-2,3,3a,4,5,6,6a,7-octahydro-1H-pyrrolo[3,4-
d]carbazol-5-ol 
Figure 68 red PMB alcohol 
 
To a solution of (6S,6aS,11bS)-6-butyl-2-(4-methoxybenzyl)-2,3,6a,7-
tetrahydro-1H-pyrrolo[3,4-d]carbazol-5(6H)-one (0.5 g, 1.23 mmol, 1 eq.) in 
methanol (15 ml) at room temperature was added Pd(OH)2 supported on 
carbon (0.05 g, 10% w.). The solvent and atmosphere were saturated with H2 
and the mixture was stirred under hydrogen pressure for 4 days. The mixture 
was filtered through a pad of celite and eluted with methanol then the 
volatiles were removed in vacuo. The resulting residue was purified by 
column chromatography using flash silica gel, dichloromethane and 
methanol to afford an off-white solid; 0.19 g (55%).  
 
 
CAS: / 
Formula: C18H26N2O 
Molecular weight: 286.42 g/mol 
MP: 54-56°C          Litt: / 
 
1H NMR (400 MHz, CDCl3) δ 7.12 (d, J = 7.4 Hz, 1H, H18), 7.06 (td, J = 7.6, 
1.2 Hz, 1H, H16), 6.82 (td, J = 7.5, 0.9 Hz, 1H, H17), 6.68 (d, J = 7.6 Hz, 1H, 
H15), 4.03 (bs, 1H, H13), 3.86 (dd, J = 7.9, 5.0 Hz, 1H, H5), 3.68 (d, J = 4.2 
Hz, 1H, H12), 3.36 (dd, J = 11.0, 6.9 Hz, 1H, H2), 3.24 (d, J = 11.4 Hz, 1H, 
H21), 3.15 (d, J = 11.4 Hz, 1H, H21), 2.85 (dd, J = 11.0, 2.9 Hz, 1H, H2), 2.37 
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(dtd, J = 9.4, 6.5, 2.9 Hz, 1H, H3), 1.96 – 1.86 (m, 1H, H7), 1.79 – 1.64 (m, 
2H, H4), 1.53 – 1.28 (m, 6H, H8 + H9 + H10), 0.91 (t, J = 7.0 Hz, 3H, H11). 
 
13C NMR (100 MHz, CDCl3) δ 148.52 (C14), 135.75 (C19), 127.32 (C16), 
121.83 (C18), 119.31 (C17), 109.90 (C15), 67.67 (C5), 65.56 (C12), 56.88 
(C21), 53.40 (C20), 51.04 (C2), 43.67 (C7), 38.64 (C3), 31.86 (C4), 29.83 
(C8), 28.98 (C9), 22.80 (C10), 13.82 (C11). 
 
IR (cm-1): 3322 (O-H Stretching + N-H stretching), 2953 (C-H stretching), 
2926 (C-H stretching), 2869 (C-H stretching), 1606 (C=C aromatic 
stretching), 1481 (C=C aromatic stretching), 1462 (CH2 scissoring), 1263 (C-
N stretching), 907,  748 (C-H bending out of plan of ortho di-substituted 
aromatic ring), 728 (C-H bending out of plan of ortho di-substituted 
aromatic ring). 
 
HRMS m/z calculated for C18H27N2O1 [M+H]+: 287.2123. Found: 287.2111. 
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(4aR,6S,7R,7aS,12bS)-7-butyl-2-(4-methoxybenzyl)-1,2,3,4,4a,5,6,7,7a,8-
decahydropyrido[4,3-d]carbazol-6-ol 
Figure 69: alcohol LT 6,6 
 
To a solution of (4aR,7R,7aS,12bS)-7-butyl-2-(4-methoxybenzyl)-
1,2,3,4,4a,5,7a,8-octahydropyrido[4,3-d]carbazol-6(7H)- (1 g, 2.39 mmol, 1 
eq.) in dichloromethane (30 ml) at -78°C was added dropwise a solution of 
DiBAL-H in toluene (6 ml, 5.97 mmol, 2.5 eq.). After 20 minutes at -78°C, the 
reaction was quenched with a saturated aqueous potassium sodium tartrate 
then allowed to reach room temperature and stirred for 2 additional hours. 
The mixture was extracted two time with dichloromethane, the organic 
phases were combined and dried over sodium sulfate. The volatiles were 
removed in vacuo to afford a yellow oil. The resulting residue was purified by 
column chromatography using flash silica gel, pentane and diethyl ether to 
afford the desired product as an off-white solid; 9.3 g (93%).  
 
 
CAS: / 
Formula: 
C27H36N2O2 
Molecular weight: 
420.59 g/mol 
MP: 54-55°C      Litt: / 
 
1H NMR (400 MHz, CDCl3) δ 8.02 (dd, J = 7.6, 0.8 Hz, 1H, H24), 7.23 – 7.17 
(m, 2H, H4), 7.09 (td, J = 7.6, 1.3 Hz, 1H, H22), 6.82 – 6.80 (m, 2H, H3), 6.81 
(td, J = 7.4, 1.0 Hz, 1H, H23), 6.61 (dd, J = 7.8, 0.6 Hz, 1H, H21), 4.06 – 3.90 
(m, 2H, H11 + H19), 3.78 (s, 3H, H1), 3.51 – 3.47 (m, 1H, H18), 3.45 (d, J = 
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13.2 Hz, 1H, H6), 3.38 (d, J = 13.0 Hz, 1H, H6’), 3.20 (d, J = 11.0 Hz, 1H, H12), 
3.08 (dt, J = 10.8, 1.7 Hz, 1H, H7), 2.86 (d, J = 10.2 Hz, 1H, H27), 2.11 – 2.01 
(m, 2H, H7’ + H10’), 1.99 (d, J = 10.2 Hz, 1H, H27’), 1.88 (dd, J = 12.5, 4.1 
Hz, 1H, H8), 1.81 – 1.71 (m, 1H, H14), 1.71 – 1.60 (m, 1H, H13), 1.55 – 1.26 
(m, 7H, H8’ + H9 + H14’ + H15 + H16), 1.04 – 0.88 (m, 4H, H17 + H10). 
 
13C NMR (100 MHz, CDCl3) δ 158.65 (C2), 149.79 (C20), 132.86 (C25), 
131.12 (C5), 130.22 (C24), 130.10 (C4), 128.09 (C22), 119.04 (C23), 113.66 
(C3), 110.10 (C21), 69.27 (C11), 66.07 (C18), 65.76 (C27), 62.60 (C6), 55.35 
(C1), 54.26 (C7), 49.47 (C26), 39.12 (C9), 38.74 (C13), 37.44 (C10), 29.62 
(C15), 28.93 (C14), 26.79 (C8), 23.23 (C16), 14.28 (C17). 
 
IR (film, cm-1): 3347 (O-H stretching + N-H stretching), 2928 (C-H 
stretching), 2858 (C-H stretching), 1609 (C=C aromatic stretching), 1587 
(C=C aromatic stretching), 1510 (C=C aromatic stretching), 1483 (C=C 
aromatic stretching), 1463 (CH2 scissoring), 1243 (C-N stretching), 1033 (C-
O stretching), 827 (C-H bending out of plan of para disubstituted aromatic 
ring, 747 (C-H bending out of plan of ortho disubstituted aromatic ring). 
 
HRMS m/z calculated for C27H37N2O2 [M+H]+: 421.2855. Found: 421.2853 
HRMS m/z calculated for C27H36N2O223Na1 [M+Na]+: 443.2674. Found: 
443.2657. 
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Final report; processing .tmp file: 
  103 unique conformations found so far 
  103 minimized with good convergence 
Found    19 confs within  1.00 kcal/mol ( 4.18 kJ/mol) of glob. min. 
Found    45 confs within  2.00 kcal/mol ( 8.37 kJ/mol) of glob. min. 
Found    57 confs within  3.00 kcal/mol (12.55 kJ/mol) of glob. min. 
Found   102 confs within  5.00 kcal/mol (20.92 kJ/mol) of glob. min. 
Found   103 confs within 10.00 kcal/mol (41.84 kJ/mol) of glob. min. 
Global minimum E =    397.51 found     7 times. 
 1000 steps performed so far, out of  1000 
 E of low-energy structures above global min [kJ/mol],  and no. times 
found: 
    E:  0.00  0.14  0.31  0.46  1.46  1.61  2.12  2.23  2.25  2.61  2.89  3.02 
  No.:     7     9     9    17     7    11    11    11    12    11     8    11 
  
Input structure with title on the next line is given SerNo:        1 
O=C1[C@@H](CCCC)[C@@H]([C@@]23C(CN(CC4=CC=C(OC)C=C4)C3)=C
1)NC5=C2C=CC=C5 
Auto summary for input structure      1: 
 Total number of structures processed =        1000 
 Conformations with poor convergence marked with a * 
 Conformation       1 (    397.5088     kJ/mol) was found     7 times 
 Conformation       2 (    397.6481     kJ/mol) was found     9 times 
 Conformation       3 (    397.8218     kJ/mol) was found     9 times 
 Conformation       4 (    397.9730     kJ/mol) was found    17 times 
 Conformation       5 (    398.9704     kJ/mol) was found     7 times 
 Conformation       6 (    399.1152     kJ/mol) was found    11 times 
 Conformation       7 (    399.6242     kJ/mol) was found    11 times 
 Conformation       8 (    399.7419     kJ/mol) was found    11 times 
 Conformation       9 (    399.7550     kJ/mol) was found    12 times 
 Conformation      10 (    400.1194     kJ/mol) was found    11 times 
 Conformation      11 (    400.3948     kJ/mol) was found     8 times 
 Conformation      12 (    400.5244     kJ/mol) was found    11 times 
 Conformation      13 (    400.6304     kJ/mol) was found    12 times 
 Conformation      14 (    400.7063     kJ/mol) was found     8 times 
 Conformation      15 (    400.8584     kJ/mol) was found     9 times 
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(4aR,7R,7aS,12bS)-7-butyl-1,2,3,4,4a,5,7a,8-octahydropyrido[4,3-
d]carbazol-6(7H)-one 
Figure 70: LT 6,6 sans PMB 
 
To a solution of (4aR,7R,7aS,12bS)-7-butyl-2-(4-methoxybenzyl)-
1,2,3,4,4a,5,7a,8-octahydropyrido[4,3-d]carbazol-6(7H)-one (660 mg, 1.57 
mmol, 1 eq.) in methanol (15 ml) and tetrahydrofuran (5 ml) at room 
temperature was added palladium hydroxide 20 % supported on carbon (66 
mg) and the mixture was flushed with hydrogen and stirred under 4 
atmosphere of hydrogen for 8 days. The mixture was filtered through a pad 
of celite and eluted with solution tetrahydrofuran/methanol (1-1). The 
volatiles were removed in vacuo and the residue was purified by column 
chromatography using flash silica gel, dichloromethane and methanol to 
afford an off-white solid; 0.21 g (45%20) 
 
CAS: / 
Formula: C19H26N2O1 
Molecular weight: 298.43 g/mol 
MP: 133-134°C         Litt: / 
 
1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 7.1 Hz, 1H, H19), 7.03 (td, J = 7.7, 
1.2 Hz, 1H, H17), 6.65 (td, J = 7.5, 1.0 Hz, 1H, H18), 6.50 (d, J = 7.4 Hz, 1H, 
H16), 3.88 (s, 1H, H14), 3.82 (dd, J = 5.3, 1.2 Hz, 1H, H13), 3.35 (dd, J = 12.8, 
                                                          
20 Almost half of starting material left after 8 days, not the best process. 
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4.2 Hz, 1H, H2), 3.16 (d, J = 12.1 Hz, 1H, H22), 2.86 (td, J = 12.7, 3.4 Hz, 1H, 
H2), 2.79 (d, J = 12.1 Hz, 1H, H22), 2.66 (dd, J = 11.9, 6.1 Hz, 1H, H8), 2.53 
– 2.41 (m, 1H, H4), 2.22 (dd, J = 18.6, 4.6 Hz, 1H, H5), 2.01 – 1.90 (m, 2H, 
H3 + H5’), 1.90 – 1.81 (m, 1H, H9), 1.60 (d, J = 12.6 Hz, 1H, H3’), 1.45 – 1.23 
(m, 5H, H9 + H10 + H11), 0.93 (t, J = 7.1 Hz, 3H, H12). 
 
13C NMR (100 MHz, CDCl3) δ 211.36 (C6), 150.51 (C15), 129.86 (C20), 
128.62 (C17), 127.25 (C19), 117.89 (C18), 109.05 (C16), 65.37 (C13), 58.35 
(C22), 50.42 (C8), 49.24 (C21), 46.26 (C2), 43.63 (C5), 37.62 (C4), 29.58 
(C10), 27.86 (C3), 24.48 (C9), 23.02 (C11), 14.11 (C12). 
 
IR (film, cm-1): 3367 (N-H stretching), 2929 (C-H stretching), 2859 (C-H 
stretching), 1706 (C=O stretching of saturated cyclic 6-membered ring 
ketone), 1604 (C=C aromatic stretching), 1588 (C=C aromatic stretching), 
1483 (CH2 scissoring), 1466 (CH3 asymmetric deformation), 1314 (C-N 
stretching), 1252 (C-N stretching), 909, 724 (C-H bending out of plan of 
ortho di-substituted aromatic ring).  
 
HRMS m/z calculated for C19H27N2O1 [M+H]+: 299.2123. Found: 299.2119. 
HRMS m/z calculated for C19H26N2O123Na1 [M+Na]+: 321.1942. Found: 
321.1935. 
 
